
<html lang="en"     class="pb-page"  data-request-id="16b9006b-aede-4f32-8721-8db5815e4e3c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00358;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2018.61.issue-18;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases" /></meta><meta name="dc.Creator" content="Jakob&#xA;S.  Pallesen" /></meta><meta name="dc.Creator" content="Kim T.  Tran" /></meta><meta name="dc.Creator" content="Anders  Bach" /></meta><meta name="dc.Description" content="The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) ..." /></meta><meta name="Description" content="The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 11, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00358" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00358" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00358" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00358" /></link>
        
    
    

<title>Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00358" /></meta><meta property="og:title" content="Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0008.jpeg" /></meta><meta property="og:description" content="The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases. Inhibition of the protein–protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-associated protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes. To date, several non-covalent small-molecule Keap1–Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability. This Perspective describes current small-molecule Keap1–Nrf2 inhibitors with experimental evidence for the ability to inhibit the Keap1–Nrf2 interaction by binding to Keap1 in a non-covalent manner. Binding data, biostructural studies, and biological activity are summarized for the inhibitors, and their potential as CNS tool compounds is discussed by analyzing physicochemical properties, including CNS multiparameter optimization (MPO) scoring algorithms. Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00358"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00358">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00358&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00358&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00358&amp;href=/doi/10.1021/acs.jmedchem.8b00358" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8088-8103</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00370" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b00589" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jakob S. Pallesen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jakob S. Pallesen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jakob%0AS.++Pallesen">Jakob S. Pallesen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kim T. Tran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kim T. Tran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kim+T.++Tran">Kim T. Tran</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Anders Bach</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anders Bach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +4521288604. E-mail: <a href="/cdn-cgi/l/email-protection#a1c0cfc5c4d3d28fc3c0c2c9e1d2d4cfc58fcad48fc5ca"><span class="__cf_email__" data-cfemail="16777872736465387477757e5665637872387d6338727d">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anders++Bach">Anders Bach</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4305-9910" title="Orcid link">http://orcid.org/0000-0003-4305-9910</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00358&amp;href=/doi/10.1021%2Facs.jmedchem.8b00358" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8088–8103</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 11, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 March 2018</li><li><span class="item_label"><b>Published</b> online</span>11 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 September 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00358" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00358</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8088%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJakob%250AS.%2BPallesen%252C%2BKim%2BT.%2BTran%252C%2BAnders%2BBach%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D18%26contentID%3Dacs.jmedchem.8b00358%26title%3DNon-covalent%2BSmall-Molecule%2BKelch-like%2BECH-Associated%2BProtein%2B1%25E2%2580%2593Nuclear%2BFactor%2BErythroid%2B2-Related%2BFactor%2B2%2B%2528Keap1%25E2%2580%2593Nrf2%2529%2BInhibitors%2Band%2BTheir%2BPotential%2Bfor%2BTargeting%2BCentral%2BNervous%2BSystem%2BDiseases%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8103%26publicationDate%3DSeptember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00358"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3394</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">37</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00358" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jakob\nS.&quot;,&quot;last_name&quot;:&quot;Pallesen&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;T. Tran&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;Bach&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;8088-8103&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00358&quot;},&quot;abstract&quot;:&quot;The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases. Inhibition of the protein–protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-associated protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes. To date, several non-covalent small-molecule Keap1–Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability. This Perspective describes current small-molecule Keap1–Nrf2 inhibitors with experimental evidence for the ability to inhibit the Keap1–Nrf2 interaction by binding to Keap1 in a non-covalent manner. Binding data, biostructural studies, and biological activity are summarized for the inhibitors, and their potential as CNS tool compounds is discuss&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00358&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00358" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00358&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00358" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00358&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00358" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00358&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00358&amp;href=/doi/10.1021/acs.jmedchem.8b00358" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00358" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00358" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (13 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00358%26sid%3Dliteratum%253Aachs%26pmid%3D29750408%26genre%3Darticle%26aulast%3DPallesen%26date%3D2018%26atitle%3DNon-covalent%2BSmall-Molecule%2BKelch-like%2BECH-Associated%2BProtein%2B1%25E2%2580%2593Nuclear%2BFactor%2BErythroid%2B2-Related%2BFactor%2B2%2B%2528Keap1%25E2%2580%2593Nrf2%2529%2BInhibitors%2Band%2BTheir%2BPotential%2Bfor%2BTargeting%2BCentral%2BNervous%2BSystem%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D18%26spage%3D8088%26epage%3D8103%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291012" title="Organic acids">Organic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/jmcmar.2018.61.issue-18/20180927/jmcmar.2018.61.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases. Inhibition of the protein–protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-associated protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes. To date, several non-covalent small-molecule Keap1–Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability. This Perspective describes current small-molecule Keap1–Nrf2 inhibitors with experimental evidence for the ability to inhibit the Keap1–Nrf2 interaction by binding to Keap1 in a non-covalent manner. Binding data, biostructural studies, and biological activity are summarized for the inhibitors, and their potential as CNS tool compounds is discussed by analyzing physicochemical properties, including CNS multiparameter optimization (MPO) scoring algorithms. Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50472" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50472" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Oxygen, O<sub>2</sub>, is essential for cellular energy metabolism and living systems, but as a side effect of these metabolic processes, reactive oxygen species (ROS) are produced. Also, ROS play a major role in cancers, inflammatory diseases, and neurodegenerative diseases.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> The damaging effect of ROS is attenuated by the antioxidant defense system, consisting of detoxification and antioxidant enzymes such as superoxide dismutase (SOD), catalase, GPx, thioredoxin, HO-1, ferritin, glutathione reductase, NAD(P)H dehydrogenase (quinone) 1 (NQO1), and glutathione S-transferase (GST).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> The antioxidant enzymes are regulated through the antioxidant response element (ARE), and nuclear factor erythroid 2-related factor 2 (Nrf2) is one of the major ARE-binding transcription factors.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Studies have confirmed the protective effect of Nrf2 against oxidative stress, which makes upregulation of Nrf2 activity an interesting therapeutic strategy especially against inflammation and central nervous system (CNS) diseases.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> Under unstressed conditions, the cellular concentration of Nrf2 remains low because it is negatively regulated by the substrate adaptor protein Kelch-like ECH-associated protein 1 (Keap1), which binds to Nrf2 in the cytosol and targets it for ubiquitination and proteasomal degradation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Upon oxidative stress, Keap1 acts as a redox sensor and regulator, as the reactive oxidants modify the sulfhydryl groups on specific Keap1 cysteine residues (i.e., Cys151, Cys257, Cys273, Cys288, and Cys297).<a onclick="showRef(event, 'ref8 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref10 ref11">(8,10,11)</a> This results in a conformational change in Keap1 that perturbs the Keap1–Nrf2 protein–protein interaction (PPI) and prevents ubiquitination. As a result thereof, Nrf2 accumulates and translocates into the nucleus, where it forms a transcription factor complex that binds to the ARE promoter region and induces gene expression of antioxidant enzymes.<a onclick="showRef(event, 'ref8 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref12">(8,12)</a> Thus, inhibition of the PPI between Keap1 and Nrf2 has been suggested as a potential strategy for therapeutic agents as a means to further boost the antioxidant response against oxidative stress.</div><div class="NLM_p">Nrf2 modulators can be divided into two categories: covalent Keap1 modifiers and non-covalent (peptide or small-molecule) Keap1–Nrf2 PPI inhibitors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Dimethyl fumarate (DMF, Tecfidera) is a covalent Keap1 modifier and an approved drug for multiple sclerosis. During absorption, DMF is converted to monomethyl fumarate (MMF), which covalently reacts with Cys151 of Keap1 and results in Nrf2-mediated gene transactivation in brain neurons and glial cells.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Bardoxolone (CDDO) is another example of a potent inducer of the Nrf2 pathway that also covalently, yet reversibly, reacts with Cys151 of Keap1.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a> The methyl ester of bardoxolone (CDDO-Me) failed a phase 3 clinical trial for the treatment of kidney disease in diabetic patients because it increased the risk of heart failure;<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> however, CDDO-Me is still being investigated in clinical trials of kidney and pulmonary hypertension disorders.</div><div class="NLM_p">In general, it can be difficult to control the reactivity of covalent modifiers, and it is a general concern that such compounds bind unspecifically and thus lead to side effects and reduced modulation of the intended target. Thus, non-covalent inhibitors might provide a more attractive strategy.<a onclick="showRef(event, 'ref4 ref8 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref4 ref8 ref20 ref21">(4,8,20,21)</a> To date, several peptide-based Keap1–Nrf2 inhibitors have been designed and serve as useful research tool compounds,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> but low bioavailability and cell permeability limit their use. To overcome the lack of cell permeability, a Tat peptide and a calpain (Cal) cleavage sequence were fused to the Nrf2-derived peptide LDEETGELFLP, resulting in the peptide inhibitor Tat-Cal-DEETGE, which demonstrates Nrf2 activation and antioxidant gene induction in brain-injured mice.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Nrf2 has been shown to play an important role in CNS diseases. Activation of Nrf2 is found to protect neurons against ischemic and hemorrhagic stroke, traumatic brain injury, and neurodegenerative disorders in animals.<a onclick="showRef(event, 'ref8 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref8 ref25 ref26 ref27">(8,25−27)</a> These data have been elucidated by genetic knockout studies and inhibition of Keap1–Nrf2 by either covalent modifiers or peptides.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> For example, the covalent modifier acetyl-11-keto-β-boswellic acid reduced infarct volume by 34% when administrated at reperfusion after 2 h of middle cerebral artery occlusion in rats.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Also, Tat-Cal-DEETGE reduced traumatic brain injury-associated disruption of the blood–brain barrier (BBB) after intracerebroventricular injection 2 h before injury and when administered directly into the cortex 10 min after injury.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Additionally, this peptide reduced oxidative stress and neuronal cell death in the hippocampus in a global cerebral ischemia rat model.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Small-molecule Keap1–Nrf2 PPI inhibitors that enter the brain after peripheral administration have not yet been identified but would be an ideal tool to further investigate the potential of Keap1–Nrf2 inhibition as a drug discovery strategy for modulating CNS diseases.</div><div class="NLM_p last">The focus of this Perspective is non-covalent small-molecule Keap1–Nrf2 inhibitors and their potential for targeting CNS diseases. We have included those compounds where experimental evidence for their ability to inhibit the Keap1–Nrf2 interaction by binding to Keap1 in a non-covalent manner has been presented in the literature or patent applications. Binding data, biostructural studies, biological activity, and physicochemical properties will be discussed to elucidate the potential of the published small-molecule inhibitors as tool compounds or lead molecules for studying the Keap1–Nrf2 system in relation to CNS diseases. The CNS multiparameter optimization (CNS MPO) desirability tool combined with a second version (CNS MPO.v2) will guide this discussion,<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30−33)</a> and various strategies for targeting Keap1 for CNS diseases with small molecules will be described. Also, structural similarity to pan-assay interference compounds (PAINS)<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> or molecular properties indicating toxicity or reactivity issues will be analyzed and discussed using the FAF-Drugs4 filtering tool.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Molecular Mechanisms of Keap1–Nrf2 Inhibition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nrf2 consists of six domains, designated Nrf2–ECH homology (Neh) 1–6, of which the N-terminally located Neh2 domain constitutes a negative regulatory domain, as it is responsible for binding to Keap1.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Keap1 consists of three functional domains: (1) A broad complex, tramtrack, and bric-à-brac (BTB) domain, (2) an intervening region (IVR), and (3) a Kelch domain, also known as the double glycine repeat (DGR) or DC domain (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular mechanisms of the Keap1–Nrf2–ARE pathway and the hypothesized effect of reversible non-covalent inhibitors targeting Keap1 and thus the Keap1–Nrf2 PPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Under basal conditions, Keap1 self-associates to form a homodimer via its BTB domain, which also constitutes the adaptor site for the assembly of cullin 3 (Cul3), RING-box protein 1 (Rbx1), and ubiquitin-charged E2 enzyme to form the fully functional cullin–RING ligase 3 (CRL3) complex that ubiquitinates Nrf2 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> It is well-established that Keap1 associates with Nrf2 in a two-site molecular recognition fashion: via its two Kelch domains, the Keap1 homodimer interacts with the Neh2 domain of a single Nrf2 protein at two evolutionary conserved binding motifs within Neh2, called ETGE and DLG from the amino acids they contain.<a onclick="showRef(event, 'ref9 ref37 ref39'); return false;" href="javascript:void(0);" class="ref ref9 ref37 ref39">(9,37,39)</a> Although ETGE binds the Kelch domain significantly more strongly than does DLG (<i>K</i><sub>d</sub> = 19 nM vs 1 μM, respectively), both motifs have been shown to be indispensable for the Keap1-dependent repression of Nrf2. Thus, it is proposed that the two-site binding of Neh2 provides a fine-tuned spatial orientation of the lysine-rich α-helix flanked by the ETGE and DLG motifs that facilitates CRL3-mediated polyubiquitination.<a onclick="showRef(event, 'ref37 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref39 ref40">(37,39,40)</a></div><div class="NLM_p">In particular, three models have been proposed for the molecular events initiated in the induced state (i.e., the presence of oxidants or electrophiles) that eventually lead to Nrf2 stabilization (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The “hinge-and-latch model” proposes that covalent modification of cysteine residues within the Keap1 IVR domain (especially Cys273 and Cys288) perturbs the oligomeric complex conformation in such a way that the low-affinity DLG motif dissociates from the Keap1 Kelch domain, thus disrupting the fixed arrangement of Nrf2 needed for ubiquitination.<a onclick="showRef(event, 'ref8 ref37'); return false;" href="javascript:void(0);" class="ref ref8 ref37">(8,37)</a> The model is weakened by the lack of empirical evidence for DLG dissociation under oxidative assault and by observations that inducers (exemplified by two well-known chemopreventive Nrf2 activators, 5,6-dihydrocyclopenta[<i>c</i>]-1,2-dithiole-3(4<i>H</i>)-thione (CPDT) and sulforaphane) have in fact been shown to increase the association between Nrf2 and Keap1 in human and rat bladder cancer cell lines.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a></div><div class="NLM_p">The “Cul3-dissociation model” proposes that the ability of Keap1 to assemble into a fully functional CRL3 complex is crucial for regulation of Nrf2 levels in response to inducers; here, covalent modification of cysteine residues in the BTB domain (especially Cys151) has been shown to decrease the association between Keap1 and Cul3 and thus encumber ubiquitination.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The model is undermined by recent conflicting experimental results showing that Cul3–Keap1 dissociation is not required for immediate Nrf2 stabilization.<a onclick="showRef(event, 'ref12 ref42'); return false;" href="javascript:void(0);" class="ref ref12 ref42">(12,42)</a></div><div class="NLM_p">The employment of Förster resonance energy transfer (FRET)-based methods has provided new insights into the dynamic nature of Keap1–Nrf2 complexation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Under basal conditions, the Keap1–Nrf2 complex appears to alternate in a cyclic fashion between an “open state”, in which Keap1 interacts with only the ETGE motif, and a “closed state”, in which the Keap1 homodimer interacts with both Neh2 motifs. Only the closed state allows polyubiquitination to take place, and the presence of the open state has been suggested to allow further regulatory modes to exist. The “conformation cycling model” proposes that cysteine modifications on Keap1 produce a dysfunctional closed state of the Keap1–Nrf2 complex in which both Neh2 domains are still bound to Keap1 but ubiquitination cannot take place (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref12 ref41'); return false;" href="javascript:void(0);" class="ref ref12 ref41">(12,41)</a></div><div class="NLM_p">Although distinctive, all three models agree that Nrf2 does not dissociate (fully) from Keap1 in the induced state and that increased Nrf2 levels are due to trapping of Keap1 in some kind of unproductive state combined with de novo synthesis of Nrf2. As it is believed that the Keap1–Nrf2 system operates close to saturation, even a slight decrease in functional Keap1 would allow Nrf2 to accumulate.<a onclick="showRef(event, 'ref12 ref41'); return false;" href="javascript:void(0);" class="ref ref12 ref41">(12,41)</a></div><div class="NLM_p last">The precise mechanism(s) of a non-covalent inhibitor of the Keap1–Nrf2 PPI has to our knowledge not yet been elucidated. On the basis of the three models following cysteine modifications on Keap1, we hypothesize that in the context of oxidative stress, such an inhibitor could (1) affect a subpopulation of Keap1–Nrf2 complexes that have not entered the induced state, e.g., by binding to free Keap1 or the open-state complex, in either case hampering the formation of the closed state and reducing the constitutive Nrf2 degradation, or (2) aid in liberating Nrf2 from the induced-state complex, thus directly increasing Nrf2 levels (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). It is unknown whether such an inhibitor would disrupt the Keap1–Nrf2 ETGE interaction or the Keap1–Nrf2 DLG interaction, or both; however, on the basis of the above models, breaking the weaker interaction to DLG would be sufficient to inhibit Nrf2 repression.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  The Keap1–Nrf2 PPI Interface</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PPIs are generally considered difficult or even “undruggable” as drug targets, as the interaction surface can be very large, shallow, and dispersed. However, certain PPI classes have recently been shown to be suitable for small-molecule disruption, including more globular protein–peptide interactions such as the Keap1–Nrf2 PPI.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">The binding between Keap1 and Nrf2 is confined to the interactions between the six-bladed β-propeller Keap1 Kelch domain and the two Nrf2 motifs, ETGE and DLG, of the intrinsically disordered peptide Neh2 domain (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, top row).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> X-ray crystallography of truncated Neh2 peptides containing either the ETGE or DLG motif has provided detailed structural information on these interaction surfaces.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a> Although the buried surface area of the Kelch–DLG interface (∼780 Å<sup>2</sup>) is significantly larger than that of the Kelch–ETGE interface (∼550 Å<sup>2</sup>), both are relatively small compared with those of classical PPIs (1000–6000 Å<sup>2</sup>) and are characterized by the Kelch protein partner adopting a concave binding surface similar to small-molecule binding pockets of traditional targets.<a onclick="showRef(event, 'ref44 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref47">(44,47)</a> The binding pocket has classically been subdivided into five interconnected epitopes, designated P1–P5, where P1 and P2 mainly contain polar residues (Arg483, Ser508, Ser363, Arg380, Asn382, and Arg415), P4 and P5 contain mostly nonpolar residues (Tyr525, Gln530, Tyr572, Tyr334, and Phe577), and P3 contains small polar and nonpolar residues (Gly509, Ala556, Gly571, Ser602, Ser555, and Gly603) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, top row).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Recently, a hitherto unexplored P6 subpocket on the Kelch surface induced by an extended DLG-containing peptide (DLGex) was observed.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Although interesting, this subpocket is fairly superficial and disconnected from the other epitopes, which might make it difficult to target with small molecules. Overall, the Kelch binding pocket is quite polar and basic because of the presence of multiple charged arginine residues (i.e., Arg483, Arg415, and Arg380), which make key salt bridges with carboxylic acid residues in both the ETGE and DLG motifs. Importantly, mutation studies, in silico binding analysis, and medicinal chemistry efforts have indicated the crucial importance of occupying P1 and P2, which can thus be considered “hot spots” of the Kelch binding pocket.<a onclick="showRef(event, 'ref46 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref48 ref49">(46,48,49)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Top row: X-ray structures of the Keap1 Kelch domain with truncated Neh2 peptides containing the ETGE (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FLU">2FLU</a>) or DLG (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WN7">3WN7</a>) motif. Rows 2–4: X-ray structures of the Kelch domain in complex with ligands (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for PDB IDs). For compound <b>23</b>, the cocrystallized and soaking forms of the ligand have been superimposed. The Keap1 Kelch domain is shown in the same orientation in all pictures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Taking the size, depth, and polarity of the Keap1 Kelch pocket into account, in silico analysis by SiteMap<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> predicts the pocket to range from difficult to druggable (Dscore = 0.7–1.0 depending on the X-ray structure used). The main challenge appears to lie in the fact that many known ligands rely on interactions of carboxylic acid residues with the arginine hot spot residues to get affinity, which results in polar compounds with low cell permeability and CNS availability. Taking advantage of all of the features of the binding pocket, especially the nonpolar and aromatic residues, is likely key to balancing affinity and pharmacokinetic properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4.  Keap1–Nrf2 PPI Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To date, several non-covalent small-molecule Keap1–Nrf2 inhibitors have been identified, as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Published Non-covalent Small-Molecule Keap1–Nrf2 PPI Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0004.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0005.gif" alt="" id="GRAPHIC-d214e441-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0006.gif" alt="" id="GRAPHIC-d214e442-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">All data were obtained from ChemAxon or calculated as described by Ertl et al.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">CNS MPO algorithm.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">CNS MPO.v2 algorithm.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></p></div></div><div></div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">4.1.  Inhibitors Containing a 1,2,3,4-Tetrahydroisoquinoline Core</h3><div class="NLM_p">Hu et al.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> were the first to report a reversible small-molecule Keap1–Nrf2 inhibitor. Compound <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was identified by high-throughput screening (HTS) of the commercially available MLPCN library using a homogeneous fluorescence polarization (FP) competition assay measuring the interaction between the Keap1 Kelch domain and a fluorescently labeled Nrf2-derived peptide. The initial HTS hit was a mix of four stereoisomers, and the most promising stereoisomer had an IC<sub>50</sub> of 3 μM (FP). After resynthesis and separation of the stereoisomers, <b>1</b>, also known as LH601A, was shown to be at least 100-fold more potent than the other stereoisomers, with a <i>K</i><sub>d</sub> of 1.0 μM in a surface plasmon resonance (SPR) competition assay. Compound <b>1</b> was also active in functional cell assays, where it could induce downstream ARE activation (EC<sub>50</sub> of 18 μM) and promote translocation of Nrf2 in the nuclei of human bone osteosarcoma epithelial cells (EC<sub>50</sub> of 12 μM).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p last">A later X-ray structure of the Keap1 Kelch domain cocrystallized with <b>1</b> revealed that <b>1</b> occupies the polar subpocket P2, the nonpolar subpocket P5, and P3 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This information was used to guide further structure–activity relationship (SAR) studies in which 12 analogues were synthesized and used to demonstrate that the phthalimide, the aryl ring of the tetrahydroisoquinoline, and the cyclohexanecarboxylic acid were all important for the potency of <b>1</b>. However, a few modifications were allowed, as bioisosteric replacement of the carboxylic acid with a tetrazole led to a 3-fold increase in the IC<sub>50</sub> of <b>2</b> relative to <b>1</b> in the FP assay. Interestingly, X-ray structures show that the carboxylic acid of <b>1</b> and the tetrazole of <b>2</b> are both placed in subpocket P2 and interact with Asn414 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Removal of the phthalimide carbonyl of <b>1</b>, as in <b>3</b>, resulted in a 2-fold reduction in the IC<sub>50</sub> relative to <b>1</b>, and further methylation at the 5-position (<b>4</b>) resulted in a similar IC<sub>50</sub> value as for <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">4.2.  Inhibitors Containing a 1,4-Diaminonaphthalene Core</h3><div class="NLM_p">In recent years, Keap1–Nrf2 PPI inhibitors with a 1,4-diaminonaphthalene core have attracted a lot of interest. Compound <b>5</b> was identified by Marcotte et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> using a homogeneous confocal fluorescence anisotropy assay (two-dimensional fluorescence intensity distribution analysis (2D-FIDA)) to screen the Evotec Lead Discovery Library (267 551 compounds). The symmetric compound <b>5</b> showed an IC<sub>50</sub> of 2.7 μM in the 2D-FIDA assay and was able to increase Nrf2-dependent luciferase reporter activity in cell-based assays (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The X-ray structure of the Keap1 Kelch domain cocrystallized with <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) showed that the naphthalene group of <b>5</b> occupied subpocket P3 and the anisole groups occupied the two hydrophobic subpockets P4 and P5.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Crucially, the two important hydrophilic subpockets P1 and P2 were unoccupied.</div><div class="NLM_p">Jiang et al.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> used this information for structure-based optimization and introduced <i>N</i>-acetic acid groups on both sulfonamides of <b>5</b> to furnish compound <b>6</b>. At that time, <b>6</b> was the most potent Keap1–Nrf2 inhibitor, with more than a 200-fold improvement in potency relative to <b>5</b>; the <i>K</i><sub>d</sub> of <b>6</b> was determined to be 3.59 nM in a biolayer interferometry (BLI) assay and its IC<sub>50</sub> to be 28.6 nM by FP (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This improvement in activity indicates interactions between the carboxylic acids of compound <b>6</b> and the important arginine residues in subpockets P1 and P2 (Arg415 and Arg483, respectively), as also suggested by in silico docking.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In order to improve the physicochemical and drug-like properties of compound <b>6</b>, further SAR studies were performed. Compound <b>7</b>, with <i>p</i>-acetamido substituents instead of <i>p</i>-methoxy groups, demonstrated a good balance of activity, physiochemical properties (solubility and cLogD), and cellular Nrf2 activity slightly better than <b>6</b>.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Lu et al.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> did a carboxylic acid bioisosteric replacement study of <b>7</b> to further optimize the drug-like properties and membrane permeability. Replacing the carboxylic acid moieties with tetrazoles led to compound <b>8</b>, which retained the activity in the low nanomolar range and improved the p<i>K</i><sub>a</sub> and cLogD profiles compared with <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Jain et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> generated the diacetamide-substituted analogue of <b>5</b>, i.e., compound <b>9</b>, which was more promising than a series of asymmetric analogues with different substituents on the sulfonamide. In an FP assay, compound <b>9</b> showed activity in the low nanomolar range (IC<sub>50</sub> of 63 nM) without having to resort to carboxylic acid groups (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The binding mode of <b>9</b> was confirmed by X-ray analysis, which showed the location of the amide groups in the two hydrophilic subpockets P1 and P2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">The first asymmetric compound of the 1,4-diaminonaphthalene series to be cocrystallized with Keap1 was compound <b>10</b>, also called RA839 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>10</b> was identified by screening followed by structural modifications and exhibited an IC<sub>50</sub> of 0.14 μM in an FP assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The binding mode is similar to that of <b>5</b>, but instead of occupying the hydrophobic subpocket P4, the carboxylic acid forms a charge-assisted interaction with Arg483 in P1. The cellular activity of <b>10</b> was confirmed in various assays, and it significantly increased hepatic mRNA levels of the Nrf2 target genes in mice.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">Saito et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> identified compound <b>11</b>, which is similar to <b>5</b>, by FP-based HTS of the Drug Discovery Initiative Library (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>11</b> inhibits the interaction between Keap1 and a phosphorylated peptide of p62 (<i>p</i>-p62), which is found to bind in the same pocket of the Keap1 Kelch domain as Nrf2 does.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The inhibitory activity was confirmed by a SAR study of <b>11</b> where the compound demonstrated inhibition of Keap1–<i>p</i>-p62 and Keap1–Nrf2 PPIs (IC<sub>50</sub> values of 1.5 and 6.2 μM, respectively; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Also, the X-ray structure of the Keap1 Kelch domain cocrystallized with <b>11</b> disclosed a similar binding mode as with <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Compound <b>11</b> contains an aliphatic ketone, which is categorized as a protein-reactive electrophile (FAF-Drugs4 analysis), which could give rise to undesirable off-target effects.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_p last">Compound <b>12</b> has a unique benzoindole core substituted with a hydroxylamine group and was discovered by HTS of the Drug Discovery Initiative Library using an FP assay.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Currently, <b>12</b> is the most rigid analogue of <b>5</b> and also demonstrates an improved Keap1–Nrf2 PPI inhibitory activity (IC<sub>50</sub> of 0.20 μM; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The metabolic stability of <b>12</b> in human liver microsomes is more than 8-fold greater than that of <b>5</b>. A series of N-substituted hydrazide compounds based on <b>12</b> was developed and demonstrated similar inhibitory activity and metabolic stability as <b>12</b>.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> There is a risk that the hydroxamic acid of <b>12</b> could undergo acylation and Lossen rearrangement to form a reactive isocyanate intermediate, which could interact with different biomolecules (FAF-Drugs4 analysis).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">4.3.  Inhibitors Containing a 3-Phenylpropanoic Acid Core</h3><div class="NLM_p">In a collaboration between Astex Pharmaceuticals and GlaxoSmithKline Pharmaceuticals, Davies et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> identified compound <b>13</b> using fragment-based drug discovery (FBDD) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Approximately 330 fragments were screened using X-ray crystallography, which identified subpockets P1, P4, and P5 as hot spots for fragment binding. The X-ray structures revealed that three different fragments, <b>14</b>–<b>16</b>, occupied each of their hotspots and interacted with key amino acids such as Arg483 (subpocket P1), Tyr525 (P4), and Ser602 (P5), respectively (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure-based progression of the initial X-ray crystallography fragment hits <b>14</b>, <b>15</b>, and <b>16</b> (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNQ">5FNQ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZJ">5FZJ</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZN">5FZN</a>, respectively) into <b>17</b> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNT">5FNT</a>) and finally to <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite a low potency (IC<sub>50</sub> > 1 mM, FP), phenylacetic acid fragment <b>14</b> was identified as a promising “anchor fragment” for hit elaboration because of its multiple exit vectors as shown by the X-ray structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Fragment <b>14</b> was modified in a stepwise manner to occupy all three hotspots in the binding pocket. First, a benzotriazole moiety was attached to the benzylic position of fragment <b>14</b> in order to reach hotspot P4 and form a π–π stacking interaction with Tyr525 (similar to fragment <b>15</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). This modification led to an improved activity (IC<sub>50</sub> of 61 μM). Growth from the 3-position of the phenyl ring of fragment <b>14</b> with a sulfonamide moiety (corresponding to fragment <b>16</b>) led to an interaction with Ser525 in hotspot P5 and a further improved activity (IC<sub>50</sub> of 3.4 μM) (compound <b>17</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Subsequent modifications, including replacement of the <i>p</i>-chlorine with a methyl group, introduction of the electron-donating methoxy group on the benzotriazole, and cyclization of the phenylsulfonamide, resulted in compound <b>13</b> with very high affinity as measured by FP (IC<sub>50</sub> of 15 nM) and isothermal titration calorimetry (ITC) (<i>K</i><sub>d</sub> of 1.3 nM) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Compound <b>13</b> was found to be selective toward the Keap1 Kelch domain across a panel of 49 targets with potential toxicity liabilities. Furthermore, <b>13</b> activates the Nrf2 pathway in human bronchial epithelial cells (both normal cells and cells derived from chronic obstructive pulmonary disease (COPD) patients) and thereby induces target gene expression and downstream antioxidant activities. Also, assessment of <b>13</b> in in vivo models related to COPD was performed. After intravenous infusion over 6 h in rats, animals treated with <b>13</b> showed induced pulmonary expression of Nrf2-regulated genes, and the compound attenuated ozone-induced pulmonary inflammation and depletion of lung glutathione levels.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p last">Further development and biological characterization of 270 analogues of <b>13</b> containing the same 3-phenylpropanoic acid core have been published in a patent application.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The inhibitory activity of the compounds was determined in a Keap1–Nrf2 competition FP assay and a BEAS-2B cell assay of NQO1 activity. Eleven of the analogues demonstrated a strong inhibitory activity with IC<sub>50</sub> < 10 nM.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.4.  Inhibitors Containing a 1-Phenylpyrazole Core</h3><div class="NLM_p last">Recently, two new compound series, both containing a 1-phenylpyrazole core, were presented in patent applications by Astex Pharmaceuticals and GlaxoSmithKline.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> In the first, about 65 compounds with a biarylpyrazole core were presented and tested for inhibitory activity in the Keap1–Nrf2 competition FP assay and the NQO1-activity cell assay. Also, the ability to inhibit the Keap1–Nrf2 PPI was assessed in a time-resolved FRET (TR-FRET) assay. One of the most promising biarylpyrazole-containing compounds is compound <b>18</b>, with an IC<sub>50</sub> in the range of 10–100 nM in the FP assay and IC<sub>50</sub> < 10 nM in the TR-FRET assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In the second phenylpyrazole patent application, approximately 25 compounds with a cycloalkylarylpyrazole core were presented, with compound <b>19</b> being one of the most promising compounds, showing high Keap1–Nrf2 inhibitory activity (IC<sub>50</sub> in the range of 10–100 nM in both the FP and TR-FRET assays) and potency in cells (EC<sub>50</sub> of 79 nM) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">4.5.  Inhibitors Containing a 1,4-Diphenyl-1,2,3-triazole Core</h3><div class="NLM_p">An in silico screen of 178 000 fragments from the ZINC database formed the starting point for the discovery of the 1,4-diphenyl-1,2,3-triazole-containing compound <b>20</b>.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> On the basis of their docking scores, 364 molecules were selected for further structural analysis, such as common features of the molecules and key amino acid interaction partners in the binding pocket. After pharmacophore modeling, an initial hit was found containing two carboxylic acids. Further SAR studies were conducted to identify <b>20</b> with improved Keap1–Nrf2 inhibitory activity (IC<sub>50</sub> of 7.1 μM, FP) and promising gene induction in cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p last">The nitroarene scaffold, as in <b>20</b>, is flagged as a “low risk” problem in the FAF-Drugs4 analysis because of its potential toxicity. The primary pathways of biotransformation to toxic metabolites involve reduction of the nitro group to stabilized nitro radicals. Under anaerobic conditions, the nitro radicals can be reduced further to hydroxylamine and amine metabolites. In a more aerobic environment, the radicals can reduce oxygen to form toxic oxygen species.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">4.6.  Inhibitors Containing a 4-Phenyl-1,2,4-triazole Core</h3><div class="NLM_p last">Compounds <b>21</b> and <b>22</b>, containing a 4-phenyl-1,2,4-triazole core, were identified by screening and a follow-up SAR study.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> They are both able to activate the Nrf2–ARE pathway in cells. On the basis of docking results, the nitro group in the two compounds interacts with the key amino acid Arg483. Binding to the Keap1 Kelch domains of <b>21</b> and <b>22</b> was confirmed by SPR, suggesting <i>K</i><sub>d</sub> values of 22.8 and 16.5 μM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Compounds <b>21</b> and <b>22</b> contain a triazole-3-thiol core, which can be categorized as an activated aryl thioether. The heterocycle is electron-withdrawing and can in some cases activate the thioether, leading to nonspecific reactivity with biological nucleophiles.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.7.  Inhibitors Containing a 1-(1,3,4-Oxadiazol-2-yl)urea Core</h3><div class="NLM_p">Satoh et al.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> selected 65 compounds on the basis of in silico screening of both in-house and commercially available compounds tested against the Keap1 Kelch domain using an existing crystal structure (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FLU">2FLU</a>). By SPR, 27 compounds were found to be active, and medicinal chemistry performed on the most promising hit led to the discovery of compound <b>23</b>. Interestingly, two different crystal structures of the human Keap1 Kelch domain with <b>23</b> have been determined by soaking (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VNH">3VNH</a>) and cocrystallization (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VNG">3VNG</a>) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In the soaking form, compound <b>23</b> binds deeper within the binding pocket of the Kelch domain compared with the cocrystallization form and interacts with amino acids in subpockets P1–P3. This tighter binding was confirmed by molecular dynamics simulations.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p last">The structurally related compound <b>24</b>, called NK-252, was presented as a potential Keap1–Nrf2 PPI inhibitor in a study focusing on nonalcoholic fatty liver disease.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Compound <b>24</b> caused dose-dependent Nrf2 activation in a luciferase NQO1–ARE reporter gene assay, and SPR analysis revealed dose-dependent binding to the Keap1 Kelch domain at 12.5–100 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>); however, a <i>K</i><sub>d</sub> value was not determined, likely because saturation was not achieved at the tested concentrations.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.8.  Inhibitor Containing a Hydrazinecarbohydrazide Core</h3><div class="NLM_p last">Structure-based virtual screening of the Specs database was performed by Sun et al.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> to discover the hydrazinecarbohydrazide-containing compound <b>25</b>. First, a focused Keap1–Nrf2 library of 21 199 compounds was prepared from the 251 774 compounds from the Specs database. After a pharmacophore search, docking, and visual inspection, <b>25</b> was identified as a promising inhibitor of the Keap1–Nrf2 interaction. Compound <b>25</b> was shown to have an EC<sub>50</sub> of 9.8 μM in an FP assay and Nrf2 transcriptional activity in a cellular ARE–luciferase reporter assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> However, compound <b>25</b> contains acylhydrazone groups, which have been shown to be electrophilic under acidic conditions and hydrolyze to hydrazides, which can undergo metabolic oxidation to reactive nitrogen species (FAF-Drugs4).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.9.  Inhibitor Containing a Pyrimidin-4(3<i>H</i>)-one Core</h3><div class="NLM_p last">Besides compound <b>5</b>, Marcotte et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> also identified <b>26</b> with a pyrimidin-4(3<i>H</i>)-one core. Compound <b>26</b> demonstrated a lower activity than <b>5</b>, with an IC<sub>50</sub> of 118 μM in the FP assay and no activity in a luciferase cell reporter assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The X-ray structure of the Keap1 Kelch domain cocrystallized with <b>26</b> demonstrated that two molecules were bound side by side in the binding pocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Compound <b>26</b> contains a pyrimidine-2-thiol core, which can be categorized as an activated aryl thioether, similar to compounds <b>21</b> and <b>22</b>, that can show nonspecific reactivity with biological nucleophiles.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.10.  Inhibitors Containing a Pyrazolidin-3-one Core, a 4-Aminophenol Core, or a Thiazolidine-2,4-dione Core</h3><div class="NLM_p">Three structurally different series of Keap1–Nrf2 PPI inhibitors were identified by Zhuang et al.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> using structure-based virtual screening of 153 611 compounds from the Specs database, resulting in 65 initial hits. Nine compounds demonstrated inhibitory activity in the low micromolar range in an FP assay, leading to the identification of the three scaffolds. SAR studies on the pyrazolidin-3-one compounds led to the identification of compound <b>27</b>, which exhibited good inhibitory activity with a <i>K</i><sub>d</sub> of 15.2 μM in the FP assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> However, FAF-Drugs4 identified <b>27</b> as a PAINS because of the α,β-unsaturated carbonyl, which can react with protein thiol groups and thus give rise to off-target activity.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The other pyrazolidin-3-one-containing compounds described in this study also contain an α,β-unsaturated carbonyl; however, they are not all active in the FP assay, indicating that <b>27</b> could be a true Keap1–Nrf2 PPI inhibitor.</div><div class="NLM_p">The second lead scaffold consists of a 4-aminophenol core, which was used for SAR analysis. The initial hit from the screening, compound <b>28</b>, was actually the most potent one among the compounds from the SAR study, with a <i>K</i><sub>d</sub> of 2.9 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Compound <b>28</b> is also categorized as a PAINS because of the <i>p</i>-hydroxysulfonamide motif, which has redox cycling activity that could potentially lead to generation of reactive metabolites and irreversible alkylation of endogenous proteins.<a onclick="showRef(event, 'ref73 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref73 ref76 ref77">(73,76,77)</a> Also, similar to <b>21</b>, <b>22</b>, and <b>26</b>, compound <b>28</b> contains an activated aryl thioether. Again, however not all of the compounds from this SAR analysis containing a <i>p</i>-hydroxysulfonamide motif were active in the FP assay, indicating that <b>28</b> could be a true Keap1–Nrf2 PPI inhibitor. Compound <b>28</b> was later used as a lead scaffold for a SAR study where the introduction of <i>N</i>-acetic acid groups on the sulfonamide and replacement of the <i>p</i>-isopropyl group with an ethyl gave a 6-fold-improved affinity (<i>K</i><sub>d</sub> of 1.14 μM compared with 7.24 μM for <b>28</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p last">The last of the three new inhibitors identified by Zhuang et al. contained a thiazolidine-2,4-dione core. SAR analysis did not improve the inhibitory activity, as the initial hit, compound <b>29</b>, remained the most potent derivative, with <i>K</i><sub>d</sub> of 10.4 μM in an FP assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Similar to <b>27</b>, compound <b>29</b> also contains an α,β-unsaturated carbonyl and is categorized as a PAINS.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">5.  Central Nervous System Permeability</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Targeting the CNS is challenging because the BBB provides a unique membrane that segregates the CNS and the circulation system and prevents unwanted chemicals from entering the brain. The BBB is formed by capillary endothelial cells kept together by tight junctions that efficiently avoid penetration of polar compounds.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> As the binding pocket of the Keap1 Kelch domain is polar, development of a potent Keap1 inhibitor with high CNS permeability is likely even more challenging.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Many of the published Keap1–Nrf2 inhibitors contain carboxylic acids (<b>1</b>, <b>3</b>, <b>4</b>, <b>6</b>, <b>7</b>, <b>10</b>, <b>13</b>, <b>18</b>, <b>19</b>, <b>23</b>, <b>25</b>, <b>27</b>, and <b>29</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), the charge of which at physiological pH is likely to prevent or decrease CNS permeability.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Also, similar to many other PPI-engaging proteins, Keap1’s binding pocket is relatively large. These challenges are confirmed by the only two studies where CNS exposure has been experimentally investigated, as described in the following section together with a discussion of CNS MPO scores.</div><div class="NLM_p">To further analyze the promise of current Keap1 inhibitors as CNS agents, we calculated their CNS MPO<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and modified CNS MPO.v2<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> scores. Through study of a set of marketed CNS drugs and an internal set of Pfizer CNS candidates, the CNS MPO algorithm was defined to provide guidance in drug design to accelerate the identification of CNS-permeable and drug-like compounds. The CNS MPO score is based on a set of six fundamental physiochemical parameters: (1) lipophilicity, as expressed in the partition coefficient (cLogP); (2) distribution coefficient at pH 7.4 (cLogD); (3) molecular weight (MW); (4) topological polar surface area (tPSA); (5) number of hydrogen-bond donors (HBD); and (6) most basic center (p<i>K</i><sub>a</sub>).<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(30,32)</a> Each parameter is scored with a value between 0 and 1 based on a simple linear function, and the six values are added to obtain the final CNS MPO score, which can vary from 0–6. Higher CNS MPO scores are desirable for CNS drug candidates, as they would suggest BBB permeability and absorption, distribution, metabolism, and excretion (ADME) properties in ranges similar to those for the CNS drug test set. An optimal CNS candidate with a CNS MPO score of 6 would have the following property values: cLogP ≤ 3, cLogD ≤ 2, MW ≤ 360 Da, tPSA = 40–90 Å<sup>2</sup>, HBD = 0, and p<i>K</i><sub>a</sub> ≤ 8. The algorithm was applied to the two data sets and showed that 74% of the marketed CNS drugs were characterized with CNS MPO scores greater than 4, in comparison with 60% of the Pfizer CNS candidates. Additionally, approximately 95% of the compounds with CNS MPO scores greater than 5 showed high passive permeability, low P-glycoprotein (P-gp) liability, favorable metabolic stability, and high cellular viability.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">Rankovic<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> developed a modified version of the CNS MPO algorithm, termed CNS MPO.v2, describing the physicochemical properties for brain-penetrant compounds versus peripherally restricted molecules. In this analysis, the test sets included not only marketed drugs but also research molecules with available mouse brain exposure data. The results suggested that the most critical physicochemical properties in regard to CNS permeability are molecular size and hydrogen-bond capacity and not lipophilicity as previously stated. In general, brain-penetrant compounds were found to have MW ≤ 470 Da, tPSA ≤ 90 Å<sup>2</sup>, and HBD ≤ 2.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> However, it should be noted that both data sets contained a low number (<5%) of carboxylic acids or related bioisosteres that are likely to be negatively charged at physiological pH. Several amino acid-like compounds are known to be actively transported across the BBB, but penetration by ionizable compounds and especially carboxylic acids is generally not well understood.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Interestingly, the CNS MPOv.2 algorithm allows higher MW and HBD compared with CNS MPO. Whereas CNS MPO.v2 is predictive for brain penetration, CNS MPO also takes metabolic stability and high cellular viability into account.</div><div class="NLM_p">Jnoff et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> assessed the CNS permeability of the 1,2,3,4-tetrahydroisoquinoline-containing compounds <b>1</b>–<b>3</b> and <b>30</b>–<b>32</b> using an MDCK-MDR1 cell assay and measuring brain exposure in mice (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>1</b> showed a very small unbound brain-to-plasma ratio (<0.01) in mice and a high efflux ratio (ER = 20) in MDCK-MDR1 cells (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In Mdr1a/1b/Bcrp (P-gp) knockout mice, the unbound brain-to-plasma ratio was improved more than 40-fold, establishing that <b>1</b> is a P-gp substrate. The improved CNS profile of compound <b>30</b> indicates that the carboxylic acid of compound <b>1</b> is responsible for the poor CNS permeability, but it is unfortunately also important for affinity to Keap1 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Replacement of the carboxylic acid of <b>1</b> with the tetrazole bioisostere (compound <b>2</b>) or a zwitterionic amino acid (compound <b>31</b>) did not improve the CNS profile (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Interestingly, and in accordance with the analyses behind the CNS MPO algorithms,<a onclick="showRef(event, 'ref30 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref32 ref33">(30,32,33)</a> it was seen that tPSA reduction led to a 3-fold improvement in ER for <b>3</b> (tPSA of 77.9 Å<sup>2</sup>) compared with <b>1</b> (tPSA of 96.7 Å<sup>2</sup>). Furthermore, when the phthalimide group of compound <b>1</b> is replaced by a phenyl group (compound <b>32</b>, tPSA of 57.6 Å<sup>2</sup>), the ER is reduced 28-fold and in vivo brain exposure is significantly increased, with an unbound brain-to-plasma ratio of 0.9 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Unfortunately, the inhibitory activity does not follow the improved CNS profile, as an IC<sub>50</sub> of >100 μM was determined for <b>32</b>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The CNS MPO analysis suggests that the reason for the improved CNS profile could be not only the reduced tPSA but also the reduction of the molecular weight. Noticeably, the calculated CNS MPO scores for <b>1</b>, <b>2</b>, and <b>3</b> correlate with the experimentally determined ERs (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. CNS Permeability of Inhibitors Containing a 1,2,3,4-Tetrahydroisoquinoline Core<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0007.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">MDCK-MDR1 cells.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Also see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div></div><div></div></div><div class="NLM_p">Kazantsev at al.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> used HPLC to quantify compound <b>21</b> in wild-type mouse cortices (<i>N</i> = 3). After daily intraperitoneal injections of <b>21</b> escalating from 50 to 275 mg/kg, the concentration of <b>21</b> was determined to ∼0.5 μM in homogenized brain tissue. The concentration of <b>21</b> in the blood was not specified, which makes it impossible to evaluate the brain-to-plasma ratio. Also, the duration of administration of the compound is uncertain and a very high dose was injected. Overall, this study indicates that only small amounts of <b>21</b> can enter the brain, which correlates with an intermediate CNS MPO.v2 score of 4.0 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Most of the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> have rather low MPO scores (<3), such as <b>8</b>, <b>11</b>, and <b>26</b>, indicating that it would likely be futile to use them in experiments directed toward the CNS. Likewise, optimizing them into more promising CNS candidates will be difficult because the inhibitors are generally large and many contain carboxylic acids. For example, the CNS MPO and MPO.v2 scores for the 1,4-diaminonaphthalene-containing compounds (<b>5</b>–<b>9</b>, <b>11</b>, and <b>12</b>) are lower than 3.6 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) because of MW ≳ 500 Da, tPSA > 120 Å<sup>2</sup>, and HBD ≥ 2, which combined make them unlikely to penetrate the BBB. Furthermore, the essential physicochemical properties of compound <b>25</b>, <b>26</b>, <b>28</b>, and <b>29</b> do not comply with CNS permeability, as can be seen from the very low MPO scores (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Compound <b>10</b> is the only compound from the 1,4-diaminonaphthalene series with a reasonable MPO score of 3.9–4.4 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A possible way to optimize <b>10</b> for BBB penetration could be to decrease the molecular weight, for example by removing chemical groups that may not contribute to affinity. As an example, if all four methyl groups were removed from the benzene ring of <b>10</b>, the resulting compound would have an MPO.v2 score of 4.6, compared with the score of 3.9 for <b>10</b>, and thereby a higher theoretical chance of penetrating the BBB.</div><div class="NLM_p">Compound <b>19</b> is a very potent inhibitor of Keap1–Nrf2 and has a CNS MPO score of 4.1 and a CNS MPO.v2 score of 3.9 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Without optimization it would probably be difficult for <b>19</b> to penetrate the BBB at relevant concentrations. However, further SAR studies focusing on maintaining high activity while improving the CNS MPO scores slightly could lead to interesting CNS candidates.</div><div class="NLM_p">Another compound with promising MPO scores is <b>20</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Further improvement of the MPO scores could be done by optimization of lipophilicity (cLogP), for example by exchanging the iodine atom with a methyl group. This modification would reduce cLogP from 4.58 to 4.16, which would increase the MPO scores by 0.2. Interestingly, this modification has been tested and shows similar inhibitory activity as <b>20</b>.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p last">Compound <b>24</b> has the most promising MPO scores among the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, and a further reduction in HBD from 2 to 1, e.g., by replacing the urea with an amide, would increase the MPO.v2 score to 5.1, indicating a very high chance of CNS permeability. However, before making further SAR studies of <b>24</b>, it is preferable to establish the <i>K</i><sub>d</sub> value to Keap1 and to test its ability to inhibit the Keap1–Nrf2 interaction in simple in vitro assays.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">6.  Keap1–Nrf2 Small-Molecule Inhibitors Targeting the Brain</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As described above, the binding pocket of the Keap1 Kelch domain has polar regions and is relatively large. Additionally, no experimental data suggest good BBB penetration of any published small-molecule Keap1–Nrf2 inhibitors. The fact that the majority of the compounds contain carboxylic acids or have MPO scores generally indicating poor CNS permeability underlines how challenging it will be to target Keap1 for CNS diseases. To circumvent this major drug discovery challenge, here we suggest three strategies for targeting Keap1 in the CNS with small molecules.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">6.1.  Fragment-Based Drug Discovery</h3><div class="NLM_p last">FBDD has grown into a useful strategy for developing potent drug-like PPI inhibitors and has already been applied to discover the small-molecule Keap1–Nrf2 inhibitor <b>13</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61−63)</a> The principle of FBDD is to screen for fragments (i.e., small substructures of drug-like compounds with molecular weights of 100–300 Da) against the target followed by optimization by linking or merging fragment hits or growing a single fragment into larger and more potent molecules.<a onclick="showRef(event, 'ref44 ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref44 ref79 ref80 ref81">(44,79−81)</a> Fragment hits are often prioritized on the basis of their ligand efficiency (LE),<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> i.e., the molecule’s free energy of binding divided by its number of non-hydrogen atoms. A core principle of FBDD is to start from a small but ligand-efficient fragment hit and by careful optimization improve the affinity while maintaining the high LE and staying within the physicochemical drug-like space.<a onclick="showRef(event, 'ref79 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref81">(79,81)</a> This mindset correlates well with the design and optimization of compounds for CNS guided by CNS MPO scores. Thus, starting from a ligand-efficient Keap1-binding fragment hit and ascertaining that size, lipophilicity, and HBD are kept within recommended CNS MPO values during the optimization should enhance the chances of developing small molecules with high CNS permeability targeting the Keap1–Nrf2 PPI.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">6.2.  Bioisosteric Replacement</h3><div class="NLM_p">As can be seen from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, many of the most potent Keap1 inhibitors contain carboxylic acids, which are often associated with poor CNS penetration due to high plasma protein binding, poor passive permeability, and P-gp recognition.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A potential strategy to circumvent the CNS challenges of Keap1 inhibitors is to replace the carboxylic acid groups with a carboxylic acid bioisostere, leading to analogues with more CNS-preferential physicochemical properties (e.g., related to lipophilicity, acidity, HBD, and MW).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p last">Lu et al.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> performed a bioisosteric replacement study of <b>7</b> in order to improve the drug-like properties and membrane permeability. Eight structurally different chemical groups were substituted for the carboxylic acid group, including an ester, a tetrazole, and a hydroxamic acid, leading to diverse physicochemical properties of the compounds. The tetrazole (<b>8</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was the only bioisostere that was able to maintain biological activity against the Keap1 Kelch domain. Furthermore, the higher p<i>K</i><sub>a</sub> and cLogD compared to the carboxylic acid-containing <b>7</b> might be beneficial for the CNS permeability; however, brain exposure was not the focus of this study and was therefore not tested. Interestingly, replacing the carboxylic acids with amide groups led to an inactive compound.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> This is in contrast to the study by Jain et al.,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> where the amide substitution was able to retain the activity of the resulting compound (<b>9</b>) compared with the activity of <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Overall, these studies show that tetrazoles can substitute for the carboxylic acids with preserved affinity to Keap1, as was also shown for compounds <b>1</b> and <b>2</b>,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and that amides in some cases can do the same. This also indicates that carboxylic acid groups are not strictly required for obtaining high affinity to the Keap1 Kelch domain and that the bioisosteric replacement strategy could be further explored in order to design CNS-permeable Keap1–Nrf2 inhibitors.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">6.3.  The Prodrug Approach</h3><div class="NLM_p">The prodrug approach is another potential strategy for targeting CNS diseases<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> in which undesirable groups of the lead compound are coupled with a promoiety, resulting in altered physicochemical properties and a prodrug more likely to reach the CNS. After penetration of the BBB, the promoiety must be cleaved off by enzymes or oxidation/reduction, liberating the compound to interact with the target protein.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p last">A typical prodrug strategy for carboxylic acids is esterification, as this modifies the physicochemical properties of the compound, the chemical linking of the promoiety is well-established, and they are easily cleaved by enzymes, such as esterases and peptidases.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Small alkyl groups (e.g., methyl or ethyl) would increase the molecular weight only slightly and potentially provide ester prodrugs with more favorable physicochemical properties for reaching the CNS. However, the main caveat of this strategy is the difficulty in finding esters that are stable toward esterases in blood plasma but sensitive to enzyme cleavage in the brain.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Nevertheless, successful applications of this strategy for targeting the CNS have been reported. For example, the BBB permeability of the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen is very low because of its lipophilicity and the ionization of its carboxylic acid group. However, coupling of a diacetylglyceride to the acid of ketoprofen led to improved delivery to the brain via increased permeability through the BBB and rapid hydrolysis of the prodrug within the brain.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Also, the carboxylic acid of another NSAID, dexibuprofen, was modified via different esterifications, and the prodrugs showed improved BBB permeability compared with the parent compound.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The prodrug and esterification approach could theoretically be used to improve the CNS profiles of current Keap1 inhibitors, but it is also challenging because the conversion of the CNS prodrugs needs to be selective and rapid enough to compete with elimination from the target tissue.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Also, the molecular size of the compounds is a critical factor and could be a problem for the published Keap1 inhibitors, which are generally already large. Another strategy that could be further pursued is exemplified by the previously mentioned reversible Keap1–Nrf2 peptide inhibitor Tat-Cal-DEETGE, where Cal is cleaved off in the cell to afford the active peptide.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Similarly, hybrids of small molecules and cell-penetrating peptides, such as Tat, which can lead to some BBB permeability,<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> could be attempted for targeting Keap1 in the CNS.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">7.  Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Over the past years, the PPI between Keap1 and Nrf2 has been widely studied, and Keap1 has emerged as a promising drug target against inflammation and CNS diseases. Identification of brain-targeting small-molecule Keap1–Nrf2 inhibitors is of great interest because activation of Nrf2 has been found to protect neurons against stroke (ischemic and hemorrhagic), traumatic brain injury, and neurodegenerative disorders. Several non-covalent small-molecule Keap1–Nrf2 inhibitors with promising potencies and biological activities have been developed. However, none of these has been shown to be able to penetrate the BBB, and the majority contain carboxylic acids, which usually prevent CNS permeability. Unfortunately, the binding pocket of the Keap1 Kelch domain is polar and relatively large compared with traditional targets, making it a challenging task to target Keap1 in the CNS. Different strategies can be attempted to circumvent this major drug discovery challenge, such as FBDD, carboxylic acid bioisosteric replacement, and the prodrug approach. During optimization using any of these strategies, it is essential to balance the physicochemical properties (e.g., guided by CNS MPO scoring algorithms) to increase the chances of obtaining CNS permeability in the search of brain-targeting small-molecule Keap1–Nrf2 inhibitors.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00358" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders Bach</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4305-9910" title="Orcid link">http://orcid.org/0000-0003-4305-9910</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4928272d2c3b3a672b282a21093a3c272d67223c672d22"><span class="__cf_email__" data-cfemail="0e6f606a6b7c7d206c6f6d664e7d7b606a20657b206a65">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jakob
S. Pallesen</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim T. Tran</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Design
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Jakob
S. Pallesen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=BIO-d214e1904-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jakob S. Pallesen</b> obtained his Bachelor’s degree in 2012 from the School of Pharmaceutical Sciences at the University of Copenhagen in Denmark and his Master’s degree in 2015 from the Department of Drug Design and Pharmacology at the University of Copenhagen. After employment as a scientific assistant, he began his Ph.D. studies in 2016 in medicinal chemistry, working under the supervision of Associate Professor Anders Bach. His work focuses on employing fragment-based drug discovery, including medicinal chemistry, in silico methods, and biochemical and biophysical testing, to find new Keap1–Nrf2 small-molecule inhibitors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Kim T. Tran</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=BIO-d214e1909-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kim T. Tran</b> obtained his Bachelor’s degree within pharmacy in 2016 at the University of Copenhagen. Currently he is a Master’s student in medicinal chemistry in the Department of Drug Design and Pharmacology at the University of Copenhagen, working under the supervision of Associate Professor Anders Bach. His work focuses on employing fragment-based drug discovery, including medicinal chemistry and in silico methods, to find new small-molecule inhibitors against Keap1.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Anders Bach</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=BIO-d214e1914-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Anders Bach</b> obtained his Bachelor’s degree within biochemistry in 2002 and his Master’s degree within human biology in 2005 from the University of Copenhagen. He received his Ph.D. in medicinal chemistry from the Department of Drug Design and Pharmacology at the University of Copenhagen in 2009. He continued as a postdoc at the University of Copenhagen until 2012, when he joined the Italian Institute of Technology, Department of Drug Discovery and Development (Genoa, Italy) also as a postdoc. Currently he is an associate professor in the Department of Drug Design and Pharmacology, where he recently started up his own research group focusing on fragment-based drug discovery and protein–protein interactions involved in CNS diseases.</p></figure></div><div class="ack" id="ACK-d214e1919-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Lundbeck Foundation is acknowledged for its financial support (Grant R190-2014-3710 for A.B.; the Drug Research Academy/Lundbeck Foundation Scholarship for K.T.T.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NAD(P)H dehydrogenase (quinone) 1</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione S-transferase</p></td></tr><tr><td class="NLM_term">ARE</td><td class="NLM_def"><p class="first last">antioxidant response element</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethyl fumarate</p></td></tr><tr><td class="NLM_term">MMF</td><td class="NLM_def"><p class="first last">monomethyl fumarate</p></td></tr><tr><td class="NLM_term">Cal</td><td class="NLM_def"><p class="first last">calpain</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan-assay interference compounds</p></td></tr><tr><td class="NLM_term">CNS MPO</td><td class="NLM_def"><p class="first last">central nervous system multiparameter optimization</p></td></tr><tr><td class="NLM_term">Neh</td><td class="NLM_def"><p class="first last">Nrf2–ECH homology</p></td></tr><tr><td class="NLM_term">BTB</td><td class="NLM_def"><p class="first last">broad complex, tramtrack, and bric-à-brac</p></td></tr><tr><td class="NLM_term">IVR</td><td class="NLM_def"><p class="first last">intervening region</p></td></tr><tr><td class="NLM_term">DGR</td><td class="NLM_def"><p class="first last">double glycine repeat</p></td></tr><tr><td class="NLM_term">Cul3</td><td class="NLM_def"><p class="first last">cullin 3</p></td></tr><tr><td class="NLM_term">Rbx1</td><td class="NLM_def"><p class="first last">RING-box protein 1</p></td></tr><tr><td class="NLM_term">CRL3</td><td class="NLM_def"><p class="first last">cullin-RING ligase 3</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">Förster resonance energy transfer</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">biolayer interferometry</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug discovery</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved FRET</p></td></tr><tr><td class="NLM_term">cLogP</td><td class="NLM_def"><p class="first last">partition coefficient</p></td></tr><tr><td class="NLM_term">cLogD</td><td class="NLM_def"><p class="first last">distribution coefficient</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">number of hydrogen-bond donors</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 90 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. F.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+mitochondrial+reactive+oxygen+species+as+novel+therapy+for+inflammatory+diseases+and+cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0ljYeGOPfld7gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520mitochondrial%2520reactive%2520oxygen%2520species%2520as%2520novel%2520therapy%2520for%2520inflammatory%2520diseases%2520and%2520cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uttara, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, R. T.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.2174/157015909787602823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.2174%2F157015909787602823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19721819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=65-74&author=B.+Uttaraauthor=A.+V.+Singhauthor=P.+Zamboniauthor=R.+T.+Mahajan&title=Oxidative+stress+and+neurodegenerative+diseases%3A+a+review+of+upstream+and+downstream+antioxidant+therapeutic+options&doi=10.2174%2F157015909787602823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options</span></div><div class="casAuthors">Uttara, Bayani; Singh, Ajay V.; Zamboni, Paolo; Mahajan, R. T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-74</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Free radicals are common outcome of normal aerobic cellular metab.  In-built antioxidant system of body plays its decisive role in prevention of any loss due to free radicals.  However, imbalanced defense mechanism of antioxidants, overprodn. or incorporation of free radicals from environment to living system leads to serious penalty leading to neuro-degeneration.  Neural cells suffer functional or sensory loss in neurodegenerative diseases.  Apart from several other environmental or genetic factors, oxidative stress (OS) leading to free radical attack on neural cells contributes calamitous role to neuro-degeneration.  Though, oxygen is imperative for life, imbalanced metab. and excess reactive oxygen species (ROS) generation end into a range of disorders such as Alzheimer's disease, Parkinson's disease, aging and many other neural disorders.  Toxicity of free radicals contributes to proteins and DNA injury, inflammation, tissue damage and subsequent cellular apoptosis.  Antioxidants are now being looked upon as persuasive therapeutic against solemn neuronal loss, as they have capability to combat by neutralizing free radicals.  Diet is major source of antioxidants, as well as medicinal herbs are catching attention to be com. source of antioxidants at present.  Recognition of upstream and downstream antioxidant therapy to oxidative stress has been proved an effective tool in alteration of any neuronal damage as well as free radical scavenging.  Antioxidants have a wide scope to sequester metal ions involved in neuronal plaque formation to prevent oxidative stress.  In addn., antioxidant therapy is vital in scavenging free radicals and ROS preventing neuronal degeneration in post-oxidative stress scenario.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm2Msbx6GXlLVg90H21EOLACvtfcHk0ljSR4aEQGTS5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqsrfN&md5=297ced2dd24a0567a0e0a1ca5e9311ab</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F157015909787602823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015909787602823%26sid%3Dliteratum%253Aachs%26aulast%3DUttara%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DA.%2BV.%26aulast%3DZamboni%26aufirst%3DP.%26aulast%3DMahajan%26aufirst%3DR.%2BT.%26atitle%3DOxidative%2520stress%2520and%2520neurodegenerative%2520diseases%253A%2520a%2520review%2520of%2520upstream%2520and%2520downstream%2520antioxidant%2520therapeutic%2520options%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2009%26volume%3D7%26spage%3D65%26epage%3D74%26doi%3D10.2174%2F157015909787602823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepkowski, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruszewski, M. K.</span></span> <span> </span><span class="NLM_article-title">Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2011.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21295136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12rtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1186-1195&author=T.+M.+Stepkowskiauthor=M.+K.+Kruszewski&title=Molecular+cross-talk+between+the+NRF2%2FKEAP1+signaling+pathway%2C+autophagy%2C+and+apoptosis&doi=10.1016%2Fj.freeradbiomed.2011.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis</span></div><div class="casAuthors">Stepkowski, Tomasz M.; Kruszewski, Marcin K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1186-1195</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, perturbations in the cellular thiol level and redox balance, affects many cellular functions, including signaling pathways.  This, in turn, may cause the induction of autophagy or apoptosis.  The NRF2/KEAP1 signaling pathway is the main pathway responsible for cell defense against oxidative stress and maintaining the cellular redox balance at physiol. levels.  The relation between NRF2/KEAP1 signaling and regulation of apoptosis and autophagy is not well understood.  In this hypothesis article we discuss how KEAP1 protein and its direct interactants (such as PGAM5, prothymosin α, FAC1 (BPTF), and p62) provide a mol. foundation for a possible cross-talk between NRF2/KEAP1, apoptosis, and autophagy pathways.  We present a hypothesis for how NRF2/KEAP1 may interfere with the cellular apoptosis-regulatory machinery through activation of the ASK1 kinase by a KEAP1 binding partner-PGAM5.  Based on very recent exptl. evidence, new hypotheses for a cross-talk between NF-κB and the NRF2/KEAP1 pathway in the context of autophagy-related "mol. hub" protein p62 are also presented.  The roles of KEAP1 mol. binding partners in apoptosis regulation during carcinogenesis and in neurodegenerative diseases are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo1dlSR-O8bVg90H21EOLACvtfcHk0lgpxWPBnHX5Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12rtrc%253D&md5=0f1109f42ac9cbe9e2f86f77f2a74f43</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DStepkowski%26aufirst%3DT.%2BM.%26aulast%3DKruszewski%26aufirst%3DM.%2BK.%26atitle%3DMolecular%2520cross-talk%2520between%2520the%2520NRF2%252FKEAP1%2520signaling%2520pathway%252C%2520autophagy%252C%2520and%2520apoptosis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D50%26spage%3D1186%26epage%3D1195%26doi%3D10.1016%2Fj.freeradbiomed.2011.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Targeting Oxidative Stress in Stroke</span>. In  <i>Neuroprotective Therapy for Stroke and Ischemic Disease</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapchak, P. A</span>, <span class="NLM_string-name">Zhang, J.</span></span>, Eds.; <span class="NLM_series">Springer Series in Translational Stroke Research</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">250</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1007%2F978-3-319-45345-3_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=203-250&author=A.+Bachauthor=P.+A+Lapchak&author=J.+Zhang&title=Neuroprotective+Therapy+for+Stroke+and+Ischemic+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-45345-3_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-45345-3_8%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DA.%26atitle%3DTargeting%2520Oxidative%2520Stress%2520in%2520Stroke%26btitle%3DNeuroprotective%2520Therapy%2520for%2520Stroke%2520and%2520Ischemic%2520Disease%26aulast%3DLapchak%26aufirst%3DP.%2BA%26pub%3DSpringer%26date%3D2017%26spage%3D203%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rushmore, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span> <span> </span><span class="NLM_article-title">The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">11632</span>– <span class="NLM_lpage">11639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=11632-11639&author=T.+H.+Rushmoreauthor=M.+R.+Mortonauthor=C.+B.+Pickett&title=The+antioxidant+responsive+element.+Activation+by+oxidative+stress+and+identification+of+the+DNA+consensus+sequence+required+for+functional+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRushmore%26aufirst%3DT.%2BH.%26aulast%3DMorton%26aufirst%3DM.%2BR.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26atitle%3DThe%2520antioxidant%2520responsive%2520element.%2520Activation%2520by%2520oxidative%2520stress%2520and%2520identification%2520of%2520the%2520DNA%2520consensus%2520sequence%2520required%2520for%2520functional%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D11632%26epage%3D11639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1101/gad.13.1.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1101%2Fgad.13.1.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=9887101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=76-86&author=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=T.+Ishiiauthor=K.+Igarashiauthor=J.+D.+Engelauthor=M.+Yamamoto&title=Keap1+represses+nuclear+activation+of+antioxidant+responsive+elements+by+Nrf2+through+binding+to+the+amino-terminal+Neh2+domain&doi=10.1101%2Fgad.13.1.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span></div><div class="casAuthors">Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Ishii, Tetsuro; Igarashi, Kazuhiko; Engel, James Douglas; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-86</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is essential for the antioxidant responsive element 〈ARE〉-mediated induction of phase II detoxifying and oxidative stress enzyme genes.  Detailed anal. of differential Nrf2 activity displayed in transfected cell lines ultimately led to the identification of a new protein, which we named Keap1, that suppresses Nrf2 transcriptional activity by specific binding to its evolutionarily conserved amino-terminal regulatory domain.  The closest homolog of Keap1 is a Drosophila actin-binding protein called Kelch, implying that Keap1 might be a Nrf2 cytoplasmic effector.  We then showed that electrophilic agents antagonize Keap1 inhibition of Nrf2 activity in vivo, allowing Nrf2 to traverse from the cytoplasm to the nucleus and potentiate the ARE response.  We postulate that Keap1 and Nrf2 constitute a crucial cellular sensor for oxidative stress, and together mediate a key step in the signaling pathway that leads to transcriptional activation by this novel Nrf2 nuclear shuttling mechanism.  The activation of Nrf2 leads in turn to the induction of phase II enzyme and antioxidative stress genes in response to electrophiles and reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQy--aOMXTI7Vg90H21EOLACvtfcHk0lgpxWPBnHX5Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D&md5=1f6cdf6615b03719dedbffe01d0be2ec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.1.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.1.76%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520represses%2520nuclear%2520activation%2520of%2520antioxidant%2520responsive%2520elements%2520by%2520Nrf2%2520through%2520binding%2520to%2520the%2520amino-terminal%2520Neh2%2520domain%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D76%26epage%3D86%26doi%3D10.1101%2Fgad.13.1.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Targeting NRF2 signaling for cancer chemoprevention</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2009.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.taap.2009.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19732782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1GktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2010&pages=66-76&author=M.+K.+Kwakauthor=T.+W.+Kensler&title=Targeting+NRF2+signaling+for+cancer+chemoprevention&doi=10.1016%2Fj.taap.2009.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NRF2 signaling for cancer chemoprevention</span></div><div class="casAuthors">Kwak, Mi-Kyoung; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-76</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Modulation of the metab. and disposition of carcinogens through induction of cytoprotective enzymes is one of several promising strategies to prevent cancer.  Chemopreventive efficacies of inducers such as dithiolethiones and sulforaphane have been extensively studied in animals as well as in humans.  The KEAP1-NRF2 system is a key, but not unilateral, mol. target for these chemopreventive agents.  The transcription factor NRF2 (NF-E2-related factor 2) is a master regulator of the expression of a subset of genes, which produce proteins responsible for the detoxication of electrophiles and reactive oxygen species as well as the removal or repair of some of their damage products.  It is believed that chemopreventive enzyme inducers affect the interaction between KEAP1 and NRF2 through either mediating conformational changes of the KEAP1 protein or activating phosphorylation cascades targeting the KEAP1-NRF2 complex.  These events in turn affect NRF2 stability and trafficking.  Recent advances elucidating the underlying structural biol. of KEAP1-NRF2 signaling and identification of the gene clusters under the transcriptional control of NRF2 are facilitating understanding of the potential pleiotropic effects of NRF2 activators and discovery of novel classes of potent chemopreventive agents such as the triterpenoids.  Although there is appropriately a concern regarding a deleterious role of the KEAP1-NRF2 system in cancer cell biol., esp. as the pathway affects cell survival and drug resistance, the development and the use of NRF2 activators as chemopreventive agents still holds a great promise for protection of normal cells from a diversity of environmental stresses that contribute to the burden of cancer and other chronic, degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWff4laOk-bbVg90H21EOLACvtfcHk0lhwK8q0lvNrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1GktLs%253D&md5=3d842b5dd1a4cd52a6d3bfaa1175741d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2009.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2009.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DM.%2BK.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520NRF2%2520signaling%2520for%2520cancer%2520chemoprevention%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2010%26volume%3D244%26spage%3D66%26epage%3D76%26doi%3D10.1016%2Fj.taap.2009.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule modulators of Keap1–Nrf2-ARE pathway as potential preventive and therapeutic agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/med.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Hu&title=Small+molecule+modulators+of+Keap1%E2%80%93Nrf2-ARE+pathway+as+potential+preventive+and+therapeutic+agents&doi=10.1002%2Fmed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0lhwK8q0lvNrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520Keap1%25E2%2580%2593Nrf2-ARE%2520pathway%2520as%2520potential%2520preventive%2520and%2520therapeutic%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726%26doi%3D10.1002%2Fmed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Kelch-like ECH-associated protein 1. nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein–protein interaction inhibitors: achievements, challenges, and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=Q.+D.+You&title=Discovery+and+development+of+Kelch-like+ECH-associated+protein+1.+nuclear+factor+erythroid+2-related+factor+2+%28KEAP1%3ANRF2%29+protein%E2%80%93protein+interaction+inhibitors%3A+achievements%2C+challenges%2C+and+future+directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0lhMlmISW9dyqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Kelch-like%2520ECH-associated%2520protein%25201.%2520nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%253A%2520achievements%252C%2520challenges%252C%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Breemen, R. B.</span></span> <span> </span><span class="NLM_article-title">Sites of alkylation of human Keap1 by natural chemoprevention agents</span>. <i>J. Am. Soc. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2226</span>– <span class="NLM_lpage">2232</span>, <span class="refDoi"> DOI: 10.1016/j.jasms.2007.09.015</span> </span><div class="citationLinks">[<a href="/doi/10.1016/j.jasms.2007.09.015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlynsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=2226-2232&author=Y.+Luoauthor=A.+L.+Egglerauthor=D.+Liuauthor=G.+Liuauthor=A.+D.+Mesecarauthor=R.+B.+van+Breemen&title=Sites+of+alkylation+of+human+Keap1+by+natural+chemoprevention+agents&doi=10.1016%2Fj.jasms.2007.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sites of Alkylation of Human Keap1 by Natural Chemoprevention Agents</span></div><div class="casAuthors">Luo, Yan; Eggler, Aimee L.; Liu, Dongting; Liu, Guowen; Mesecar, Andrew D.; van Breemen, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2226-2232</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Under basal conditions, the interaction of the cytosolic protein Keap1 (Kelch-like ECH-assocd. protein 1) with the transcription factor nuclear factor-E2-related factor 2 (Nrf2) results in a low level of expression of cytoprotective genes whose promoter region contains the antioxidant response element (ARE).  Alkylation of one or more of the 27 cysteine sulfhydryl groups of human Keap1 is proposed to lead to Nrf2 nuclear accumulation, to upregulation of cytoprotective gene expression by the ARE, and to prevention of degenerative diseases, such as cancer.  Therefore, identification of the most reactive of these cysteine residues toward specific electrophiles should help clarify this mechanism of cancer prevention, also known as chemoprevention.  To address this issue, preliminary analyses of tryptic digests of Keap1 alkylated by the model electrophile 1-biotinamido-4-(4'-[maleimidoethyl-cyclohexane]-carboxamido) butane were carried out using liq. chromatog.-tandem mass spectrometry (LC-MS/MS) with a cylindrical ion trap mass spectrometer and also using LC-MS/MS with a hybrid linear ion trap FT ICR mass spectrometer.  Because the FT ICR instrument provided more complete peptide sequencing coverage and enabled the identification of more alkylated cysteine residues, only this instrument was used in subsequent studies of Keap1 alkylation by three electrophilic natural products that can upregulate the ARE, xanthohumol, isoliquiritigenin, and 10-shogaol.  Among the various cysteine residues of Keap1, C151 was most reactive toward these three electrophiles.  These in vitro results agree with evidence from in vivo expts., and indicate that C151 is the most important site of alkylation on Keap1 by chemoprevention agents that function by activating the ARE through Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1CfFns9I_jrVg90H21EOLACvtfcHk0lhMlmISW9dyqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlynsbzM&md5=b55586ce57947e0db94395c5785a54b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.jasms.2007.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jasms.2007.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DEggler%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3Dvan%2BBreemen%26aufirst%3DR.%2BB.%26atitle%3DSites%2520of%2520alkylation%2520of%2520human%2520Keap1%2520by%2520natural%2520chemoprevention%2520agents%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D2007%26volume%3D18%26spage%3D2226%26epage%3D2232%26doi%3D10.1016%2Fj.jasms.2007.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzclaw, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">11908</span>– <span class="NLM_lpage">11913</span>, <span class="refDoi"> DOI: 10.1073/pnas.172398899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1073%2Fpnas.172398899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=12193649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11908-11913&author=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=R.+N.+Coleauthor=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=M.+Yamamotoauthor=P.+Talalay&title=Direct+evidence+that+sulfhydryl+groups+of+Keap1+are+the+sensors+regulating+induction+of+phase+2+enzymes+that+protect+against+carcinogens+and+oxidants&doi=10.1073%2Fpnas.172398899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Cole, Robert N.; Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Yamamoto, Masayuki; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11908-11913</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coordinate induction of phase 2 proteins and elevation of glutathione protect cells against the toxic and carcinogenic effects of electrophiles and oxidants.  All inducers react covalently with thiols at rates that are closely related to their potencies.  Inducers disrupt the cytoplasmic complex between the actin-bound protein Keap1 and the transcription factor Nrf2, thereby releasing Nrf2 to migrate to the nucleus where it activates the antioxidant response element (ARE) of phase 2 genes and accelerates their transcription.  We cloned, overexpressed, and purified murine Keap1 and demonstrated on native gels the formation of complexes of Keap1 with the Neh2 domain of Nrf2 and their concn.-dependent disruption by inducers such as sulforaphane and bis(2-hydroxybenzylidene)acetone.  The kinetics, stoichiometry, and order of reactivities of the most reactive of the 25 cysteine thiol groups of Keap1 have been detd. by tritium incorporation from [3H]dexamethasone mesylate (an inducer and irreversible modifier of thiols) and by UV spectroscopy with sulforaphane, 2,2'-dipyridyl disulfide and 4,4'-dipyridyl disulfide (titrants of thiol groups), and two closely related Michael reaction acceptors [bis(2- and 4-hydroxybenzylidene)acetones] that differ 100-fold in inducer potency and the UV spectra of which are bleached by thiol addn.  With large excesses of these reagents nearly all thiols of Keap1 react, but sequential reaction with three successive single equiv. (per cysteine residue) of dipyridyl disulfides revealed excellent agreement with pseudo-first order kinetics, rapid successive declines in reaction velocity, and the stoichiometric formation of two equiv. of thiopyridone per reacted cysteine.  This finding suggests that reaction of cysteine thiols is followed by rapid formation of protein disulfide linkages.  The most reactive residues of Keap1 (C257, C273, C288, and C297) were identified by mapping the dexamethasone-modified cysteines by mass spectrometry of tryptic peptides.  These residues are located in the intervening region between BTB and Kelch repeat domains of Keap1 and probably are the direct sensors of inducers of the phase 2 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAg7V1wdZgxLVg90H21EOLACvtfcHk0lhQ5el_Ms-AHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D&md5=83a3b1b0549cf21153805e9c04f36620</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172398899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172398899%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DCole%26aufirst%3DR.%2BN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DDirect%2520evidence%2520that%2520sulfhydryl%2520groups%2520of%2520Keap1%2520are%2520the%2520sensors%2520regulating%2520induction%2520of%2520phase%25202%2520enzymes%2520that%2520protect%2520against%2520carcinogens%2520and%2520oxidants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11908%26epage%3D11913%26doi%3D10.1073%2Fpnas.172398899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1–Nrf2 protein complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">15259</span>– <span class="NLM_lpage">15264</span>, <span class="refDoi"> DOI: 10.1073/pnas.1305687110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1073%2Fpnas.1305687110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15259-15264&author=L.+Bairdauthor=D.+Lleresauthor=S.+Swiftauthor=A.+T.+Dinkova-Kostova&title=Regulatory+flexibility+in+the+Nrf2-mediated+stress+response+is+conferred+by+conformational+cycling+of+the+Keap1%E2%80%93Nrf2+protein+complex&doi=10.1073%2Fpnas.1305687110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1305687110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1305687110%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DRegulatory%2520flexibility%2520in%2520the%2520Nrf2-mediated%2520stress%2520response%2520is%2520conferred%2520by%2520conformational%2520cycling%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D15259%26epage%3D15264%26doi%3D10.1073%2Fpnas.1305687110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide and small molecule inhibitors of the Keap1–Nrf2 protein–protein interaction</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1042/BST20150051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1042%2FBST20150051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26551711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=674-679&author=G.+Wells&title=Peptide+and+small+molecule+inhibitors+of+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1042%2FBST20150051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid-2-related factor 2 (Nrf2) up-regulates the expression of a range of cytoprotective enzymes with antioxidant response elements in their promoter regions and thus can protect cells against oxidative damage.  Increasing Nrf2 activity has been proposed as a therapeutic intervention in a range of chronic neurodegenerative conditions and cancer chemoprevention.  One of the main mechanisms by which Nrf2 is neg. regulated involves an interaction with the ubiquitination facilitator protein, Kelch-like ECH-assocd. protein 1 (Keap1) that facilitates degrdn. of Nrf2.  Inhibition of this process underlies the mode of action of a broad group of compds. that increase Nrf2 activity.  A no. of natural products, including the isothiocyanate sulforaphane, up-regulate Nrf2 by interacting with Keap1 in a covalent manner to stall its activity.  Recently, a no. of peptide and small mol. inhibitors of the protein-protein interaction (PPI) between Keap1 and Nrf2 have been described.  These classes of compd. have contrasting modes of action at the mol. level and there is emerging evidence that their biol. activities have similarities and differences.  This review describes the various classes of PPI inhibitor that have been described in the literature and the biol. evaluations that have been performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQzcvZNfjrLVg90H21EOLACvtfcHk0lgojL-0dJnqXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E&md5=2cb4acbd2a04ecdf29424638894c81e3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBST20150051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150051%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520small%2520molecule%2520inhibitors%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D674%26epage%3D679%26doi%3D10.1042%2FBST20150051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bista, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hronowsky, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellrichmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goelz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span> <span> </span><span class="NLM_article-title">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">678</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1093/brain/awq386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1093%2Fbrain%2Fawq386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21354971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=678-692&author=R.+A.+Linkerauthor=D.+H.+Leeauthor=S.+Ryanauthor=A.+M.+van+Damauthor=R.+Conradauthor=P.+Bistaauthor=W.+Zengauthor=X.+Hronowskyauthor=A.+Bukoauthor=S.+Chollateauthor=G.+Ellrichmannauthor=W.+Bruckauthor=K.+Dawsonauthor=S.+Goelzauthor=S.+Wieseauthor=R.+H.+Scannevinauthor=M.+Lukashevauthor=R.+Gold&title=Fumaric+acid+esters+exert+neuroprotective+effects+in+neuroinflammation+via+activation+of+the+Nrf2+antioxidant+pathway&doi=10.1093%2Fbrain%2Fawq386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span></div><div class="casAuthors">Linker Ralf A; Lee De-Hyung; Ryan Sarah; van Dam Anne M; Conrad Rebecca; Bista Pradeep; Zeng Weike; Hronowsky Xiaoping; Buko Alex; Chollate Sowmya; Ellrichmann Gisa; Bruck Wolfgang; Dawson Kate; Goelz Susan; Wiese Stefan; Scannevin Robert H; Lukashev Matvey; Gold Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">Pt 3</span>),
    <span class="NLM_cas:pages">678-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation and oxidative stress are thought to promote tissue damage in multiple sclerosis.  Thus, novel therapeutics enhancing cellular resistance to free radicals could prove useful for multiple sclerosis treatment.  BG00012 is an oral formulation of dimethylfumarate.  In a phase II multiple sclerosis trial, BG00012 demonstrated beneficial effects on relapse rate and magnetic resonance imaging markers indicative of inflammation as well as axonal destruction.  First we have studied effects of dimethylfumarate on the disease course, central nervous system, tissue integrity and the molecular mechanism of action in an animal model of chronic multiple sclerosis: myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis in C57BL/6 mice.  In the chronic phase of experimental autoimmune encephalomyelitis, preventive or therapeutic application of dimethylfumarate ameliorated the disease course and improved preservation of myelin, axons and neurons.  In vitro, the application of fumarates increased murine neuronal survival and protected human or rodent astrocytes against oxidative stress.  Application of dimethylfumarate led to stabilization of the transcription factor nuclear factor (erythroid-derived 2)-related factor 2, activation of nuclear factor (erythroid-derived 2)-related factor 2-dependent transcriptional activity and accumulation of NADP(H) quinoline oxidoreductase-1 as a prototypical target gene.  Furthermore, the immediate metabolite of dimethylfumarate, monomethylfumarate, leads to direct modification of the inhibitor of nuclear factor (erythroid-derived 2)-related factor 2, Kelch-like ECH-associated protein 1, at cysteine residue 151.  In turn, increased levels of nuclear factor (erythroid-derived 2)-related factor 2 and reduced protein nitrosylation were detected in the central nervous sytem of dimethylfumarate-treated mice.  Nuclear factor (erythroid-derived 2)-related factor 2 was also upregulated in the spinal cord of autopsy specimens from untreated patients with multiple sclerosis.  In dimethylfumarate-treated mice suffering from experimental autoimmune encephalomyelitis, increased immunoreactivity for nuclear factor (erythroid-derived 2)-related factor 2 was detected by confocal microscopy in neurons of the motor cortex and the brainstem as well as in oligodendrocytes and astrocytes.  In mice deficient for nuclear factor (erythroid-derived 2)-related factor 2 on the same genetic background, the dimethylfumarate mediated beneficial effects on clinical course, axon preservation and astrocyte activation were almost completely abolished thus proving the functional relevance of this transcription factor for the neuroprotective mechanism of action.  We conclude that the ability of dimethylfumarate to activate nuclear factor (erythroid-derived 2)-related factor 2 may offer a novel cytoprotective modality that further augments the natural antioxidant responses in multiple sclerosis tissue and is not yet targeted by other multiple sclerosis therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAUtIRbYJEbB0LsK7uFuY7fW6udTcc2ebkCrz2uLaJl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D&md5=d113bf628d25500b5c612938a7571fd9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawq386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawq386%26sid%3Dliteratum%253Aachs%26aulast%3DLinker%26aufirst%3DR.%2BA.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DRyan%26aufirst%3DS.%26aulast%3Dvan%2BDam%26aufirst%3DA.%2BM.%26aulast%3DConrad%26aufirst%3DR.%26aulast%3DBista%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHronowsky%26aufirst%3DX.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DEllrichmann%26aufirst%3DG.%26aulast%3DBruck%26aufirst%3DW.%26aulast%3DDawson%26aufirst%3DK.%26aulast%3DGoelz%26aufirst%3DS.%26aulast%3DWiese%26aufirst%3DS.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DR.%26atitle%3DFumaric%2520acid%2520esters%2520exert%2520neuroprotective%2520effects%2520in%2520neuroinflammation%2520via%2520activation%2520of%2520the%2520Nrf2%2520antioxidant%2520pathway%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D678%26epage%3D692%26doi%3D10.1093%2Fbrain%2Fawq386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prosperini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontecorvo, S.</span></span> <span> </span><span class="NLM_article-title">Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations</span>. <i>Ther. Clin. Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.2147/TCRM.S85099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.2147%2FTCRM.S85099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27042079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtlWrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=339-350&author=L.+Prosperiniauthor=S.+Pontecorvo&title=Dimethyl+fumarate+in+the+management+of+multiple+sclerosis%3A+appropriate+patient+selection+and+special+considerations&doi=10.2147%2FTCRM.S85099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations</span></div><div class="casAuthors">Prosperini, Luca; Pontecorvo, Simona</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">339-350</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1178-203X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Delayed-release di-Me fumarate (DMF), also known as gastroresistant DMF, is the most recently approved oral disease-modifying treatment (DMT) for relapsing multiple sclerosis.  Two randomized clin. trials (Detn. of the Efficacy and Safety of Oral Fumarate in Relapsing -Remitting MS [DEFINE] and Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis [CONFIRM]) demonstrated significant efficacy in reducing relapse rate and radiol. signs of disease activity, as seen on magnetic resonance imaging.  The DEFINE study also indicated a significant effect of DMF on disability worsening, while the low incidence of confirmed disability worsening in the CONFIRM trial rendered an insignificant redn. among the DMF-treated groups when compared to placebo.  DMF also demonstrated a good safety profile and acceptable tolerability, since the most common side effects (gastrointestinal events and flushing reactions) are usually transient and mild to moderate in severity.  Here, we discuss the place in therapy of DMF for individuals with relapsing multiple sclerosis, providing a tentative therapeutic algorithm to manage newly diagnosed patients and those who do not adequately respond to self-injectable DMTs.  Literature data supporting the potential role of DMF as a first-line therapy are presented.  The possibility of using DMF as switching treatment or even as an add-on strategy in patients with breakthrough disease despite self-injectable DMTs will also be discussed.  Lastly, we argue about the role of DMF as an exit strategy from natalizumab-treated patients who are considered at risk for developing multifocal progressive leukoencephalopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNXQ26o8mDiLVg90H21EOLACvtfcHk0ljyhX_pesT1yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtlWrsbc%253D&md5=1e0dda79d7ded97c83232b0e46d88fbd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2147%2FTCRM.S85099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FTCRM.S85099%26sid%3Dliteratum%253Aachs%26aulast%3DProsperini%26aufirst%3DL.%26aulast%3DPontecorvo%26aufirst%3DS.%26atitle%3DDimethyl%2520fumarate%2520in%2520the%2520management%2520of%2520multiple%2520sclerosis%253A%2520appropriate%2520patient%2520selection%2520and%2520special%2520considerations%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2016%26volume%3D12%26spage%3D339%26epage%3D350%26doi%3D10.2147%2FTCRM.S85099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickle, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span> <span> </span><span class="NLM_article-title">Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e98896</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0098896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1371%2Fjournal.pone.0098896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24896564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e98896&author=A.+Cleasbyauthor=J.+Yonauthor=P.+J.+Dayauthor=C.+Richardsonauthor=I.+J.+Tickleauthor=P.+A.+Williamsauthor=J.+F.+Callahanauthor=R.+Carrauthor=N.+Conchaauthor=J.+K.+Kernsauthor=H.+Qiauthor=T.+Sweitzerauthor=P.+Wardauthor=T.+G.+Davies&title=Structure+of+the+BTB+domain+of+Keap1+and+its+interaction+with+the+triterpenoid+antagonist+CDDO&doi=10.1371%2Fjournal.pone.0098896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO</span></div><div class="casAuthors">Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Callahan, James F.; Carr, Robin; Concha, Nestor; Kerns, Jeffrey K.; Qi, Hongwei; Sweitzer, Thomas; Ward, Paris; Davies, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e98896/1-e98896/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A review.  The protein Keap1 is central to the regulation of the Nrf2-mediated cytoprotective response, and is increasingly recognized as an important target for therapeutic intervention in a range of diseases involving excessive oxidative stress and inflammation.  The BTB domain of Keap1 plays key roles in sensing environmental electrophiles and in mediating interactions with the Cul3/Rbx1 E3 ubiquitin ligase system, and is believed to be the target for several small mol. covalent activators of the Nrf2 pathway.  However, despite structural information being available for several BTB domains from related proteins, there have been no reported crystal structures of Keap1 BTB, and this has precluded a detailed understanding of its mechanism of action and interaction with antagonists.  We report here the first structure of the BTB domain of Keap1, which is thought to contain the key cysteine residue responsible for interaction with electrophiles, as well as structures of the covalent complex with the antagonist CDDO/bardoxolone, and of the constitutively inactive C151W BTB mutant.  In addn. to providing the first structural confirmation of antagonist binding to Keap1 BTB, we also present biochem. evidence that adduction of Cys 151 by CDDO is capable of inhibiting the binding of Cul3 to Keap1, and discuss how this class of compd. might exert Nrf2 activation through disruption of the BTB-Cul3 interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-yi4jSWD-bVg90H21EOLACvtfcHk0ljyhX_pesT1yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I&md5=f9c6542ff2508a74313e996ccdafa0ae</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0098896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0098896%26sid%3Dliteratum%253Aachs%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DT.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26atitle%3DStructure%2520of%2520the%2520BTB%2520domain%2520of%2520Keap1%2520and%2520its%2520interaction%2520with%2520the%2520triterpenoid%2520antagonist%2520CDDO%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De98896%26doi%3D10.1371%2Fjournal.pone.0098896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2219</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2005.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=15837296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2215-2219&author=R.+D.+Couchauthor=R.+G.+Browningauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=D.+L.+Wrightauthor=M.+B.+Spornauthor=A.+C.+Anderson&title=Studies+on+the+reactivity+of+CDDO%2C+a+promising+new+chemopreventive+and+chemotherapeutic+agent%3A+implications+for+a+molecular+mechanism+of+action&doi=10.1016%2Fj.bmcl.2005.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span></div><div class="casAuthors">Couch, Robin D.; Browning, R. Greg; Honda, Tadashi; Gribble, Gordon W.; Wright, Dennis L.; Sporn, Michael B.; Anderson, Amy C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2215-2219</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CDDO, a semi-synthetic triterpenoid derived from oleanolic acid, has the potential to be used as a chemopreventive and chemotherapeutic agent.  The structure of CDDO contains two α,β-unsatd. carbonyl moieties, suggesting a mechanism of action involving a conjugate nucleophilic addn.  Spectroscopic evaluation with thiol nucleophiles illustrates that an addn. does indeed occur, but this addn. is selective and reversible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEly4KE1L3bVg90H21EOLACvtfcHk0ljtZGilE5fHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D&md5=403474a7b33ce6f42e93ad3f9bbd84b0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DCouch%26aufirst%3DR.%2BD.%26aulast%3DBrowning%26aufirst%3DR.%2BG.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DStudies%2520on%2520the%2520reactivity%2520of%2520CDDO%252C%2520a%2520promising%2520new%2520chemopreventive%2520and%2520chemotherapeutic%2520agent%253A%2520implications%2520for%2520a%2520molecular%2520mechanism%2520of%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2215%26epage%3D2219%26doi%3D10.1016%2Fj.bmcl.2005.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morra, R. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendis, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mierke, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span> <span> </span><span class="NLM_article-title">New monocyclic, bicyclic, and tricyclic ethynylcyanodienones as activators of the Keap1/Nrf2/ARE pathway and inhibitors of inducible nitric oxide synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4738</span>– <span class="NLM_lpage">4748</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4738-4748&author=W.+Liauthor=S.+Zhengauthor=M.+Higginsauthor=R.+P.+Morraauthor=A.+T.+Mendisauthor=C.+W.+Chienauthor=I.+Ojimaauthor=D.+F.+Mierkeauthor=A.+T.+Dinkova-Kostovaauthor=T.+Honda&title=New+monocyclic%2C+bicyclic%2C+and+tricyclic+ethynylcyanodienones+as+activators+of+the+Keap1%2FNrf2%2FARE+pathway+and+inhibitors+of+inducible+nitric+oxide+synthase&doi=10.1021%2Facs.jmedchem.5b00393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00393%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DMorra%26aufirst%3DR.%2BP.%26aulast%3DMendis%26aufirst%3DA.%2BT.%26aulast%3DChien%26aufirst%3DC.%2BW.%26aulast%3DOjima%26aufirst%3DI.%26aulast%3DMierke%26aufirst%3DD.%2BF.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHonda%26aufirst%3DT.%26atitle%3DNew%2520monocyclic%252C%2520bicyclic%252C%2520and%2520tricyclic%2520ethynylcyanodienones%2520as%2520activators%2520of%2520the%2520Keap1%252FNrf2%252FARE%2520pathway%2520and%2520inhibitors%2520of%2520inducible%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4738%26epage%3D4748%26doi%3D10.1021%2Facs.jmedchem.5b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Zeeuw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambers Heerspink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaziri, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrolstad, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1306033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1056%2FNEJMoa1306033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24206459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=2492-2503&author=D.+de%0AZeeuwauthor=T.+Akizawaauthor=P.+Audhyaauthor=G.+L.+Bakrisauthor=M.+Chinauthor=H.+Christ-Schmidtauthor=A.+Goldsberryauthor=M.+Houserauthor=M.+Krauthauthor=H.+J.+Lambers+Heerspinkauthor=J.+J.+McMurrayauthor=C.+J.+Meyerauthor=H.+H.+Parvingauthor=G.+Remuzziauthor=R.+D.+Totoauthor=N.+D.+Vaziriauthor=C.+Wannerauthor=J.+Wittesauthor=D.+Wrolstadauthor=G.+M.+Chertow&title=Bardoxolone+methyl+in+type+2+diabetes+and+stage+4+chronic+kidney+disease&doi=10.1056%2FNEJMoa1306033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span></div><div class="casAuthors">de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L.; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Lambers Heerspink, Hiddo J.; McMurray, John J.; Meyer, Colin J.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D.; Vaziri, Nosratola D.; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2492-2503</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Although inhibitors of the renin-angiotensin-aldosterone system can slow the progression of diabetic kidney disease, the residual risk is high.  Whether nuclear I factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown.  METHODS: We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estd. glomerular filtration rate [GFR], 15 to <30 mL per min per 1.73 m2 of body-surface area) to bardoxolone Me, at a daily dose of 20 mg, or placebo.  The primary composite outcome was end-stage renal disease (ESRD) or death from cardiovascular causes.  RESULTS: The sponsor and the steering committee terminated the trial on the recommendation of the independent data and safety monitoring committee; the median follow-up was 9 mo.  A total of 69 of 1088 patients (6%) randomly assigned to bardoxolone Me and 69 of 1097 (6%) randomly assigned to placebo had a primary composite outcome (hazard ratio in the bardoxolone Me group vs. the placebo group, 0.98; 95% confidence interval [CI], 0.70 to 1.37; P = 0.92).  In the bardoxolone Me group, ESRD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, ESRD developed In 51 patients, and 19 patients died from cardiovascular causes.  A total of 96 patients in the bardoxolone Me group were hospitalized for heart failure or died from heart failure, as compared with 55 in the placebo group (hazard ratio, 1.83; 95% CI, 1.32 to 2.55; P < 0.001).  Estd. GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significantly and body wt. decreased significantly in the bardoxolone Me group, as compared with the placebo group.  CONCLUSIONS: Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone Me did not reduce the risk of ESRD or death from cardiovascular causes.  A higher rate of cardiovascular events with bardoxolone Me than with placebo prompted termination of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI6Z9q4C0LLVg90H21EOLACvtfcHk0lguKME2wE1Aqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D&md5=1bcc997b57ba700423e0549a617231b5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1306033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1306033%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DHouser%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWrolstad%26aufirst%3DD.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26atitle%3DBardoxolone%2520methyl%2520in%2520type%25202%2520diabetes%2520and%2520stage%25204%2520chronic%2520kidney%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D2492%26epage%3D2503%26doi%3D10.1056%2FNEJMoa1306033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Updated research and applications of small molecule inhibitors of Keap1–Nrf2 protein–protein interaction: a review</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1861</span>– <span class="NLM_lpage">1870</span>, <span class="refDoi"> DOI: 10.2174/0929867321666140217104648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.2174%2F0929867321666140217104648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24533814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1GntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1861-1870&author=C.+Zhuangauthor=Z.+Miaoauthor=C.+Shengauthor=W.+Zhang&title=Updated+research+and+applications+of+small+molecule+inhibitors+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction%3A+a+review&doi=10.2174%2F0929867321666140217104648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review</span></div><div class="casAuthors">Zhuang, Chunlin; Miao, Zhenyuan; Sheng, Chunquan; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1861-1870</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2-ARE pathway is one of the most important regulators of cytoprotective responses to oxidative and/or electrophilic stresses, which is believed to play a crit. role in the development of many diseases, such as cancer, Alzheimer's, Parkinson's, and inflammatory bowel disease.  Recent research indicates that the modulation of ARE activation via direct inhibition of the Keap1-Nrf2protein-protein interaction has many advantages, particularly the low cytotoxicity, over indirect covalent modulators of Keap1 protein for the discovery of novel small mol. modulators of this pathway.  However, most known inducers (e.g., triterpenoids, isothiocyanates and sulfoxythiocarbamates) that activate the ARE system through electrophilic attacks on the cysteine sulfhydryl group of Keap1 also disrupt the Keap1-Nrf2 interaction.  The understanding of co-crystal complex of the Keap1-Nrf2 interaction thus provides a structural basis for the rational design of highly potent direct inhibitors.  This review summarizes the recent advances in the medicinal chem. of small-mol. inhibitors in the areas of drug design, structure-activity relationships, and biol. and biochem. properties.  The peptides designed from DLG and ETGE motifs of Nrf2 protein that binds to Keap1 Kelch domain with promising binding affinities are highlighted.  This review also includes recently reported non-peptide inhibitors with moderate inhibition by high-throughput screening.  It is clear that further research is required for the discovery of more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL9p68R4_XjbVg90H21EOLACvtfcHk0lgJog3U7uku4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1GntLc%253D&md5=2212c05157cd12e7dcf342b1db2afe76</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140217104648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140217104648%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DUpdated%2520research%2520and%2520applications%2520of%2520small%2520molecule%2520inhibitors%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%253A%2520a%2520review%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1861%26epage%3D1870%26doi%3D10.2174%2F0929867321666140217104648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abed, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.apsb.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26579458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=285-299&author=D.+A.+Abedauthor=M.+Goldsteinauthor=H.+Albanyanauthor=H.+Jinauthor=L.+Hu&title=Discovery+of+direct+inhibitors+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+as+potential+therapeutic+and+preventive+agents&doi=10.1016%2Fj.apsb.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents</span></div><div class="casAuthors">Abed Dhulfiqar Ali; Goldstein Melanie; Albanyan Haifa; Jin Huijuan; Hu Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-99</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">The Keap1-Nrf2-ARE pathway is an important antioxidant defense mechanism that protects cells from oxidative stress and the Keap1-Nrf2 protein-protein interaction (PPI) has become an important drug target to upregulate the expression of ARE-controlled cytoprotective oxidative stress response enzymes in the development of therapeutic and preventive agents for a number of diseases and conditions.  However, most known Nrf2 activators/ARE inducers are indirect inhibitors of Keap1-Nrf2 PPI and they are electrophilic species that act by modifying the sulfhydryl groups of Keap1 s cysteine residues.  The electrophilicity of these indirect inhibitors may cause "off-target" side effects by reacting with cysteine residues of other important cellular proteins.  Efforts have recently been focused on the development of direct inhibitors of Keap1-Nrf2 PPI.  This article reviews these recent research efforts including the development of high throughput screening assays, the discovery of peptide and small molecule direct inhibitors, and the biophysical characterization of the binding of these inhibitors to the target Keap1 Kelch domain protein.  These non-covalent direct inhibitors of Keap1-Nrf2 PPI could potentially be developed into effective therapeutic or preventive agents for a variety of diseases and conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl5Pq5LRczm8ffW6udTcc2eZatfsoKS1-1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D&md5=a22499ab91854a1038e0f18fee0886e3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DAbed%26aufirst%3DD.%2BA.%26aulast%3DGoldstein%26aufirst%3DM.%26aulast%3DAlbanyan%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520direct%2520inhibitors%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520as%2520potential%2520therapeutic%2520and%2520preventive%2520agents%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D285%26epage%3D299%26doi%3D10.1016%2Fj.apsb.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bakry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laoruchupong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.10.486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2011.10.486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22107959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=444-451&author=R.+Hancockauthor=H.+C.+Bertrandauthor=T.+Tsujitaauthor=S.+Nazauthor=A.+El-Bakryauthor=J.+Laoruchupongauthor=J.+D.+Hayesauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1016%2Fj.freeradbiomed.2011.10.486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Hancock, Rowena; Bertrand, Helene C.; Tsujita, Tadayuki; Naz, Shama; El-Bakry, Ayman; Laoruchupong, Jitnueng; Hayes, John D.; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-451</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Disruption of the interaction between the ubiquitination facilitator protein Keap1 and the cap'n'collar basic-region leucine-zipper transcription factor Nrf2 is a potential strategy to enhance expression of antioxidant and free radical detoxification gene products regulated by Nrf2.  Agents that disrupt this protein-protein interaction may be useful pharmacol. probes and future cancer-chemopreventive agents.  We describe the structure-activity relationships for a series of peptides based upon regions of the Nrf2 Neh2 domain, of varying length and sequence, that interact with the Keap1 Kelch domain and disrupt the interaction with Nrf2.  We have also investigated sequestosome-1 (p62) and prothymosin-α sequences that have been reported to interact with Keap1.  To achieve this we have developed a high-throughput fluorescence polarization (FP) assay to screen inhibitors.  In addn. to screening synthetic peptides, we have used a phage display library approach to identify putative peptide ligands with non-native sequence motifs.  Candidate peptides from the phage display library screening protocol were evaluated in the FP assay to quantify their binding activity.  Hybrid peptides based upon the Nrf2 "ETGE" motif and the sequestosome-1 "Keap1-interaction region" have superior binding activity compared to either native peptide alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrdLfQUd3TrVg90H21EOLACvtfcHk0li_-xkfj1Gz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D&md5=e48014219fb0738c2af6cb8301d73968</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.10.486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.10.486%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DTsujita%26aufirst%3DT.%26aulast%3DNaz%26aufirst%3DS.%26aulast%3DEl-Bakry%26aufirst%3DA.%26aulast%3DLaoruchupong%26aufirst%3DJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D444%26epage%3D451%26doi%3D10.1016%2Fj.freeradbiomed.2011.10.486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction with improved binding and cellular activity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3557</span>, <span class="refDoi"> DOI: 10.1039/c3ob40249e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1039%2Fc3ob40249e" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=3553-3557&author=R.+Hancockauthor=M.+Schaapauthor=H.+Pfisterauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+with+improved+binding+and+cellular+activity&doi=10.1039%2Fc3ob40249e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc3ob40249e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob40249e%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DSchaap%26aufirst%3DM.%26aulast%3DPfister%26aufirst%3DH.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520with%2520improved%2520binding%2520and%2520cellular%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D3553%26epage%3D3557%26doi%3D10.1039%2Fc3ob40249e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">14727</span>– <span class="NLM_lpage">14739</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1304-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1523%2FJNEUROSCI.1304-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26538645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVOnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=14727-14739&author=J.+Tuauthor=X.+Zhangauthor=Y.+Zhuauthor=Y.+Daiauthor=N.+Liauthor=F.+Yangauthor=Q.+Zhangauthor=D.+W.+Brannauthor=R.+Wang&title=Cell-permeable+peptide+targeting+the+Nrf2-Keap1+interaction%3A+a+potential+novel+therapy+for+global+cerebral+ischemia&doi=10.1523%2FJNEUROSCI.1304-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia</span></div><div class="casAuthors">Tu, Jingyi; Zhang, Xi; Zhu, Ying; Dai, Yongxin; Li, Ning; Yang, Fang; Zhang, Quanguang; Brann, Darrell W.; Wang, Ruimin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">14727-14739</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The current study examd. efficacy of a small Tat (trans-activator of transcription)-conjugated peptide activator of the Nrf2 (nuclear factor-E2-related factor-2) antioxidant/cell-defense pathway as a potential injury-specific, novel neuroprotectant against global cerebral ischemia (GCI).  A competitive peptide, DEETGE-CAL-Tat, was designed to facilitate Nrf2 activation by disrupting interaction of Nrf2 with Keap1 (kelch-like ECH-assocd. protein 1), a protein that sequesters Nrf2 in the cytoplasm and thereby inactivates it.  The DEETGE-CAL-Tat peptide contained the crit. sequence DEETGE for the Nrf2-Keap1 interaction, the cell transduction domain of the HIV-Tat protein, and the cleavage sequence of calpain, which is sensitive to Ca2+ increase and allows injury-specific activation of Nrf2.  Using an animal model of GCI, we demonstrated that pretreatment with the DEETGE-CAL-Tat peptide markedly decreased Nrf2 interaction with Keap1 in the rat hippocampal CA1 region after GCI, and enhanced Nrf2 nuclear translocation and DNA binding.  The DEETGE-CAL-Tat peptide also induced Nrf2 antioxidant/cytoprotective target genes, reduced oxidative stress, and induced strong neuroprotection and marked preservation of hippocampal-dependent cognitive function after GCI.  These effects were specific as control peptides lacked neuroprotective ability.  Intriguingly, the DEETGE-CAL-Tat peptide effects were also injury specific, as it had no effect upon neuronal survival or cognitive performance in sham nonischemic animals.  Of significant interest, peripheral, postischemia administration of the DEETGE-CAL-Tat peptide from days 1-9 after GCI also induced robust neuroprotection and strongly preserved hippocampal-dependent cognitive function.  Based on its robust neuroprotective and cognitive-preserving effects, and its unique injury-specific activation properties, the DEETGE-CAL-Tat peptide represents a novel, and potentially promising new therapeutic modality for the treatment of GCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvuEdGjFKibVg90H21EOLACvtfcHk0li_-xkfj1Gz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVOnsbs%253D&md5=b603f6dc11efba2ebe24531d18833687</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1304-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1304-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBrann%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DCell-permeable%2520peptide%2520targeting%2520the%2520Nrf2-Keap1%2520interaction%253A%2520a%2520potential%2520novel%2520therapy%2520for%2520global%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D14727%26epage%3D14739%26doi%3D10.1523%2FJNEUROSCI.1304-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adibhatla, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. F.</span></span> <span> </span><span class="NLM_article-title">Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1089/ars.2009.2668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1089%2Fars.2009.2668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19624272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFejt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=125-169&author=R.+M.+Adibhatlaauthor=J.+F.+Hatcher&title=Lipid+oxidation+and+peroxidation+in+CNS+health+and+disease%3A+from+molecular+mechanisms+to+therapeutic+opportunities&doi=10.1089%2Fars.2009.2668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities</span></div><div class="casAuthors">Adibhatla, Rao Muralikrishna; Hatcher, James Franklin</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-169</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are produced at low levels in mammalian cells by various metabolic processes, such as oxidative phosphorylation by the mitochondrial respiratory chain, NAD(P)H oxidases, and arachidonic acid oxidative metab.  To maintain physiol. redox balance, cells have endogenous antioxidant defenses regulated at the transcriptional level by Nrf2/ARE.  Oxidative stress results when ROS prodn. exceeds the cell's ability to detoxify ROS.  Overprodn. of ROS damages cellular components, including lipids, leading to decline in physiol. function and cell death.  Reaction of ROS with lipids produces oxidized phospholipids, which give rise to 4-hydroxynonenal, 4-oxo-2-nonenal, and acrolein.  The brain is susceptible to oxidative damage due to its high lipid content and oxygen consumption.  Neurodegenerative diseases (AD, ALS, bipolar disorder, epilepsy, Friedreich's ataxia, HD, MS, NBIA, NPC, PD, peroxisomal disorders, schizophrenia, Wallerian degeneration, Zellweger syndrome) and CNS traumas (stroke, TBI, SCI) are problems of vast clin. importance.  Free iron can react with H2O2 via the Fenton reaction, a primary cause of lipid peroxidn., and may be of particular importance for these CNS injuries and disorders.  Cholesterol is an important regulator of lipid organization and the precursor for neurosteroid biosynthesis.  Atherosclerosis, the major risk factor for ischemic stroke, involves accumulation of oxidized LDL in the arteries, leading to foam cell formation and plaque development.  This review will discuss the role of lipid oxidn./peroxidn. in various CNS injuries/disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6QAQGRT8aBLVg90H21EOLACvtfcHk0lh9R68el7Lu1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFejt7k%253D&md5=1a9a6eee4ce7f486ee3e14d38b8ecb6c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1089%2Fars.2009.2668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2009.2668%26sid%3Dliteratum%253Aachs%26aulast%3DAdibhatla%26aufirst%3DR.%2BM.%26aulast%3DHatcher%26aufirst%3DJ.%2BF.%26atitle%3DLipid%2520oxidation%2520and%2520peroxidation%2520in%2520CNS%2520health%2520and%2520disease%253A%2520from%2520molecular%2520mechanisms%2520to%2520therapeutic%2520opportunities%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D12%26spage%3D125%26epage%3D169%26doi%3D10.1089%2Fars.2009.2668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakhan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchgessner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, M.</span></span> <span> </span><span class="NLM_article-title">Inflammatory mechanisms in ischemic stroke: therapeutic approaches</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">97</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-7-97</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1186%2F1479-5876-7-97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19919699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BD1MjnsVOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=97&author=S.+E.+Lakhanauthor=A.+Kirchgessnerauthor=M.+Hofer&title=Inflammatory+mechanisms+in+ischemic+stroke%3A+therapeutic+approaches&doi=10.1186%2F1479-5876-7-97"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory mechanisms in ischemic stroke: therapeutic approaches</span></div><div class="casAuthors">Lakhan Shaheen E; Kirchgessner Annette; Hofer Magdalena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute ischemic stroke is the third leading cause of death in industrialized countries and the most frequent cause of permanent disability in adults worldwide.  Despite advances in the understanding of the pathophysiology of cerebral ischemia, therapeutic options remain limited.  Only recombinant tissue-plasminogen activator (rt-PA) for thrombolysis is currently approved for use in the treatment of this devastating disease.  However, its use is limited by its short therapeutic window (three hours), complications derived essentially from the risk of hemorrhage, and the potential damage from reperfusion/ischemic injury.  Two important pathophysiological mechanisms involved during ischemic stroke are oxidative stress and inflammation.  Brain tissue is not well equipped with antioxidant defenses, so reactive oxygen species and other free radicals/oxidants, released by inflammatory cells, threaten tissue viability in the vicinity of the ischemic core.  This review will discuss the molecular aspects of oxidative stress and inflammation in ischemic stroke and potential therapeutic strategies that target neuroinflammation and the innate immune system.  Currently, little is known about endogenous counterregulatory immune mechanisms.  However, recent studies showing that regulatory T cells are major cerebroprotective immunomodulators after stroke suggest that targeting the endogenous adaptive immune response may offer novel promising neuroprotectant therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTETPbMSXvQl3tlzo9xastyfW6udTcc2eaim5T_mv65I7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjnsVOmsg%253D%253D&md5=df8fa746b9c3666041afe3ffaffba56c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-7-97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-7-97%26sid%3Dliteratum%253Aachs%26aulast%3DLakhan%26aufirst%3DS.%2BE.%26aulast%3DKirchgessner%26aufirst%3DA.%26aulast%3DHofer%26aufirst%3DM.%26atitle%3DInflammatory%2520mechanisms%2520in%2520ischemic%2520stroke%253A%2520therapeutic%2520approaches%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2009%26volume%3D7%26spage%3D97%26doi%3D10.1186%2F1479-5876-7-97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iadecola, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anrather, J.</span></span> <span> </span><span class="NLM_article-title">Stroke research at a crossroad: asking the brain for directions</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1038/nn.2953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnn.2953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22030546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOntbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1363-1368&author=C.+Iadecolaauthor=J.+Anrather&title=Stroke+research+at+a+crossroad%3A+asking+the+brain+for+directions&doi=10.1038%2Fnn.2953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stroke research at a crossroad: asking the brain for directions</span></div><div class="casAuthors">Iadecola, Costantino; Anrather, Josef</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1363-1368</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ischemic stroke remains a vexing public health problem.  Although progress was made in prevention and supportive care, efforts to protect the brain from ischemic cell death have failed.  Thus, no new treatment has made it from bench to bedside since tissue plasminogen activator was introduced in 1996.  The brain has a remarkable capacity for self-preservation, illustrated by the protective responses induced by ischemia, preconditioning, and exercise.  Here we describe the mechanisms underlying brain self-protection, with the goal of identifying features that could provide insight into stroke therapy.  Unlike traditional therapeutic approaches based on counteracting selected pathways of the ischemic cascade, endogenous neuroprotection relies on coordinated neurovascular programs that support cerebral perfusion, mitigate the harmful effects of cerebral ischemia and promote tissue restoration.  Learning how the brain triggers and implements these protective measures may advance our quest to treat stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQwg7h9tgHHbVg90H21EOLACvtfcHk0linS350fCq15g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOntbbI&md5=fff08d9100d361c026927e2adb7f6d14</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnn.2953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2953%26sid%3Dliteratum%253Aachs%26aulast%3DIadecola%26aufirst%3DC.%26aulast%3DAnrather%26aufirst%3DJ.%26atitle%3DStroke%2520research%2520at%2520a%2520crossroad%253A%2520asking%2520the%2520brain%2520for%2520directions%26jtitle%3DNat.%2520Neurosci.%26date%3D2011%26volume%3D14%26spage%3D1363%26epage%3D1368%26doi%3D10.1038%2Fnn.2953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by acetyl-11-keto-β-Boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathway</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">7002</span>, <span class="refDoi"> DOI: 10.1038/srep07002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fsrep07002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=25384416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFeisbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=7002&author=Y.+Dingauthor=M.+Chenauthor=M.+Wangauthor=M.+Wangauthor=T.+Zhangauthor=J.+Parkauthor=Y.+Zhuauthor=C.+Guoauthor=Y.+Jiaauthor=Y.+Liauthor=A.+Wen&title=Neuroprotection+by+acetyl-11-keto-%CE%B2-Boswellic+acid%2C+in+ischemic+brain+injury+involves+the+Nrf2%2FHO-1+defense+pathway&doi=10.1038%2Fsrep07002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway</span></div><div class="casAuthors">Ding, Yi; Chen, Min Chun; Wang, Min; Wang, Ming Ming; Zhang, Tiejun; Park, Jongsun; Zhu, Yan Rong; Guo, Chao; Jia, Yan Yan; Li, Yu Wen; Wen, Ai Dong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7002</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Stroke is a complex disease involved oxidative stress-related pathways in its pathogenesis.  The nuclear factor erythroid-2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway has been considered a potential target for neuroprotection in stroke.  Acetyl-11-Keto-β-Boswellic Acid (AKBA) is an active triterpenoid compd. from the ext. of Boswellia serrate.  The present study was to det. whether AKBA, a novel Nrf2 activator, can protect against cerebral ischemic injury.  The stroke model was produced in Sprague-Dawley rats via middle cerebral artery occlusion.  To model ischemia-like conditions in vitro, primary cultured cortical neurons were exposed to transient oxygen and glucose deprivation (OGD).  Treatment of AKBA significantly reduced infarct vols. and apoptotic cells, and also increased neurol. scores by elevating the Nrf2 and HO-1 expression in brain tissues in middle cerebral artery occlusion (MCAO) rats at 48 h post reperfusion.  In primary cultured neurons, AKBA increased the Nrf2 and HO-1 expression, which provided protection against OGD-induced oxidative insult.  Addnl., AKBA treatment increased Nrf2 binding activity to antioxidant-response elements (ARE).  The protective effect of AKBA was attenuated by knockdown of Nrf2 or HO-1.  In conclusion, these findings provide evidence that AKBA protects neurons against ischemic injury, and this neuroprotective effect involves the Nrf2/HO-1 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroNA7k0hGA_LVg90H21EOLACvtfcHk0linS350fCq15g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFeisbrF&md5=7c26017e01978c693c0ec01cd78d47b8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep07002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07002%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DA.%26atitle%3DNeuroprotection%2520by%2520acetyl-11-keto-%25CE%25B2-Boswellic%2520acid%252C%2520in%2520ischemic%2520brain%2520injury%2520involves%2520the%2520Nrf2%252FHO-1%2520defense%2520pathway%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D7002%26doi%3D10.1038%2Fsrep07002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, P. K.</span></span> <span> </span><span class="NLM_article-title">A novel strategy to activate cytoprotective genes in the injured brain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2011.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bbrc.2011.03.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21414291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFaitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=501-506&author=J.+Zhaoauthor=J.+B.+Redellauthor=A.+N.+Mooreauthor=P.+K.+Dash&title=A+novel+strategy+to+activate+cytoprotective+genes+in+the+injured+brain&doi=10.1016%2Fj.bbrc.2011.03.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A novel strategy to activate cytoprotective genes in the injured brain</span></div><div class="casAuthors">Zhao, Jing; Redell, John B.; Moore, Anthony N.; Dash, Pramod K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">501-506</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor E2-related factor 2 (Nrf2) regulates the expression of multiple cytoprotective genes that were shown to offer protection in response to a no. of insults.  The present study describes a novel strategy to increase expression of Nrf2-responsive genes in brain injured mice.  Under normal conditions, the adapter protein Kelch-like ECH-assocd. protein 1 (Keap1) binds to Nrf2 and promotes its proteosomal degrdn. in the cytoplasm.  The amino acid sequence DEETGE, located at amino acid 77-82 of Nrf2, is crit. for Nrf2-Keap1 interaction, and synthetic peptides contg. this sequence can be used to disrupt the complex in vitro.  We obsd. that intracerebroventricular (i.c.v.) infusion of a peptide contg. the DEETGE sequence along with the cell transduction domain of the HIV-TAT protein (TAT-DEETGE) into brain-injured mice did not increase the mRNA levels for Nrf2-driven genes.  However, when a calpain cleavage sequence was introduced between the TAT sequence and the DEETGE sequence, the new peptide (TAT-CAL-DEETGE) increased the mRNA levels of these genes.  Increased gene expression was not obsd. when the TAT-CAL-DEETGE peptide was injected into uninjured animals.  Furthermore, injection of TAT-CAL-DEETGE peptides before or after brain injury reduced blood-brain barrier compromise, a prominent secondary pathol. that neg. influences outcome.  The present strategy to increase Nrf2-responsive gene expression can be adapted to treat other insults or diseases based on their underlying mechanism(s) of cellular damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr77EqR_7kXobVg90H21EOLACvtfcHk0lhC8myYakKBlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFaitLs%253D&md5=7f8cb360245d4dac11e9b5d248f7b4c0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2011.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2011.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DRedell%26aufirst%3DJ.%2BB.%26aulast%3DMoore%26aufirst%3DA.%2BN.%26aulast%3DDash%26aufirst%3DP.%2BK.%26atitle%3DA%2520novel%2520strategy%2520to%2520activate%2520cytoprotective%2520genes%2520in%2520the%2520injured%2520brain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D407%26spage%3D501%26epage%3D506%26doi%3D10.1016%2Fj.bbrc.2011.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Central nervous system multiparameter optimization desirability: application in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=767-775&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Central+nervous+system+multiparameter+optimization+desirability%3A+application+in+drug+discovery&doi=10.1021%2Facschemneuro.6b00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">767-775</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant progress has been made in prospectively designing mols. using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the anal. reported herein of a second wave of drug candidates that originated after the development and implementation of this tool.  This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochem. properties.  The CNS MPO tool has helped to increase the percentage of compds. nominated for clin. development that exhibit alignment of ADME attributes, cross the blood-brain barrier, and reside in lower-risk safety space (low ClogP and high TPSA).  The use of this tool has played a role in reducing the no. of compds. submitted to exploratory toxicity studies and increasing the survival of our drug candidates through regulatory toxicol. into First in Human studies.  Overall, the CNS MPO algorithm has helped to improve the prioritization of design ideas and the quality of the compds. nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46WD7qMaX6bVg90H21EOLACvtfcHk0lg7sfxdNyxJ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D&md5=061c3aef6c88758cbaee1a2abb34796a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00029%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DCentral%2520nervous%2520system%2520multiparameter%2520optimization%2520desirability%253A%2520application%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D767%26epage%3D775%26doi%3D10.1021%2Facschemneuro.6b00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lg7sfxdNyxJ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lg7sfxdNyxJ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS physicochemical property space shaped by a diverse set of molecules with experimentally determined exposure in the mouse brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5954</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5943-5954&author=Z.+Rankovic&title=CNS+physicochemical+property+space+shaped+by+a+diverse+set+of+molecules+with+experimentally+determined+exposure+in+the+mouse+brain&doi=10.1021%2Facs.jmedchem.6b01469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5943-5954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the "limits and boundaries" of the central nervous system (CNS) property space is a crit. aspect of modern CNS drug design.  Medicinal chemists are often guided by the physicochem. properties of marketed CNS drugs, which are heavily biased toward "traditional" aminergic targets and commonly described as small lipophilic amines.  This miniperspective describes the statistical anal. of the calcd. physicochem. properties for a diverse set of ligands for mostly "nontraditional" CNS targets and classified as either "brain penetrant" or "peripherally restricted" on the basis of the exptl. mouse brain exposure.  The results suggested that (a) the physicochem. property space conducive to brain exposure is larger than the one defined by the marketed CNS drugs and (b) the most crit. brain exposure determinants are descriptors of the mol. size and hydrogen bond capacity.  These findings led to a modified version of the CNS MPO scoring algorithm, termed CNS MPO.v2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f3JpTCJ29rVg90H21EOLACvtfcHk0ljBKwkiLTMbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D&md5=bff2a3cd68c033d6cae235a7524cc528</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01469%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520physicochemical%2520property%2520space%2520shaped%2520by%2520a%2520diverse%2520set%2520of%2520molecules%2520with%2520experimentally%2520determined%2520exposure%2520in%2520the%2520mouse%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5943%26epage%3D5954%26doi%3D10.1021%2Facs.jmedchem.6b01469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Observations on screening-based research and some concerning trends in the literature</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1546</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.4155%2Ffmc.10.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21426147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1529-1546&author=J.+B.+Baell&title=Observations+on+screening-based+research+and+some+concerning+trends+in+the+literature&doi=10.4155%2Ffmc.10.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Observations on screening-based research and some concerning trends in the literature</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1529-1546</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Academic drug discovery is being accompanied by a plethora of publications that report screening hits as good starting points for drug discovery or as useful tool compds., whereas in many cases this is not so.  These compds. may be protein-reactive but can also interfere in bioassays via a no. of other means, and it can be very hard to prove early on that they represent false starts.  This, for instance, makes it difficult for journals in their assessment of manuscripts submitted for publication.  Wider awareness and recognition of these problematic compds. will help the academic drug-discovery community focus on and publish genuinely optimizable screening hits.  This will be of general benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob88J0NH5Mx7Vg90H21EOLACvtfcHk0ljBKwkiLTMbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI&md5=14f916535540fc04e37c2eb21cfe7876</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.237%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DObservations%2520on%2520screening-based%2520research%2520and%2520some%2520concerning%2520trends%2520in%2520the%2520literature%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D1529%26epage%3D1546%26doi%3D10.4155%2Ffmc.10.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhS1qzYjeDNUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagorce, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miteva, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villoutreix, B. O.</span></span> <span> </span><span class="NLM_article-title">FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects</span>. <i>BMC Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">396</span>, <span class="refDoi"> DOI: 10.1186/1471-2105-9-396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1186%2F1471-2105-9-396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=18816385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BD1cnkt12guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=396&author=D.+Lagorceauthor=O.+Sperandioauthor=H.+Galonsauthor=M.+A.+Mitevaauthor=B.+O.+Villoutreix&title=FAF-Drugs2%3A+free+ADME%2Ftox+filtering+tool+to+assist+drug+discovery+and+chemical+biology+projects&doi=10.1186%2F1471-2105-9-396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects</span></div><div class="casAuthors">Lagorce David; Sperandio Olivier; Galons Herve; Miteva Maria A; Villoutreix Bruno O</div><div class="citationInfo"><span class="NLM_cas:title">BMC bioinformatics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Drug discovery and chemical biology are exceedingly complex and demanding enterprises.  In recent years there are been increasing awareness about the importance of predicting/optimizing the absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of small chemical compounds along the search process rather than at the final stages.  Fast methods for evaluating ADMET properties of small molecules often involve applying a set of simple empirical rules (educated guesses) and as such, compound collections' property profiling can be performed in silico.  Clearly, these rules cannot assess the full complexity of the human body but can provide valuable information and assist decision-making.  RESULTS:  This paper presents FAF-Drugs2, a free adaptable tool for ADMET filtering of electronic compound collections.  FAF-Drugs2 is a command line utility program (e.g., written in Python) based on the open source chemistry toolkit OpenBabel, which performs various physicochemical calculations, identifies key functional groups, some toxic and unstable molecules/functional groups.  In addition to filtered collections, FAF-Drugs2 can provide, via Gnuplot, several distribution diagrams of major physicochemical properties of the screened compound libraries.  CONCLUSION:  We have developed FAF-Drugs2 to facilitate compound collection preparation, prior to (or after) experimental screening or virtual screening computations.  Users can select to apply various filtering thresholds and add rules as needed for a given project.  As it stands, FAF-Drugs2 implements numerous filtering rules (23 physicochemical rules and 204 substructure searching rules) that can be easily tuned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBtoXIMaxI83O4gDb7JggCfW6udTcc2eYrtqGdNBgAJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnkt12guw%253D%253D&md5=ddbb936ae32172dd6a77ec2e83dddb7b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1186%2F1471-2105-9-396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2105-9-396%26sid%3Dliteratum%253Aachs%26aulast%3DLagorce%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DO.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMiteva%26aufirst%3DM.%2BA.%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26atitle%3DFAF-Drugs2%253A%2520free%2520ADME%252Ftox%2520filtering%2520tool%2520to%2520assist%2520drug%2520discovery%2520and%2520chemical%2520biology%2520projects%26jtitle%3DBMC%2520Bioinf.%26date%3D2008%26volume%3D9%26spage%3D396%26doi%3D10.1186%2F1471-2105-9-396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusunoki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2887</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1128/MCB.26.8.2887-2900.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.26.8.2887-2900.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=16581765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2887-2900&author=K.+I.+Tongauthor=Y.+Katohauthor=H.+Kusunokiauthor=K.+Itohauthor=T.+Tanakaauthor=M.+Yamamoto&title=Keap1+recruits+Neh2+through+binding+to+ETGE+and+DLG+motifs%3A+characterization+of+the+two-site+molecular+recognition+model&doi=10.1128%2FMCB.26.8.2887-2900.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span></div><div class="casAuthors">Tong, Kit I.; Katoh, Yasutake; Kusunoki, Hideki; Itoh, Ken; Tanaka, Toshiyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2887-2900</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the phase 2 detoxification enzymes and antioxidant proteins is induced at the transcriptional level by Nrf2 and neg. regulated at the posttranslational level by Keap1 through protein-protein interactions with Nrf2 and subsequent proteolysis of Nrf2.  We found that the Neh2 domain of Nrf2 is an intrinsically disordered but biol. active regulatory domain contg. a 33-residue central α-helix followed by a mini antiparallel β-sheet.  Isothermal calorimetry anal. indicated that one Neh2 mol. interacts with two mols. of Keap1 via two binding sites, the stronger binding ETGE motif and the weaker binding DLG motif.  NMR titrn. study showed that these two motifs of the Neh2 domain bind to an overlapping site on the bottom surface of the β-propeller structure of Keap1.  In contrast, the central α-helix of the Neh2 domain does not have any observable affinity to Keap1, suggesting that this region may serve as a bridge connecting the two motifs for the assocn. with the two β-propeller structures of a dimer of Keap1.  Based on these observations, we propose that Keap1 recruits Nrf2 by the ETGE motif and that the DLG motif of the Neh2 domain locks its lysine-rich central α-helix in a correct position to benefit ubiquitin (Ub) signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4AlViBIZg7Vg90H21EOLACvtfcHk0lhq5rFCF-Qe_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D&md5=f6a5af3be5757cd665f234562d48d727</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.8.2887-2900.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.8.2887-2900.2006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DKusunoki%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520recruits%2520Neh2%2520through%2520binding%2520to%2520ETGE%2520and%2520DLG%2520motifs%253A%2520characterization%2520of%2520the%2520two-site%2520molecular%2520recognition%2520model%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2887%26epage%3D2900%26doi%3D10.1128%2FMCB.26.8.2887-2900.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Keap1 interactions with Nrf2</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26057936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=101-107&author=P.+Canningauthor=F.+J.+Sorrellauthor=A.+N.+Bullock&title=Structural+basis+of+Keap1+interactions+with+Nrf2&doi=10.1016%2Fj.freeradbiomed.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of KEAP1 interactions with Nrf2</span></div><div class="casAuthors">Canning, Peter; Sorrell, Fiona J.; Bullock, Alex N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  KEAP1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degrdn. of Nrf2.  Oxidative stress disables KEAP1, allowing Nrf2 protein levels to accumulate for the transactivation of crit. stress response genes.  Consequently, the KEAP1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer.  Here we review current progress toward the structure detn. of KEAP1 and its protein complexes with Cul3, Nrf2 substrate, and small-mol. antagonists.  Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBBMS70b7hbVg90H21EOLACvtfcHk0lhq5rFCF-Qe_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK&md5=12b7b36caa16cf3cd3d95d84162eed80</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DCanning%26aufirst%3DP.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26atitle%3DStructural%2520basis%2520of%2520Keap1%2520interactions%2520with%2520Nrf2%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.freeradbiomed.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a ″tethering″ mechanism: a two-site interaction model for the Nrf2-Keap1 complex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">24756</span>– <span class="NLM_lpage">24768</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601119200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1074%2Fjbc.M601119200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=24756-24768&author=M.+McMahonauthor=N.+Thomasauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Dimerization+of+substrate+adaptors+can+facilitate+cullin-mediated+ubiquitylation+of+proteins+by+a+%E2%80%B3tethering%E2%80%B3+mechanism%3A+a+two-site+interaction+model+for+the+Nrf2-Keap1+complex&doi=10.1074%2Fjbc.M601119200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601119200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601119200%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DDimerization%2520of%2520substrate%2520adaptors%2520can%2520facilitate%2520cullin-mediated%2520ubiquitylation%2520of%2520proteins%2520by%2520a%2520%25E2%2580%25B3tethering%25E2%2580%25B3%2520mechanism%253A%2520a%2520two-site%2520interaction%2520model%2520for%2520the%2520Nrf2-Keap1%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D24756%26epage%3D24768%26doi%3D10.1074%2Fjbc.M601119200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osanai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2443.2002.00561.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1046%2Fj.1365-2443.2002.00561.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=12167159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslyju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=807-820&author=M.+Kobayashiauthor=K.+Itohauthor=T.+Suzukiauthor=H.+Osanaiauthor=K.+Nishikawaauthor=Y.+Katohauthor=Y.+Takagiauthor=M.+Yamamoto&title=Identification+of+the+interactive+interface+and+phylogenic+conservation+of+the+Nrf2-Keap1+system&doi=10.1046%2Fj.1365-2443.2002.00561.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system</span></div><div class="casAuthors">Kobayashi, Makoto; Itoh, Ken; Suzuki, Takafumi; Osanai, Hitoshi; Nishikawa, Keizo; Katoh, Yasutake; Takagi, Yaeko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">807-820</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 and its neg. regulator Keap1 play important roles in transcriptional induction of a set of detoxifying and anti-oxidant enzymes.  To gain an insight into our present enigma as to how cells receive oxidative and electrophilic signals and transduce them to Nrf2, we have developed a zebrafish model system for mol. toxicol. studies.  We systematically cloned zebrafish cytoprotective enzyme cDNAs and found their expression to be efficiently induced by electrophilic agents.  We consequently identified the presence of Nrf2 and Keap1 in zebrafish.  Both loss- and gain-of-function analyses demonstrated that Nrf2 is the primary regulator of a subset of cytoprotective enzyme genes, while Keap1 suppresses Nrf2 activity in zebrafish.  An ETGE motif, crit. for the Nrf2-Keap1 interaction, was identified in the Neh2 domain of Nrf2 by reverse 2-hybrid screening and indispensable for the regulation of Nrf2 activity in zebrafish.  Taken together, these results indicate that the Nrf2-Keap1 system is highly conserved among vertebrates and that the interface between Nrf2 and Keap1 forms an important mol. basis of this regulatory system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGwSXik-wPrVg90H21EOLACvtfcHk0lgGiF34ubWPNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslyju7Y%253D&md5=4c820d01a25f334c42c3c90ee7d341da</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2443.2002.00561.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2443.2002.00561.x%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOsanai%26aufirst%3DH.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DTakagi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520interactive%2520interface%2520and%2520phylogenic%2520conservation%2520of%2520the%2520Nrf2-Keap1%2520system%26jtitle%3DGenes%2520Cells%26date%3D2002%26volume%3D7%26spage%3D807%26epage%3D820%26doi%3D10.1046%2Fj.1365-2443.2002.00561.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Monitoring Keap1–Nrf2 interactions in single live cells</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2014.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.biotechadv.2014.03.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1133-1144&author=L.+Bairdauthor=S.+Swiftauthor=D.+Lleresauthor=A.+T.+Dinkova-Kostova&title=Monitoring+Keap1%E2%80%93Nrf2+interactions+in+single+live+cells&doi=10.1016%2Fj.biotechadv.2014.03.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2014.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2014.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DMonitoring%2520Keap1%25E2%2580%2593Nrf2%2520interactions%2520in%2520single%2520live%2520cells%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2014%26volume%3D32%26spage%3D1133%26epage%3D1144%26doi%3D10.1016%2Fj.biotechadv.2014.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paonessa, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanism of chemical activation of Nrf2</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e35122</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0035122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1371%2Fjournal.pone.0035122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22558124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e35122&author=Y.+Liauthor=J.+D.+Paonessaauthor=Y.+Zhang&title=Mechanism+of+chemical+activation+of+Nrf2&doi=10.1371%2Fjournal.pone.0035122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of chemical activation of Nrf2</span></div><div class="casAuthors">Li, Yun; Paonessa, Joseph D.; Zhang, Yuesheng</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e35122</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">NF-E2 related factor-2 (Nrf2) promotes the transcription of many cytoprotective genes and is a major drug target for prevention of cancer and other diseases.  Indeed, the cancer-preventive activities of several well-known chem. agents were shown to depend on Nrf2 activation.  It is well known that chemopreventive Nrf2 activators stabilize Nrf2 by blocking its ubiquitination, but previous studies have indicated that this process occurs exclusively in the cytoplasm.  Kelch-like ECH-assocd. protein 1 (Keap1) binds to Nrf2 and orchestrates Nrf2 ubiquitination and it has been a widely-held view that inhibition of Nrf2 ubiquitination by chemopreventive agents results from the dissocn. of Nrf2 from its repressor Keap1.  Here, we show that while the activation of Nrf2 by prototypical chem. activators, including 5,6-dihydrocyclopenta-1,2-dithiole-3-thione (CPDT) and sulforaphane (SF), results solely from inhibition of its ubiquitination, such inhibition occurs predominantly in the nucleus.  Moreover, the Nrf2 activators promote Nrf2 assocn. with Keap1, rather than disassocn., which appears to result from inhibition of Nrf2 phosphorylation at Ser40.  Available evidence suggests the Nrf2 activators may block Nrf2 ubiquitination by altering Keap1 conformation via reaction with the thiols of specific Keap1 cysteines.  We further show that while the inhibitory effects of CPDT and SF on Nrf2 ubiquitination depend entirely on Keap1, Nrf2 is also degraded by a Keap1-independent mechanism.  These findings provide significant new insight about Nrf2 activation and suggest that exogenous chem. activators of Nrf2 enter the nucleus to exert most of their inhibitory impact on Nrf2 ubiquitination and degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHQw95dGtFnbVg90H21EOLACvtfcHk0lhtBX9_kDGjEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D&md5=8b9417e76f781711ba9f1d993c017d0c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0035122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0035122%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPaonessa%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520chemical%2520activation%2520of%2520Nrf2%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De35122%26doi%3D10.1371%2Fjournal.pone.0035122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">10941</span>– <span class="NLM_lpage">10953</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.24.10941-10953.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.24.24.10941-10953.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=15572695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10941-10953&author=D.+D.+Zhangauthor=S.+C.+Loauthor=J.+V.+Crossauthor=D.+J.+Templetonauthor=M.+Hannink&title=Keap1+is+a+redox-regulated+substrate+adaptor+protein+for+a+Cul3-dependent+ubiquitin+ligase+complex&doi=10.1128%2FMCB.24.24.10941-10953.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex</span></div><div class="casAuthors">Zhang, Donna D.; Lo, Shih-Ching; Cross, Janet V.; Templeton, Dennis J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10941-10953</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The bZIP transcription factor Nrf2 controls a genetic program that protects cells from oxidative damage and maintains cellular redox homeostasis.  Keap1, a BTB-Kelch protein, is the major upstream regulator of Nrf2 and controls both the subcellular localization and steady-state levels of Nrf2.  In this report, we demonstrate that Keap1 functions as a substrate adaptor protein for a Cul3-dependent E3 ubiquitin ligase complex.  Keap1 assembles into a functional E3 ubiquitin ligase complex with Cul3 and Rbx1 that targets multiple lysine residues located in the N-terminal Neh2 domain of Nrf2 for ubiquitin conjugation both in vivo and in vitro.  Keap1-dependent ubiquitination of Nrf2 is inhibited following exposure of cells to quinone-induced oxidative stress and sulforaphane, a cancer-preventive isothiocyanate.  A mutant Keap1 protein contg. a single cysteine-to-serine substitution at residue 151 within the BTB domain of Keap1 is markedly resistant to inhibition by either quinone-induced oxidative stress or sulforaphane.  Inhibition of Keap1-dependent ubiquitination of Nrf2 correlates with decreased assocn. of Keap1 with Cul3.  Neither quinone-induced oxidative stress nor sulforaphane disrupts assocn. between Keap1 and Nrf2.  Our results suggest that the ability of Keap1 to assemble into a functional E3 ubiquitin ligase complex is the crit. determinant that controls steady-state levels of Nrf2 in response to cancer-preventive compds. and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGone13ov1mSELVg90H21EOLACvtfcHk0lhtBX9_kDGjEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL&md5=cc8f2a059999d82c91ef482fb8e385d8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.24.10941-10953.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.24.10941-10953.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DCross%26aufirst%3DJ.%2BV.%26aulast%3DTempleton%26aufirst%3DD.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DKeap1%2520is%2520a%2520redox-regulated%2520substrate%2520adaptor%2520protein%2520for%2520a%2520Cul3-dependent%2520ubiquitin%2520ligase%2520complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D10941%26epage%3D10953%26doi%3D10.1128%2FMCB.24.24.10941-10953.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein–protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533-550&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein%E2%80%93protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0ljB_W75d3jL1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein%25E2%2580%2593protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26epage%3D550%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henzl, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3605</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fsj.emboj.7601243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=16888629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3605-3617&author=S.+C.+Loauthor=X.+Liauthor=M.+T.+Henzlauthor=L.+J.+Beamerauthor=M.+Hannink&title=Structure+of+the+Keap1%3ANrf2+interface+provides+mechanistic+insight+into+Nrf2+signaling&doi=10.1038%2Fsj.emboj.7601243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling</span></div><div class="casAuthors">Lo, Shih-Ching; Li, Xuchu; Henzl, Michael T.; Beamer, Lesa J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3605-3617</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Keap1 is a BTB-Kelch substrate adaptor protein that regulates steady-state levels of Nrf2, a bZIP transcription factor, in response to oxidative stress.  We have detd. the structure of the Kelch domain of Keap1 bound to a 16-mer peptide from Nrf2 contg. a highly conserved DxETGE motif.  The Nrf2 peptide contains two short antiparallel β-strands connected by two overlapping type I β-turns stabilized by the aspartate and threonine residues.  The β-turn region fits into a binding pocket on the top face of the Kelch domain and the glutamate residues form multiple hydrogen bonds with highly conserved residues in Keap1.  Mutagenesis expts. confirmed the role of individual amino acids for binding of Nrf2 to Keap1 and for Keap1-mediated repression of Nrf2-dependent gene expression.  Our results provide a detailed picture of how a BTB-Kelch substrate adaptor protein binds to its cognate substrate and will enable the rational design of novel chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJXSF9pJFdLVg90H21EOLACvtfcHk0ljB_W75d3jL1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D&md5=df96ad6cb82632192d5d693ea87c85ad</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601243%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHenzl%26aufirst%3DM.%2BT.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520Keap1%253ANrf2%2520interface%2520provides%2520mechanistic%2520insight%2520into%2520Nrf2%2520signaling%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3605%26epage%3D3617%26doi%3D10.1038%2Fsj.emboj.7601243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirotsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">7511</span>– <span class="NLM_lpage">7521</span>, <span class="refDoi"> DOI: 10.1128/MCB.00753-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.00753-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=17785452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GltrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=7511-7521&author=K.+I.+Tongauthor=B.+Padmanabhanauthor=A.+Kobayashiauthor=C.+Shangauthor=Y.+Hirotsuauthor=S.+Yokoyamaauthor=M.+Yamamoto&title=Different+electrostatic+potentials+define+ETGE+and+DLG+motifs+as+hinge+and+latch+in+oxidative+stress+response&doi=10.1128%2FMCB.00753-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response</span></div><div class="casAuthors">Tong, Kit I.; Padmanabhan, Balasundaram; Kobayashi, Akira; Shang, Chengwei; Hirotsu, Yosuke; Yokoyama, Shigeyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7511-7521</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Nrf2 is the regulator of the oxidative/electrophilic stress response.  Its turnover is maintained by Keap1-mediated proteasomal degrdn. via a two-site substrate recognition mechanism in which two Nrf2-Keap1 binding sites form a hinge and latch.  The E3 ligase adaptor Keap1 recognizes Nrf2 through its conserved ETGE and DLG motifs.  In this study, we examd. how the ETGE and DLG motifs bind to Keap1 in a very similar fashion but with different binding affinities by comparing the crystal structure of the Keap1-DC domain (double glycine repeat domain [DGR] plus C-terminal region of Keap1) in complex with an Nrf2 DLG motif-based peptide to the structure of a Keap1-DC domain/ETGE peptide complex.  We found that these two motifs interact with the same basic surface of either Keap1-DC domain in the Keap1 homodimer.  The DLG motif works to correctly position the lysines within the Nrf2 Neh2 domain for efficient ubiquitination.  Together with the results from calorimetric and functional studies, we conclude that different electrostatic potentials primarily define the ETGE and DLG motifs as a hinge and latch that senses the oxidative/electrophilic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri-Hlz79iKkbVg90H21EOLACvtfcHk0ljHo3-KiJG7Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GltrvE&md5=7be354fadaf3a9181e05a8fe9ec3fb3f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FMCB.00753-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00753-07%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DShang%26aufirst%3DC.%26aulast%3DHirotsu%26aufirst%3DY.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDifferent%2520electrostatic%2520potentials%2520define%2520ETGE%2520and%2520DLG%2520motifs%2520as%2520hinge%2520and%2520latch%2520in%2520oxidative%2520stress%2520response%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D7511%26epage%3D7521%26doi%3D10.1128%2FMCB.00753-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohuchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1128/MCB.01191-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.01191-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24366543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVSktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=832-846&author=T.+Fukutomiauthor=K.+Takagiauthor=T.+Mizushimaauthor=N.+Ohuchiauthor=M.+Yamamoto&title=Kinetic%2C+thermodynamic%2C+and+structural+characterizations+of+the+association+between+Nrf2-DLGex+degron+and+Keap1&doi=10.1128%2FMCB.01191-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1</span></div><div class="casAuthors">Fukutomi, Toshiaki; Takagi, Kenji; Mizushima, Tsunehiro; Ohuchi, Noriaki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">832-846, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 (NF-E2-related factor 2) coordinately regulates cytoprotective gene expression, but under unstressed conditions, Nrf2 is degraded rapidly through Keap1 (Kelch-like ECH-assocd. protein 1)-mediated ubiquitination.  Nrf2 harbors two Keap1-binding motifs, DLG and ETGE.  Interactions between these two motifs and Keap1 constitute a key regulatory nexus for cellular Nrf2 activity through the formation of a two-site binding hinge-and-latch mechanism.  In this study, we detd. the min. Keap1-binding sequence of the DLG motif, the low-affinity latch site, and defined a new DLGex motif that covers a sequence much longer than that previously defined.  We have successfully clarified the crystal structure of the Keap1-DC-DLGex complex at 1.6 Å.  DLGex possesses a complicated helix structure, which interprets well the human-cancer-derived loss-of-function mutations in DLGex.  In thermodn. analyses, Keap1-DLGex binding is characterized as enthalpy and entropy driven, while Keap1-ETGE binding is characterized as purely enthalpy driven.  In kinetic analyses, Keap1-DLGex binding follows a fast-assocn. and fast-dissocn. model, while Keap1-ETGE binding contains a slow-reaction step that leads to a stable conformation.  These results demonstrate that the mode of DLGex binding to Keap1 is distinct from that of ETGE structurally, thermodynamically, and kinetically and support our contention that the DLGex motif serves as a converter transmitting environmental stress to Nrf2 induction as the latch site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL52FE-hZoIbVg90H21EOLACvtfcHk0ljHo3-KiJG7Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVSktrs%253D&md5=3ec5af933ac7ca319cf4a0ad39a2d689</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FMCB.01191-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01191-13%26sid%3Dliteratum%253Aachs%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DOhuchi%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKinetic%252C%2520thermodynamic%252C%2520and%2520structural%2520characterizations%2520of%2520the%2520association%2520between%2520Nrf2-DLGex%2520degron%2520and%2520Keap1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2014%26volume%3D34%26spage%3D832%26epage%3D846%26doi%3D10.1128%2FMCB.01191-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9799-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1007%2Fs10822-014-9799-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=25301376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1233-1245&author=Z.+Y.+Jiangauthor=L.+L.+Xuauthor=M.+C.+Luauthor=Y.+Panauthor=H.+Z.+Huangauthor=X.+J.+Zhangauthor=H.+P.+Sunauthor=Q.+D.+You&title=Investigation+of+the+intermolecular+recognition+mechanism+between+the+E3+ubiquitin+ligase+Keap1+and+substrate+based+on+multiple+substrates+analysis&doi=10.1007%2Fs10822-014-9799-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Xu, Li-Li; Lu, Meng-Chen; Pan, Yang; Huang, Hao-Ze; Zhang, Xiao-Jin; Sun, Hao-Peng; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1233-1245</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are attractive drug targets due to their specificity to the ubiquitin machinery.  However, the development of E3 ligase inhibitors has proven challenging for the fact that they must disrupt protein-protein interactions (PPIs).  The E3 ligase involved in interactome provide new hope for the discovery of the E3 ligase inhibitors.  These currently known natural binding partners of the E3 ligase can benefit the discovery of other unknown substrates and also the E3 ligase inhibitors.  Herein, we present a novel strategy that using multiple substrates to elucidate the mol. recognition mechanism of E3 ubiquitin ligase.  Mol. dynamics simulation, mol. mechanics-generalized born surface area (MM-GBSA) binding energy calcn. and energy decompn. scheme were incorporated to evaluate the quant. contributions of sub-pocket and per-residue to binding.  In this case, Kelch-like ECH-assocd. protein-1 (Keap1), a substrate adaptor component of the Cullin-RING ubiquitin ligases complex, is applied for the investigation of how it recognize its substrates, esp. Nrf2, a master regulator of the antioxidant response.  By analyzing multiple substrates binding determinants, we found that both the polar sub-pockets (P1 and P2) and the nonpolar sub-pockets (P4 and P5) of Keap1 can make remarkable contributions to intermol. interactions.  This finding stresses the requirement for substrates to interact with the polar and nonpolar sub-pockets simultaneously.  The results discussed in this paper not only show the binding determinants of the Keap1 substrates but also provide valuable implications for both Keap1 substrate discovery and PPI inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppReS77bpky7Vg90H21EOLACvtfcHk0lhQHSYJhdzsvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI&md5=359ff305f89c6a69cca48f60d019c765</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9799-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9799-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.%2BZ.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DH.%2BP.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DInvestigation%2520of%2520the%2520intermolecular%2520recognition%2520mechanism%2520between%2520the%2520E3%2520ubiquitin%2520ligase%2520Keap1%2520and%2520substrate%2520based%2520on%2520multiple%2520substrates%2520analysis%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D1233%26epage%3D1245%26doi%3D10.1007%2Fs10822-014-9799-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryuzoji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.ejmech.2015.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26363505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=252-268&author=A.+D.+Jainauthor=H.+Pottetiauthor=B.+G.+Richardsonauthor=L.+Kingsleyauthor=J.+P.+Lucianoauthor=A.+F.+Ryuzojiauthor=H.+Leeauthor=A.+Krunicauthor=A.+D.+Mesecarauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Probing+the+structural+requirements+of+non-electrophilic+naphthalene-based+Nrf2+activators&doi=10.1016%2Fj.ejmech.2015.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span></div><div class="casAuthors">Jain, Atul D.; Potteti, Haranatha; Richardson, Benjamin G.; Kingsley, Laura; Luciano, Julia P.; Ryuzoji, Aya F.; Lee, Hyun; Krunic, Aleksej; Mesecar, Andrew D.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-268</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Activation of the transcription factor Nrf2 has been posited to be a promising therapeutic strategy in a no. of inflammatory and oxidative stress diseases due to its regulation of detoxifying enzymes.  In this work, the authors have developed a comprehensive structure-activity relationship around a known, naphthalene-based nonelectrophilic activator of Nrf2, and the authors report highly potent nonelectrophilic activators of Nrf2.  Computational docking anal. of a subset of the compd. series demonstrates the importance of water mol. displacement for affinity, and the x-ray structure of di-amide I supports the computational anal.  One of the best compds., acid II, has an IC50 of 61 nM in a fluorescence anisotropy assay and a Kd of 120 nM in a surface plasmon resonance assay.  Addnl., the authors demonstrate that the Et ester of II is an efficacious inducer of Nrf2 target genes, exhibiting ex vivo efficacy similar to the well-known electrophilic activator, sulforaphane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcvlMBGU0C7Vg90H21EOLACvtfcHk0lhQHSYJhdzsvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ&md5=750fd3ca47f1a122618942312390891b</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DKingsley%26aufirst%3DL.%26aulast%3DLuciano%26aufirst%3DJ.%2BP.%26aulast%3DRyuzoji%26aufirst%3DA.%2BF.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DProbing%2520the%2520structural%2520requirements%2520of%2520non-electrophilic%2520naphthalene-based%2520Nrf2%2520activators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D252%26epage%3D268%26doi%3D10.1016%2Fj.ejmech.2015.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span> <span> </span><span class="NLM_article-title">Identifying and characterizing binding sites and assessing druggability</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1021/ci800324m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800324m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=377-389&author=T.+A.+Halgren&title=Identifying+and+characterizing+binding+sites+and+assessing+druggability&doi=10.1021%2Fci800324m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying and Characterizing Binding Sites and Assessing Druggability</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-389</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Identification and characterization of binding sites is key in the process of structure-based drug design.  In some cases there may not be any information about the binding site for a target of interest.  In other cases, a putative binding site has been identified by computational or exptl. means, but the druggability of the target is not known.  Even when a site for a given target is known, it may be desirable to find addnl. sites whose targeting could produce a desired biol. response.  A new program, called SiteMap, is presented for identifying and analyzing binding sites and for predicting target druggability.  In a large-scale validation, SiteMap correctly identifies the known binding site as the top-ranked site in 86% of the cases, with best results (>98%) coming for sites that bind ligands with subnanomolar affinity.  In addn., a modified version of the score employed for binding-site identification allows SiteMap to accurately classify the druggability of proteins as measured by their ability to bind passively absorbed small mols. tightly.  In characterizing binding sites, SiteMap provides quant. and graphical information that can help guide efforts to critically assess virtual hits in a lead-discovery application or to modify ligand structure to enhance potency or improve phys. properties in a lead-optimization context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfAt0-gvcXDLVg90H21EOLACvtfcHk0lhdsmxfRz8JTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D&md5=f03c7b27e30ae03d10e4127ed1f1ed3c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci800324m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800324m%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DIdentifying%2520and%2520characterizing%2520binding%2520sites%2520and%2520assessing%2520druggability%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D377%26epage%3D389%26doi%3D10.1021%2Fci800324m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emge, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandapani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3039</span>– <span class="NLM_lpage">3043</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2013.03.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3039-3043&author=L.+Huauthor=S.+Mageshauthor=L.+Chenauthor=L.+Wangauthor=T.+A.+Lewisauthor=Y.+Chenauthor=C.+Khodierauthor=D.+Inoyamaauthor=L.+J.+Beamerauthor=T.+J.+Emgeauthor=J.+Shenauthor=J.+E.+Kerriganauthor=A.+N.+Kongauthor=S.+Dandapaniauthor=M.+Palmerauthor=S.+L.+Schreiberauthor=B.+Munoz&title=Discovery+of+a+small-molecule+inhibitor+and+cellular+probe+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1016%2Fj.bmcl.2013.03.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKhodier%26aufirst%3DC.%26aulast%3DInoyama%26aufirst%3DD.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DEmge%26aufirst%3DT.%2BJ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DKerrigan%26aufirst%3DJ.%2BE.%26aulast%3DKong%26aufirst%3DA.%2BN.%26aulast%3DDandapani%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DMunoz%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520a%2520small-molecule%2520inhibitor%2520and%2520cellular%2520probe%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3039%26epage%3D3043%26doi%3D10.1016%2Fj.bmcl.2013.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jnoff, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromidge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookfield, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corden, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duclos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryatt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genicot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jigorel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maghames, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mushi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stimson, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courade, J. P.</span></span> <span> </span><span class="NLM_article-title">Binding mode and structure–activity relationships around direct inhibitors of the Nrf2-Keap1 complex</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1002%2Fcmdc.201300525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=699-705&author=E.+Jnoffauthor=C.+Albrechtauthor=J.+J.+Barkerauthor=O.+Barkerauthor=E.+Beaumontauthor=S.+Bromidgeauthor=F.+Brookfieldauthor=M.+Brooksauthor=C.+Bubertauthor=T.+Ceskaauthor=V.+Cordenauthor=G.+Dawsonauthor=S.+Duclosauthor=T.+Fryattauthor=C.+Genicotauthor=E.+Jigorelauthor=J.+Kwongauthor=R.+Maghamesauthor=I.+Mushiauthor=R.+Pikeauthor=Z.+A.+Sandsauthor=M.+A.+Smithauthor=C.+C.+Stimsonauthor=J.+P.+Courade&title=Binding+mode+and+structure%E2%80%93activity+relationships+around+direct+inhibitors+of+the+Nrf2-Keap1+complex&doi=10.1002%2Fcmdc.201300525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300525%26sid%3Dliteratum%253Aachs%26aulast%3DJnoff%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DC.%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DBeaumont%26aufirst%3DE.%26aulast%3DBromidge%26aufirst%3DS.%26aulast%3DBrookfield%26aufirst%3DF.%26aulast%3DBrooks%26aufirst%3DM.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DCeska%26aufirst%3DT.%26aulast%3DCorden%26aufirst%3DV.%26aulast%3DDawson%26aufirst%3DG.%26aulast%3DDuclos%26aufirst%3DS.%26aulast%3DFryatt%26aufirst%3DT.%26aulast%3DGenicot%26aufirst%3DC.%26aulast%3DJigorel%26aufirst%3DE.%26aulast%3DKwong%26aufirst%3DJ.%26aulast%3DMaghames%26aufirst%3DR.%26aulast%3DMushi%26aufirst%3DI.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DSands%26aufirst%3DZ.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DStimson%26aufirst%3DC.%2BC.%26aulast%3DCourade%26aufirst%3DJ.%2BP.%26atitle%3DBinding%2520mode%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520around%2520direct%2520inhibitors%2520of%2520the%2520Nrf2-Keap1%2520complex%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D699%26epage%3D705%26doi%3D10.1002%2Fcmdc.201300525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hus, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hession, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmanene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roecklin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span> <span> </span><span class="NLM_article-title">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4019</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmc.2013.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=23647822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4011-4019&author=D.+Marcotteauthor=W.+Zengauthor=J.+C.+Husauthor=A.+McKenzieauthor=C.+Hessionauthor=P.+Jinauthor=C.+Bergeronauthor=A.+Lugovskoyauthor=I.+Enyedyauthor=H.+Cuervoauthor=D.+Wangauthor=C.+Atmaneneauthor=D.+Roecklinauthor=M.+Vecchiauthor=V.+Vivatauthor=J.+Kraemerauthor=D.+Winklerauthor=V.+Hongauthor=J.+Chaoauthor=M.+Lukashevauthor=L.+Silvian&title=Small+molecules+inhibit+the+interaction+of+Nrf2+and+the+Keap1+Kelch+domain+through+a+non-covalent+mechanism&doi=10.1016%2Fj.bmc.2013.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span></div><div class="casAuthors">Marcotte, Douglas; Zeng, Weike; Hus, Jean-Christophe; McKenzie, Andres; Hession, Cathy; Jin, Ping; Bergeron, Chris; Lugovskoy, Alexey; Enyedy, Istvan; Cuervo, Hernan; Wang, Deping; Atmanene, Cedric; Roecklin, Dominique; Vecchi, Malgorzata; Vivat, Valerie; Kraemer, Joachim; Winkler, Dirk; Hong, Victor; Chao, Jianhua; Lukashev, Matvey; Silvian, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4011-4019</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 binds to the Nrf2 transcription factor to promote its degrdn., resulting in the loss of gene products that protect against oxidative stress.  While cell-active small mols. have been identified that modify cysteines in Keap1 and effect the Nrf2 dependent pathway, few act through a non-covalent mechanism.  We have identified and characterized several small mol. compds. that specifically bind to the Keap1 Kelch-DC domain as measured by NMR, native mass spectrometry and X-ray crystallog.  One compd. upregulates Nrf2 response genes measured by a luciferase cell reporter assay.  The non-covalent inhibition strategy presents a reasonable course of action to avoid toxic side-effects due to non-specific cysteine modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KaDM3q3CeLVg90H21EOLACvtfcHk0lhKRqPxlIwALA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D&md5=b49b42b1621c6f08fbb3449621e4b109</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHus%26aufirst%3DJ.%2BC.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DHession%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DCuervo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DAtmanene%26aufirst%3DC.%26aulast%3DRoecklin%26aufirst%3DD.%26aulast%3DVecchi%26aufirst%3DM.%26aulast%3DVivat%26aufirst%3DV.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DV.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DSilvian%26aufirst%3DL.%26atitle%3DSmall%2520molecules%2520inhibit%2520the%2520interaction%2520of%2520Nrf2%2520and%2520the%2520Keap1%2520Kelch%2520domain%2520through%2520a%2520non-covalent%2520mechanism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4011%26epage%3D4019%26doi%3D10.1016%2Fj.bmc.2013.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Keap1–Nrf2 protein–protein interaction inhibitor based on molecular binding determinants analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=L.+L.+Xuauthor=T.+T.+Yangauthor=M.+Y.+Xiauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+of+potent+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitor+based+on+molecular+binding+determinants+analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0lhKRqPxlIwALA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.%2BT.%26aulast%3DXi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%2520based%2520on%2520molecular%2520binding%2520determinants%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity and structure-property relationship and exploratory in vivo evaluation of the nanomolar Keap1–Nrf2 protein–protein interaction inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6410</span>– <span class="NLM_lpage">6421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6410-6421&author=Z.+Y.+Jiangauthor=L.+L.+Xuauthor=M.+C.+Luauthor=Z.+Y.+Chenauthor=Z.+W.+Yuanauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=H.+P.+Sunauthor=Q.+D.+You&title=Structure-activity+and+structure-property+relationship+and+exploratory+in+vivo+evaluation+of+the+nanomolar+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitor&doi=10.1021%2Facs.jmedchem.5b00185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00185%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DYuan%26aufirst%3DZ.%2BW.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DH.%2BP.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DStructure-activity%2520and%2520structure-property%2520relationship%2520and%2520exploratory%2520in%2520vivo%2520evaluation%2520of%2520the%2520nanomolar%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6410%26epage%3D6421%26doi%3D10.1021%2Facs.jmedchem.5b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Polar recognition group study of Keap1–Nrf2 protein–protein interaction inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=835-840&author=M.+C.+Luauthor=S.+J.+Tanauthor=J.+A.+Jiauthor=Z.+Y.+Chenauthor=Z.+W.+Yuanauthor=Q.+D.+Youauthor=Z.+Y.+Jiang&title=Polar+recognition+group+study+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitors&doi=10.1021%2Facsmedchemlett.5b00407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DTan%26aufirst%3DS.%2BJ.%26aulast%3DJi%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DYuan%26aufirst%3DZ.%2BW.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26atitle%3DPolar%2520recognition%2520group%2520study%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D835%26epage%3D840%26doi%3D10.1021%2Facsmedchemlett.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margerie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szillat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gussregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Knethen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">28446</span>– <span class="NLM_lpage">28455</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.678136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1074%2Fjbc.M115.678136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26459563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=28446-28455&author=A.+F.+Winkelauthor=C.+K.+Engelauthor=D.+Margerieauthor=A.+Kanntauthor=H.+Szillatauthor=H.+Glombikauthor=C.+Kallusauthor=S.+Rufauthor=S.+Gussregenauthor=J.+Riedelauthor=A.+W.+Herlingauthor=A.+von+Knethenauthor=A.+Weigertauthor=B.+Bruneauthor=D.+Schmoll&title=Characterization+of+RA839%2C+a+noncovalent+small+molecule+binder+to+Keap1+and+selective+activator+of+Nrf2+signaling&doi=10.1074%2Fjbc.M115.678136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span></div><div class="casAuthors">Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">28446-28455</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activation of the transcription factor NF-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes.  Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keap1 (kelch-like ECH-assocd. protein 1).  Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl]pyrrolidine-3-carboxylic acid (RA839), a small mol. that binds noncovalently to the Nrf2-interacting kelch domain of Keap1 with a Kd of ∼6 μm, as demonstrated by x-ray co-crystn. and isothermal titrn. calorimetry.  Whole genome DNA arrays showed that at 10 μm RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages.  Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling.  These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression.  RA839 regulated only two genes in Nrf2 knock-out macrophages.  Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compd. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid Me ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages.  In mice, RA839 acutely induced Nrf2 target gene expression in liver.  RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compd. to study the biol. of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu4FlVebzcbVg90H21EOLACvtfcHk0liUruRgm2X0Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF&md5=082998a0e4685dc8622662270fbba223</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.678136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.678136%26sid%3Dliteratum%253Aachs%26aulast%3DWinkel%26aufirst%3DA.%2BF.%26aulast%3DEngel%26aufirst%3DC.%2BK.%26aulast%3DMargerie%26aufirst%3DD.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DSzillat%26aufirst%3DH.%26aulast%3DGlombik%26aufirst%3DH.%26aulast%3DKallus%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DGussregen%26aufirst%3DS.%26aulast%3DRiedel%26aufirst%3DJ.%26aulast%3DHerling%26aufirst%3DA.%2BW.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DBrune%26aufirst%3DB.%26aulast%3DSchmoll%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520RA839%252C%2520a%2520noncovalent%2520small%2520molecule%2520binder%2520to%2520Keap1%2520and%2520selective%2520activator%2520of%2520Nrf2%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D28446%26epage%3D28455%26doi%3D10.1074%2Fjbc.M115.678136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12030</span>, <span class="refDoi"> DOI: 10.1038/ncomms12030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fncomms12030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27345495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12030&author=T.+Saitoauthor=Y.+Ichimuraauthor=K.+Taguchiauthor=T.+Suzukiauthor=T.+Mizushimaauthor=K.+Takagiauthor=Y.+Hiroseauthor=M.+Nagahashiauthor=T.+Isoauthor=T.+Fukutomiauthor=M.+Ohishiauthor=K.+Endoauthor=T.+Uemuraauthor=Y.+Nishitoauthor=S.+Okudaauthor=M.+Obataauthor=T.+Kounoauthor=R.+Imamuraauthor=Y.+Tadaauthor=R.+Obataauthor=D.+Yasudaauthor=K.+Takahashiauthor=T.+Fujimuraauthor=J.+Piauthor=M.+S.+Leeauthor=T.+Uenoauthor=T.+Oheauthor=T.+Mashinoauthor=T.+Wakaiauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=H.+Motohashiauthor=S.+Waguriauthor=T.+Sogaauthor=M.+Yamamotoauthor=K.+Tanakaauthor=M.+Komatsu&title=p62%2FSqstm1+promotes+malignancy+of+HCV-positive+hepatocellular+carcinoma+through+Nrf2-dependent+metabolic+reprogramming&doi=10.1038%2Fncomms12030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span></div><div class="casAuthors">Saito, Tetsuya; Ichimura, Yoshinobu; Taguchi, Keiko; Suzuki, Takafumi; Mizushima, Tsunehiro; Takagi, Kenji; Hirose, Yuki; Nagahashi, Masayuki; Iso, Tetsuro; Fukutomi, Toshiaki; Ohishi, Maki; Endo, Keiko; Uemura, Takefumi; Nishito, Yasumasa; Okuda, Shujiro; Obata, Miki; Kouno, Tsuguka; Imamura, Riyo; Tada, Yukio; Obata, Rika; Yasuda, Daisuke; Takahashi, Kyoko; Fujimura, Tsutomu; Pi, Jingbo; Lee, Myung-Shik; Ueno, Takashi; Ohe, Tomoyuki; Mashino, Tadahiko; Wakai, Toshifumi; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo; Motohashi, Hozumi; Waguri, Satoshi; Soga, Tomoyoshi; Yamamoto, Masayuki; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12030</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P62/Sqstm1 is a multifunctional protein involved in cell survival, growth and death, that is degraded by autophagy.  Amplification of the p62/Sqstm1 gene, and aberrant accumulation and phosphorylation of p62/Sqstm1, have been implicated in tumor development.  Herein, we reveal the mol. mechanism of p62/Sqstm1-dependent malignant progression, and suggest that mol. targeting of p62/Sqstm1 represents a potential chemotherapeutic approach against hepatocellular carcinoma (HCC).  Phosphorylation of p62/Sqstm1 at Ser349 directs glucose to the glucuronate pathway, and glutamine towards glutathione synthesis through activation of the transcription factor Nrf2.  These changes provide HCC cells with tolerance to anti-cancer drugs and proliferation potency.  Phosphorylated p62/Sqstm1 accumulates in tumor regions pos. for hepatitis C virus (HCV).  An inhibitor of phosphorylated p62-dependent Nrf2 activation suppresses the proliferation and anticancer agent tolerance of HCC.  Our data indicate that this Nrf2 inhibitor could be used to make cancer cells less resistant to anticancer drugs, esp. in HCV-pos. HCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWPpd-6mfs2rVg90H21EOLACvtfcHk0lhcgOljsYpZRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF&md5=859f788e0e5ac3e5ed46eeee9da47490</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fncomms12030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12030%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DHirose%26aufirst%3DY.%26aulast%3DNagahashi%26aufirst%3DM.%26aulast%3DIso%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DUemura%26aufirst%3DT.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DObata%26aufirst%3DM.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DPi%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26aulast%3DWakai%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSqstm1%2520promotes%2520malignancy%2520of%2520HCV-positive%2520hepatocellular%2520carcinoma%2520through%2520Nrf2-dependent%2520metabolic%2520reprogramming%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12030%26doi%3D10.1038%2Fncomms12030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Keap1-phosphorylated p62 and Keap1–Nrf2 protein–protein interaction inhibitors and their inhibitory activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2016.10.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5956-5959&author=D.+Yasudaauthor=M.+Nakajimaauthor=A.+Yuasaauthor=R.+Obataauthor=K.+Takahashiauthor=T.+Oheauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=T.+Mashino&title=Synthesis+of+Keap1-phosphorylated+p62+and+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitors+and+their+inhibitory+activity&doi=10.1016%2Fj.bmcl.2016.10.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DA.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520Keap1-phosphorylated%2520p62%2520and%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%2520and%2520their%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5956%26epage%3D5959%26doi%3D10.1016%2Fj.bmcl.2016.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzo[g]indoles as a novel class of non-covalent Keap1–Nrf2 protein–protein interaction inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5006</span>– <span class="NLM_lpage">5009</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2017.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5006-5009&author=D.+Yasudaauthor=A.+Yuasaauthor=R.+Obataauthor=M.+Nakajimaauthor=K.+Takahashiauthor=T.+Oheauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=T.+Mashino&title=Discovery+of+benzo%5Bg%5Dindoles+as+a+novel+class+of+non-covalent+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitor&doi=10.1016%2Fj.bmcl.2017.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DYuasa%26aufirst%3DA.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520benzo%255Bg%255Dindoles%2520as%2520a%2520novel%2520class%2520of%2520non-covalent%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5006%26epage%3D5009%26doi%3D10.1016%2Fj.bmcl.2017.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonchuk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span> <span> </span><span class="NLM_article-title">Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein–protein interaction with high cell potency identified by fragment-based discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3991</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3991-4006&author=T.+G.+Daviesauthor=W.+E.+Wixtedauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=K.+Hearnauthor=R.+McMenaminauthor=D.+Nortonauthor=S.+J.+Richauthor=C.+Richardsonauthor=G.+Saxtyauthor=H.+M.+Willemsauthor=A.+J.+Woolfordauthor=J.+E.+Cottomauthor=J.+P.+Kouauthor=J.+G.+Yonchukauthor=H.+G.+Feldserauthor=Y.+Sanchezauthor=J.+P.+Foleyauthor=B.+J.+Bologneseauthor=G.+Loganauthor=P.+L.+Podolinauthor=H.+Yanauthor=J.+F.+Callahanauthor=T.+D.+Heightmanauthor=J.+K.+Kerns&title=Monoacidic+inhibitors+of+the+Kelch-like+ECH-associated+protein+1%3A+nuclear+factor+erythroid+2-related+factor+2+%28KEAP1%3ANRF2%29+protein%E2%80%93protein+interaction+with+high+cell+potency+identified+by+fragment-based+discovery&doi=10.1021%2Facs.jmedchem.6b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span></div><div class="casAuthors">Davies, Thomas G.; Wixted, William E.; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Hearn, Keisha; McMenamin, Rachel; Norton, David; Rich, Sharna J.; Richardson, Caroline; Saxty, Gordon; Willems, Henriette M. G.; Woolford, Alison J.-A.; Cottom, Joshua E.; Kou, Jen-Pyng; Yonchuk, John G.; Feldser, Heidi G.; Sanchez, Yolanda; Foley, Joseph P.; Bolognese, Brian J.; Logan, Gregory; Podolin, Patricia L.; Yan, Hongxing; Callahan, James F.; Heightman, Tom D.; Kerns, Jeffrey K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3991-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">KEAP1 is the key regulator of the NRF2-mediated cytoprotective response, and increasingly recognized as a target for diseases involving oxidative stress.  Pharmacol. intervention has focused on mols. that decrease NRF2-ubiquitination through covalent modification of KEAP1 cysteine residues, but such electrophilic compds. lack selectivity and may be assocd. with off-target toxicity.  We report here the first use of a fragment-based approach to directly target the KEAP1 Kelch-NRF2 interaction.  X-ray crystallog. screening identified three distinct "hot-spots" for fragment binding within the NRF2 binding pocket of KEAP1, allowing progression of a weak fragment hit to mols. with nanomolar affinity for KEAP1 while maintaining drug-like properties.  This work resulted in a promising lead compd. (I) which exhibits tight and selective binding to KEAP1, and activates the NRF2 antioxidant response in cellular and in vivo models, thereby providing a high quality chem. probe to explore the therapeutic potential of disrupting the KEAP1-NRF2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-gfBTuYreLVg90H21EOLACvtfcHk0lgdlkoiNzzr5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D&md5=ae42cc9f06d14b340cb3a8f5d6c157a7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00228%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DKou%26aufirst%3DJ.%2BP.%26aulast%3DYonchuk%26aufirst%3DJ.%2BG.%26aulast%3DFeldser%26aufirst%3DH.%2BG.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLogan%26aufirst%3DG.%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26atitle%3DMonoacidic%2520inhibitors%2520of%2520the%2520Kelch-like%2520ECH-associated%2520protein%25201%253A%2520nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein%25E2%2580%2593protein%2520interaction%2520with%2520high%2520cell%2520potency%2520identified%2520by%2520fragment-based%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3991%26epage%3D4006%26doi%3D10.1021%2Facs.jmedchem.6b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span>; <span class="NLM_string-name">Kerns, J. J.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Nie, H.</span>; <span class="NLM_string-name">Pero, J. E.</span>; <span class="NLM_string-name">Davies, T. G.</span>; <span class="NLM_string-name">Heightman, T. D.</span>; <span class="NLM_string-name">Woolford, A.</span>; <span class="NLM_string-name">Griffiths-Jones, C. M.</span>; <span class="NLM_string-name">Norton, D.</span>; <span class="NLM_string-name">Willems, H. M. G.</span>; <span class="NLM_string-name">Verdonk, M. L.</span>; <span class="NLM_string-name">Carr, M. G.</span></span> <span> </span><span class="NLM_article-title">Biaryl Pyrazoles as Nrf2 Regulators</span>. <span class="NLM_patent">WO2017060854</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+F.+Callahan&author=J.+J.+Kerns&author=T.+Li&author=H.+Nie&author=J.+E.+Pero&author=T.+G.+Davies&author=T.+D.+Heightman&author=A.+Woolford&author=C.+M.+Griffiths-Jones&author=D.+Norton&author=H.+M.+G.+Willems&author=M.+L.+Verdonk&author=M.+G.+Carr&title=Biaryl+Pyrazoles+as+Nrf2+Regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26atitle%3DBiaryl%2520Pyrazoles%2520as%2520Nrf2%2520Regulators%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span>; <span class="NLM_string-name">Kerns, J. J.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Nie, H.</span>; <span class="NLM_string-name">Pero, J. E.</span>; <span class="NLM_string-name">Davies, T. G.</span>; <span class="NLM_string-name">Heightman, T. D.</span>; <span class="NLM_string-name">Woolford, A. J.</span>; <span class="NLM_string-name">Griffiths-Jones, C. M.</span>; <span class="NLM_string-name">Norton, D.</span>; <span class="NLM_string-name">Verdonk, M. L.</span>; <span class="NLM_string-name">Howard, S.</span></span> <span> </span><span class="NLM_article-title">Arylcyclohexyl Pyrazoles as Nrf2 Regulators</span>. <span class="NLM_patent">WO2017060855</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+F.+Callahan&author=J.+J.+Kerns&author=T.+Li&author=H.+Nie&author=J.+E.+Pero&author=T.+G.+Davies&author=T.+D.+Heightman&author=A.+J.+Woolford&author=C.+M.+Griffiths-Jones&author=D.+Norton&author=M.+L.+Verdonk&author=S.+Howard&title=Arylcyclohexyl+Pyrazoles+as+Nrf2+Regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26atitle%3DArylcyclohexyl%2520Pyrazoles%2520as%2520Nrf2%2520Regulators%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgakopoulos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiollier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of triazole derivatives that induce Nrf2 dependent gene products and inhibit the Keap1–Nrf2 protein–protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7186</span>– <span class="NLM_lpage">7194</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7186-7194&author=H.+C.+Bertrandauthor=M.+Schaapauthor=L.+Bairdauthor=N.+D.+Georgakopoulosauthor=A.+Fowkesauthor=C.+Thiollierauthor=H.+Kachiauthor=A.+T.+Dinkova-Kostovaauthor=G.+Wells&title=Design%2C+synthesis%2C+and+evaluation+of+triazole+derivatives+that+induce+Nrf2+dependent+gene+products+and+inhibit+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1021%2Facs.jmedchem.5b00602"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00602%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DSchaap%26aufirst%3DM.%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DGeorgakopoulos%26aufirst%3DN.%2BD.%26aulast%3DFowkes%26aufirst%3DA.%26aulast%3DThiollier%26aufirst%3DC.%26aulast%3DKachi%26aufirst%3DH.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520triazole%2520derivatives%2520that%2520induce%2520Nrf2%2520dependent%2520gene%2520products%2520and%2520inhibit%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7186%26epage%3D7194%26doi%3D10.1021%2Facs.jmedchem.5b00602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazantsev, A. G.</span>; <span class="NLM_string-name">Thompson, L.</span>; <span class="NLM_string-name">Abagyan, R.</span>; <span class="NLM_string-name">Casale, M.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Activators of Nrf2 Pathway</span>. <span class="NLM_patent">WO2014197818</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+G.+Kazantsev&author=L.+Thompson&author=R.+Abagyan&author=M.+Casale&title=Small+Molecule+Activators+of+Nrf2+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSmall%2520Molecule%2520Activators%2520of%2520Nrf2%2520Pathway%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saburi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naitow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimozono, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunishima, N.</span></span> <span> </span><span class="NLM_article-title">Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.fob.2015.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.fob.2015.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26199865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaitbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=557-570&author=M.+Satohauthor=H.+Saburiauthor=T.+Tanakaauthor=Y.+Matsuuraauthor=H.+Naitowauthor=R.+Shimozonoauthor=N.+Yamamotoauthor=H.+Inoueauthor=N.+Nakamuraauthor=Y.+Yoshizawaauthor=T.+Aokiauthor=R.+Tanimuraauthor=N.+Kunishima&title=Multiple+binding+modes+of+a+small+molecule+to+human+Keap1+revealed+by+X-ray+crystallography+and+molecular+dynamics+simulation&doi=10.1016%2Fj.fob.2015.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation</span></div><div class="casAuthors">Satoh, Mikiya; Saburi, Hajime; Tanaka, Tomoyuki; Matsuura, Yoshinori; Naitow, Hisashi; Shimozono, Rieko; Yamamoto, Naoyoshi; Inoue, Hideki; Nakamura, Noriko; Yoshizawa, Yoshitaka; Aoki, Takumi; Tanimura, Ryuji; Kunishima, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Open Bio</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">557-570</span>CODEN:
                <span class="NLM_cas:coden">FOBEB3</span>;
        ISSN:<span class="NLM_cas:issn">2211-5463</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 protein acts as a cellular sensor for oxidative stresses and regulates the transcription level of antioxidant genes through the ubiquitination of a corresponding transcription factor, Nrf2.  A small mol. capable of binding to the Nrf2 interaction site of Keap1 could be a useful medicine.  Here, we report two crystal structures, referred to as the soaking and the cocrystn. forms, of the Kelch domain of Keap1 with a small mol., Ligand1.  In these two forms, the Ligand1 mol. occupied the binding site of Keap1 so as to mimic the ETGE motif of Nrf2, although the mode of binding differed in the two forms.  Because the Ligand1 mol. mediated the crystal packing in both the forms, the influence of crystal packing on the ligand binding was examd. using a mol. dynamics (MD) simulation in aq. conditions.  In the MD structures from the soaking form, the ligand remained bound to Keap1 for over 20 ns, whereas the ligand tended to dissoc. in the cocrystn. form.  The MD structures could be classified into a few clusters that were related to but distinct from the crystal structures, indicating that the binding modes obsd. in crystals might be atypical of those in soln.  However, the dominant ligand recognition residues in the crystal structures were commonly used in the MD structures to anchor the ligand.  Therefore, the present structural information together with the MD simulation will be a useful basis for pharmaceutical drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3082uY55kRbVg90H21EOLACvtfcHk0ljWh4UKc0EPGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaitbfF&md5=b716297a8be096ef649f22cad472c58d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.fob.2015.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fob.2015.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DM.%26aulast%3DSaburi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DY.%26aulast%3DNaitow%26aufirst%3DH.%26aulast%3DShimozono%26aufirst%3DR.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DTanimura%26aufirst%3DR.%26aulast%3DKunishima%26aufirst%3DN.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520a%2520small%2520molecule%2520to%2520human%2520Keap1%2520revealed%2520by%2520X-ray%2520crystallography%2520and%2520molecular%2520dynamics%2520simulation%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2015%26volume%3D5%26spage%3D557%26epage%3D570%26doi%3D10.1016%2Fj.fob.2015.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimozono, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, H.</span></span> <span> </span><span class="NLM_article-title">Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1124/mol.112.084269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1124%2Fmol.112.084269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=23592516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=62-70&author=R.+Shimozonoauthor=Y.+Asaokaauthor=Y.+Yoshizawaauthor=T.+Aokiauthor=H.+Nodaauthor=M.+Yamadaauthor=M.+Kainoauthor=H.+Mochizuki&title=Nrf2+activators+attenuate+the+progression+of+nonalcoholic+steatohepatitis-related+fibrosis+in+a+dietary+rat+model&doi=10.1124%2Fmol.112.084269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model</span></div><div class="casAuthors">Shimozono, Rieko; Asaoka, Yoshiji; Yoshizawa, Yoshitaka; Aoki, Takumi; Noda, Hidetoshi; Yamada, Masateru; Kaino, Mie; Mochizuki, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-70</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Oxidative stress is considered to be a key mechanism of hepatocellular injury and disease progression in patients with nonalcoholic steatohepatitis (NASH).  The transcription factor Nrf2 (nuclear factor-erythroid-2-related factor 2) plays a central role in stimulating expression of various antioxidant-assocd. genes in the cellular defense against oxidative stress.  As the cytosolic repressor kelch-like ECH-assocd. protein 1 (Keap1) neg. regulates Nrf2, activation of Nrf2 facilitated by its release from Keap1 may represent a promising strategy in the treatment of NASH.  To test this hypothesis, we used two chem. distinct types of Nrf2 activator.  One is the thiol-reactive agent oltipraz (OPZ), a typical Nrf2 activator, and the other is a novel biaryl urea compd., termed NK-252 (1-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)-3-(pyridin-2-ylmethyl)urea).  NK-252 exhibits a greater Nrf2-activating potential than OPZ.  Furthermore, in vitro binding studies revealed that NK-252 interacts with the domain contg. the Nrf2-binding site of Keap1, whereas OPZ does not.  This finding indicates that NK-252 is more potent than OPZ due to its unique mechanism of action.  For in vivo animal model studies, we used rats on a choline-deficient L-amino acid-defined (CDAA) diet, which demonstrate pathol. findings similar to those seen in human NASH.  The administration of OPZ or NK-252 significantly attenuated the progression of histol. abnormalities in rats on a CDAA diet, esp. hepatic fibrosis.  In conclusion, by using Nrf2 activators with independent mechanisms of action, we show that, in a rat model of NASH, the activation of Nrf2 is responsible for the antifibrotic effects of these drugs.  This strategy of Nrf2 activation presents new opportunities for treatment of NASH patients with hepatic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPPmcfr7KwlbVg90H21EOLACvtfcHk0lghC4Vv1pkonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjJ&md5=6e58be4d60b2ed64524e8799275c04a0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.084269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.084269%26sid%3Dliteratum%253Aachs%26aulast%3DShimozono%26aufirst%3DR.%26aulast%3DAsaoka%26aufirst%3DY.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DKaino%26aufirst%3DM.%26aulast%3DMochizuki%26aufirst%3DH.%26atitle%3DNrf2%2520activators%2520attenuate%2520the%2520progression%2520of%2520nonalcoholic%2520steatohepatitis-related%2520fibrosis%2520in%2520a%2520dietary%2520rat%2520model%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D62%26epage%3D70%26doi%3D10.1124%2Fmol.112.084269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-d.</span></span> <span> </span><span class="NLM_article-title">Novel protein–protein interaction inhibitor of Nrf2–Keap1 discovered by structure-based virtual screening</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1039/C3MD00240C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1039%2FC3MD00240C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=93-98&author=H.-P.+Sunauthor=Z.-Y.+Jiangauthor=M.-Y.+Zhangauthor=M.-C.+Luauthor=T.-T.+Yangauthor=Y.+Panauthor=H.-Z.+Huangauthor=X.-J.+Zhangauthor=Q.-d.+You&title=Novel+protein%E2%80%93protein+interaction+inhibitor+of+Nrf2%E2%80%93Keap1+discovered+by+structure-based+virtual+screening&doi=10.1039%2FC3MD00240C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2FC3MD00240C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MD00240C%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.-P.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DZhang%26aufirst%3DM.-Y.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DYang%26aufirst%3DT.-T.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.-Z.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DYou%26aufirst%3DQ.-d.%26atitle%3DNovel%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%2520of%2520Nrf2%25E2%2580%2593Keap1%2520discovered%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D93%26epage%3D98%26doi%3D10.1039%2FC3MD00240C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanapillai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span> <span> </span><span class="NLM_article-title">Rapid identification of Keap1–Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1126</span>, <span class="refDoi"> DOI: 10.1021/jm4017174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1121-1126&author=C.+Zhuangauthor=S.+Narayanapillaiauthor=W.+Zhangauthor=Y.+Y.+Shamauthor=C.+Xing&title=Rapid+identification+of+Keap1%E2%80%93Nrf2+small-molecule+inhibitors+through+structure-based+virtual+screening+and+hit-based+substructure+search&doi=10.1021%2Fjm4017174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm4017174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017174%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DNarayanapillai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DXing%26aufirst%3DC.%26atitle%3DRapid%2520identification%2520of%2520Keap1%25E2%2580%2593Nrf2%2520small-molecule%2520inhibitors%2520through%2520structure-based%2520virtual%2520screening%2520and%2520hit-based%2520substructure%2520search%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1121%26epage%3D1126%26doi%3D10.1021%2Fjm4017174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-growing guided design of Keap1–Nrf2 protein–protein interaction inhibitors for targeting myocarditis</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2018.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=29428410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=228-237&author=N.+Mengauthor=H.+Tangauthor=H.+Zhangauthor=C.+Jiangauthor=L.+Suauthor=X.+Minauthor=W.+Zhangauthor=H.+Zhangauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Zhuang&title=Fragment-growing+guided+design+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitors+for+targeting+myocarditis&doi=10.1016%2Fj.freeradbiomed.2018.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis</span></div><div class="casAuthors">Meng, Ning; Tang, Hua; Zhang, Hao; Jiang, Chengshi; Su, Li; Min, Xiao; Zhang, Wannian; Zhang, Hua; Miao, Zhenyuan; Zhang, Wen; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the Keap1-Nrf2 protein-protein interactions are being intensely pursued as a new therapeutic strategy for oxidative stress-related diseases, such as cancer, diabetes, Alzheimer's disease, arteriosclerosis, inflammation and myocarditis.  However, there are not enough studies on antioxidant treatments using small mols. in myocarditis.  The authors herein provided a series of novel hydronaphthoquinones as the Keap1-Nrf2 interaction inhibitors targeting LPS-induced myocarditis both in vitro and in vivo.  These compds. were designed through an in-silico fragment growing approach based on the previous reported compd.  The new compds. were predicted to form addnl. hydrogen bonds with the S363 residue, leading to higher inhibitory activity.  Among these new derivs., compds. I and II emerged as inhibitors with significant biochem. potency, as detd. by fluorescent anisotropy assay and confirmed by surface plasmon resonance (SPR) and differential scanning fluorometry (DSF) assays.  These inhibitors can dose-dependently protect the H9c2 cardiac cells against LPS-induced injury (100% at 2 μM and 4 μM) and effectively prolong survival or save the life of LPS-injured mice.  Mechanistic studies showed that these inhibitors could release Nrf2 in H9c2 cells and LPS-inflammatory mouse models and translocate into the nucleus in a dose-response manner, which significantly increased the downstream genes (HO-1, NQO-1) and the pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), while ROS prodn. dramatically decreased.  Their protective effects and the mechanism of action were further confirmed by siNrf2 transfected expt.  Collectively, the novel hydronaphthoquinones can be used as promising lead compds. for the study of Keap1-Nrf2 protein-protein interactions and further antimyocarditis drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8LWG_bMTJLVg90H21EOLACvtfcHk0lhCWAJo0Rg5AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D&md5=71299d349ff1e7ba6aa29967e9380ebe</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DFragment-growing%2520guided%2520design%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%2520for%2520targeting%2520myocarditis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D117%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.freeradbiomed.2018.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P.</span></span> <span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3714</span>– <span class="NLM_lpage">3717</span>, <span class="refDoi"> DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lhCWAJo0Rg5AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rishton, G. M.</span></span> <span> </span><span class="NLM_article-title">Nonleadlikeness and leadlikeness in biochemical screening</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/S1359644602025722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2FS1359644602025722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=12565011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fls1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=86-96&author=G.+M.+Rishton&title=Nonleadlikeness+and+leadlikeness+in+biochemical+screening&doi=10.1016%2FS1359644602025722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Nonleadlikeness and leadlikeness in biochemical screening</span></div><div class="casAuthors">Rishton Gilbert M</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-96</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Biochemical assays have largely supplanted functional biological assays as drug screening tools in the early stages of drug discovery.  The de-selection of compounds that are 'nonleadlike' binders (and bonders) and the proactive selection of those compounds that are 'leadlike' in their binding to the target are vital components of the screening effort.  The physiochemical properties of leadlikeness and the surprising differences between those properties and the now classical definitions of druglikeness are becoming apparent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFoWSt5LTTmsrRqEXsZufAfW6udTcc2eaM-Qb85orOmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fls1SjtQ%253D%253D&md5=5e34cece6f751fa727f949c3526aa95c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS1359644602025722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359644602025722%26sid%3Dliteratum%253Aachs%26aulast%3DRishton%26aufirst%3DG.%2BM.%26atitle%3DNonleadlikeness%2520and%2520leadlikeness%2520in%2520biochemical%2520screening%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D86%26epage%3D96%26doi%3D10.1016%2FS1359644602025722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Structural Alerts for Toxicity</span>. In  <i>Burger’s Medicinal Chemistry, Drug Discovery, and Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, D. J.</span>, <span class="NLM_string-name">Rotella, D. P.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">334</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1002%2F0471266949.bmc128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=301-334&author=J.+Blaggauthor=D.+J.+Abraham&author=D.+P.+Rotella&title=Burger%E2%80%99s+Medicinal+Chemistry%2C+Drug+Discovery%2C+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2F0471266949.bmc128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471266949.bmc128%26sid%3Dliteratum%253Aachs%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructural%2520Alerts%2520for%2520Toxicity%26btitle%3DBurger%25E2%2580%2599s%2520Medicinal%2520Chemistry%252C%2520Drug%2520Discovery%252C%2520and%2520Development%26aulast%3DAbraham%26aufirst%3DD.%2BJ.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2010%26spage%3D301%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. D.</span>; <span class="NLM_string-name">Davies, T. G.</span>; <span class="NLM_string-name">Woolford, A. J.</span>; <span class="NLM_string-name">Griffiths-Jones, C. M.</span>; <span class="NLM_string-name">Willems, H. M. G.</span>; <span class="NLM_string-name">Norton, D.</span>; <span class="NLM_string-name">Saxty, G.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Kerns, J. K.</span>; <span class="NLM_string-name">Davies, R. S.</span>; <span class="NLM_string-name">Yan, H.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Regulators</span>. <span class="NLM_patent">WO2015092713</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+D.+Boehm&author=T.+G.+Davies&author=A.+J.+Woolford&author=C.+M.+Griffiths-Jones&author=H.+M.+G.+Willems&author=D.+Norton&author=G.+Saxty&author=T.+Li&author=J.+K.+Kerns&author=R.+S.+Davies&author=H.+Yan&title=Nrf2+Regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DJ.%2BD.%26atitle%3DNrf2%2520Regulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. D.</span></span> <span> </span><span class="NLM_article-title">Metabolic activation and drug toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1021/jm00349a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00349a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=753-765&author=S.+D.+Nelson&title=Metabolic+activation+and+drug+toxicity&doi=10.1021%2Fjm00349a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation and drug toxicity</span></div><div class="casAuthors">Nelson, Sidney D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-65</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review with 128 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzUsG75cxLYLVg90H21EOLACvtfcHk0lgfpnuIoEEbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D&md5=89c759fff948a83bb8edebef1c8cdbad</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm00349a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00349a001%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DMetabolic%2520activation%2520and%2520drug%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D753%26epage%3D765%26doi%3D10.1021%2Fjm00349a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanmart, S.</span></span> <span> </span><span class="NLM_article-title">Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00361</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00361" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=497-503&author=M.+Pouliotauthor=S.+Jeanmart&title=Pan+assay+interference+compounds+%28PAINS%29+and+other+promiscuous+compounds+in+antifungal+research&doi=10.1021%2Facs.jmedchem.5b00361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research</span></div><div class="casAuthors">Pouliot, Martin; Jeanmart, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">497-503</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Every week, articles disclosing new antifungal leads reported as promising starting points for optimization projects are published.  In many cases, the mechanism that accounts for their antifungal activity has not been fully elucidated.  More significantly, the detrimental impact that could result from certain embedded chem. features has been underestimated or even overlooked.  In the course of the authors' research in the agrochem. area, the authors have concluded that in many cases such leads are actually nonoptimizable because they either contain what are now recognized as pan assay interference compds. (PAINS) or other promiscuous groups.  This article is aimed at highlighting the pitfalls the authors have encountered and hopefully to steer other research groups away from them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqURFxdfKNQIbVg90H21EOLACvtfcHk0lh-IQO9H0VhoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE&md5=af11fcafd47de435fcc5fdf05080023a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00361%26sid%3Dliteratum%253Aachs%26aulast%3DPouliot%26aufirst%3DM.%26aulast%3DJeanmart%26aufirst%3DS.%26atitle%3DPan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520and%2520other%2520promiscuous%2520compounds%2520in%2520antifungal%2520research%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D497%26epage%3D503%26doi%3D10.1021%2Facs.jmedchem.5b00361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span> <span> </span><span class="NLM_article-title">PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2091</span>– <span class="NLM_lpage">2113</span>, <span class="refDoi"> DOI: 10.1021/jm5019093</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2091-2113&author=J.+L.+Dahlinauthor=J.+W.+Nissinkauthor=J.+M.+Strasserauthor=S.+Francisauthor=L.+Higginsauthor=H.+Zhouauthor=Z.+Zhangauthor=M.+A.+Walters&title=PAINS+in+the+assay%3A+chemical+mechanisms+of+assay+interference+and+promiscuous+enzymatic+inhibition+observed+during+a+sulfhydryl-scavenging+HTS&doi=10.1021%2Fjm5019093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS</span></div><div class="casAuthors">Dahlin, Jayme L.; Nissink, J. Willem M.; Strasser, Jessica M.; Francis, Subhashree; Higgins, LeeAnn; Zhou, Hui; Zhang, Zhiguo; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2091-2113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant resources in early drug discovery are spent unknowingly pursuing artifacts and promiscuous bioactive compds., while understanding the chem. basis for these adverse behaviors often goes unexplored in pursuit of lead compds.  Nearly all the hits from our recent sulfhydryl-scavenging high-throughput screen (HTS) targeting the histone acetyltransferase Rtt109 were such compds.  Herein, we characterize the chem. basis for assay interference and promiscuous enzymic inhibition for several prominent chemotypes identified by this HTS, including some pan-assay interference compds. (PAINS).  Protein mass spectrometry and ALARM NMR confirmed these compds. react covalently with cysteines on multiple proteins.  Unfortunately, compds. contg. these chemotypes have been published as screening actives in reputable journals and even touted as chem. probes or preclin. candidates.  Our detailed characterization and identification of such thiol-reactive chemotypes should accelerate triage of nuisance compds., guide screening library design, and prevent follow-up on undesirable chem. matter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4XTJapoezkrVg90H21EOLACvtfcHk0lh-IQO9H0VhoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeisbY%253D&md5=3f77702544cea2ec4c8184b60dd38b8a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm5019093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019093%26sid%3Dliteratum%253Aachs%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%26aulast%3DStrasser%26aufirst%3DJ.%2BM.%26aulast%3DFrancis%26aufirst%3DS.%26aulast%3DHiggins%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DPAINS%2520in%2520the%2520assay%253A%2520chemical%2520mechanisms%2520of%2520assay%2520interference%2520and%2520promiscuous%2520enzymatic%2520inhibition%2520observed%2520during%2520a%2520sulfhydryl-scavenging%2520HTS%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2091%26epage%3D2113%26doi%3D10.1021%2Fjm5019093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">8238</span>– <span class="NLM_lpage">8259</span>, <span class="refDoi"> DOI: 10.1039/C5CS00252D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1039%2FC5CS00252D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=8238-8259&author=C.+Shengauthor=G.+Dongauthor=Z.+Miaoauthor=W.+Zhangauthor=W.+Wang&title=State-of-the-art+strategies+for+targeting+protein%E2%80%93protein+interactions+by+small-molecule+inhibitors&doi=10.1039%2FC5CS00252D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1039%2FC5CS00252D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00252D%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DState-of-the-art%2520strategies%2520for%2520targeting%2520protein%25E2%2580%2593protein%2520interactions%2520by%2520small-molecule%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D8238%26epage%3D8259%26doi%3D10.1039%2FC5CS00252D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0lhzMBdcXGBFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrd1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=15286733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=660-672&author=D.+C.+Reesauthor=M.+Congreveauthor=C.+W.+Murrayauthor=R.+Carr&title=Fragment-based+lead+discovery&doi=10.1038%2Fnrd1467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery</span></div><div class="casAuthors">Rees, David C.; Congreve, Miles; Murray, Christopher W.; Carr, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery is gaining momentum in both large pharmaceutical companies and biotechnol. labs. as a complementary approach to traditional screening.  This is because fragment-based approaches require significantly fewer compds. to be screened and synthesized, and are showing a high success rate in generating chem. series with lead-like properties.  Compared with traditional screening hits, the starting fragments have considerably lower mol. mass, and although the binding interactions of these fragments with a target protein are weak, they are structurally understood through x-ray crystallog. or NMR, and they exhibit high 'ligand efficiency'.  Here, the authors use examples from 25 different protein targets to describe chem. strategies that exploit this structural knowledge to rapidly develop fragments into high-affinity leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbKeUzFFIlhbVg90H21EOLACvtfcHk0lhzMBdcXGBFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D&md5=8d49ac7f698c9b9d573ee3c3485eced8</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnrd1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1467%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DR.%26atitle%3DFragment-based%2520lead%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D660%26epage%3D672%26doi%3D10.1038%2Fnrd1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based approaches in drug discovery and chemical biology</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4990</span>– <span class="NLM_lpage">5003</span>, <span class="refDoi"> DOI: 10.1021/bi3005126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3005126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4990-5003&author=D.+E.+Scottauthor=A.+G.+Coyneauthor=S.+A.+Hudsonauthor=C.+Abell&title=Fragment-based+approaches+in+drug+discovery+and+chemical+biology&doi=10.1021%2Fbi3005126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Scott, Duncan E.; Coyne, Anthony G.; Hudson, Sean A.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4990-5003</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based approaches to finding novel small mols. that bind to proteins are now firmly established in drug discovery and chem. biol.  Initially developed primarily in a few centers in the biotech and pharma industry, this methodol. has now been adopted widely in both the pharmaceutical industry and academia.  After the initial success with kinase targets, the versatility of this approach has now expanded to a broad range of different protein classes.  Herein we describe recent fragment-based approaches to a wide range of target types, including Hsp90, β-secretase, and allosteric sites in human immunodeficiency virus protease and fanesyl pyrophosphate synthase.  The role of fragment-based approaches in an academic research environment is also examd. with an emphasis on neglected diseases such as tuberculosis.  The development of a fragment library, the fragment screening process, and the subsequent fragment hit elaboration will be discussed using examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2ry6mWC83bVg90H21EOLACvtfcHk0lg20CHd4uvRSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D&md5=39a6f0f741e711fd572e24c95142f55d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fbi3005126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3005126%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DHudson%26aufirst%3DS.%2BA.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-based%2520approaches%2520in%2520drug%2520discovery%2520and%2520chemical%2520biology%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D4990%26epage%3D5003%26doi%3D10.1021%2Fbi3005126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lg20CHd4uvRSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lassalas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasfargeas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayendran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Structure property relationships of carboxylic acid isosteres</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3183</span>– <span class="NLM_lpage">3203</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3183-3203&author=P.+Lassalasauthor=B.+Gayauthor=C.+Lasfargeasauthor=M.+J.+Jamesauthor=V.+Tranauthor=K.+G.+Vijayendranauthor=K.+R.+Brundenauthor=M.+C.+Kozlowskiauthor=C.+J.+Thomasauthor=A.+B.+Smithauthor=D.+M.+Hurynauthor=C.+Ballatore&title=Structure+property+relationships+of+carboxylic+acid+isosteres&doi=10.1021%2Facs.jmedchem.5b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Property Relationships of Carboxylic Acid Isosteres</span></div><div class="casAuthors">Lassalas, Pierrik; Gay, Bryant; Lasfargeas, Caroline; James, Michael J.; Tran, Van; Vijayendran, Krishna G.; Brunden, Kurt R.; Kozlowski, Marisa C.; Thomas, Craig J.; Smith, Amos B.; Huryn, Donna M.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3183-3203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of a carboxylic acid with a surrogate structure, or (bio)-isostere, is a classical strategy in medicinal chem.  The general underlying principle is that by maintaining the features of the carboxylic acid crit. for biol. activity, but appropriately modifying the physicochem. properties, improved analogs may result.  In this context, a systematic assessment of the physicochem. properties of carboxylic acid isosteres would be desirable to enable more informed decisions of potential replacements to be used for analog design.  Herein we report the structure-property relationships (SPR) of 35 phenylpropionic acid derivs., in which the carboxylic acid moiety is replaced with a series of known isosteres.  The data set generated provides an assessment of the relative impact on the physicochem. properties that these replacements may have compared to the carboxylic acid analog.  As such, this study presents a framework for how to rationally apply isosteric replacements of the carboxylic acid functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIF98i2ITNrLVg90H21EOLACvtfcHk0lg20CHd4uvRSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D&md5=34490fc72fdb321d8c9751bef1bf79c5</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01963%26sid%3Dliteratum%253Aachs%26aulast%3DLassalas%26aufirst%3DP.%26aulast%3DGay%26aufirst%3DB.%26aulast%3DLasfargeas%26aufirst%3DC.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DTran%26aufirst%3DV.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DKozlowski%26aufirst%3DM.%2BC.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DStructure%2520property%2520relationships%2520of%2520carboxylic%2520acid%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3183%26epage%3D3203%26doi%3D10.1021%2Facs.jmedchem.5b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalpiaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciliberti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vertuani, S.</span></span> <span> </span><span class="NLM_article-title">Progress in drug delivery to the central nervous system by the prodrug approach</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1065</span>, <span class="refDoi"> DOI: 10.3390/molecules13051035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.3390%2Fmolecules13051035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=1035-1065&author=B.+Pavanauthor=A.+Dalpiazauthor=N.+Cilibertiauthor=C.+Biondiauthor=S.+Manfrediniauthor=S.+Vertuani&title=Progress+in+drug+delivery+to+the+central+nervous+system+by+the+prodrug+approach&doi=10.3390%2Fmolecules13051035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13051035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13051035%26sid%3Dliteratum%253Aachs%26aulast%3DPavan%26aufirst%3DB.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DCiliberti%26aufirst%3DN.%26aulast%3DBiondi%26aufirst%3DC.%26aulast%3DManfredini%26aufirst%3DS.%26aulast%3DVertuani%26aufirst%3DS.%26atitle%3DProgress%2520in%2520drug%2520delivery%2520to%2520the%2520central%2520nervous%2520system%2520by%2520the%2520prodrug%2520approach%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D1035%26epage%3D1065%26doi%3D10.3390%2Fmolecules13051035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gynther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, J.</span></span> <span> </span><span class="NLM_article-title">Prodrug approaches for CNS delivery</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1208/s12248-008-9009-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1208%2Fs12248-008-9009-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=18446509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=92-102&author=J.+Rautioauthor=K.+Laineauthor=M.+Gyntherauthor=J.+Savolainen&title=Prodrug+approaches+for+CNS+delivery&doi=10.1208%2Fs12248-008-9009-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrug approaches for CNS delivery</span></div><div class="casAuthors">Rautio, Jarkko; Laine, Krista; Gynther, Mikko; Savolainen, Jouko</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-102</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Central nervous system (CNS) drug delivery remains a major challenge, despite extensive efforts that have been made to develop novel strategies to overcome obstacles.  Prodrugs are bioreversible derivs. of drug mols. that must undergo an enzymic and/or chem. transformation in vivo to release the active parent drug, which subsequently exerts the desired pharmacol. effect.  In both drug discovery and drug development, prodrugs have become an established tool for improving physicochem., biopharmaceutical or pharmacokinetic properties of pharmacol. active agents that overcome barriers to a drug's usefulness.  This review provides insight into various prodrug strategies explored to date for CNS drug delivery, including lipophilic prodrugs, carrier- and receptor-mediated prodrug delivery systems, and gene-directed enzyme prodrug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSfsvhXux64rVg90H21EOLACvtfcHk0livYqhZ0EZnVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLrI&md5=bb800b45fb0c0d7f76b47fb6893a3f1a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1208%2Fs12248-008-9009-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-008-9009-8%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DGynther%26aufirst%3DM.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrug%2520approaches%2520for%2520CNS%2520delivery%26jtitle%3DAAPS%2520J.%26date%3D2008%26volume%3D10%26spage%3D92%26epage%3D102%26doi%3D10.1208%2Fs12248-008-9009-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maag, H.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Carboxylic Acids</span>. In  <i>Prodrugs: Challenges and Rewards</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>, <span class="NLM_string-name">Borchardt, R. T.</span>, <span class="NLM_string-name">Hageman, M. J.</span>, <span class="NLM_string-name">Oliyai, R.</span>, <span class="NLM_string-name">Maag, H.</span>, <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_series">Biotechnology: Pharmaceutical Aspects</span>, Vol.  <span class="NLM_volume">V</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">729</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1007%2F978-0-387-49785-3_20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=703-729&author=H.+Maagauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs%3A+Challenges+and+Rewards"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-49785-3_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-49785-3_20%26sid%3Dliteratum%253Aachs%26aulast%3DMaag%26aufirst%3DH.%26atitle%3DProdrugs%2520of%2520Carboxylic%2520Acids%26btitle%3DProdrugs%253A%2520Challenges%2520and%2520Rewards%26aulast%3DStella%26aufirst%3DV.%2BJ.%26volume%3DV%26pub%3DSpringer%26date%3D2007%26spage%3D703%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span> <span> </span><span class="NLM_article-title">Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer’s disease</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.3109/10611860008997913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.3109%2F10611860008997913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=11328663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVOlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=371-381&author=Y.+Deguchiauthor=H.+Hayashiauthor=S.+Fujiiauthor=T.+Naitoauthor=Y.+Yokoyamaauthor=S.+Yamadaauthor=R.+Kimura&title=Improved+brain+delivery+of+a+nonsteroidal+anti-inflammatory+drug+with+a+synthetic+glyceride+ester%3A+a+preliminary+attempt+at+a+CNS+drug+delivery+system+for+the+therapy+of+Alzheimer%E2%80%99s+disease&doi=10.3109%2F10611860008997913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease</span></div><div class="casAuthors">Deguchi, Yoshiharu; Hayashi, Hideki; Fujii, Shinobu; Naito, Takafumi; Yokoyama, Yoshinari; Yamada, Shizuo; Kimura, Ryohei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">371-381</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">1,3-Diacetyl-2-ketoprofen glyceride (DAKG), a prodrug of ketoprofen, was synthesized as a model compd. in our attempt to develop a central nervous system (CNS) drug delivery system to treat Alzheimer's disease.  The primary purpose of the present study is to test whether DAKG improves the delivery of ketoprofen to the brain and to quant. evaluate several factors that influence the brain distribution of this prodrug.  DdY mice were injected with either ketoprofen or DAKG at a dose of 40 μmol/kg and then the plasma and brain pharmacokinetics of these agents were assessed.  The brain uptake clearance of ketoprofen and DAKG across the BBB was measured by in situ mouse brain perfusion.  In addn., the efflux permeability of ketoprofen through the BBB was evaluated using the in vivo mouse brain microdialysis technique.  The in vivo metab. of DAKG in the brain was assessed by a short infusion into the internal carotid artery coupled with the brain metab. index (BMI) method.  Administration of DAKG produced an approx. 3-fold increase in the area under the brain concn. - time curve of ketoprofen, compared with administration of ketoprofen itself.  The brain uptake clearance (CLin) of ketoprofen across the BBB was 0.0308 ± 0.0046 mL/min/g whereas the CLin of DAKG was 1.60 ± 0.16 mL/min/g, suggesting a marked increase in BBB permeability following lipidization of ketoprofen.  The BMI method confirmed that DAKG is taken up by the brain to rapidly release ketoprofen in a dose-dependent manner.  The in vitro metab. studies revealed that isolated bovine brain capillaries as well as whole brain homogenate have the hydrolysis activity to DAKG.  In addn., the brain concn. of ketoprofen after DAKG administration was maintained for a significant period following co-administration of probenecid.  These results suggest that DAKG improves the delivery of ketoprofen to the brain, and this improved delivery is due to avid uptake of DAKG across the BBB followed by rapid hydrolysis to ketoprofen within the brain.  The ketoprofen produced in the brain was probably cleared by the active efflux system operating in the BBB.  Significant inhibition of this efflux system by co-administration of probenecid could result in a sustained concn. of ketoprofen in the brain following DAKG administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSshGDxzDXuLVg90H21EOLACvtfcHk0livYqhZ0EZnVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVOlsLc%253D&md5=54fc943c4423f082e2251baff9f20c87</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3109%2F10611860008997913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611860008997913%26sid%3Dliteratum%253Aachs%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DR.%26atitle%3DImproved%2520brain%2520delivery%2520of%2520a%2520nonsteroidal%2520anti-inflammatory%2520drug%2520with%2520a%2520synthetic%2520glyceride%2520ester%253A%2520a%2520preliminary%2520attempt%2520at%2520a%2520CNS%2520drug%2520delivery%2520system%2520for%2520the%2520therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2000%26volume%3D8%26spage%3D371%26epage%3D381%26doi%3D10.3109%2F10611860008997913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. R.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo investigation of dexibuprofen derivatives for CNS delivery</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/aps.2011.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Faps.2011.144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=279-288&author=X.+Zhangauthor=X.+Liuauthor=T.+Gongauthor=X.+Sunauthor=Z.+R.+Zhang&title=In+vitro+and+in+vivo+investigation+of+dexibuprofen+derivatives+for+CNS+delivery&doi=10.1038%2Faps.2011.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.144%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%2BR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520investigation%2520of%2520dexibuprofen%2520derivatives%2520for%2520CNS%2520delivery%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2012%26volume%3D33%26spage%3D279%26epage%3D288%26doi%3D10.1038%2Faps.2011.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vestergaard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Round, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrup, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajhede, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristensen, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambertsen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strømgaard, K.</span></span> <span> </span><span class="NLM_article-title">A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1–2 and protects against ischemic brain damage</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3317</span>– <span class="NLM_lpage">3322</span>, <span class="refDoi"> DOI: 10.1073/pnas.1113761109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1073%2Fpnas.1113761109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=3317-3322&author=A.+Bachauthor=B.+H.+Clausenauthor=M.+M%C3%B8llerauthor=B.+Vestergaardauthor=C.+N.+Chiauthor=A.+Roundauthor=P.+L.+S%C3%B8rensenauthor=K.+B.+Nissenauthor=J.+S.+Kastrupauthor=M.+Gajhedeauthor=P.+Jemthauthor=A.+S.+Kristensenauthor=P.+Lundstr%C3%B6mauthor=K.+L.+Lambertsenauthor=K.+Str%C3%B8mgaard&title=A+high-affinity%2C+dimeric+inhibitor+of+PSD-95+bivalently+interacts+with+PDZ1%E2%80%932+and+protects+against+ischemic+brain+damage&doi=10.1073%2Fpnas.1113761109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1113761109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1113761109%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DA.%26aulast%3DClausen%26aufirst%3DB.%2BH.%26aulast%3DM%25C3%25B8ller%26aufirst%3DM.%26aulast%3DVestergaard%26aufirst%3DB.%26aulast%3DChi%26aufirst%3DC.%2BN.%26aulast%3DRound%26aufirst%3DA.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DP.%2BL.%26aulast%3DNissen%26aufirst%3DK.%2BB.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DJemth%26aufirst%3DP.%26aulast%3DKristensen%26aufirst%3DA.%2BS.%26aulast%3DLundstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DLambertsen%26aufirst%3DK.%2BL.%26aulast%3DStr%25C3%25B8mgaard%26aufirst%3DK.%26atitle%3DA%2520high-affinity%252C%2520dimeric%2520inhibitor%2520of%2520PSD-95%2520bivalently%2520interacts%2520with%2520PDZ1%25E2%2580%25932%2520and%2520protects%2520against%2520ischemic%2520brain%2520damage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D3317%26epage%3D3322%26doi%3D10.1073%2Fpnas.1113761109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia Boy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nothelfer, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leotta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics of cell-penetrating peptides</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2224</span>– <span class="NLM_lpage">2231</span>, <span class="refDoi"> DOI: 10.1021/mp100223d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100223d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gkur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=2224-2231&author=D.+Sarkoauthor=B.+Beijerauthor=R.+Garcia+Boyauthor=E.+M.+Nothelferauthor=K.+Leottaauthor=M.+Eisenhutauthor=A.+Altmannauthor=U.+Haberkornauthor=W.+Mier&title=The+pharmacokinetics+of+cell-penetrating+peptides&doi=10.1021%2Fmp100223d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The Pharmacokinetics of Cell-Penetrating Peptides</span></div><div class="casAuthors">Sarko, Dikran; Beijer, Barbro; Boy, Regine Garcia; Nothelfer, Eva-Maria; Leotta, Karin; Eisenhut, Michael; Altmann, Annette; Haberkorn, Uwe; Mier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2224-2231</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are able to penetrate the cell membrane carrying cargoes such as peptides, proteins, oligonucleotides, siRNAs, radioisotopes, liposomes, and nanoparticles.  Consequently, many delivery approaches have been developed to use CPPs as tools for drug delivery.  However, until now a systematic anal. of their in vivo properties including potential tumor binding specificity for drug targeting purposes has not been conducted.  Ten of the most commonly applied CPPs were obtained by solid phase peptide synthesis and labeled with 111In or 68Ga.  Uptake studies were conducted using a panel of six tumor cell lines of different origin.  The stability of the peptides was examd. in human serum.  Biodistribution expts. were conducted in nude mice bearing human prostate carcinoma.  Finally, positron emission tomog. (PET) measurements were performed in male Wistar rats.  The in vitro uptake studies revealed high cellular uptake values, but no specificity toward any of the cell lines.  The biodistribution in PC-3 tumor-bearing nude mice showed a high transient accumulation in well-perfused organs and a rapid clearance from the blood.  All of the CPPs revealed a relatively low accumulation rate in the brain.  The highest uptake values were obsd. in the liver (with a maximal uptake of 51 %ID/g obsd. for oligoarginine (R9)) and the kidneys (with a maximal uptake of 94 %ID/g obsd. for NLS).  The uptake values in the PC-3 tumor were low at all time points, indicating a lack of tumor specific accumulation for all peptides studied.  A micro-PET imaging study with 68Ga-labeled penetratin, Tat and transportan10 (TP10) confirmed the organ distribution data.  These data reveal that CPPs do not show evidence for application in tumor targeting purposes in vivo.  However, CPPs readily penetrate into most organs and show rapid clearance from the circulation.  The high uptake rates obsd. in vitro and the relatively low specificity in vivo imply that CPPs would be better suited for topical application in combination with cargoes which show passive targeting and dominate the pharmacokinetic behavior.  In conclusion, CPPs are suitable as drug carriers for in vivo application provided that their pharmacokinetic properties are also considered in design of CPP drug delivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqalW7MWeOmobVg90H21EOLACvtfcHk0lhdsIE9GJwH4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gkur%252FI&md5=a45b2dc677852994c347fb9c46b75bc5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fmp100223d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100223d%26sid%3Dliteratum%253Aachs%26aulast%3DSarko%26aufirst%3DD.%26aulast%3DBeijer%26aufirst%3DB.%26aulast%3DGarcia%2BBoy%26aufirst%3DR.%26aulast%3DNothelfer%26aufirst%3DE.%2BM.%26aulast%3DLeotta%26aufirst%3DK.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DAltmann%26aufirst%3DA.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DMier%26aufirst%3DW.%26atitle%3DThe%2520pharmacokinetics%2520of%2520cell-penetrating%2520peptides%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D2224%26epage%3D2231%26doi%3D10.1021%2Fmp100223d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 37 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Elisa Sassetti, Mads H. Clausen, <span class="NLM_string-name hlFld-ContribAuthor">Luca Laraia</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of Reactive Oxygen Species Production. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5252-5275. <a href="https://doi.org/10.1021/acs.jmedchem.0c01914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01914%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BReactive%252BOxygen%252BSpecies%252BProduction%26aulast%3DSassetti%26aufirst%3DElisa%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D04112020%26date%3D15042021%26volume%3D64%26issue%3D9%26spage%3D5252%26epage%3D5275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jakob S. Pallesen, Dilip Narayanan, Kim T. Tran, Sara M. Ø. Solbak, Giuseppe Marseglia, Louis M. E. Sørensen, Lars J. Høj, Federico Munafò, Rosa M. C. Carmona, Anthony D. Garcia, Haritha L. Desu, Roberta Brambilla, Tommy N. Johansen, Grzegorz M. Popowicz, Michael Sattler, Michael Gajhede, <span class="NLM_string-name hlFld-ContribAuthor">Anders Bach</span>. </span><span class="cited-content_cbyCitation_article-title">Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4623-4661. <a href="https://doi.org/10.1021/acs.jmedchem.0c02094" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02094%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDeconstructing%252BNoncovalent%252BKelch-like%252BECH-Associated%252BProtein%252B1%252B%252528Keap1%252529%252BInhibitors%252Binto%252BFragments%252Bto%252BReconstruct%252BNew%252BPotent%252BCompounds%26aulast%3DPallesen%26aufirst%3DJakob%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03122020%26date%3D05042021%26volume%3D64%26issue%3D8%26spage%3D4623%26epage%3D4661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhuang Zhang, Lanlan Peng, Yaru Fu, Wenjuan Wang, Pengcheng Wang, <span class="NLM_string-name hlFld-ContribAuthor">Feimeng Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Ginnalin A Binds to the Subpockets of Keap1 Kelch Domain To Activate the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 872-882. <a href="https://doi.org/10.1021/acschemneuro.0c00713" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00713%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DGinnalin%252BA%252BBinds%252Bto%252Bthe%252BSubpockets%252Bof%252BKeap1%252BKelch%252BDomain%252BTo%252BActivate%252Bthe%252BNrf2-Regulated%252BAntioxidant%252BDefense%252BSystem%252Bin%252BSH-SY5Y%252BCells%26aulast%3DZhang%26aufirst%3DZhuang%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D06112020%26date%3D04022021%26date%3D11022021%26volume%3D12%26issue%3D5%26spage%3D872%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabio Begnini, Vasanthanathan Poongavanam, Björn Over, Marie Castaldo, Stefan Geschwindner, Patrik Johansson, Mohit Tyagi, Christian Tyrchan, Lisa Wissler, Peter Sjö, Stefan Schiesser, <span class="NLM_string-name hlFld-ContribAuthor">Jan Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Mining Natural Products for Macrocycles to Drug Difficult Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1054-1072. <a href="https://doi.org/10.1021/acs.jmedchem.0c01569" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01569%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMining%252BNatural%252BProducts%252Bfor%252BMacrocycles%252Bto%252BDrug%252BDifficult%252BTargets%26aulast%3DBegnini%26aufirst%3DFabio%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D08092020%26date%3D18122020%26volume%3D64%26issue%3D2%26spage%3D1054%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hai-Shan Zhou, Lv-Bin Hu, Han Zhang, Wen-Xin Shan, Yan Wang, Xue Li, Tian Liu, Jing Zhao, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Zheng-Yu Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 11149-11168. <a href="https://doi.org/10.1021/acs.jmedchem.0c01116" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01116%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BIndoline-Based%252BKelch-like%252BECH-Associated%252BProtein%252B1-Nuclear%252BFactor%252B%252528Erythroid-Derived%252B2%252529-Like%252B2%252B%252528Keap1-Nrf2%252529%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%26aulast%3DZhou%26aufirst%3DHai-Shan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29062020%26date%3D18092020%26date%3D09092020%26volume%3D63%26issue%3D19%26spage%3D11149%26epage%3D11168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong Zhang, Zeyu Shi, Yujun Zhou, Qiong Xiao, Hongyue Wang, <span class="NLM_string-name hlFld-ContribAuthor">Ying Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 7986-8002. <a href="https://doi.org/10.1021/acs.jmedchem.9b01865" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01865%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252BSubstrate%252BProteins%252Bof%252BKelch-like%252BECH%252BAssociated%252BProtein%252B1%252B%252528Keap1%252529%252Band%252BPotential%252BChallenges%252Bfor%252Bthe%252BDevelopment%252Bof%252BSmall-Molecule%252BInhibitors%252Bof%252Bthe%252BKeap1-Nuclear%252BFactor%252BErythroid%252B2-Related%252BFactor%252B2%252B%252528Nrf2%252529%252BProtein%2525E2%252580%252593Protein%252BInteraction%26aulast%3DZhang%26aufirst%3DYong%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11112019%26date%3D08042020%26date%3D01042020%26volume%3D63%26issue%3D15%26spage%3D7986%26epage%3D8002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Phillip R. Lazzara, Brian P. David, Aparna Ankireddy, Benjamin G. Richardson, Katherine Dye, Kiira M. Ratia, Sekhar P. Reddy, <span class="NLM_string-name hlFld-ContribAuthor">Terry W. Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6547-6560. <a href="https://doi.org/10.1021/acs.jmedchem.9b01074" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01074%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIsoquinoline%252BKelch-like%252BECH-Associated%252BProtein%252B1-Nuclear%252BFactor%252B%252528Erythroid-Derived%252B2%252529-like%252B2%252B%252528KEAP1-NRF2%252529%252BInhibitors%252Bwith%252BHigh%252BMetabolic%252BStability%26aulast%3DLazzara%26aufirst%3DPhillip%2BR.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D03072019%26date%3D14112019%26date%3D04112019%26volume%3D63%26issue%3D12%26spage%3D6547%26epage%3D6560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jesus M. Ontoria, Ilaria Biancofiore, Paola Fezzardi, Federica Ferrigno, Esther Torrente, Stefania Colarusso, Elisabetta Bianchi, Matteo Andreini, Alexandros Patsilinakos, Georg Kempf, Martin Augustin, Stefan Steinbacher, Vincenzo Summa, Robert Pacifici, Ignacio Muñoz-Sanjuan, Larry Park, Alberto Bresciani, Celia Dominguez, Leticia Toledo Sherman, <span class="NLM_string-name hlFld-ContribAuthor">Steven Harper</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 740-746. <a href="https://doi.org/10.1021/acsmedchemlett.9b00594" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00594%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCombined%252BPeptide%252Band%252BSmall-Molecule%252BApproach%252Btoward%252BNonacidic%252BTHIQ%252BInhibitors%252Bof%252Bthe%252BKEAP1%25252FNRF2%252BInteraction%26aulast%3DOntoria%26aufirst%3DJesus%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11122019%26date%3D03042020%26date%3D10042020%26date%3D03042020%26volume%3D11%26issue%3D5%26spage%3D740%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zi-Long Song, Feifei Bai, Baoxin Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jianguo Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Dithiolethiones and Identification of Potential Neuroprotective Agents via Activation of Nrf2-Driven Antioxidant Enzymes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2020,</strong> <em>68 </em>
                                    (7)
                                     , 2214-2231. <a href="https://doi.org/10.1021/acs.jafc.9b06360" title="DOI URL">https://doi.org/10.1021/acs.jafc.9b06360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.9b06360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.9b06360%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DSynthesis%252Bof%252BDithiolethiones%252Band%252BIdentification%252Bof%252BPotential%252BNeuroprotective%252BAgents%252Bvia%252BActivation%252Bof%252BNrf2-Driven%252BAntioxidant%252BEnzymes%26aulast%3DSong%26aufirst%3DZi-Long%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2020%26date%3D10102019%26date%3D27012020%26date%3D16012020%26date%3D06022020%26date%3D27012020%26volume%3D68%26issue%3D7%26spage%3D2214%26epage%3D2231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kim T. Tran, Jakob S. Pallesen, Sara M. Ø. Solbak, Dilip Narayanan, Amina Baig, Jie Zang, Alejandro Aguayo-Orozco, Rosa M. C. Carmona, Anthony D. Garcia, <span class="NLM_string-name hlFld-ContribAuthor">Anders Bach</span>. </span><span class="cited-content_cbyCitation_article-title">A Comparative Assessment Study of Known Small-Molecule Keap1−Nrf2 Protein–Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 8028-8052. <a href="https://doi.org/10.1021/acs.jmedchem.9b00723" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00723</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00723%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BComparative%252BAssessment%252BStudy%252Bof%252BKnown%252BSmall-Molecule%252BKeap1%2525E2%252588%252592Nrf2%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%25253A%252BChemical%252BSynthesis%25252C%252BBinding%252BProperties%25252C%252Band%252BCellular%252BActivity%26aulast%3DTran%26aufirst%3DKim%2BT.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16052019%26date%3D27082019%26date%3D14082019%26volume%3D62%26issue%3D17%26spage%3D8028%26epage%3D8052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Meng-Chen Lu, Xian Zhang, Feng Wu, Shi-Jie Tan, Jing Zhao, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Zheng-Yu Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6796-6813. <a href="https://doi.org/10.1021/acs.jmedchem.9b00818" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00818%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BKelch-Like%252BECH-Associated%252BProtein%252B1-Nuclear%252BFactor%252BErythroid%252B2-Related%252BFactor%252B2%252B%252528Keap1%2525E2%252580%252593Nrf2%252529%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitor%252Bwith%252BNatural%252BProline%252BStructure%252Bas%252Ba%252BCytoprotective%252BAgent%252Bagainst%252BAcetaminophen-Induced%252BHepatotoxicity%26aulast%3DLu%26aufirst%3DMeng-Chen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19052019%26date%3D17072019%26date%3D08072019%26volume%3D62%26issue%3D14%26spage%3D6796%26epage%3D6813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tom D. Heightman, James F. Callahan, Elisabetta Chiarparin, Joseph E. Coyle, Charlotte Griffiths-Jones, Ami S. Lakdawala, Rachel McMenamin, Paul N. Mortenson, David Norton, Torren M. Peakman, Sharna J. Rich, Caroline Richardson, William L. Rumsey, Yolanda Sanchez, Gordon Saxty, Henriëtte
M. G. Willems, Lawrence Wolfe, III, Alison J.-A. Woolford, Zining Wu, Hongxing Yan, Jeffrey K. Kerns, <span class="NLM_string-name hlFld-ContribAuthor">Thomas G. Davies</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4683-4702. <a href="https://doi.org/10.1021/acs.jmedchem.9b00279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00279%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252Band%252BStructure%2525E2%252580%252593Conformation%252BRelationships%252Bof%252BAryl%252BPropionic%252BAcid%252BInhibitors%252Bof%252Bthe%252BKelch-like%252BECH-Associated%252BProtein%252B1%25252FNuclear%252BFactor%252BErythroid%252B2-Related%252BFactor%252B2%252B%252528KEAP1%25252FNRF2%252529%252BProtein%2525E2%252580%252593Protein%252BInteraction%26aulast%3DHeightman%26aufirst%3DTom%2BD.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12022019%26date%3D25042019%26date%3D11042019%26volume%3D62%26issue%3D9%26spage%3D4683%26epage%3D4702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin
G. Richardson, Atul D. Jain, Haranatha R. Potteti, Phillip R. Lazzara, Brian P. David, Chandra R. Tamatam, Ewelina Choma, Kornelia Skowron, Katherine Dye, Zamia Siddiqui, Yue-Ting Wang, Aleksej Krunic, Sekhar P. Reddy, <span class="NLM_string-name hlFld-ContribAuthor">Terry W. Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 8029-8047. <a href="https://doi.org/10.1021/acs.jmedchem.8b01133" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01133%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReplacement%252Bof%252Ba%252BNaphthalene%252BScaffold%252Bin%252BKelch-like%252BECH-Associated%252BProtein%252B1%252B%252528KEAP1%252529%25252FNuclear%252BFactor%252B%252528Erythroid-derived%252B2%252529-like%252B2%252B%252528NRF2%252529%252BInhibitors%26aulast%3DRichardson%26aufirst%3DBenjamin%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18072018%26date%3D31082018%26date%3D20082018%26volume%3D61%26issue%3D17%26spage%3D8029%26epage%3D8047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Xu</span>, <span class="hlFld-ContribAuthor ">Haihu  Chen</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chengguo  Xing</span>, <span class="hlFld-ContribAuthor ">Zhuo  Qu</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113599. <a href="https://doi.org/10.1016/j.ejmech.2021.113599" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113599%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bmolecular%252Bhybridization%252Bdesign%252Bof%252BKeap1-Nrf2%252Binhibitors%252Bas%252Bnovel%252Bprotective%252Bagents%252Bof%252Bacute%252Blung%252Binjury%26aulast%3DZhang%26aufirst%3DLe%26date%3D2021%26volume%3D222%26spage%3D113599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Gorgulla</span>, <span class="hlFld-ContribAuthor ">Süleyman Selim  Çınaroğlu</span>, <span class="hlFld-ContribAuthor ">Patrick D.  Fischer</span>, <span class="hlFld-ContribAuthor ">Konstantin  Fackeldey</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wagner</span>, <span class="hlFld-ContribAuthor ">Haribabu  Arthanari</span>. </span><span class="cited-content_cbyCitation_article-title">VirtualFlow Ants—Ultra-Large Virtual Screenings with Artificial Intelligence Driven Docking Algorithm Based on Ant Colony Optimization. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 5807. <a href="https://doi.org/10.3390/ijms22115807" title="DOI URL">https://doi.org/10.3390/ijms22115807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22115807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22115807%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DVirtualFlow%252BAnts%2525E2%252580%252594Ultra-Large%252BVirtual%252BScreenings%252Bwith%252BArtificial%252BIntelligence%252BDriven%252BDocking%252BAlgorithm%252BBased%252Bon%252BAnt%252BColony%252BOptimization%26aulast%3DGorgulla%26aufirst%3DChristoph%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D5807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Jiménez‐Grávalos</span>, <span class="hlFld-ContribAuthor ">Miguel  Gallegos</span>, <span class="hlFld-ContribAuthor ">Ángel  Martín Pendás</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Novikov</span>. </span><span class="cited-content_cbyCitation_article-title">Challenging the electrostatic
              σ
              ‐hole picture of halogen bonding using minimal models and the interacting quantum atoms approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2021,</strong> <em>42 </em>
                                    (10)
                                     , 676-687. <a href="https://doi.org/10.1002/jcc.26488" title="DOI URL">https://doi.org/10.1002/jcc.26488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.26488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.26488%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DChallenging%252Bthe%252Belectrostatic%252B%2525CF%252583%252B%2525E2%252580%252590hole%252Bpicture%252Bof%252Bhalogen%252Bbonding%252Busing%252Bminimal%252Bmodels%252Band%252Bthe%252Binteracting%252Bquantum%252Batoms%252Bapproach%26aulast%3DJim%25C3%25A9nez%25E2%2580%2590Gr%25C3%25A1valos%26aufirst%3DFernando%26date%3D2021%26date%3D2021%26volume%3D42%26issue%3D10%26spage%3D676%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeyun  Jo</span>, <span class="hlFld-ContribAuthor ">Lara  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Jonathan  Iaconelli</span>, <span class="hlFld-ContribAuthor ">Jinsook  Kwak</span>, <span class="hlFld-ContribAuthor ">Manoj  Kumar</span>, <span class="hlFld-ContribAuthor ">Yunjin  Jung</span>, <span class="hlFld-ContribAuthor ">Luke L.  Lairson</span>, <span class="hlFld-ContribAuthor ">Arnab K.  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Peter G.  Schultz</span>, <span class="hlFld-ContribAuthor ">Michael J.  Bollong</span>, <span class="hlFld-ContribAuthor ">Hwayoung  Yun</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>108 </em>, 104614. <a href="https://doi.org/10.1016/j.bioorg.2020.104614" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104614%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Band%252BSAR%252Bstudies%252Bof%252B3-amino-4-%252528phenylsulfonyl%252529tetrahydrothiophene%252B1%25252C1-dioxides%252Bas%252Bnon-electrophilic%252Bantioxidant%252Bresponse%252Belement%252B%252528ARE%252529%252Bactivators%26aulast%3DJo%26aufirst%3DJeyun%26date%3D2021%26volume%3D108%26spage%3D104614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zi-Long  Song</span>, <span class="hlFld-ContribAuthor ">Yanan  Hou</span>, <span class="hlFld-ContribAuthor ">Feifei  Bai</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for neuroprotection. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104520. <a href="https://doi.org/10.1016/j.bioorg.2020.104520" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104520%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DGeneration%252Bof%252Bpotent%252BNrf2%252Bactivators%252Bvia%252Btuning%252Bthe%252Belectrophilicity%252Band%252Bsteric%252Bhindrance%252Bof%252Bvinyl%252Bsulfones%252Bfor%252Bneuroprotection%26aulast%3DSong%26aufirst%3DZi-Long%26date%3D2021%26volume%3D107%26spage%3D104520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniele  Moretti</span>, <span class="hlFld-ContribAuthor ">Sara  Tambone</span>, <span class="hlFld-ContribAuthor ">Mauro  Cerretani</span>, <span class="hlFld-ContribAuthor ">Paola  Fezzardi</span>, <span class="hlFld-ContribAuthor ">Antonino  Missineo</span>, <span class="hlFld-ContribAuthor ">Leticia-Toledo  Sherman</span>, <span class="hlFld-ContribAuthor ">Ignacio  Munoz-Sajuan</span>, <span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">Celia  Dominquez</span>, <span class="hlFld-ContribAuthor ">Robert  Pacifici</span>, <span class="hlFld-ContribAuthor ">Licia  Tomei</span>, <span class="hlFld-ContribAuthor ">Larry  Park</span>, <span class="hlFld-ContribAuthor ">Alberto  Bresciani</span>. </span><span class="cited-content_cbyCitation_article-title">NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2021,</strong> <em>162 </em>, 243-254. <a href="https://doi.org/10.1016/j.freeradbiomed.2020.10.022" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2020.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2020.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2020.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DNRF2%252Bactivation%252Bby%252Breversible%252BKEAP1%252Bbinding%252Binduces%252Bthe%252Bantioxidant%252Bresponse%252Bin%252Bprimary%252Bneurons%252Band%252Bastrocytes%252Bof%252Ba%252BHuntington%252527s%252Bdisease%252Bmouse%252Bmodel%26aulast%3DMoretti%26aufirst%3DDaniele%26date%3D2021%26volume%3D162%26spage%3D243%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuyu  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Lu</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Wang</span>, <span class="hlFld-ContribAuthor ">Guimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingchun  Yao</span>, <span class="hlFld-ContribAuthor ">Chenghong  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Icaritin activates Nrf2/Keap1 signaling to protect neuronal cells from oxidative stress. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (1)
                                     , 111-120. <a href="https://doi.org/10.1111/cbdd.13765" title="DOI URL">https://doi.org/10.1111/cbdd.13765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13765%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIcaritin%252Bactivates%252BNrf2%25252FKeap1%252Bsignaling%252Bto%252Bprotect%252Bneuronal%252Bcells%252Bfrom%252Boxidative%252Bstress%26aulast%3DXu%26aufirst%3DYuyu%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D1%26spage%3D111%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Chen  Lu</span>, <span class="hlFld-ContribAuthor ">Hong-Li  Shao</span>, <span class="hlFld-ContribAuthor ">Tian  Liu</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Zheng-Yu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112734. <a href="https://doi.org/10.1016/j.ejmech.2020.112734" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112734%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-oxy-2-phenylacetic%252Bacid%252Bsubstituted%252Bnaphthalene%252Bsulfonamide%252Bderivatives%252Bas%252Bpotent%252BKEAP1-NRF2%252Bprotein-protein%252Binteraction%252Binhibitors%252Bfor%252Binflammatory%252Bconditions%26aulast%3DLu%26aufirst%3DMeng-Chen%26date%3D2020%26volume%3D207%26spage%3D112734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam  Rolt</span>, <span class="hlFld-ContribAuthor ">Lynne S.  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of the anti-ageing effects of polyphenolics: mitigation of oxidative stress. </span><span class="cited-content_cbyCitation_journal-name">BMC Chemistry</span><span> <strong>2020,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13065-020-00696-0" title="DOI URL">https://doi.org/10.1186/s13065-020-00696-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13065-020-00696-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13065-020-00696-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Chemistry%26atitle%3DStructural%252Bbasis%252Bof%252Bthe%252Banti-ageing%252Beffects%252Bof%252Bpolyphenolics%25253A%252Bmitigation%252Bof%252Boxidative%252Bstress%26aulast%3DRolt%26aufirst%3DAdam%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaohui  Jiang</span>, <span class="hlFld-ContribAuthor ">Lingyun  Fu</span>, <span class="hlFld-ContribAuthor ">Yini  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Hu</span>, <span class="hlFld-ContribAuthor ">Hong  Yang</span>, <span class="hlFld-ContribAuthor ">Yanyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Luo</span>, <span class="hlFld-ContribAuthor ">Shiquan  Gan</span>, <span class="hlFld-ContribAuthor ">Ling  Tao</span>, <span class="hlFld-ContribAuthor ">Guiyou  Liang</span>, <span class="hlFld-ContribAuthor ">Xiangchun  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-63498-3" title="DOI URL">https://doi.org/10.1038/s41598-020-63498-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-63498-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-63498-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCyclovirobuxine%252BD%252Bprotects%252Bagainst%252Bdiabetic%252Bcardiomyopathy%252Bby%252Bactivating%252BNrf2-mediated%252Bantioxidant%252Bresponses%26aulast%3DJiang%26aufirst%3DZhaohui%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago L.  Duarte</span>, <span class="hlFld-ContribAuthor ">Nick P.  Talbot</span>, <span class="hlFld-ContribAuthor ">Hal  Drakesmith</span>. </span><span class="cited-content_cbyCitation_article-title">NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2020,</strong> <em>36 </em><a href="https://doi.org/10.1089/ars.2020.8148" title="DOI URL">https://doi.org/10.1089/ars.2020.8148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2020.8148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2020.8148%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DNRF2%252Band%252BHypoxia-Inducible%252BFactors%25253A%252BKey%252BPlayers%252Bin%252Bthe%252BRedox%252BControl%252Bof%252BSystemic%252BIron%252BHomeostasis%26aulast%3DDuarte%26aufirst%3DTiago%2BL.%26date%3D2020%26date%3D2020%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefania  Colarusso</span>, <span class="hlFld-ContribAuthor ">Daniele  De Simone</span>, <span class="hlFld-ContribAuthor ">Tommaso  Frattarelli</span>, <span class="hlFld-ContribAuthor ">Matteo  Andreini</span>, <span class="hlFld-ContribAuthor ">Mauro  Cerretani</span>, <span class="hlFld-ContribAuthor ">Antonino  Missineo</span>, <span class="hlFld-ContribAuthor ">Daniele  Moretti</span>, <span class="hlFld-ContribAuthor ">Sara  Tambone</span>, <span class="hlFld-ContribAuthor ">Georg  Kempf</span>, <span class="hlFld-ContribAuthor ">Martin  Augustin</span>, <span class="hlFld-ContribAuthor ">Stefan  Steinbacher</span>, <span class="hlFld-ContribAuthor ">Ignacio  Munoz-Sanjuan</span>, <span class="hlFld-ContribAuthor ">Larry  Park</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Licia  Tomei</span>, <span class="hlFld-ContribAuthor ">Alberto  Bresciani</span>, <span class="hlFld-ContribAuthor ">Celia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Leticia  Toledo-Sherman</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Bianchi</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (21)
                                     , 115738. <a href="https://doi.org/10.1016/j.bmc.2020.115738" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115738%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Blinear%252Band%252Bcyclic%252Bpeptide%252Binhibitors%252Bof%252BKEAP1-NRF2%252Bprotein-protein%252Binteraction%26aulast%3DColarusso%26aufirst%3DStefania%26date%3D2020%26volume%3D28%26issue%3D21%26spage%3D115738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Sun</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Huang</span>, <span class="hlFld-ContribAuthor ">Yufei  Chen</span>, <span class="hlFld-ContribAuthor ">Hao  Shang</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Ling  He</span>, <span class="hlFld-ContribAuthor ">Chengguo  Xing</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104172. <a href="https://doi.org/10.1016/j.bioorg.2020.104172" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104172%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDirect%252Binhibition%252Bof%252BKeap1-Nrf2%252BProtein-Protein%252Binteraction%252Bas%252Ba%252Bpotential%252Btherapeutic%252Bstrategy%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSun%26aufirst%3DYi%26date%3D2020%26volume%3D103%26spage%3D104172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengchen  Lu</span>, <span class="hlFld-ContribAuthor ">Xian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2020,</strong> <em>34 </em>, 101565. <a href="https://doi.org/10.1016/j.redox.2020.101565" title="DOI URL">https://doi.org/10.1016/j.redox.2020.101565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2020.101565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2020.101565%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3DA%252Bhydrogen%252Bperoxide%252Bresponsive%252Bprodrug%252Bof%252BKeap1-Nrf2%252Binhibitor%252Bfor%252Bimproving%252Boral%252Babsorption%252Band%252Bselective%252Bactivation%252Bin%252Binflammatory%252Bconditions%26aulast%3DLu%26aufirst%3DMengchen%26date%3D2020%26volume%3D34%26spage%3D101565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilip  Narayanan</span>, <span class="hlFld-ContribAuthor ">Sana  Ma</span>, <span class="hlFld-ContribAuthor ">Dennis  Özcelik</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Redox Landscape in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 1706. <a href="https://doi.org/10.3390/cancers12071706" title="DOI URL">https://doi.org/10.3390/cancers12071706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12071706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12071706%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252Bthe%252BRedox%252BLandscape%252Bin%252BCancer%252BTherapy%26aulast%3DNarayanan%26aufirst%3DDilip%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D7%26spage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donna D.  Zhang</span>, <span class="hlFld-ContribAuthor ">Eli  Chapman</span>. </span><span class="cited-content_cbyCitation_article-title">The role of natural products in revealing NRF2 function. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2020,</strong> <em>37 </em>
                                    (6)
                                     , 797-826. <a href="https://doi.org/10.1039/C9NP00061E" title="DOI URL">https://doi.org/10.1039/C9NP00061E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NP00061E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NP00061E%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DThe%252Brole%252Bof%252Bnatural%252Bproducts%252Bin%252Brevealing%252BNRF2%252Bfunction%26aulast%3DZhang%26aufirst%3DDonna%2BD.%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D6%26spage%3D797%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumi  Lee</span>, <span class="hlFld-ContribAuthor ">Longqin  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Nrf2 activation through the inhibition of Keap1–Nrf2 protein–protein interaction. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (5)
                                     , 846-867. <a href="https://doi.org/10.1007/s00044-020-02539-y" title="DOI URL">https://doi.org/10.1007/s00044-020-02539-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02539-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02539-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DNrf2%252Bactivation%252Bthrough%252Bthe%252Binhibition%252Bof%252BKeap1%2525E2%252580%252593Nrf2%252Bprotein%2525E2%252580%252593protein%252Binteraction%26aulast%3DLee%26aufirst%3DSumi%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D5%26spage%3D846%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Gorgulla</span>, <span class="hlFld-ContribAuthor ">Andras  Boeszoermenyi</span>, <span class="hlFld-ContribAuthor ">Zi-Fu  Wang</span>, <span class="hlFld-ContribAuthor ">Patrick D.  Fischer</span>, <span class="hlFld-ContribAuthor ">Paul W.  Coote</span>, <span class="hlFld-ContribAuthor ">Krishna M.  Padmanabha Das</span>, <span class="hlFld-ContribAuthor ">Yehor S.  Malets</span>, <span class="hlFld-ContribAuthor ">Dmytro S.  Radchenko</span>, <span class="hlFld-ContribAuthor ">Yurii S.  Moroz</span>, <span class="hlFld-ContribAuthor ">David A.  Scott</span>, <span class="hlFld-ContribAuthor ">Konstantin  Fackeldey</span>, <span class="hlFld-ContribAuthor ">Moritz  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Iryna  Iavniuk</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wagner</span>, <span class="hlFld-ContribAuthor ">Haribabu  Arthanari</span>. </span><span class="cited-content_cbyCitation_article-title">An open-source drug discovery platform enables ultra-large virtual screens. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2020,</strong> <em>580 </em>
                                    (7805)
                                     , 663-668. <a href="https://doi.org/10.1038/s41586-020-2117-z" title="DOI URL">https://doi.org/10.1038/s41586-020-2117-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-020-2117-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-020-2117-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DAn%252Bopen-source%252Bdrug%252Bdiscovery%252Bplatform%252Benables%252Bultra-large%252Bvirtual%252Bscreens%26aulast%3DGorgulla%26aufirst%3DChristoph%26date%3D2020%26date%3D2020%26volume%3D580%26issue%3D7805%26spage%3D663%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haishan  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (3)
                                     , 209-225. <a href="https://doi.org/10.1080/13543776.2020.1715365" title="DOI URL">https://doi.org/10.1080/13543776.2020.1715365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1715365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1715365%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bsmall%252Bmolecule%252BNrf2%252Bactivators%25253A%252Ba%252Bpatent%252Breview%252B%2525282017-present%252529%26aulast%3DZhou%26aufirst%3DHaishan%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D209%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhi  Lin</span>, <span class="hlFld-ContribAuthor ">Yuting  Qiao</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Qin  Nan</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecular Nrf2 inhibitors as chemosensitizers for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (3)
                                     , 243-267. <a href="https://doi.org/10.4155/fmc-2019-0285" title="DOI URL">https://doi.org/10.4155/fmc-2019-0285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0285%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecular%252BNrf2%252Binhibitors%252Bas%252Bchemosensitizers%252Bfor%252Bcancer%252Btherapy%26aulast%3DLin%26aufirst%3DHongzhi%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D243%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhi  Lin</span>, <span class="hlFld-ContribAuthor ">Yuting  Qiao</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126853. <a href="https://doi.org/10.1016/j.bmcl.2019.126853" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126853</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126853%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bevaluation%252Bof%252BNrf2%252Bactivators%252Bwith%252B1%25252C3%25252C4-oxa%25252Fthiadiazole%252Bcore%252Bas%252Bneuro-protective%252Bagents%252Bagainst%252Boxidative%252Bstress%252Bin%252BPC-12%252Bcells%26aulast%3DLin%26aufirst%3DHongzhi%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ai-Ling  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Shen</span>, <span class="hlFld-ContribAuthor ">Tian  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-Xing  Zhou</span>, <span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Jin-Tong  Song</span>, <span class="hlFld-ContribAuthor ">Peng-Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Dong-Mei  Ren</span>, <span class="hlFld-ContribAuthor ">Hong-Xiang  Lou</span>, <span class="hlFld-ContribAuthor ">Xiao-Ning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2019,</strong> <em>141 </em>, 21-33. <a href="https://doi.org/10.1016/j.freeradbiomed.2019.06.001" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2019.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2019.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2019.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DNovel%252Bditerpenoid-type%252Bactivators%252Bof%252Bthe%252BKeap1%25252FNrf2%25252FARE%252Bsignaling%252Bpathway%252Band%252Btheir%252Bregulation%252Bof%252Bredox%252Bhomeostasis%26aulast%3DLi%26aufirst%3DAi-Ling%26date%3D2019%26volume%3D141%26spage%3D21%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Chen  Lu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Yu-Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Tian  Liu</span>, <span class="hlFld-ContribAuthor ">Meng-Min  Tao</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Zheng-Yu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2019,</strong> <em>26 </em>, 101266. <a href="https://doi.org/10.1016/j.redox.2019.101266" title="DOI URL">https://doi.org/10.1016/j.redox.2019.101266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2019.101266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2019.101266%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3DCPUY192018%25252C%252Ba%252Bpotent%252Binhibitor%252Bof%252Bthe%252BKeap1-Nrf2%252Bprotein-protein%252Binteraction%25252C%252Balleviates%252Brenal%252Binflammation%252Bin%252Bmice%252Bby%252Brestricting%252Boxidative%252Bstress%252Band%252BNF-%2525CE%2525BAB%252Bactivation%26aulast%3DLu%26aufirst%3DMeng-Chen%26date%3D2019%26volume%3D26%26spage%3D101266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Cuadrado</span>, <span class="hlFld-ContribAuthor ">Ana I.  Rojo</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Wells</span>, <span class="hlFld-ContribAuthor ">John D.  Hayes</span>, <span class="hlFld-ContribAuthor ">Sharon P.  Cousin</span>, <span class="hlFld-ContribAuthor ">William L.  Rumsey</span>, <span class="hlFld-ContribAuthor ">Otis C.  Attucks</span>, <span class="hlFld-ContribAuthor ">Stephen  Franklin</span>, <span class="hlFld-ContribAuthor ">Anna-Liisa  Levonen</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Kensler</span>, <span class="hlFld-ContribAuthor ">Albena T.  Dinkova-Kostova</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (4)
                                     , 295-317. <a href="https://doi.org/10.1038/s41573-018-0008-x" title="DOI URL">https://doi.org/10.1038/s41573-018-0008-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-018-0008-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-018-0008-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTherapeutic%252Btargeting%252Bof%252Bthe%252BNRF2%252Band%252BKEAP1%252Bpartnership%252Bin%252Bchronic%252Bdiseases%26aulast%3DCuadrado%26aufirst%3DAntonio%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D4%26spage%3D295%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular mechanisms of the Keap1–Nrf2–ARE pathway and the hypothesized effect of reversible non-covalent inhibitors targeting Keap1 and thus the Keap1–Nrf2 PPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Top row: X-ray structures of the Keap1 Kelch domain with truncated Neh2 peptides containing the ETGE (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FLU">2FLU</a>) or DLG (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WN7">3WN7</a>) motif. Rows 2–4: X-ray structures of the Kelch domain in complex with ligands (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for PDB IDs). For compound <b>23</b>, the cocrystallized and soaking forms of the ligand have been superimposed. The Keap1 Kelch domain is shown in the same orientation in all pictures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/medium/jm-2018-00358v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure-based progression of the initial X-ray crystallography fragment hits <b>14</b>, <b>15</b>, and <b>16</b> (PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNQ">5FNQ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZJ">5FZJ</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZN">5FZN</a>, respectively) into <b>17</b> (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNT">5FNT</a>) and finally to <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00358/20180920/images/large/jm-2018-00358v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00358&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 90 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. F.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/1756-8722-6-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1186%2F1756-8722-6-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=23442817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=19&author=X.+Liauthor=P.+Fangauthor=J.+Maiauthor=E.+T.+Choiauthor=H.+Wangauthor=X.+F.+Yang&title=Targeting+mitochondrial+reactive+oxygen+species+as+novel+therapy+for+inflammatory+diseases+and+cancers&doi=10.1186%2F1756-8722-6-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</span></div><div class="casAuthors">Li, Xinyuan; Fang, Pu; Mai, Jietang; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  There are multiple sources of reactive oxygen species (ROS) in the cell.  As a major site of ROS prodn., mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the prodn. of proinflammatory cytokines and pathol. conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS prodn. above basal levels.  Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic.  Therefore, we update recent understanding of how mitochondria generate and regulate the prodn. of mtROS and the function of mtROS both in physiol. and pathol. conditions.  In addn., we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail.  Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdw7mjnRfUbVg90H21EOLACvtfcHk0lhFl0MBfHux6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKisbY%253D&md5=d041a496a1ede846460023f0cc54885a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-19%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DE.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%2BF.%26atitle%3DTargeting%2520mitochondrial%2520reactive%2520oxygen%2520species%2520as%2520novel%2520therapy%2520for%2520inflammatory%2520diseases%2520and%2520cancers%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D19%26doi%3D10.1186%2F1756-8722-6-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uttara, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, R. T.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.2174/157015909787602823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.2174%2F157015909787602823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19721819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=65-74&author=B.+Uttaraauthor=A.+V.+Singhauthor=P.+Zamboniauthor=R.+T.+Mahajan&title=Oxidative+stress+and+neurodegenerative+diseases%3A+a+review+of+upstream+and+downstream+antioxidant+therapeutic+options&doi=10.2174%2F157015909787602823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options</span></div><div class="casAuthors">Uttara, Bayani; Singh, Ajay V.; Zamboni, Paolo; Mahajan, R. T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-74</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Free radicals are common outcome of normal aerobic cellular metab.  In-built antioxidant system of body plays its decisive role in prevention of any loss due to free radicals.  However, imbalanced defense mechanism of antioxidants, overprodn. or incorporation of free radicals from environment to living system leads to serious penalty leading to neuro-degeneration.  Neural cells suffer functional or sensory loss in neurodegenerative diseases.  Apart from several other environmental or genetic factors, oxidative stress (OS) leading to free radical attack on neural cells contributes calamitous role to neuro-degeneration.  Though, oxygen is imperative for life, imbalanced metab. and excess reactive oxygen species (ROS) generation end into a range of disorders such as Alzheimer's disease, Parkinson's disease, aging and many other neural disorders.  Toxicity of free radicals contributes to proteins and DNA injury, inflammation, tissue damage and subsequent cellular apoptosis.  Antioxidants are now being looked upon as persuasive therapeutic against solemn neuronal loss, as they have capability to combat by neutralizing free radicals.  Diet is major source of antioxidants, as well as medicinal herbs are catching attention to be com. source of antioxidants at present.  Recognition of upstream and downstream antioxidant therapy to oxidative stress has been proved an effective tool in alteration of any neuronal damage as well as free radical scavenging.  Antioxidants have a wide scope to sequester metal ions involved in neuronal plaque formation to prevent oxidative stress.  In addn., antioxidant therapy is vital in scavenging free radicals and ROS preventing neuronal degeneration in post-oxidative stress scenario.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm2Msbx6GXlLVg90H21EOLACvtfcHk0liG0VWQS1z1kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqsrfN&md5=297ced2dd24a0567a0e0a1ca5e9311ab</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F157015909787602823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015909787602823%26sid%3Dliteratum%253Aachs%26aulast%3DUttara%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DA.%2BV.%26aulast%3DZamboni%26aufirst%3DP.%26aulast%3DMahajan%26aufirst%3DR.%2BT.%26atitle%3DOxidative%2520stress%2520and%2520neurodegenerative%2520diseases%253A%2520a%2520review%2520of%2520upstream%2520and%2520downstream%2520antioxidant%2520therapeutic%2520options%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2009%26volume%3D7%26spage%3D65%26epage%3D74%26doi%3D10.2174%2F157015909787602823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepkowski, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruszewski, M. K.</span></span> <span> </span><span class="NLM_article-title">Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2011.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21295136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12rtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=1186-1195&author=T.+M.+Stepkowskiauthor=M.+K.+Kruszewski&title=Molecular+cross-talk+between+the+NRF2%2FKEAP1+signaling+pathway%2C+autophagy%2C+and+apoptosis&doi=10.1016%2Fj.freeradbiomed.2011.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis</span></div><div class="casAuthors">Stepkowski, Tomasz M.; Kruszewski, Marcin K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1186-1195</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, perturbations in the cellular thiol level and redox balance, affects many cellular functions, including signaling pathways.  This, in turn, may cause the induction of autophagy or apoptosis.  The NRF2/KEAP1 signaling pathway is the main pathway responsible for cell defense against oxidative stress and maintaining the cellular redox balance at physiol. levels.  The relation between NRF2/KEAP1 signaling and regulation of apoptosis and autophagy is not well understood.  In this hypothesis article we discuss how KEAP1 protein and its direct interactants (such as PGAM5, prothymosin α, FAC1 (BPTF), and p62) provide a mol. foundation for a possible cross-talk between NRF2/KEAP1, apoptosis, and autophagy pathways.  We present a hypothesis for how NRF2/KEAP1 may interfere with the cellular apoptosis-regulatory machinery through activation of the ASK1 kinase by a KEAP1 binding partner-PGAM5.  Based on very recent exptl. evidence, new hypotheses for a cross-talk between NF-κB and the NRF2/KEAP1 pathway in the context of autophagy-related "mol. hub" protein p62 are also presented.  The roles of KEAP1 mol. binding partners in apoptosis regulation during carcinogenesis and in neurodegenerative diseases are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo1dlSR-O8bVg90H21EOLACvtfcHk0liG0VWQS1z1kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12rtrc%253D&md5=0f1109f42ac9cbe9e2f86f77f2a74f43</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DStepkowski%26aufirst%3DT.%2BM.%26aulast%3DKruszewski%26aufirst%3DM.%2BK.%26atitle%3DMolecular%2520cross-talk%2520between%2520the%2520NRF2%252FKEAP1%2520signaling%2520pathway%252C%2520autophagy%252C%2520and%2520apoptosis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D50%26spage%3D1186%26epage%3D1195%26doi%3D10.1016%2Fj.freeradbiomed.2011.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span> <span> </span><span class="NLM_article-title">Targeting Oxidative Stress in Stroke</span>. In  <i>Neuroprotective Therapy for Stroke and Ischemic Disease</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapchak, P. A</span>, <span class="NLM_string-name">Zhang, J.</span></span>, Eds.; <span class="NLM_series">Springer Series in Translational Stroke Research</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">250</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1007%2F978-3-319-45345-3_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=203-250&author=A.+Bachauthor=P.+A+Lapchak&author=J.+Zhang&title=Neuroprotective+Therapy+for+Stroke+and+Ischemic+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-45345-3_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-45345-3_8%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DA.%26atitle%3DTargeting%2520Oxidative%2520Stress%2520in%2520Stroke%26btitle%3DNeuroprotective%2520Therapy%2520for%2520Stroke%2520and%2520Ischemic%2520Disease%26aulast%3DLapchak%26aufirst%3DP.%2BA%26pub%3DSpringer%26date%3D2017%26spage%3D203%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rushmore, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span> <span> </span><span class="NLM_article-title">The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">11632</span>– <span class="NLM_lpage">11639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=11632-11639&author=T.+H.+Rushmoreauthor=M.+R.+Mortonauthor=C.+B.+Pickett&title=The+antioxidant+responsive+element.+Activation+by+oxidative+stress+and+identification+of+the+DNA+consensus+sequence+required+for+functional+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRushmore%26aufirst%3DT.%2BH.%26aulast%3DMorton%26aufirst%3DM.%2BR.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26atitle%3DThe%2520antioxidant%2520responsive%2520element.%2520Activation%2520by%2520oxidative%2520stress%2520and%2520identification%2520of%2520the%2520DNA%2520consensus%2520sequence%2520required%2520for%2520functional%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D11632%26epage%3D11639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1101/gad.13.1.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1101%2Fgad.13.1.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=9887101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=76-86&author=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=T.+Ishiiauthor=K.+Igarashiauthor=J.+D.+Engelauthor=M.+Yamamoto&title=Keap1+represses+nuclear+activation+of+antioxidant+responsive+elements+by+Nrf2+through+binding+to+the+amino-terminal+Neh2+domain&doi=10.1101%2Fgad.13.1.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain</span></div><div class="casAuthors">Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Ishii, Tetsuro; Igarashi, Kazuhiko; Engel, James Douglas; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-86</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is essential for the antioxidant responsive element 〈ARE〉-mediated induction of phase II detoxifying and oxidative stress enzyme genes.  Detailed anal. of differential Nrf2 activity displayed in transfected cell lines ultimately led to the identification of a new protein, which we named Keap1, that suppresses Nrf2 transcriptional activity by specific binding to its evolutionarily conserved amino-terminal regulatory domain.  The closest homolog of Keap1 is a Drosophila actin-binding protein called Kelch, implying that Keap1 might be a Nrf2 cytoplasmic effector.  We then showed that electrophilic agents antagonize Keap1 inhibition of Nrf2 activity in vivo, allowing Nrf2 to traverse from the cytoplasm to the nucleus and potentiate the ARE response.  We postulate that Keap1 and Nrf2 constitute a crucial cellular sensor for oxidative stress, and together mediate a key step in the signaling pathway that leads to transcriptional activation by this novel Nrf2 nuclear shuttling mechanism.  The activation of Nrf2 leads in turn to the induction of phase II enzyme and antioxidative stress genes in response to electrophiles and reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQy--aOMXTI7Vg90H21EOLACvtfcHk0lgCKMJN5KcMiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvF2qsg%253D%253D&md5=1f6cdf6615b03719dedbffe01d0be2ec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.1.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.1.76%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520represses%2520nuclear%2520activation%2520of%2520antioxidant%2520responsive%2520elements%2520by%2520Nrf2%2520through%2520binding%2520to%2520the%2520amino-terminal%2520Neh2%2520domain%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D76%26epage%3D86%26doi%3D10.1101%2Fgad.13.1.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span> <span> </span><span class="NLM_article-title">Targeting NRF2 signaling for cancer chemoprevention</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2009.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.taap.2009.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19732782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1GktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2010&pages=66-76&author=M.+K.+Kwakauthor=T.+W.+Kensler&title=Targeting+NRF2+signaling+for+cancer+chemoprevention&doi=10.1016%2Fj.taap.2009.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NRF2 signaling for cancer chemoprevention</span></div><div class="casAuthors">Kwak, Mi-Kyoung; Kensler, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-76</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Modulation of the metab. and disposition of carcinogens through induction of cytoprotective enzymes is one of several promising strategies to prevent cancer.  Chemopreventive efficacies of inducers such as dithiolethiones and sulforaphane have been extensively studied in animals as well as in humans.  The KEAP1-NRF2 system is a key, but not unilateral, mol. target for these chemopreventive agents.  The transcription factor NRF2 (NF-E2-related factor 2) is a master regulator of the expression of a subset of genes, which produce proteins responsible for the detoxication of electrophiles and reactive oxygen species as well as the removal or repair of some of their damage products.  It is believed that chemopreventive enzyme inducers affect the interaction between KEAP1 and NRF2 through either mediating conformational changes of the KEAP1 protein or activating phosphorylation cascades targeting the KEAP1-NRF2 complex.  These events in turn affect NRF2 stability and trafficking.  Recent advances elucidating the underlying structural biol. of KEAP1-NRF2 signaling and identification of the gene clusters under the transcriptional control of NRF2 are facilitating understanding of the potential pleiotropic effects of NRF2 activators and discovery of novel classes of potent chemopreventive agents such as the triterpenoids.  Although there is appropriately a concern regarding a deleterious role of the KEAP1-NRF2 system in cancer cell biol., esp. as the pathway affects cell survival and drug resistance, the development and the use of NRF2 activators as chemopreventive agents still holds a great promise for protection of normal cells from a diversity of environmental stresses that contribute to the burden of cancer and other chronic, degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWff4laOk-bbVg90H21EOLACvtfcHk0lgCKMJN5KcMiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1GktLs%253D&md5=3d842b5dd1a4cd52a6d3bfaa1175741d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2009.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2009.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DM.%2BK.%26aulast%3DKensler%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520NRF2%2520signaling%2520for%2520cancer%2520chemoprevention%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2010%26volume%3D244%26spage%3D66%26epage%3D76%26doi%3D10.1016%2Fj.taap.2009.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule modulators of Keap1–Nrf2-ARE pathway as potential preventive and therapeutic agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/med.21257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1002%2Fmed.21257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22549716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=687-726&author=S.+Mageshauthor=Y.+Chenauthor=L.+Hu&title=Small+molecule+modulators+of+Keap1%E2%80%93Nrf2-ARE+pathway+as+potential+preventive+and+therapeutic+agents&doi=10.1002%2Fmed.21257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents</span></div><div class="casAuthors">Magesh, Sadagopan; Chen, Yu; Hu, Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-726</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Kelch-like ECH-assocd. protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage.  Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins.  Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases.  Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clin. trials.  Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy.  Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy.  Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small mol. modulators.  We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction. © 2012 Wiley Periodicals, Inc.  Med Res Rev., 32, No. 4, 687-726, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhLmdkuTSh7Vg90H21EOLACvtfcHk0lgCKMJN5KcMiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVegsrw%253D&md5=2104d731cb251e0d9b6d2ad73a735175</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.21257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21257%26sid%3Dliteratum%253Aachs%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520Keap1%25E2%2580%2593Nrf2-ARE%2520pathway%2520as%2520potential%2520preventive%2520and%2520therapeutic%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D687%26epage%3D726%26doi%3D10.1002%2Fmed.21257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of Kelch-like ECH-associated protein 1. nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein–protein interaction inhibitors: achievements, challenges, and future directions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10837</span>– <span class="NLM_lpage">10858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10837-10858&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=Q.+D.+You&title=Discovery+and+development+of+Kelch-like+ECH-associated+protein+1.+nuclear+factor+erythroid+2-related+factor+2+%28KEAP1%3ANRF2%29+protein%E2%80%93protein+interaction+inhibitors%3A+achievements%2C+challenges%2C+and+future+directions&doi=10.1021%2Facs.jmedchem.6b00586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10837-10858</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The transcription factor Nrf2 is the primary regulator of the cellular defense system, and enhancing Nrf2 activity has potential usages in various diseases, esp. chronic age-related and inflammatory diseases.  Recently, directly targeting Keap1-Nrf2 protein-protein interaction (PPI) has been an emerging strategy to selectively and effectively activate Nrf2.  This Perspective summarizes the progress in the discovery and development of Keap1-Nrf2 PPI inhibitors, including the Keap1-Nrf2 regulatory mechanisms, biochem. techniques for inhibitor identification, and approaches for identifying peptide and small-mol. inhibitors, as well as discusses privileged structures and future directions for further development of Keap1-Nrf2 PPI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuMv4k9xi9LVg90H21EOLACvtfcHk0lgCKMJN5KcMiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Smtb%252FO&md5=487aa677ae8a86d71e2b15561656b0b7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00586%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Kelch-like%2520ECH-associated%2520protein%25201.%2520nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%253A%2520achievements%252C%2520challenges%252C%2520and%2520future%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10837%26epage%3D10858%26doi%3D10.1021%2Facs.jmedchem.6b00586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Breemen, R. B.</span></span> <span> </span><span class="NLM_article-title">Sites of alkylation of human Keap1 by natural chemoprevention agents</span>. <i>J. Am. Soc. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2226</span>– <span class="NLM_lpage">2232</span>, <span class="refDoi"> DOI: 10.1016/j.jasms.2007.09.015</span> </span><div class="citationLinks">[<a href="/doi/10.1016/j.jasms.2007.09.015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlynsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=2226-2232&author=Y.+Luoauthor=A.+L.+Egglerauthor=D.+Liuauthor=G.+Liuauthor=A.+D.+Mesecarauthor=R.+B.+van+Breemen&title=Sites+of+alkylation+of+human+Keap1+by+natural+chemoprevention+agents&doi=10.1016%2Fj.jasms.2007.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sites of Alkylation of Human Keap1 by Natural Chemoprevention Agents</span></div><div class="casAuthors">Luo, Yan; Eggler, Aimee L.; Liu, Dongting; Liu, Guowen; Mesecar, Andrew D.; van Breemen, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2226-2232</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Under basal conditions, the interaction of the cytosolic protein Keap1 (Kelch-like ECH-assocd. protein 1) with the transcription factor nuclear factor-E2-related factor 2 (Nrf2) results in a low level of expression of cytoprotective genes whose promoter region contains the antioxidant response element (ARE).  Alkylation of one or more of the 27 cysteine sulfhydryl groups of human Keap1 is proposed to lead to Nrf2 nuclear accumulation, to upregulation of cytoprotective gene expression by the ARE, and to prevention of degenerative diseases, such as cancer.  Therefore, identification of the most reactive of these cysteine residues toward specific electrophiles should help clarify this mechanism of cancer prevention, also known as chemoprevention.  To address this issue, preliminary analyses of tryptic digests of Keap1 alkylated by the model electrophile 1-biotinamido-4-(4'-[maleimidoethyl-cyclohexane]-carboxamido) butane were carried out using liq. chromatog.-tandem mass spectrometry (LC-MS/MS) with a cylindrical ion trap mass spectrometer and also using LC-MS/MS with a hybrid linear ion trap FT ICR mass spectrometer.  Because the FT ICR instrument provided more complete peptide sequencing coverage and enabled the identification of more alkylated cysteine residues, only this instrument was used in subsequent studies of Keap1 alkylation by three electrophilic natural products that can upregulate the ARE, xanthohumol, isoliquiritigenin, and 10-shogaol.  Among the various cysteine residues of Keap1, C151 was most reactive toward these three electrophiles.  These in vitro results agree with evidence from in vivo expts., and indicate that C151 is the most important site of alkylation on Keap1 by chemoprevention agents that function by activating the ARE through Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1CfFns9I_jrVg90H21EOLACvtfcHk0lj7t40F7Ah4tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlynsbzM&md5=b55586ce57947e0db94395c5785a54b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.jasms.2007.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jasms.2007.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DEggler%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3Dvan%2BBreemen%26aufirst%3DR.%2BB.%26atitle%3DSites%2520of%2520alkylation%2520of%2520human%2520Keap1%2520by%2520natural%2520chemoprevention%2520agents%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D2007%26volume%3D18%26spage%3D2226%26epage%3D2232%26doi%3D10.1016%2Fj.jasms.2007.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzclaw, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">11908</span>– <span class="NLM_lpage">11913</span>, <span class="refDoi"> DOI: 10.1073/pnas.172398899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1073%2Fpnas.172398899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=12193649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11908-11913&author=A.+T.+Dinkova-Kostovaauthor=W.+D.+Holtzclawauthor=R.+N.+Coleauthor=K.+Itohauthor=N.+Wakabayashiauthor=Y.+Katohauthor=M.+Yamamotoauthor=P.+Talalay&title=Direct+evidence+that+sulfhydryl+groups+of+Keap1+are+the+sensors+regulating+induction+of+phase+2+enzymes+that+protect+against+carcinogens+and+oxidants&doi=10.1073%2Fpnas.172398899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Holtzclaw, W. David; Cole, Robert N.; Itoh, Ken; Wakabayashi, Nobunao; Katoh, Yasutake; Yamamoto, Masayuki; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11908-11913</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Coordinate induction of phase 2 proteins and elevation of glutathione protect cells against the toxic and carcinogenic effects of electrophiles and oxidants.  All inducers react covalently with thiols at rates that are closely related to their potencies.  Inducers disrupt the cytoplasmic complex between the actin-bound protein Keap1 and the transcription factor Nrf2, thereby releasing Nrf2 to migrate to the nucleus where it activates the antioxidant response element (ARE) of phase 2 genes and accelerates their transcription.  We cloned, overexpressed, and purified murine Keap1 and demonstrated on native gels the formation of complexes of Keap1 with the Neh2 domain of Nrf2 and their concn.-dependent disruption by inducers such as sulforaphane and bis(2-hydroxybenzylidene)acetone.  The kinetics, stoichiometry, and order of reactivities of the most reactive of the 25 cysteine thiol groups of Keap1 have been detd. by tritium incorporation from [3H]dexamethasone mesylate (an inducer and irreversible modifier of thiols) and by UV spectroscopy with sulforaphane, 2,2'-dipyridyl disulfide and 4,4'-dipyridyl disulfide (titrants of thiol groups), and two closely related Michael reaction acceptors [bis(2- and 4-hydroxybenzylidene)acetones] that differ 100-fold in inducer potency and the UV spectra of which are bleached by thiol addn.  With large excesses of these reagents nearly all thiols of Keap1 react, but sequential reaction with three successive single equiv. (per cysteine residue) of dipyridyl disulfides revealed excellent agreement with pseudo-first order kinetics, rapid successive declines in reaction velocity, and the stoichiometric formation of two equiv. of thiopyridone per reacted cysteine.  This finding suggests that reaction of cysteine thiols is followed by rapid formation of protein disulfide linkages.  The most reactive residues of Keap1 (C257, C273, C288, and C297) were identified by mapping the dexamethasone-modified cysteines by mass spectrometry of tryptic peptides.  These residues are located in the intervening region between BTB and Kelch repeat domains of Keap1 and probably are the direct sensors of inducers of the phase 2 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAg7V1wdZgxLVg90H21EOLACvtfcHk0lj7t40F7Ah4tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqtb0%253D&md5=83a3b1b0549cf21153805e9c04f36620</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172398899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172398899%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHoltzclaw%26aufirst%3DW.%2BD.%26aulast%3DCole%26aufirst%3DR.%2BN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DWakabayashi%26aufirst%3DN.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DDirect%2520evidence%2520that%2520sulfhydryl%2520groups%2520of%2520Keap1%2520are%2520the%2520sensors%2520regulating%2520induction%2520of%2520phase%25202%2520enzymes%2520that%2520protect%2520against%2520carcinogens%2520and%2520oxidants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D11908%26epage%3D11913%26doi%3D10.1073%2Fpnas.172398899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1–Nrf2 protein complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">15259</span>– <span class="NLM_lpage">15264</span>, <span class="refDoi"> DOI: 10.1073/pnas.1305687110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1073%2Fpnas.1305687110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15259-15264&author=L.+Bairdauthor=D.+Lleresauthor=S.+Swiftauthor=A.+T.+Dinkova-Kostova&title=Regulatory+flexibility+in+the+Nrf2-mediated+stress+response+is+conferred+by+conformational+cycling+of+the+Keap1%E2%80%93Nrf2+protein+complex&doi=10.1073%2Fpnas.1305687110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1305687110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1305687110%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DRegulatory%2520flexibility%2520in%2520the%2520Nrf2-mediated%2520stress%2520response%2520is%2520conferred%2520by%2520conformational%2520cycling%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D15259%26epage%3D15264%26doi%3D10.1073%2Fpnas.1305687110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide and small molecule inhibitors of the Keap1–Nrf2 protein–protein interaction</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1042/BST20150051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1042%2FBST20150051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26551711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=674-679&author=G.+Wells&title=Peptide+and+small+molecule+inhibitors+of+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1042%2FBST20150051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">674-679</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor erythroid-2-related factor 2 (Nrf2) up-regulates the expression of a range of cytoprotective enzymes with antioxidant response elements in their promoter regions and thus can protect cells against oxidative damage.  Increasing Nrf2 activity has been proposed as a therapeutic intervention in a range of chronic neurodegenerative conditions and cancer chemoprevention.  One of the main mechanisms by which Nrf2 is neg. regulated involves an interaction with the ubiquitination facilitator protein, Kelch-like ECH-assocd. protein 1 (Keap1) that facilitates degrdn. of Nrf2.  Inhibition of this process underlies the mode of action of a broad group of compds. that increase Nrf2 activity.  A no. of natural products, including the isothiocyanate sulforaphane, up-regulate Nrf2 by interacting with Keap1 in a covalent manner to stall its activity.  Recently, a no. of peptide and small mol. inhibitors of the protein-protein interaction (PPI) between Keap1 and Nrf2 have been described.  These classes of compd. have contrasting modes of action at the mol. level and there is emerging evidence that their biol. activities have similarities and differences.  This review describes the various classes of PPI inhibitor that have been described in the literature and the biol. evaluations that have been performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQzcvZNfjrLVg90H21EOLACvtfcHk0lip6ESpNYycHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsb3E&md5=2cb4acbd2a04ecdf29424638894c81e3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBST20150051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150051%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520small%2520molecule%2520inhibitors%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D674%26epage%3D679%26doi%3D10.1042%2FBST20150051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bista, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hronowsky, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellrichmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruck, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goelz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span> <span> </span><span class="NLM_article-title">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">678</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1093/brain/awq386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1093%2Fbrain%2Fawq386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21354971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=678-692&author=R.+A.+Linkerauthor=D.+H.+Leeauthor=S.+Ryanauthor=A.+M.+van+Damauthor=R.+Conradauthor=P.+Bistaauthor=W.+Zengauthor=X.+Hronowskyauthor=A.+Bukoauthor=S.+Chollateauthor=G.+Ellrichmannauthor=W.+Bruckauthor=K.+Dawsonauthor=S.+Goelzauthor=S.+Wieseauthor=R.+H.+Scannevinauthor=M.+Lukashevauthor=R.+Gold&title=Fumaric+acid+esters+exert+neuroprotective+effects+in+neuroinflammation+via+activation+of+the+Nrf2+antioxidant+pathway&doi=10.1093%2Fbrain%2Fawq386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway</span></div><div class="casAuthors">Linker Ralf A; Lee De-Hyung; Ryan Sarah; van Dam Anne M; Conrad Rebecca; Bista Pradeep; Zeng Weike; Hronowsky Xiaoping; Buko Alex; Chollate Sowmya; Ellrichmann Gisa; Bruck Wolfgang; Dawson Kate; Goelz Susan; Wiese Stefan; Scannevin Robert H; Lukashev Matvey; Gold Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">Pt 3</span>),
    <span class="NLM_cas:pages">678-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation and oxidative stress are thought to promote tissue damage in multiple sclerosis.  Thus, novel therapeutics enhancing cellular resistance to free radicals could prove useful for multiple sclerosis treatment.  BG00012 is an oral formulation of dimethylfumarate.  In a phase II multiple sclerosis trial, BG00012 demonstrated beneficial effects on relapse rate and magnetic resonance imaging markers indicative of inflammation as well as axonal destruction.  First we have studied effects of dimethylfumarate on the disease course, central nervous system, tissue integrity and the molecular mechanism of action in an animal model of chronic multiple sclerosis: myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis in C57BL/6 mice.  In the chronic phase of experimental autoimmune encephalomyelitis, preventive or therapeutic application of dimethylfumarate ameliorated the disease course and improved preservation of myelin, axons and neurons.  In vitro, the application of fumarates increased murine neuronal survival and protected human or rodent astrocytes against oxidative stress.  Application of dimethylfumarate led to stabilization of the transcription factor nuclear factor (erythroid-derived 2)-related factor 2, activation of nuclear factor (erythroid-derived 2)-related factor 2-dependent transcriptional activity and accumulation of NADP(H) quinoline oxidoreductase-1 as a prototypical target gene.  Furthermore, the immediate metabolite of dimethylfumarate, monomethylfumarate, leads to direct modification of the inhibitor of nuclear factor (erythroid-derived 2)-related factor 2, Kelch-like ECH-associated protein 1, at cysteine residue 151.  In turn, increased levels of nuclear factor (erythroid-derived 2)-related factor 2 and reduced protein nitrosylation were detected in the central nervous sytem of dimethylfumarate-treated mice.  Nuclear factor (erythroid-derived 2)-related factor 2 was also upregulated in the spinal cord of autopsy specimens from untreated patients with multiple sclerosis.  In dimethylfumarate-treated mice suffering from experimental autoimmune encephalomyelitis, increased immunoreactivity for nuclear factor (erythroid-derived 2)-related factor 2 was detected by confocal microscopy in neurons of the motor cortex and the brainstem as well as in oligodendrocytes and astrocytes.  In mice deficient for nuclear factor (erythroid-derived 2)-related factor 2 on the same genetic background, the dimethylfumarate mediated beneficial effects on clinical course, axon preservation and astrocyte activation were almost completely abolished thus proving the functional relevance of this transcription factor for the neuroprotective mechanism of action.  We conclude that the ability of dimethylfumarate to activate nuclear factor (erythroid-derived 2)-related factor 2 may offer a novel cytoprotective modality that further augments the natural antioxidant responses in multiple sclerosis tissue and is not yet targeted by other multiple sclerosis therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAUtIRbYJEbB0LsK7uFuY7fW6udTcc2eYo9vlZGTmAPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3it1alsw%253D%253D&md5=d113bf628d25500b5c612938a7571fd9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawq386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawq386%26sid%3Dliteratum%253Aachs%26aulast%3DLinker%26aufirst%3DR.%2BA.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DRyan%26aufirst%3DS.%26aulast%3Dvan%2BDam%26aufirst%3DA.%2BM.%26aulast%3DConrad%26aufirst%3DR.%26aulast%3DBista%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHronowsky%26aufirst%3DX.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DEllrichmann%26aufirst%3DG.%26aulast%3DBruck%26aufirst%3DW.%26aulast%3DDawson%26aufirst%3DK.%26aulast%3DGoelz%26aufirst%3DS.%26aulast%3DWiese%26aufirst%3DS.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DR.%26atitle%3DFumaric%2520acid%2520esters%2520exert%2520neuroprotective%2520effects%2520in%2520neuroinflammation%2520via%2520activation%2520of%2520the%2520Nrf2%2520antioxidant%2520pathway%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D678%26epage%3D692%26doi%3D10.1093%2Fbrain%2Fawq386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prosperini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontecorvo, S.</span></span> <span> </span><span class="NLM_article-title">Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations</span>. <i>Ther. Clin. Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">339</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.2147/TCRM.S85099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.2147%2FTCRM.S85099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27042079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtlWrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=339-350&author=L.+Prosperiniauthor=S.+Pontecorvo&title=Dimethyl+fumarate+in+the+management+of+multiple+sclerosis%3A+appropriate+patient+selection+and+special+considerations&doi=10.2147%2FTCRM.S85099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations</span></div><div class="casAuthors">Prosperini, Luca; Pontecorvo, Simona</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutics and Clinical Risk Management</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">339-350</span>CODEN:
                <span class="NLM_cas:coden">TCRMA6</span>;
        ISSN:<span class="NLM_cas:issn">1178-203X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Delayed-release di-Me fumarate (DMF), also known as gastroresistant DMF, is the most recently approved oral disease-modifying treatment (DMT) for relapsing multiple sclerosis.  Two randomized clin. trials (Detn. of the Efficacy and Safety of Oral Fumarate in Relapsing -Remitting MS [DEFINE] and Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis [CONFIRM]) demonstrated significant efficacy in reducing relapse rate and radiol. signs of disease activity, as seen on magnetic resonance imaging.  The DEFINE study also indicated a significant effect of DMF on disability worsening, while the low incidence of confirmed disability worsening in the CONFIRM trial rendered an insignificant redn. among the DMF-treated groups when compared to placebo.  DMF also demonstrated a good safety profile and acceptable tolerability, since the most common side effects (gastrointestinal events and flushing reactions) are usually transient and mild to moderate in severity.  Here, we discuss the place in therapy of DMF for individuals with relapsing multiple sclerosis, providing a tentative therapeutic algorithm to manage newly diagnosed patients and those who do not adequately respond to self-injectable DMTs.  Literature data supporting the potential role of DMF as a first-line therapy are presented.  The possibility of using DMF as switching treatment or even as an add-on strategy in patients with breakthrough disease despite self-injectable DMTs will also be discussed.  Lastly, we argue about the role of DMF as an exit strategy from natalizumab-treated patients who are considered at risk for developing multifocal progressive leukoencephalopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNXQ26o8mDiLVg90H21EOLACvtfcHk0lip6ESpNYycHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtlWrsbc%253D&md5=1e0dda79d7ded97c83232b0e46d88fbd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2147%2FTCRM.S85099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FTCRM.S85099%26sid%3Dliteratum%253Aachs%26aulast%3DProsperini%26aufirst%3DL.%26aulast%3DPontecorvo%26aufirst%3DS.%26atitle%3DDimethyl%2520fumarate%2520in%2520the%2520management%2520of%2520multiple%2520sclerosis%253A%2520appropriate%2520patient%2520selection%2520and%2520special%2520considerations%26jtitle%3DTher.%2520Clin.%2520Risk%2520Manage.%26date%3D2016%26volume%3D12%26spage%3D339%26epage%3D350%26doi%3D10.2147%2FTCRM.S85099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickle, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span> <span> </span><span class="NLM_article-title">Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e98896</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0098896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1371%2Fjournal.pone.0098896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24896564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e98896&author=A.+Cleasbyauthor=J.+Yonauthor=P.+J.+Dayauthor=C.+Richardsonauthor=I.+J.+Tickleauthor=P.+A.+Williamsauthor=J.+F.+Callahanauthor=R.+Carrauthor=N.+Conchaauthor=J.+K.+Kernsauthor=H.+Qiauthor=T.+Sweitzerauthor=P.+Wardauthor=T.+G.+Davies&title=Structure+of+the+BTB+domain+of+Keap1+and+its+interaction+with+the+triterpenoid+antagonist+CDDO&doi=10.1371%2Fjournal.pone.0098896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO</span></div><div class="casAuthors">Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Callahan, James F.; Carr, Robin; Concha, Nestor; Kerns, Jeffrey K.; Qi, Hongwei; Sweitzer, Thomas; Ward, Paris; Davies, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e98896/1-e98896/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A review.  The protein Keap1 is central to the regulation of the Nrf2-mediated cytoprotective response, and is increasingly recognized as an important target for therapeutic intervention in a range of diseases involving excessive oxidative stress and inflammation.  The BTB domain of Keap1 plays key roles in sensing environmental electrophiles and in mediating interactions with the Cul3/Rbx1 E3 ubiquitin ligase system, and is believed to be the target for several small mol. covalent activators of the Nrf2 pathway.  However, despite structural information being available for several BTB domains from related proteins, there have been no reported crystal structures of Keap1 BTB, and this has precluded a detailed understanding of its mechanism of action and interaction with antagonists.  We report here the first structure of the BTB domain of Keap1, which is thought to contain the key cysteine residue responsible for interaction with electrophiles, as well as structures of the covalent complex with the antagonist CDDO/bardoxolone, and of the constitutively inactive C151W BTB mutant.  In addn. to providing the first structural confirmation of antagonist binding to Keap1 BTB, we also present biochem. evidence that adduction of Cys 151 by CDDO is capable of inhibiting the binding of Cul3 to Keap1, and discuss how this class of compd. might exert Nrf2 activation through disruption of the BTB-Cul3 interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-yi4jSWD-bVg90H21EOLACvtfcHk0liCeJHS--eJ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlsr7I&md5=f9c6542ff2508a74313e996ccdafa0ae</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0098896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0098896%26sid%3Dliteratum%253Aachs%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DConcha%26aufirst%3DN.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DT.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26atitle%3DStructure%2520of%2520the%2520BTB%2520domain%2520of%2520Keap1%2520and%2520its%2520interaction%2520with%2520the%2520triterpenoid%2520antagonist%2520CDDO%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De98896%26doi%3D10.1371%2Fjournal.pone.0098896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couch, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2219</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2005.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=15837296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2215-2219&author=R.+D.+Couchauthor=R.+G.+Browningauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=D.+L.+Wrightauthor=M.+B.+Spornauthor=A.+C.+Anderson&title=Studies+on+the+reactivity+of+CDDO%2C+a+promising+new+chemopreventive+and+chemotherapeutic+agent%3A+implications+for+a+molecular+mechanism+of+action&doi=10.1016%2Fj.bmcl.2005.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action</span></div><div class="casAuthors">Couch, Robin D.; Browning, R. Greg; Honda, Tadashi; Gribble, Gordon W.; Wright, Dennis L.; Sporn, Michael B.; Anderson, Amy C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2215-2219</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CDDO, a semi-synthetic triterpenoid derived from oleanolic acid, has the potential to be used as a chemopreventive and chemotherapeutic agent.  The structure of CDDO contains two α,β-unsatd. carbonyl moieties, suggesting a mechanism of action involving a conjugate nucleophilic addn.  Spectroscopic evaluation with thiol nucleophiles illustrates that an addn. does indeed occur, but this addn. is selective and reversible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEly4KE1L3bVg90H21EOLACvtfcHk0liCeJHS--eJ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWqs78%253D&md5=403474a7b33ce6f42e93ad3f9bbd84b0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DCouch%26aufirst%3DR.%2BD.%26aulast%3DBrowning%26aufirst%3DR.%2BG.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DStudies%2520on%2520the%2520reactivity%2520of%2520CDDO%252C%2520a%2520promising%2520new%2520chemopreventive%2520and%2520chemotherapeutic%2520agent%253A%2520implications%2520for%2520a%2520molecular%2520mechanism%2520of%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2215%26epage%3D2219%26doi%3D10.1016%2Fj.bmcl.2005.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morra, R. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendis, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mierke, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span> <span> </span><span class="NLM_article-title">New monocyclic, bicyclic, and tricyclic ethynylcyanodienones as activators of the Keap1/Nrf2/ARE pathway and inhibitors of inducible nitric oxide synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4738</span>– <span class="NLM_lpage">4748</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4738-4748&author=W.+Liauthor=S.+Zhengauthor=M.+Higginsauthor=R.+P.+Morraauthor=A.+T.+Mendisauthor=C.+W.+Chienauthor=I.+Ojimaauthor=D.+F.+Mierkeauthor=A.+T.+Dinkova-Kostovaauthor=T.+Honda&title=New+monocyclic%2C+bicyclic%2C+and+tricyclic+ethynylcyanodienones+as+activators+of+the+Keap1%2FNrf2%2FARE+pathway+and+inhibitors+of+inducible+nitric+oxide+synthase&doi=10.1021%2Facs.jmedchem.5b00393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00393%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DMorra%26aufirst%3DR.%2BP.%26aulast%3DMendis%26aufirst%3DA.%2BT.%26aulast%3DChien%26aufirst%3DC.%2BW.%26aulast%3DOjima%26aufirst%3DI.%26aulast%3DMierke%26aufirst%3DD.%2BF.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DHonda%26aufirst%3DT.%26atitle%3DNew%2520monocyclic%252C%2520bicyclic%252C%2520and%2520tricyclic%2520ethynylcyanodienones%2520as%2520activators%2520of%2520the%2520Keap1%252FNrf2%252FARE%2520pathway%2520and%2520inhibitors%2520of%2520inducible%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4738%26epage%3D4748%26doi%3D10.1021%2Facs.jmedchem.5b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Zeeuw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audhya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ-Schmidt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambers Heerspink, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toto, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaziri, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrolstad, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1306033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1056%2FNEJMoa1306033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24206459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=2492-2503&author=D.+de%0AZeeuwauthor=T.+Akizawaauthor=P.+Audhyaauthor=G.+L.+Bakrisauthor=M.+Chinauthor=H.+Christ-Schmidtauthor=A.+Goldsberryauthor=M.+Houserauthor=M.+Krauthauthor=H.+J.+Lambers+Heerspinkauthor=J.+J.+McMurrayauthor=C.+J.+Meyerauthor=H.+H.+Parvingauthor=G.+Remuzziauthor=R.+D.+Totoauthor=N.+D.+Vaziriauthor=C.+Wannerauthor=J.+Wittesauthor=D.+Wrolstadauthor=G.+M.+Chertow&title=Bardoxolone+methyl+in+type+2+diabetes+and+stage+4+chronic+kidney+disease&doi=10.1056%2FNEJMoa1306033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease</span></div><div class="casAuthors">de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L.; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Lambers Heerspink, Hiddo J.; McMurray, John J.; Meyer, Colin J.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D.; Vaziri, Nosratola D.; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2492-2503</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Although inhibitors of the renin-angiotensin-aldosterone system can slow the progression of diabetic kidney disease, the residual risk is high.  Whether nuclear I factor (erythroid-derived 2)-related factor 2 activators further reduce this risk is unknown.  METHODS: We randomly assigned 2185 patients with type 2 diabetes mellitus and stage 4 chronic kidney disease (estd. glomerular filtration rate [GFR], 15 to <30 mL per min per 1.73 m2 of body-surface area) to bardoxolone Me, at a daily dose of 20 mg, or placebo.  The primary composite outcome was end-stage renal disease (ESRD) or death from cardiovascular causes.  RESULTS: The sponsor and the steering committee terminated the trial on the recommendation of the independent data and safety monitoring committee; the median follow-up was 9 mo.  A total of 69 of 1088 patients (6%) randomly assigned to bardoxolone Me and 69 of 1097 (6%) randomly assigned to placebo had a primary composite outcome (hazard ratio in the bardoxolone Me group vs. the placebo group, 0.98; 95% confidence interval [CI], 0.70 to 1.37; P = 0.92).  In the bardoxolone Me group, ESRD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, ESRD developed In 51 patients, and 19 patients died from cardiovascular causes.  A total of 96 patients in the bardoxolone Me group were hospitalized for heart failure or died from heart failure, as compared with 55 in the placebo group (hazard ratio, 1.83; 95% CI, 1.32 to 2.55; P < 0.001).  Estd. GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significantly and body wt. decreased significantly in the bardoxolone Me group, as compared with the placebo group.  CONCLUSIONS: Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone Me did not reduce the risk of ESRD or death from cardiovascular causes.  A higher rate of cardiovascular events with bardoxolone Me than with placebo prompted termination of the trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI6Z9q4C0LLVg90H21EOLACvtfcHk0lgDpHrcd9VpNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKqs74%253D&md5=1bcc997b57ba700423e0549a617231b5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1306033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1306033%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZeeuw%26aufirst%3DD.%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DAudhya%26aufirst%3DP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DChrist-Schmidt%26aufirst%3DH.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DHouser%26aufirst%3DM.%26aulast%3DKrauth%26aufirst%3DM.%26aulast%3DLambers%2BHeerspink%26aufirst%3DH.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DToto%26aufirst%3DR.%2BD.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWittes%26aufirst%3DJ.%26aulast%3DWrolstad%26aufirst%3DD.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26atitle%3DBardoxolone%2520methyl%2520in%2520type%25202%2520diabetes%2520and%2520stage%25204%2520chronic%2520kidney%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D2492%26epage%3D2503%26doi%3D10.1056%2FNEJMoa1306033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Updated research and applications of small molecule inhibitors of Keap1–Nrf2 protein–protein interaction: a review</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1861</span>– <span class="NLM_lpage">1870</span>, <span class="refDoi"> DOI: 10.2174/0929867321666140217104648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.2174%2F0929867321666140217104648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24533814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1GntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1861-1870&author=C.+Zhuangauthor=Z.+Miaoauthor=C.+Shengauthor=W.+Zhang&title=Updated+research+and+applications+of+small+molecule+inhibitors+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction%3A+a+review&doi=10.2174%2F0929867321666140217104648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review</span></div><div class="casAuthors">Zhuang, Chunlin; Miao, Zhenyuan; Sheng, Chunquan; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1861-1870</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Keap1-Nrf2-ARE pathway is one of the most important regulators of cytoprotective responses to oxidative and/or electrophilic stresses, which is believed to play a crit. role in the development of many diseases, such as cancer, Alzheimer's, Parkinson's, and inflammatory bowel disease.  Recent research indicates that the modulation of ARE activation via direct inhibition of the Keap1-Nrf2protein-protein interaction has many advantages, particularly the low cytotoxicity, over indirect covalent modulators of Keap1 protein for the discovery of novel small mol. modulators of this pathway.  However, most known inducers (e.g., triterpenoids, isothiocyanates and sulfoxythiocarbamates) that activate the ARE system through electrophilic attacks on the cysteine sulfhydryl group of Keap1 also disrupt the Keap1-Nrf2 interaction.  The understanding of co-crystal complex of the Keap1-Nrf2 interaction thus provides a structural basis for the rational design of highly potent direct inhibitors.  This review summarizes the recent advances in the medicinal chem. of small-mol. inhibitors in the areas of drug design, structure-activity relationships, and biol. and biochem. properties.  The peptides designed from DLG and ETGE motifs of Nrf2 protein that binds to Keap1 Kelch domain with promising binding affinities are highlighted.  This review also includes recently reported non-peptide inhibitors with moderate inhibition by high-throughput screening.  It is clear that further research is required for the discovery of more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL9p68R4_XjbVg90H21EOLACvtfcHk0lgDpHrcd9VpNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1GntLc%253D&md5=2212c05157cd12e7dcf342b1db2afe76</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140217104648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140217104648%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DUpdated%2520research%2520and%2520applications%2520of%2520small%2520molecule%2520inhibitors%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%253A%2520a%2520review%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1861%26epage%3D1870%26doi%3D10.2174%2F0929867321666140217104648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abed, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.apsb.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26579458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=285-299&author=D.+A.+Abedauthor=M.+Goldsteinauthor=H.+Albanyanauthor=H.+Jinauthor=L.+Hu&title=Discovery+of+direct+inhibitors+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+as+potential+therapeutic+and+preventive+agents&doi=10.1016%2Fj.apsb.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents</span></div><div class="casAuthors">Abed Dhulfiqar Ali; Goldstein Melanie; Albanyan Haifa; Jin Huijuan; Hu Longqin</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-99</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">The Keap1-Nrf2-ARE pathway is an important antioxidant defense mechanism that protects cells from oxidative stress and the Keap1-Nrf2 protein-protein interaction (PPI) has become an important drug target to upregulate the expression of ARE-controlled cytoprotective oxidative stress response enzymes in the development of therapeutic and preventive agents for a number of diseases and conditions.  However, most known Nrf2 activators/ARE inducers are indirect inhibitors of Keap1-Nrf2 PPI and they are electrophilic species that act by modifying the sulfhydryl groups of Keap1 s cysteine residues.  The electrophilicity of these indirect inhibitors may cause "off-target" side effects by reacting with cysteine residues of other important cellular proteins.  Efforts have recently been focused on the development of direct inhibitors of Keap1-Nrf2 PPI.  This article reviews these recent research efforts including the development of high throughput screening assays, the discovery of peptide and small molecule direct inhibitors, and the biophysical characterization of the binding of these inhibitors to the target Keap1 Kelch domain protein.  These non-covalent direct inhibitors of Keap1-Nrf2 PPI could potentially be developed into effective therapeutic or preventive agents for a variety of diseases and conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl5Pq5LRczm8ffW6udTcc2eaeSt-E-IQDZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOkuw%253D%253D&md5=a22499ab91854a1038e0f18fee0886e3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DAbed%26aufirst%3DD.%2BA.%26aulast%3DGoldstein%26aufirst%3DM.%26aulast%3DAlbanyan%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520direct%2520inhibitors%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520as%2520potential%2520therapeutic%2520and%2520preventive%2520agents%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D285%26epage%3D299%26doi%3D10.1016%2Fj.apsb.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bakry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laoruchupong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.10.486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2011.10.486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22107959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=444-451&author=R.+Hancockauthor=H.+C.+Bertrandauthor=T.+Tsujitaauthor=S.+Nazauthor=A.+El-Bakryauthor=J.+Laoruchupongauthor=J.+D.+Hayesauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1016%2Fj.freeradbiomed.2011.10.486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction</span></div><div class="casAuthors">Hancock, Rowena; Bertrand, Helene C.; Tsujita, Tadayuki; Naz, Shama; El-Bakry, Ayman; Laoruchupong, Jitnueng; Hayes, John D.; Wells, Geoff</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-451</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Disruption of the interaction between the ubiquitination facilitator protein Keap1 and the cap'n'collar basic-region leucine-zipper transcription factor Nrf2 is a potential strategy to enhance expression of antioxidant and free radical detoxification gene products regulated by Nrf2.  Agents that disrupt this protein-protein interaction may be useful pharmacol. probes and future cancer-chemopreventive agents.  We describe the structure-activity relationships for a series of peptides based upon regions of the Nrf2 Neh2 domain, of varying length and sequence, that interact with the Keap1 Kelch domain and disrupt the interaction with Nrf2.  We have also investigated sequestosome-1 (p62) and prothymosin-α sequences that have been reported to interact with Keap1.  To achieve this we have developed a high-throughput fluorescence polarization (FP) assay to screen inhibitors.  In addn. to screening synthetic peptides, we have used a phage display library approach to identify putative peptide ligands with non-native sequence motifs.  Candidate peptides from the phage display library screening protocol were evaluated in the FP assay to quantify their binding activity.  Hybrid peptides based upon the Nrf2 "ETGE" motif and the sequestosome-1 "Keap1-interaction region" have superior binding activity compared to either native peptide alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrdLfQUd3TrVg90H21EOLACvtfcHk0lgi4VjTENXNaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVyhtA%253D%253D&md5=e48014219fb0738c2af6cb8301d73968</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.10.486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.10.486%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DTsujita%26aufirst%3DT.%26aulast%3DNaz%26aufirst%3DS.%26aulast%3DEl-Bakry%26aufirst%3DA.%26aulast%3DLaoruchupong%26aufirst%3DJ.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D444%26epage%3D451%26doi%3D10.1016%2Fj.freeradbiomed.2011.10.486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction with improved binding and cellular activity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3557</span>, <span class="refDoi"> DOI: 10.1039/c3ob40249e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1039%2Fc3ob40249e" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=3553-3557&author=R.+Hancockauthor=M.+Schaapauthor=H.+Pfisterauthor=G.+Wells&title=Peptide+inhibitors+of+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+with+improved+binding+and+cellular+activity&doi=10.1039%2Fc3ob40249e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc3ob40249e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob40249e%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%26aulast%3DSchaap%26aufirst%3DM.%26aulast%3DPfister%26aufirst%3DH.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DPeptide%2520inhibitors%2520of%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520with%2520improved%2520binding%2520and%2520cellular%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D3553%26epage%3D3557%26doi%3D10.1039%2Fc3ob40249e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brann, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">14727</span>– <span class="NLM_lpage">14739</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1304-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1523%2FJNEUROSCI.1304-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26538645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVOnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=14727-14739&author=J.+Tuauthor=X.+Zhangauthor=Y.+Zhuauthor=Y.+Daiauthor=N.+Liauthor=F.+Yangauthor=Q.+Zhangauthor=D.+W.+Brannauthor=R.+Wang&title=Cell-permeable+peptide+targeting+the+Nrf2-Keap1+interaction%3A+a+potential+novel+therapy+for+global+cerebral+ischemia&doi=10.1523%2FJNEUROSCI.1304-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia</span></div><div class="casAuthors">Tu, Jingyi; Zhang, Xi; Zhu, Ying; Dai, Yongxin; Li, Ning; Yang, Fang; Zhang, Quanguang; Brann, Darrell W.; Wang, Ruimin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">14727-14739</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The current study examd. efficacy of a small Tat (trans-activator of transcription)-conjugated peptide activator of the Nrf2 (nuclear factor-E2-related factor-2) antioxidant/cell-defense pathway as a potential injury-specific, novel neuroprotectant against global cerebral ischemia (GCI).  A competitive peptide, DEETGE-CAL-Tat, was designed to facilitate Nrf2 activation by disrupting interaction of Nrf2 with Keap1 (kelch-like ECH-assocd. protein 1), a protein that sequesters Nrf2 in the cytoplasm and thereby inactivates it.  The DEETGE-CAL-Tat peptide contained the crit. sequence DEETGE for the Nrf2-Keap1 interaction, the cell transduction domain of the HIV-Tat protein, and the cleavage sequence of calpain, which is sensitive to Ca2+ increase and allows injury-specific activation of Nrf2.  Using an animal model of GCI, we demonstrated that pretreatment with the DEETGE-CAL-Tat peptide markedly decreased Nrf2 interaction with Keap1 in the rat hippocampal CA1 region after GCI, and enhanced Nrf2 nuclear translocation and DNA binding.  The DEETGE-CAL-Tat peptide also induced Nrf2 antioxidant/cytoprotective target genes, reduced oxidative stress, and induced strong neuroprotection and marked preservation of hippocampal-dependent cognitive function after GCI.  These effects were specific as control peptides lacked neuroprotective ability.  Intriguingly, the DEETGE-CAL-Tat peptide effects were also injury specific, as it had no effect upon neuronal survival or cognitive performance in sham nonischemic animals.  Of significant interest, peripheral, postischemia administration of the DEETGE-CAL-Tat peptide from days 1-9 after GCI also induced robust neuroprotection and strongly preserved hippocampal-dependent cognitive function.  Based on its robust neuroprotective and cognitive-preserving effects, and its unique injury-specific activation properties, the DEETGE-CAL-Tat peptide represents a novel, and potentially promising new therapeutic modality for the treatment of GCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvuEdGjFKibVg90H21EOLACvtfcHk0lgi4VjTENXNaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVOnsbs%253D&md5=b603f6dc11efba2ebe24531d18833687</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1304-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1304-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DBrann%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DCell-permeable%2520peptide%2520targeting%2520the%2520Nrf2-Keap1%2520interaction%253A%2520a%2520potential%2520novel%2520therapy%2520for%2520global%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D14727%26epage%3D14739%26doi%3D10.1523%2FJNEUROSCI.1304-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adibhatla, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. F.</span></span> <span> </span><span class="NLM_article-title">Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1089/ars.2009.2668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1089%2Fars.2009.2668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19624272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFejt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=125-169&author=R.+M.+Adibhatlaauthor=J.+F.+Hatcher&title=Lipid+oxidation+and+peroxidation+in+CNS+health+and+disease%3A+from+molecular+mechanisms+to+therapeutic+opportunities&doi=10.1089%2Fars.2009.2668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities</span></div><div class="casAuthors">Adibhatla, Rao Muralikrishna; Hatcher, James Franklin</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-169</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are produced at low levels in mammalian cells by various metabolic processes, such as oxidative phosphorylation by the mitochondrial respiratory chain, NAD(P)H oxidases, and arachidonic acid oxidative metab.  To maintain physiol. redox balance, cells have endogenous antioxidant defenses regulated at the transcriptional level by Nrf2/ARE.  Oxidative stress results when ROS prodn. exceeds the cell's ability to detoxify ROS.  Overprodn. of ROS damages cellular components, including lipids, leading to decline in physiol. function and cell death.  Reaction of ROS with lipids produces oxidized phospholipids, which give rise to 4-hydroxynonenal, 4-oxo-2-nonenal, and acrolein.  The brain is susceptible to oxidative damage due to its high lipid content and oxygen consumption.  Neurodegenerative diseases (AD, ALS, bipolar disorder, epilepsy, Friedreich's ataxia, HD, MS, NBIA, NPC, PD, peroxisomal disorders, schizophrenia, Wallerian degeneration, Zellweger syndrome) and CNS traumas (stroke, TBI, SCI) are problems of vast clin. importance.  Free iron can react with H2O2 via the Fenton reaction, a primary cause of lipid peroxidn., and may be of particular importance for these CNS injuries and disorders.  Cholesterol is an important regulator of lipid organization and the precursor for neurosteroid biosynthesis.  Atherosclerosis, the major risk factor for ischemic stroke, involves accumulation of oxidized LDL in the arteries, leading to foam cell formation and plaque development.  This review will discuss the role of lipid oxidn./peroxidn. in various CNS injuries/disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6QAQGRT8aBLVg90H21EOLACvtfcHk0lgi4VjTENXNaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFejt7k%253D&md5=1a9a6eee4ce7f486ee3e14d38b8ecb6c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1089%2Fars.2009.2668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2009.2668%26sid%3Dliteratum%253Aachs%26aulast%3DAdibhatla%26aufirst%3DR.%2BM.%26aulast%3DHatcher%26aufirst%3DJ.%2BF.%26atitle%3DLipid%2520oxidation%2520and%2520peroxidation%2520in%2520CNS%2520health%2520and%2520disease%253A%2520from%2520molecular%2520mechanisms%2520to%2520therapeutic%2520opportunities%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2010%26volume%3D12%26spage%3D125%26epage%3D169%26doi%3D10.1089%2Fars.2009.2668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakhan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchgessner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, M.</span></span> <span> </span><span class="NLM_article-title">Inflammatory mechanisms in ischemic stroke: therapeutic approaches</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">97</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-7-97</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1186%2F1479-5876-7-97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=19919699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BD1MjnsVOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=97&author=S.+E.+Lakhanauthor=A.+Kirchgessnerauthor=M.+Hofer&title=Inflammatory+mechanisms+in+ischemic+stroke%3A+therapeutic+approaches&doi=10.1186%2F1479-5876-7-97"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory mechanisms in ischemic stroke: therapeutic approaches</span></div><div class="casAuthors">Lakhan Shaheen E; Kirchgessner Annette; Hofer Magdalena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute ischemic stroke is the third leading cause of death in industrialized countries and the most frequent cause of permanent disability in adults worldwide.  Despite advances in the understanding of the pathophysiology of cerebral ischemia, therapeutic options remain limited.  Only recombinant tissue-plasminogen activator (rt-PA) for thrombolysis is currently approved for use in the treatment of this devastating disease.  However, its use is limited by its short therapeutic window (three hours), complications derived essentially from the risk of hemorrhage, and the potential damage from reperfusion/ischemic injury.  Two important pathophysiological mechanisms involved during ischemic stroke are oxidative stress and inflammation.  Brain tissue is not well equipped with antioxidant defenses, so reactive oxygen species and other free radicals/oxidants, released by inflammatory cells, threaten tissue viability in the vicinity of the ischemic core.  This review will discuss the molecular aspects of oxidative stress and inflammation in ischemic stroke and potential therapeutic strategies that target neuroinflammation and the innate immune system.  Currently, little is known about endogenous counterregulatory immune mechanisms.  However, recent studies showing that regulatory T cells are major cerebroprotective immunomodulators after stroke suggest that targeting the endogenous adaptive immune response may offer novel promising neuroprotectant therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTETPbMSXvQl3tlzo9xastyfW6udTcc2eYzC9SaeVEPyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjnsVOmsg%253D%253D&md5=df8fa746b9c3666041afe3ffaffba56c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-7-97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-7-97%26sid%3Dliteratum%253Aachs%26aulast%3DLakhan%26aufirst%3DS.%2BE.%26aulast%3DKirchgessner%26aufirst%3DA.%26aulast%3DHofer%26aufirst%3DM.%26atitle%3DInflammatory%2520mechanisms%2520in%2520ischemic%2520stroke%253A%2520therapeutic%2520approaches%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2009%26volume%3D7%26spage%3D97%26doi%3D10.1186%2F1479-5876-7-97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iadecola, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anrather, J.</span></span> <span> </span><span class="NLM_article-title">Stroke research at a crossroad: asking the brain for directions</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1368</span>, <span class="refDoi"> DOI: 10.1038/nn.2953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnn.2953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22030546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOntbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1363-1368&author=C.+Iadecolaauthor=J.+Anrather&title=Stroke+research+at+a+crossroad%3A+asking+the+brain+for+directions&doi=10.1038%2Fnn.2953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stroke research at a crossroad: asking the brain for directions</span></div><div class="casAuthors">Iadecola, Costantino; Anrather, Josef</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1363-1368</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ischemic stroke remains a vexing public health problem.  Although progress was made in prevention and supportive care, efforts to protect the brain from ischemic cell death have failed.  Thus, no new treatment has made it from bench to bedside since tissue plasminogen activator was introduced in 1996.  The brain has a remarkable capacity for self-preservation, illustrated by the protective responses induced by ischemia, preconditioning, and exercise.  Here we describe the mechanisms underlying brain self-protection, with the goal of identifying features that could provide insight into stroke therapy.  Unlike traditional therapeutic approaches based on counteracting selected pathways of the ischemic cascade, endogenous neuroprotection relies on coordinated neurovascular programs that support cerebral perfusion, mitigate the harmful effects of cerebral ischemia and promote tissue restoration.  Learning how the brain triggers and implements these protective measures may advance our quest to treat stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQwg7h9tgHHbVg90H21EOLACvtfcHk0lisE38wU_uTGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOntbbI&md5=fff08d9100d361c026927e2adb7f6d14</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnn.2953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2953%26sid%3Dliteratum%253Aachs%26aulast%3DIadecola%26aufirst%3DC.%26aulast%3DAnrather%26aufirst%3DJ.%26atitle%3DStroke%2520research%2520at%2520a%2520crossroad%253A%2520asking%2520the%2520brain%2520for%2520directions%26jtitle%3DNat.%2520Neurosci.%26date%3D2011%26volume%3D14%26spage%3D1363%26epage%3D1368%26doi%3D10.1038%2Fnn.2953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by acetyl-11-keto-β-Boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathway</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">7002</span>, <span class="refDoi"> DOI: 10.1038/srep07002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fsrep07002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=25384416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFeisbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=7002&author=Y.+Dingauthor=M.+Chenauthor=M.+Wangauthor=M.+Wangauthor=T.+Zhangauthor=J.+Parkauthor=Y.+Zhuauthor=C.+Guoauthor=Y.+Jiaauthor=Y.+Liauthor=A.+Wen&title=Neuroprotection+by+acetyl-11-keto-%CE%B2-Boswellic+acid%2C+in+ischemic+brain+injury+involves+the+Nrf2%2FHO-1+defense+pathway&doi=10.1038%2Fsrep07002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway</span></div><div class="casAuthors">Ding, Yi; Chen, Min Chun; Wang, Min; Wang, Ming Ming; Zhang, Tiejun; Park, Jongsun; Zhu, Yan Rong; Guo, Chao; Jia, Yan Yan; Li, Yu Wen; Wen, Ai Dong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7002</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Stroke is a complex disease involved oxidative stress-related pathways in its pathogenesis.  The nuclear factor erythroid-2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway has been considered a potential target for neuroprotection in stroke.  Acetyl-11-Keto-β-Boswellic Acid (AKBA) is an active triterpenoid compd. from the ext. of Boswellia serrate.  The present study was to det. whether AKBA, a novel Nrf2 activator, can protect against cerebral ischemic injury.  The stroke model was produced in Sprague-Dawley rats via middle cerebral artery occlusion.  To model ischemia-like conditions in vitro, primary cultured cortical neurons were exposed to transient oxygen and glucose deprivation (OGD).  Treatment of AKBA significantly reduced infarct vols. and apoptotic cells, and also increased neurol. scores by elevating the Nrf2 and HO-1 expression in brain tissues in middle cerebral artery occlusion (MCAO) rats at 48 h post reperfusion.  In primary cultured neurons, AKBA increased the Nrf2 and HO-1 expression, which provided protection against OGD-induced oxidative insult.  Addnl., AKBA treatment increased Nrf2 binding activity to antioxidant-response elements (ARE).  The protective effect of AKBA was attenuated by knockdown of Nrf2 or HO-1.  In conclusion, these findings provide evidence that AKBA protects neurons against ischemic injury, and this neuroprotective effect involves the Nrf2/HO-1 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroNA7k0hGA_LVg90H21EOLACvtfcHk0lisE38wU_uTGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFeisbrF&md5=7c26017e01978c693c0ec01cd78d47b8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep07002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07002%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DA.%26atitle%3DNeuroprotection%2520by%2520acetyl-11-keto-%25CE%25B2-Boswellic%2520acid%252C%2520in%2520ischemic%2520brain%2520injury%2520involves%2520the%2520Nrf2%252FHO-1%2520defense%2520pathway%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D7002%26doi%3D10.1038%2Fsrep07002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, P. K.</span></span> <span> </span><span class="NLM_article-title">A novel strategy to activate cytoprotective genes in the injured brain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2011.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bbrc.2011.03.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21414291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFaitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=501-506&author=J.+Zhaoauthor=J.+B.+Redellauthor=A.+N.+Mooreauthor=P.+K.+Dash&title=A+novel+strategy+to+activate+cytoprotective+genes+in+the+injured+brain&doi=10.1016%2Fj.bbrc.2011.03.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A novel strategy to activate cytoprotective genes in the injured brain</span></div><div class="casAuthors">Zhao, Jing; Redell, John B.; Moore, Anthony N.; Dash, Pramod K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">501-506</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The transcription factor nuclear factor E2-related factor 2 (Nrf2) regulates the expression of multiple cytoprotective genes that were shown to offer protection in response to a no. of insults.  The present study describes a novel strategy to increase expression of Nrf2-responsive genes in brain injured mice.  Under normal conditions, the adapter protein Kelch-like ECH-assocd. protein 1 (Keap1) binds to Nrf2 and promotes its proteosomal degrdn. in the cytoplasm.  The amino acid sequence DEETGE, located at amino acid 77-82 of Nrf2, is crit. for Nrf2-Keap1 interaction, and synthetic peptides contg. this sequence can be used to disrupt the complex in vitro.  We obsd. that intracerebroventricular (i.c.v.) infusion of a peptide contg. the DEETGE sequence along with the cell transduction domain of the HIV-TAT protein (TAT-DEETGE) into brain-injured mice did not increase the mRNA levels for Nrf2-driven genes.  However, when a calpain cleavage sequence was introduced between the TAT sequence and the DEETGE sequence, the new peptide (TAT-CAL-DEETGE) increased the mRNA levels of these genes.  Increased gene expression was not obsd. when the TAT-CAL-DEETGE peptide was injected into uninjured animals.  Furthermore, injection of TAT-CAL-DEETGE peptides before or after brain injury reduced blood-brain barrier compromise, a prominent secondary pathol. that neg. influences outcome.  The present strategy to increase Nrf2-responsive gene expression can be adapted to treat other insults or diseases based on their underlying mechanism(s) of cellular damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr77EqR_7kXobVg90H21EOLACvtfcHk0lgMIq7RKWhnLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFaitLs%253D&md5=7f8cb360245d4dac11e9b5d248f7b4c0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2011.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2011.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DRedell%26aufirst%3DJ.%2BB.%26aulast%3DMoore%26aufirst%3DA.%2BN.%26aulast%3DDash%26aufirst%3DP.%2BK.%26atitle%3DA%2520novel%2520strategy%2520to%2520activate%2520cytoprotective%2520genes%2520in%2520the%2520injured%2520brain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D407%26spage%3D501%26epage%3D506%26doi%3D10.1016%2Fj.bbrc.2011.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Central nervous system multiparameter optimization desirability: application in drug discovery</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=767-775&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Central+nervous+system+multiparameter+optimization+desirability%3A+application+in+drug+discovery&doi=10.1021%2Facschemneuro.6b00029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">767-775</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant progress has been made in prospectively designing mols. using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the anal. reported herein of a second wave of drug candidates that originated after the development and implementation of this tool.  This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochem. properties.  The CNS MPO tool has helped to increase the percentage of compds. nominated for clin. development that exhibit alignment of ADME attributes, cross the blood-brain barrier, and reside in lower-risk safety space (low ClogP and high TPSA).  The use of this tool has played a role in reducing the no. of compds. submitted to exploratory toxicity studies and increasing the survival of our drug candidates through regulatory toxicol. into First in Human studies.  Overall, the CNS MPO algorithm has helped to improve the prioritization of design ideas and the quality of the compds. nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46WD7qMaX6bVg90H21EOLACvtfcHk0lgMIq7RKWhnLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVSktbw%253D&md5=061c3aef6c88758cbaee1a2abb34796a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00029%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DCentral%2520nervous%2520system%2520multiparameter%2520optimization%2520desirability%253A%2520application%2520in%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D767%26epage%3D775%26doi%3D10.1021%2Facschemneuro.6b00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lgMIq7RKWhnLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liNyDzqlmvBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS physicochemical property space shaped by a diverse set of molecules with experimentally determined exposure in the mouse brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5943</span>– <span class="NLM_lpage">5954</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5943-5954&author=Z.+Rankovic&title=CNS+physicochemical+property+space+shaped+by+a+diverse+set+of+molecules+with+experimentally+determined+exposure+in+the+mouse+brain&doi=10.1021%2Facs.jmedchem.6b01469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5943-5954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the "limits and boundaries" of the central nervous system (CNS) property space is a crit. aspect of modern CNS drug design.  Medicinal chemists are often guided by the physicochem. properties of marketed CNS drugs, which are heavily biased toward "traditional" aminergic targets and commonly described as small lipophilic amines.  This miniperspective describes the statistical anal. of the calcd. physicochem. properties for a diverse set of ligands for mostly "nontraditional" CNS targets and classified as either "brain penetrant" or "peripherally restricted" on the basis of the exptl. mouse brain exposure.  The results suggested that (a) the physicochem. property space conducive to brain exposure is larger than the one defined by the marketed CNS drugs and (b) the most crit. brain exposure determinants are descriptors of the mol. size and hydrogen bond capacity.  These findings led to a modified version of the CNS MPO scoring algorithm, termed CNS MPO.v2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f3JpTCJ29rVg90H21EOLACvtfcHk0liNyDzqlmvBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1yqsbk%253D&md5=bff2a3cd68c033d6cae235a7524cc528</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01469%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520physicochemical%2520property%2520space%2520shaped%2520by%2520a%2520diverse%2520set%2520of%2520molecules%2520with%2520experimentally%2520determined%2520exposure%2520in%2520the%2520mouse%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5943%26epage%3D5954%26doi%3D10.1021%2Facs.jmedchem.6b01469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Observations on screening-based research and some concerning trends in the literature</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1546</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.4155%2Ffmc.10.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=21426147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1529-1546&author=J.+B.+Baell&title=Observations+on+screening-based+research+and+some+concerning+trends+in+the+literature&doi=10.4155%2Ffmc.10.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Observations on screening-based research and some concerning trends in the literature</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1529-1546</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Academic drug discovery is being accompanied by a plethora of publications that report screening hits as good starting points for drug discovery or as useful tool compds., whereas in many cases this is not so.  These compds. may be protein-reactive but can also interfere in bioassays via a no. of other means, and it can be very hard to prove early on that they represent false starts.  This, for instance, makes it difficult for journals in their assessment of manuscripts submitted for publication.  Wider awareness and recognition of these problematic compds. will help the academic drug-discovery community focus on and publish genuinely optimizable screening hits.  This will be of general benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob88J0NH5Mx7Vg90H21EOLACvtfcHk0liNyDzqlmvBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI&md5=14f916535540fc04e37c2eb21cfe7876</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.237%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DObservations%2520on%2520screening-based%2520research%2520and%2520some%2520concerning%2520trends%2520in%2520the%2520literature%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D1529%26epage%3D1546%26doi%3D10.4155%2Ffmc.10.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0liNyDzqlmvBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lagorce, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miteva, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villoutreix, B. O.</span></span> <span> </span><span class="NLM_article-title">FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects</span>. <i>BMC Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">396</span>, <span class="refDoi"> DOI: 10.1186/1471-2105-9-396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1186%2F1471-2105-9-396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=18816385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BD1cnkt12guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=396&author=D.+Lagorceauthor=O.+Sperandioauthor=H.+Galonsauthor=M.+A.+Mitevaauthor=B.+O.+Villoutreix&title=FAF-Drugs2%3A+free+ADME%2Ftox+filtering+tool+to+assist+drug+discovery+and+chemical+biology+projects&doi=10.1186%2F1471-2105-9-396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects</span></div><div class="casAuthors">Lagorce David; Sperandio Olivier; Galons Herve; Miteva Maria A; Villoutreix Bruno O</div><div class="citationInfo"><span class="NLM_cas:title">BMC bioinformatics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Drug discovery and chemical biology are exceedingly complex and demanding enterprises.  In recent years there are been increasing awareness about the importance of predicting/optimizing the absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of small chemical compounds along the search process rather than at the final stages.  Fast methods for evaluating ADMET properties of small molecules often involve applying a set of simple empirical rules (educated guesses) and as such, compound collections' property profiling can be performed in silico.  Clearly, these rules cannot assess the full complexity of the human body but can provide valuable information and assist decision-making.  RESULTS:  This paper presents FAF-Drugs2, a free adaptable tool for ADMET filtering of electronic compound collections.  FAF-Drugs2 is a command line utility program (e.g., written in Python) based on the open source chemistry toolkit OpenBabel, which performs various physicochemical calculations, identifies key functional groups, some toxic and unstable molecules/functional groups.  In addition to filtered collections, FAF-Drugs2 can provide, via Gnuplot, several distribution diagrams of major physicochemical properties of the screened compound libraries.  CONCLUSION:  We have developed FAF-Drugs2 to facilitate compound collection preparation, prior to (or after) experimental screening or virtual screening computations.  Users can select to apply various filtering thresholds and add rules as needed for a given project.  As it stands, FAF-Drugs2 implements numerous filtering rules (23 physicochemical rules and 204 substructure searching rules) that can be easily tuned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBtoXIMaxI83O4gDb7JggCfW6udTcc2eYkJLcSYpr7TLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnkt12guw%253D%253D&md5=ddbb936ae32172dd6a77ec2e83dddb7b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1186%2F1471-2105-9-396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2105-9-396%26sid%3Dliteratum%253Aachs%26aulast%3DLagorce%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DO.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMiteva%26aufirst%3DM.%2BA.%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26atitle%3DFAF-Drugs2%253A%2520free%2520ADME%252Ftox%2520filtering%2520tool%2520to%2520assist%2520drug%2520discovery%2520and%2520chemical%2520biology%2520projects%26jtitle%3DBMC%2520Bioinf.%26date%3D2008%26volume%3D9%26spage%3D396%26doi%3D10.1186%2F1471-2105-9-396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusunoki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2887</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1128/MCB.26.8.2887-2900.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.26.8.2887-2900.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=16581765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2887-2900&author=K.+I.+Tongauthor=Y.+Katohauthor=H.+Kusunokiauthor=K.+Itohauthor=T.+Tanakaauthor=M.+Yamamoto&title=Keap1+recruits+Neh2+through+binding+to+ETGE+and+DLG+motifs%3A+characterization+of+the+two-site+molecular+recognition+model&doi=10.1128%2FMCB.26.8.2887-2900.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</span></div><div class="casAuthors">Tong, Kit I.; Katoh, Yasutake; Kusunoki, Hideki; Itoh, Ken; Tanaka, Toshiyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2887-2900</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The expression of the phase 2 detoxification enzymes and antioxidant proteins is induced at the transcriptional level by Nrf2 and neg. regulated at the posttranslational level by Keap1 through protein-protein interactions with Nrf2 and subsequent proteolysis of Nrf2.  We found that the Neh2 domain of Nrf2 is an intrinsically disordered but biol. active regulatory domain contg. a 33-residue central α-helix followed by a mini antiparallel β-sheet.  Isothermal calorimetry anal. indicated that one Neh2 mol. interacts with two mols. of Keap1 via two binding sites, the stronger binding ETGE motif and the weaker binding DLG motif.  NMR titrn. study showed that these two motifs of the Neh2 domain bind to an overlapping site on the bottom surface of the β-propeller structure of Keap1.  In contrast, the central α-helix of the Neh2 domain does not have any observable affinity to Keap1, suggesting that this region may serve as a bridge connecting the two motifs for the assocn. with the two β-propeller structures of a dimer of Keap1.  Based on these observations, we propose that Keap1 recruits Nrf2 by the ETGE motif and that the DLG motif of the Neh2 domain locks its lysine-rich central α-helix in a correct position to benefit ubiquitin (Ub) signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW4AlViBIZg7Vg90H21EOLACvtfcHk0lg5bv7-HHsdXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Slsbw%253D&md5=f6a5af3be5757cd665f234562d48d727</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.8.2887-2900.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.8.2887-2900.2006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DKusunoki%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKeap1%2520recruits%2520Neh2%2520through%2520binding%2520to%2520ETGE%2520and%2520DLG%2520motifs%253A%2520characterization%2520of%2520the%2520two-site%2520molecular%2520recognition%2520model%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2887%26epage%3D2900%26doi%3D10.1128%2FMCB.26.8.2887-2900.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Keap1 interactions with Nrf2</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2015.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26057936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=101-107&author=P.+Canningauthor=F.+J.+Sorrellauthor=A.+N.+Bullock&title=Structural+basis+of+Keap1+interactions+with+Nrf2&doi=10.1016%2Fj.freeradbiomed.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of KEAP1 interactions with Nrf2</span></div><div class="casAuthors">Canning, Peter; Sorrell, Fiona J.; Bullock, Alex N.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">Part_B</span>),
    <span class="NLM_cas:pages">101-107</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  KEAP1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degrdn. of Nrf2.  Oxidative stress disables KEAP1, allowing Nrf2 protein levels to accumulate for the transactivation of crit. stress response genes.  Consequently, the KEAP1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer.  Here we review current progress toward the structure detn. of KEAP1 and its protein complexes with Cul3, Nrf2 substrate, and small-mol. antagonists.  Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBBMS70b7hbVg90H21EOLACvtfcHk0lg5bv7-HHsdXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCkt7rK&md5=12b7b36caa16cf3cd3d95d84162eed80</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DCanning%26aufirst%3DP.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26atitle%3DStructural%2520basis%2520of%2520Keap1%2520interactions%2520with%2520Nrf2%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D88%26spage%3D101%26epage%3D107%26doi%3D10.1016%2Fj.freeradbiomed.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a ″tethering″ mechanism: a two-site interaction model for the Nrf2-Keap1 complex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">24756</span>– <span class="NLM_lpage">24768</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601119200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1074%2Fjbc.M601119200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=24756-24768&author=M.+McMahonauthor=N.+Thomasauthor=K.+Itohauthor=M.+Yamamotoauthor=J.+D.+Hayes&title=Dimerization+of+substrate+adaptors+can+facilitate+cullin-mediated+ubiquitylation+of+proteins+by+a+%E2%80%B3tethering%E2%80%B3+mechanism%3A+a+two-site+interaction+model+for+the+Nrf2-Keap1+complex&doi=10.1074%2Fjbc.M601119200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601119200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601119200%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DDimerization%2520of%2520substrate%2520adaptors%2520can%2520facilitate%2520cullin-mediated%2520ubiquitylation%2520of%2520proteins%2520by%2520a%2520%25E2%2580%25B3tethering%25E2%2580%25B3%2520mechanism%253A%2520a%2520two-site%2520interaction%2520model%2520for%2520the%2520Nrf2-Keap1%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D24756%26epage%3D24768%26doi%3D10.1074%2Fjbc.M601119200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osanai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2443.2002.00561.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1046%2Fj.1365-2443.2002.00561.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=12167159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslyju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=807-820&author=M.+Kobayashiauthor=K.+Itohauthor=T.+Suzukiauthor=H.+Osanaiauthor=K.+Nishikawaauthor=Y.+Katohauthor=Y.+Takagiauthor=M.+Yamamoto&title=Identification+of+the+interactive+interface+and+phylogenic+conservation+of+the+Nrf2-Keap1+system&doi=10.1046%2Fj.1365-2443.2002.00561.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system</span></div><div class="casAuthors">Kobayashi, Makoto; Itoh, Ken; Suzuki, Takafumi; Osanai, Hitoshi; Nishikawa, Keizo; Katoh, Yasutake; Takagi, Yaeko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">807-820</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The transcription factor Nrf2 and its neg. regulator Keap1 play important roles in transcriptional induction of a set of detoxifying and anti-oxidant enzymes.  To gain an insight into our present enigma as to how cells receive oxidative and electrophilic signals and transduce them to Nrf2, we have developed a zebrafish model system for mol. toxicol. studies.  We systematically cloned zebrafish cytoprotective enzyme cDNAs and found their expression to be efficiently induced by electrophilic agents.  We consequently identified the presence of Nrf2 and Keap1 in zebrafish.  Both loss- and gain-of-function analyses demonstrated that Nrf2 is the primary regulator of a subset of cytoprotective enzyme genes, while Keap1 suppresses Nrf2 activity in zebrafish.  An ETGE motif, crit. for the Nrf2-Keap1 interaction, was identified in the Neh2 domain of Nrf2 by reverse 2-hybrid screening and indispensable for the regulation of Nrf2 activity in zebrafish.  Taken together, these results indicate that the Nrf2-Keap1 system is highly conserved among vertebrates and that the interface between Nrf2 and Keap1 forms an important mol. basis of this regulatory system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGwSXik-wPrVg90H21EOLACvtfcHk0lgF17ja8z46mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslyju7Y%253D&md5=4c820d01a25f334c42c3c90ee7d341da</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2443.2002.00561.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2443.2002.00561.x%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOsanai%26aufirst%3DH.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DTakagi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520the%2520interactive%2520interface%2520and%2520phylogenic%2520conservation%2520of%2520the%2520Nrf2-Keap1%2520system%26jtitle%3DGenes%2520Cells%26date%3D2002%26volume%3D7%26spage%3D807%26epage%3D820%26doi%3D10.1046%2Fj.1365-2443.2002.00561.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lleres, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Monitoring Keap1–Nrf2 interactions in single live cells</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2014.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.biotechadv.2014.03.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1133-1144&author=L.+Bairdauthor=S.+Swiftauthor=D.+Lleresauthor=A.+T.+Dinkova-Kostova&title=Monitoring+Keap1%E2%80%93Nrf2+interactions+in+single+live+cells&doi=10.1016%2Fj.biotechadv.2014.03.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2014.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2014.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DLleres%26aufirst%3DD.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DMonitoring%2520Keap1%25E2%2580%2593Nrf2%2520interactions%2520in%2520single%2520live%2520cells%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2014%26volume%3D32%26spage%3D1133%26epage%3D1144%26doi%3D10.1016%2Fj.biotechadv.2014.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paonessa, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanism of chemical activation of Nrf2</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e35122</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0035122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1371%2Fjournal.pone.0035122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=22558124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e35122&author=Y.+Liauthor=J.+D.+Paonessaauthor=Y.+Zhang&title=Mechanism+of+chemical+activation+of+Nrf2&doi=10.1371%2Fjournal.pone.0035122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of chemical activation of Nrf2</span></div><div class="casAuthors">Li, Yun; Paonessa, Joseph D.; Zhang, Yuesheng</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e35122</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">NF-E2 related factor-2 (Nrf2) promotes the transcription of many cytoprotective genes and is a major drug target for prevention of cancer and other diseases.  Indeed, the cancer-preventive activities of several well-known chem. agents were shown to depend on Nrf2 activation.  It is well known that chemopreventive Nrf2 activators stabilize Nrf2 by blocking its ubiquitination, but previous studies have indicated that this process occurs exclusively in the cytoplasm.  Kelch-like ECH-assocd. protein 1 (Keap1) binds to Nrf2 and orchestrates Nrf2 ubiquitination and it has been a widely-held view that inhibition of Nrf2 ubiquitination by chemopreventive agents results from the dissocn. of Nrf2 from its repressor Keap1.  Here, we show that while the activation of Nrf2 by prototypical chem. activators, including 5,6-dihydrocyclopenta-1,2-dithiole-3-thione (CPDT) and sulforaphane (SF), results solely from inhibition of its ubiquitination, such inhibition occurs predominantly in the nucleus.  Moreover, the Nrf2 activators promote Nrf2 assocn. with Keap1, rather than disassocn., which appears to result from inhibition of Nrf2 phosphorylation at Ser40.  Available evidence suggests the Nrf2 activators may block Nrf2 ubiquitination by altering Keap1 conformation via reaction with the thiols of specific Keap1 cysteines.  We further show that while the inhibitory effects of CPDT and SF on Nrf2 ubiquitination depend entirely on Keap1, Nrf2 is also degraded by a Keap1-independent mechanism.  These findings provide significant new insight about Nrf2 activation and suggest that exogenous chem. activators of Nrf2 enter the nucleus to exert most of their inhibitory impact on Nrf2 ubiquitination and degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHQw95dGtFnbVg90H21EOLACvtfcHk0lgF17ja8z46mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFWltr4%253D&md5=8b9417e76f781711ba9f1d993c017d0c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0035122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0035122%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPaonessa%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520chemical%2520activation%2520of%2520Nrf2%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De35122%26doi%3D10.1371%2Fjournal.pone.0035122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">10941</span>– <span class="NLM_lpage">10953</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.24.10941-10953.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.24.24.10941-10953.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=15572695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=10941-10953&author=D.+D.+Zhangauthor=S.+C.+Loauthor=J.+V.+Crossauthor=D.+J.+Templetonauthor=M.+Hannink&title=Keap1+is+a+redox-regulated+substrate+adaptor+protein+for+a+Cul3-dependent+ubiquitin+ligase+complex&doi=10.1128%2FMCB.24.24.10941-10953.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex</span></div><div class="casAuthors">Zhang, Donna D.; Lo, Shih-Ching; Cross, Janet V.; Templeton, Dennis J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10941-10953</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The bZIP transcription factor Nrf2 controls a genetic program that protects cells from oxidative damage and maintains cellular redox homeostasis.  Keap1, a BTB-Kelch protein, is the major upstream regulator of Nrf2 and controls both the subcellular localization and steady-state levels of Nrf2.  In this report, we demonstrate that Keap1 functions as a substrate adaptor protein for a Cul3-dependent E3 ubiquitin ligase complex.  Keap1 assembles into a functional E3 ubiquitin ligase complex with Cul3 and Rbx1 that targets multiple lysine residues located in the N-terminal Neh2 domain of Nrf2 for ubiquitin conjugation both in vivo and in vitro.  Keap1-dependent ubiquitination of Nrf2 is inhibited following exposure of cells to quinone-induced oxidative stress and sulforaphane, a cancer-preventive isothiocyanate.  A mutant Keap1 protein contg. a single cysteine-to-serine substitution at residue 151 within the BTB domain of Keap1 is markedly resistant to inhibition by either quinone-induced oxidative stress or sulforaphane.  Inhibition of Keap1-dependent ubiquitination of Nrf2 correlates with decreased assocn. of Keap1 with Cul3.  Neither quinone-induced oxidative stress nor sulforaphane disrupts assocn. between Keap1 and Nrf2.  Our results suggest that the ability of Keap1 to assemble into a functional E3 ubiquitin ligase complex is the crit. determinant that controls steady-state levels of Nrf2 in response to cancer-preventive compds. and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGone13ov1mSELVg90H21EOLACvtfcHk0lh2cmbNT3uQtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSgsr%252FL&md5=cc8f2a059999d82c91ef482fb8e385d8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.24.10941-10953.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.24.10941-10953.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BD.%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DCross%26aufirst%3DJ.%2BV.%26aulast%3DTempleton%26aufirst%3DD.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DKeap1%2520is%2520a%2520redox-regulated%2520substrate%2520adaptor%2520protein%2520for%2520a%2520Cul3-dependent%2520ubiquitin%2520ligase%2520complex%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D10941%26epage%3D10953%26doi%3D10.1128%2FMCB.24.24.10941-10953.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein–protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533-550&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein%E2%80%93protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0lh2cmbNT3uQtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein%25E2%2580%2593protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26epage%3D550%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henzl, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannink, M.</span></span> <span> </span><span class="NLM_article-title">Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3605</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fsj.emboj.7601243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=16888629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=3605-3617&author=S.+C.+Loauthor=X.+Liauthor=M.+T.+Henzlauthor=L.+J.+Beamerauthor=M.+Hannink&title=Structure+of+the+Keap1%3ANrf2+interface+provides+mechanistic+insight+into+Nrf2+signaling&doi=10.1038%2Fsj.emboj.7601243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling</span></div><div class="casAuthors">Lo, Shih-Ching; Li, Xuchu; Henzl, Michael T.; Beamer, Lesa J.; Hannink, Mark</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3605-3617</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Keap1 is a BTB-Kelch substrate adaptor protein that regulates steady-state levels of Nrf2, a bZIP transcription factor, in response to oxidative stress.  We have detd. the structure of the Kelch domain of Keap1 bound to a 16-mer peptide from Nrf2 contg. a highly conserved DxETGE motif.  The Nrf2 peptide contains two short antiparallel β-strands connected by two overlapping type I β-turns stabilized by the aspartate and threonine residues.  The β-turn region fits into a binding pocket on the top face of the Kelch domain and the glutamate residues form multiple hydrogen bonds with highly conserved residues in Keap1.  Mutagenesis expts. confirmed the role of individual amino acids for binding of Nrf2 to Keap1 and for Keap1-mediated repression of Nrf2-dependent gene expression.  Our results provide a detailed picture of how a BTB-Kelch substrate adaptor protein binds to its cognate substrate and will enable the rational design of novel chemopreventive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJXSF9pJFdLVg90H21EOLACvtfcHk0lh2cmbNT3uQtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVGlsLo%253D&md5=df96ad6cb82632192d5d693ea87c85ad</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601243%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHenzl%26aufirst%3DM.%2BT.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DHannink%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520Keap1%253ANrf2%2520interface%2520provides%2520mechanistic%2520insight%2520into%2520Nrf2%2520signaling%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D3605%26epage%3D3617%26doi%3D10.1038%2Fsj.emboj.7601243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirotsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">7511</span>– <span class="NLM_lpage">7521</span>, <span class="refDoi"> DOI: 10.1128/MCB.00753-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.00753-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=17785452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GltrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=7511-7521&author=K.+I.+Tongauthor=B.+Padmanabhanauthor=A.+Kobayashiauthor=C.+Shangauthor=Y.+Hirotsuauthor=S.+Yokoyamaauthor=M.+Yamamoto&title=Different+electrostatic+potentials+define+ETGE+and+DLG+motifs+as+hinge+and+latch+in+oxidative+stress+response&doi=10.1128%2FMCB.00753-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response</span></div><div class="casAuthors">Tong, Kit I.; Padmanabhan, Balasundaram; Kobayashi, Akira; Shang, Chengwei; Hirotsu, Yosuke; Yokoyama, Shigeyuki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7511-7521</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Nrf2 is the regulator of the oxidative/electrophilic stress response.  Its turnover is maintained by Keap1-mediated proteasomal degrdn. via a two-site substrate recognition mechanism in which two Nrf2-Keap1 binding sites form a hinge and latch.  The E3 ligase adaptor Keap1 recognizes Nrf2 through its conserved ETGE and DLG motifs.  In this study, we examd. how the ETGE and DLG motifs bind to Keap1 in a very similar fashion but with different binding affinities by comparing the crystal structure of the Keap1-DC domain (double glycine repeat domain [DGR] plus C-terminal region of Keap1) in complex with an Nrf2 DLG motif-based peptide to the structure of a Keap1-DC domain/ETGE peptide complex.  We found that these two motifs interact with the same basic surface of either Keap1-DC domain in the Keap1 homodimer.  The DLG motif works to correctly position the lysines within the Nrf2 Neh2 domain for efficient ubiquitination.  Together with the results from calorimetric and functional studies, we conclude that different electrostatic potentials primarily define the ETGE and DLG motifs as a hinge and latch that senses the oxidative/electrophilic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri-Hlz79iKkbVg90H21EOLACvtfcHk0lgKsBK0KksQng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GltrvE&md5=7be354fadaf3a9181e05a8fe9ec3fb3f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FMCB.00753-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00753-07%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BI.%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DShang%26aufirst%3DC.%26aulast%3DHirotsu%26aufirst%3DY.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DDifferent%2520electrostatic%2520potentials%2520define%2520ETGE%2520and%2520DLG%2520motifs%2520as%2520hinge%2520and%2520latch%2520in%2520oxidative%2520stress%2520response%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D7511%26epage%3D7521%26doi%3D10.1128%2FMCB.00753-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohuchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1128/MCB.01191-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1128%2FMCB.01191-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24366543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVSktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=832-846&author=T.+Fukutomiauthor=K.+Takagiauthor=T.+Mizushimaauthor=N.+Ohuchiauthor=M.+Yamamoto&title=Kinetic%2C+thermodynamic%2C+and+structural+characterizations+of+the+association+between+Nrf2-DLGex+degron+and+Keap1&doi=10.1128%2FMCB.01191-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1</span></div><div class="casAuthors">Fukutomi, Toshiaki; Takagi, Kenji; Mizushima, Tsunehiro; Ohuchi, Noriaki; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">832-846, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 (NF-E2-related factor 2) coordinately regulates cytoprotective gene expression, but under unstressed conditions, Nrf2 is degraded rapidly through Keap1 (Kelch-like ECH-assocd. protein 1)-mediated ubiquitination.  Nrf2 harbors two Keap1-binding motifs, DLG and ETGE.  Interactions between these two motifs and Keap1 constitute a key regulatory nexus for cellular Nrf2 activity through the formation of a two-site binding hinge-and-latch mechanism.  In this study, we detd. the min. Keap1-binding sequence of the DLG motif, the low-affinity latch site, and defined a new DLGex motif that covers a sequence much longer than that previously defined.  We have successfully clarified the crystal structure of the Keap1-DC-DLGex complex at 1.6 Å.  DLGex possesses a complicated helix structure, which interprets well the human-cancer-derived loss-of-function mutations in DLGex.  In thermodn. analyses, Keap1-DLGex binding is characterized as enthalpy and entropy driven, while Keap1-ETGE binding is characterized as purely enthalpy driven.  In kinetic analyses, Keap1-DLGex binding follows a fast-assocn. and fast-dissocn. model, while Keap1-ETGE binding contains a slow-reaction step that leads to a stable conformation.  These results demonstrate that the mode of DLGex binding to Keap1 is distinct from that of ETGE structurally, thermodynamically, and kinetically and support our contention that the DLGex motif serves as a converter transmitting environmental stress to Nrf2 induction as the latch site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL52FE-hZoIbVg90H21EOLACvtfcHk0lgKsBK0KksQng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVSktrs%253D&md5=3ec5af933ac7ca319cf4a0ad39a2d689</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FMCB.01191-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01191-13%26sid%3Dliteratum%253Aachs%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DOhuchi%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DKinetic%252C%2520thermodynamic%252C%2520and%2520structural%2520characterizations%2520of%2520the%2520association%2520between%2520Nrf2-DLGex%2520degron%2520and%2520Keap1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2014%26volume%3D34%26spage%3D832%26epage%3D846%26doi%3D10.1128%2FMCB.01191-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9799-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1007%2Fs10822-014-9799-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=25301376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1233-1245&author=Z.+Y.+Jiangauthor=L.+L.+Xuauthor=M.+C.+Luauthor=Y.+Panauthor=H.+Z.+Huangauthor=X.+J.+Zhangauthor=H.+P.+Sunauthor=Q.+D.+You&title=Investigation+of+the+intermolecular+recognition+mechanism+between+the+E3+ubiquitin+ligase+Keap1+and+substrate+based+on+multiple+substrates+analysis&doi=10.1007%2Fs10822-014-9799-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Xu, Li-Li; Lu, Meng-Chen; Pan, Yang; Huang, Hao-Ze; Zhang, Xiao-Jin; Sun, Hao-Peng; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1233-1245</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are attractive drug targets due to their specificity to the ubiquitin machinery.  However, the development of E3 ligase inhibitors has proven challenging for the fact that they must disrupt protein-protein interactions (PPIs).  The E3 ligase involved in interactome provide new hope for the discovery of the E3 ligase inhibitors.  These currently known natural binding partners of the E3 ligase can benefit the discovery of other unknown substrates and also the E3 ligase inhibitors.  Herein, we present a novel strategy that using multiple substrates to elucidate the mol. recognition mechanism of E3 ubiquitin ligase.  Mol. dynamics simulation, mol. mechanics-generalized born surface area (MM-GBSA) binding energy calcn. and energy decompn. scheme were incorporated to evaluate the quant. contributions of sub-pocket and per-residue to binding.  In this case, Kelch-like ECH-assocd. protein-1 (Keap1), a substrate adaptor component of the Cullin-RING ubiquitin ligases complex, is applied for the investigation of how it recognize its substrates, esp. Nrf2, a master regulator of the antioxidant response.  By analyzing multiple substrates binding determinants, we found that both the polar sub-pockets (P1 and P2) and the nonpolar sub-pockets (P4 and P5) of Keap1 can make remarkable contributions to intermol. interactions.  This finding stresses the requirement for substrates to interact with the polar and nonpolar sub-pockets simultaneously.  The results discussed in this paper not only show the binding determinants of the Keap1 substrates but also provide valuable implications for both Keap1 substrate discovery and PPI inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppReS77bpky7Vg90H21EOLACvtfcHk0lgKsBK0KksQng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsleku7zI&md5=359ff305f89c6a69cca48f60d019c765</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9799-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9799-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.%2BZ.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DH.%2BP.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DInvestigation%2520of%2520the%2520intermolecular%2520recognition%2520mechanism%2520between%2520the%2520E3%2520ubiquitin%2520ligase%2520Keap1%2520and%2520substrate%2520based%2520on%2520multiple%2520substrates%2520analysis%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D1233%26epage%3D1245%26doi%3D10.1007%2Fs10822-014-9799-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potteti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryuzoji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krunic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span> <span> </span><span class="NLM_article-title">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.ejmech.2015.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26363505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=252-268&author=A.+D.+Jainauthor=H.+Pottetiauthor=B.+G.+Richardsonauthor=L.+Kingsleyauthor=J.+P.+Lucianoauthor=A.+F.+Ryuzojiauthor=H.+Leeauthor=A.+Krunicauthor=A.+D.+Mesecarauthor=S.+P.+Reddyauthor=T.+W.+Moore&title=Probing+the+structural+requirements+of+non-electrophilic+naphthalene-based+Nrf2+activators&doi=10.1016%2Fj.ejmech.2015.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators</span></div><div class="casAuthors">Jain, Atul D.; Potteti, Haranatha; Richardson, Benjamin G.; Kingsley, Laura; Luciano, Julia P.; Ryuzoji, Aya F.; Lee, Hyun; Krunic, Aleksej; Mesecar, Andrew D.; Reddy, Sekhar P.; Moore, Terry W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">252-268</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Activation of the transcription factor Nrf2 has been posited to be a promising therapeutic strategy in a no. of inflammatory and oxidative stress diseases due to its regulation of detoxifying enzymes.  In this work, the authors have developed a comprehensive structure-activity relationship around a known, naphthalene-based nonelectrophilic activator of Nrf2, and the authors report highly potent nonelectrophilic activators of Nrf2.  Computational docking anal. of a subset of the compd. series demonstrates the importance of water mol. displacement for affinity, and the x-ray structure of di-amide I supports the computational anal.  One of the best compds., acid II, has an IC50 of 61 nM in a fluorescence anisotropy assay and a Kd of 120 nM in a surface plasmon resonance assay.  Addnl., the authors demonstrate that the Et ester of II is an efficacious inducer of Nrf2 target genes, exhibiting ex vivo efficacy similar to the well-known electrophilic activator, sulforaphane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcvlMBGU0C7Vg90H21EOLACvtfcHk0ljPxxEUn_kAOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzJ&md5=750fd3ca47f1a122618942312390891b</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPotteti%26aufirst%3DH.%26aulast%3DRichardson%26aufirst%3DB.%2BG.%26aulast%3DKingsley%26aufirst%3DL.%26aulast%3DLuciano%26aufirst%3DJ.%2BP.%26aulast%3DRyuzoji%26aufirst%3DA.%2BF.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKrunic%26aufirst%3DA.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BW.%26atitle%3DProbing%2520the%2520structural%2520requirements%2520of%2520non-electrophilic%2520naphthalene-based%2520Nrf2%2520activators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D252%26epage%3D268%26doi%3D10.1016%2Fj.ejmech.2015.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span> <span> </span><span class="NLM_article-title">Identifying and characterizing binding sites and assessing druggability</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1021/ci800324m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800324m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=377-389&author=T.+A.+Halgren&title=Identifying+and+characterizing+binding+sites+and+assessing+druggability&doi=10.1021%2Fci800324m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying and Characterizing Binding Sites and Assessing Druggability</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-389</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Identification and characterization of binding sites is key in the process of structure-based drug design.  In some cases there may not be any information about the binding site for a target of interest.  In other cases, a putative binding site has been identified by computational or exptl. means, but the druggability of the target is not known.  Even when a site for a given target is known, it may be desirable to find addnl. sites whose targeting could produce a desired biol. response.  A new program, called SiteMap, is presented for identifying and analyzing binding sites and for predicting target druggability.  In a large-scale validation, SiteMap correctly identifies the known binding site as the top-ranked site in 86% of the cases, with best results (>98%) coming for sites that bind ligands with subnanomolar affinity.  In addn., a modified version of the score employed for binding-site identification allows SiteMap to accurately classify the druggability of proteins as measured by their ability to bind passively absorbed small mols. tightly.  In characterizing binding sites, SiteMap provides quant. and graphical information that can help guide efforts to critically assess virtual hits in a lead-discovery application or to modify ligand structure to enhance potency or improve phys. properties in a lead-optimization context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfAt0-gvcXDLVg90H21EOLACvtfcHk0ljPxxEUn_kAOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D&md5=f03c7b27e30ae03d10e4127ed1f1ed3c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci800324m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800324m%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DIdentifying%2520and%2520characterizing%2520binding%2520sites%2520and%2520assessing%2520druggability%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D377%26epage%3D389%26doi%3D10.1021%2Fci800324m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoyama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beamer, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emge, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandapani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3039</span>– <span class="NLM_lpage">3043</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2013.03.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3039-3043&author=L.+Huauthor=S.+Mageshauthor=L.+Chenauthor=L.+Wangauthor=T.+A.+Lewisauthor=Y.+Chenauthor=C.+Khodierauthor=D.+Inoyamaauthor=L.+J.+Beamerauthor=T.+J.+Emgeauthor=J.+Shenauthor=J.+E.+Kerriganauthor=A.+N.+Kongauthor=S.+Dandapaniauthor=M.+Palmerauthor=S.+L.+Schreiberauthor=B.+Munoz&title=Discovery+of+a+small-molecule+inhibitor+and+cellular+probe+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1016%2Fj.bmcl.2013.03.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DMagesh%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKhodier%26aufirst%3DC.%26aulast%3DInoyama%26aufirst%3DD.%26aulast%3DBeamer%26aufirst%3DL.%2BJ.%26aulast%3DEmge%26aufirst%3DT.%2BJ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DKerrigan%26aufirst%3DJ.%2BE.%26aulast%3DKong%26aufirst%3DA.%2BN.%26aulast%3DDandapani%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DMunoz%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520a%2520small-molecule%2520inhibitor%2520and%2520cellular%2520probe%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3039%26epage%3D3043%26doi%3D10.1016%2Fj.bmcl.2013.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jnoff, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromidge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookfield, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corden, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duclos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryatt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genicot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jigorel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maghames, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mushi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stimson, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courade, J. P.</span></span> <span> </span><span class="NLM_article-title">Binding mode and structure–activity relationships around direct inhibitors of the Nrf2-Keap1 complex</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1002%2Fcmdc.201300525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=699-705&author=E.+Jnoffauthor=C.+Albrechtauthor=J.+J.+Barkerauthor=O.+Barkerauthor=E.+Beaumontauthor=S.+Bromidgeauthor=F.+Brookfieldauthor=M.+Brooksauthor=C.+Bubertauthor=T.+Ceskaauthor=V.+Cordenauthor=G.+Dawsonauthor=S.+Duclosauthor=T.+Fryattauthor=C.+Genicotauthor=E.+Jigorelauthor=J.+Kwongauthor=R.+Maghamesauthor=I.+Mushiauthor=R.+Pikeauthor=Z.+A.+Sandsauthor=M.+A.+Smithauthor=C.+C.+Stimsonauthor=J.+P.+Courade&title=Binding+mode+and+structure%E2%80%93activity+relationships+around+direct+inhibitors+of+the+Nrf2-Keap1+complex&doi=10.1002%2Fcmdc.201300525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300525%26sid%3Dliteratum%253Aachs%26aulast%3DJnoff%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DC.%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DBeaumont%26aufirst%3DE.%26aulast%3DBromidge%26aufirst%3DS.%26aulast%3DBrookfield%26aufirst%3DF.%26aulast%3DBrooks%26aufirst%3DM.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DCeska%26aufirst%3DT.%26aulast%3DCorden%26aufirst%3DV.%26aulast%3DDawson%26aufirst%3DG.%26aulast%3DDuclos%26aufirst%3DS.%26aulast%3DFryatt%26aufirst%3DT.%26aulast%3DGenicot%26aufirst%3DC.%26aulast%3DJigorel%26aufirst%3DE.%26aulast%3DKwong%26aufirst%3DJ.%26aulast%3DMaghames%26aufirst%3DR.%26aulast%3DMushi%26aufirst%3DI.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DSands%26aufirst%3DZ.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DStimson%26aufirst%3DC.%2BC.%26aulast%3DCourade%26aufirst%3DJ.%2BP.%26atitle%3DBinding%2520mode%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520around%2520direct%2520inhibitors%2520of%2520the%2520Nrf2-Keap1%2520complex%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D699%26epage%3D705%26doi%3D10.1002%2Fcmdc.201300525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hus, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hession, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atmanene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roecklin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span> <span> </span><span class="NLM_article-title">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4019</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmc.2013.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=23647822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4011-4019&author=D.+Marcotteauthor=W.+Zengauthor=J.+C.+Husauthor=A.+McKenzieauthor=C.+Hessionauthor=P.+Jinauthor=C.+Bergeronauthor=A.+Lugovskoyauthor=I.+Enyedyauthor=H.+Cuervoauthor=D.+Wangauthor=C.+Atmaneneauthor=D.+Roecklinauthor=M.+Vecchiauthor=V.+Vivatauthor=J.+Kraemerauthor=D.+Winklerauthor=V.+Hongauthor=J.+Chaoauthor=M.+Lukashevauthor=L.+Silvian&title=Small+molecules+inhibit+the+interaction+of+Nrf2+and+the+Keap1+Kelch+domain+through+a+non-covalent+mechanism&doi=10.1016%2Fj.bmc.2013.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism</span></div><div class="casAuthors">Marcotte, Douglas; Zeng, Weike; Hus, Jean-Christophe; McKenzie, Andres; Hession, Cathy; Jin, Ping; Bergeron, Chris; Lugovskoy, Alexey; Enyedy, Istvan; Cuervo, Hernan; Wang, Deping; Atmanene, Cedric; Roecklin, Dominique; Vecchi, Malgorzata; Vivat, Valerie; Kraemer, Joachim; Winkler, Dirk; Hong, Victor; Chao, Jianhua; Lukashev, Matvey; Silvian, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4011-4019</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 binds to the Nrf2 transcription factor to promote its degrdn., resulting in the loss of gene products that protect against oxidative stress.  While cell-active small mols. have been identified that modify cysteines in Keap1 and effect the Nrf2 dependent pathway, few act through a non-covalent mechanism.  We have identified and characterized several small mol. compds. that specifically bind to the Keap1 Kelch-DC domain as measured by NMR, native mass spectrometry and X-ray crystallog.  One compd. upregulates Nrf2 response genes measured by a luciferase cell reporter assay.  The non-covalent inhibition strategy presents a reasonable course of action to avoid toxic side-effects due to non-specific cysteine modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KaDM3q3CeLVg90H21EOLACvtfcHk0lhfiv7tdvuqCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSku7w%253D&md5=b49b42b1621c6f08fbb3449621e4b109</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHus%26aufirst%3DJ.%2BC.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DHession%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DC.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DCuervo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DAtmanene%26aufirst%3DC.%26aulast%3DRoecklin%26aufirst%3DD.%26aulast%3DVecchi%26aufirst%3DM.%26aulast%3DVivat%26aufirst%3DV.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DV.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLukashev%26aufirst%3DM.%26aulast%3DSilvian%26aufirst%3DL.%26atitle%3DSmall%2520molecules%2520inhibit%2520the%2520interaction%2520of%2520Nrf2%2520and%2520the%2520Keap1%2520Kelch%2520domain%2520through%2520a%2520non-covalent%2520mechanism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4011%26epage%3D4019%26doi%3D10.1016%2Fj.bmc.2013.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Keap1–Nrf2 protein–protein interaction inhibitor based on molecular binding determinants analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2736</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/jm5000529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5000529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2736-2745&author=Z.+Y.+Jiangauthor=M.+C.+Luauthor=L.+L.+Xuauthor=T.+T.+Yangauthor=M.+Y.+Xiauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+of+potent+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitor+based+on+molecular+binding+determinants+analysis&doi=10.1021%2Fjm5000529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis</span></div><div class="casAuthors">Jiang, Zheng-Yu; Lu, Meng-Chen; Xu, Li-Li; Yang, Ting-Ting; Xi, Mei-Yang; Xu, Xiao-Li; Guo, Xiao-Ke; Zhang, Xiao-Jin; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2736-2745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Keap1 is known to mediate the ubiquitination of Nrf2, a master regulator of the antioxidant response.  Directly interrupting the Keap1-Nrf2 interaction has been emerged as a promising strategy to develop novel class of antioxidant, antiinflammatory, and anticancer agents.  On the basis of the mol. binding determinants anal. of Keap1, we successfully designed and characterized the most potent protein-protein interaction (PPI) inhibitor of Keap1-Nrf2, compd. 2, with KD value of 3.59 nM binding to Keap1 for the first time to single-digit nanomolar.  Compd. 2 can effectively disrupt the Nrf2-Keap1 interaction with an EC50 of 28.6 nM in the fluorescence polarization assay.  It can also activate the Nrf2 transcription activity in the cell-based ARE-luciferase reporter assay in a dose-dependent manner.  The qRT-PCR results of Nrf2 transcription targets gave the consistent results.  These results confirm direct and highly efficient interruption of the Keap1-Nrf2 PPI can be fully achieved by small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRS8nWHc40ZrVg90H21EOLACvtfcHk0lhfiv7tdvuqCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKmtro%253D&md5=b5d43ac3973478ecc54e26c74435f2c4</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm5000529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5000529%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DT.%2BT.%26aulast%3DXi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%2520based%2520on%2520molecular%2520binding%2520determinants%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2736%26epage%3D2745%26doi%3D10.1021%2Fjm5000529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity and structure-property relationship and exploratory in vivo evaluation of the nanomolar Keap1–Nrf2 protein–protein interaction inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6410</span>– <span class="NLM_lpage">6421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6410-6421&author=Z.+Y.+Jiangauthor=L.+L.+Xuauthor=M.+C.+Luauthor=Z.+Y.+Chenauthor=Z.+W.+Yuanauthor=X.+L.+Xuauthor=X.+K.+Guoauthor=X.+J.+Zhangauthor=H.+P.+Sunauthor=Q.+D.+You&title=Structure-activity+and+structure-property+relationship+and+exploratory+in+vivo+evaluation+of+the+nanomolar+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitor&doi=10.1021%2Facs.jmedchem.5b00185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00185%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DXu%26aufirst%3DL.%2BL.%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DYuan%26aufirst%3DZ.%2BW.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DSun%26aufirst%3DH.%2BP.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DStructure-activity%2520and%2520structure-property%2520relationship%2520and%2520exploratory%2520in%2520vivo%2520evaluation%2520of%2520the%2520nanomolar%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6410%26epage%3D6421%26doi%3D10.1021%2Facs.jmedchem.5b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Polar recognition group study of Keap1–Nrf2 protein–protein interaction inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=835-840&author=M.+C.+Luauthor=S.+J.+Tanauthor=J.+A.+Jiauthor=Z.+Y.+Chenauthor=Z.+W.+Yuanauthor=Q.+D.+Youauthor=Z.+Y.+Jiang&title=Polar+recognition+group+study+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitors&doi=10.1021%2Facsmedchemlett.5b00407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DTan%26aufirst%3DS.%2BJ.%26aulast%3DJi%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DYuan%26aufirst%3DZ.%2BW.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26atitle%3DPolar%2520recognition%2520group%2520study%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D835%26epage%3D840%26doi%3D10.1021%2Facsmedchemlett.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margerie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szillat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glombik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gussregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Knethen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmoll, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">28446</span>– <span class="NLM_lpage">28455</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.678136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1074%2Fjbc.M115.678136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26459563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=28446-28455&author=A.+F.+Winkelauthor=C.+K.+Engelauthor=D.+Margerieauthor=A.+Kanntauthor=H.+Szillatauthor=H.+Glombikauthor=C.+Kallusauthor=S.+Rufauthor=S.+Gussregenauthor=J.+Riedelauthor=A.+W.+Herlingauthor=A.+von+Knethenauthor=A.+Weigertauthor=B.+Bruneauthor=D.+Schmoll&title=Characterization+of+RA839%2C+a+noncovalent+small+molecule+binder+to+Keap1+and+selective+activator+of+Nrf2+signaling&doi=10.1074%2Fjbc.M115.678136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling</span></div><div class="casAuthors">Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">28446-28455</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activation of the transcription factor NF-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes.  Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keap1 (kelch-like ECH-assocd. protein 1).  Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl]pyrrolidine-3-carboxylic acid (RA839), a small mol. that binds noncovalently to the Nrf2-interacting kelch domain of Keap1 with a Kd of ∼6 μm, as demonstrated by x-ray co-crystn. and isothermal titrn. calorimetry.  Whole genome DNA arrays showed that at 10 μm RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages.  Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling.  These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression.  RA839 regulated only two genes in Nrf2 knock-out macrophages.  Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compd. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid Me ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages.  In mice, RA839 acutely induced Nrf2 target gene expression in liver.  RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compd. to study the biol. of Nrf2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu4FlVebzcbVg90H21EOLACvtfcHk0ljcfkocfTfmxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlsrjF&md5=082998a0e4685dc8622662270fbba223</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.678136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.678136%26sid%3Dliteratum%253Aachs%26aulast%3DWinkel%26aufirst%3DA.%2BF.%26aulast%3DEngel%26aufirst%3DC.%2BK.%26aulast%3DMargerie%26aufirst%3DD.%26aulast%3DKannt%26aufirst%3DA.%26aulast%3DSzillat%26aufirst%3DH.%26aulast%3DGlombik%26aufirst%3DH.%26aulast%3DKallus%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DS.%26aulast%3DGussregen%26aufirst%3DS.%26aulast%3DRiedel%26aufirst%3DJ.%26aulast%3DHerling%26aufirst%3DA.%2BW.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DBrune%26aufirst%3DB.%26aulast%3DSchmoll%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520RA839%252C%2520a%2520noncovalent%2520small%2520molecule%2520binder%2520to%2520Keap1%2520and%2520selective%2520activator%2520of%2520Nrf2%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D28446%26epage%3D28455%26doi%3D10.1074%2Fjbc.M115.678136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waguri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12030</span>, <span class="refDoi"> DOI: 10.1038/ncomms12030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fncomms12030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27345495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12030&author=T.+Saitoauthor=Y.+Ichimuraauthor=K.+Taguchiauthor=T.+Suzukiauthor=T.+Mizushimaauthor=K.+Takagiauthor=Y.+Hiroseauthor=M.+Nagahashiauthor=T.+Isoauthor=T.+Fukutomiauthor=M.+Ohishiauthor=K.+Endoauthor=T.+Uemuraauthor=Y.+Nishitoauthor=S.+Okudaauthor=M.+Obataauthor=T.+Kounoauthor=R.+Imamuraauthor=Y.+Tadaauthor=R.+Obataauthor=D.+Yasudaauthor=K.+Takahashiauthor=T.+Fujimuraauthor=J.+Piauthor=M.+S.+Leeauthor=T.+Uenoauthor=T.+Oheauthor=T.+Mashinoauthor=T.+Wakaiauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=H.+Motohashiauthor=S.+Waguriauthor=T.+Sogaauthor=M.+Yamamotoauthor=K.+Tanakaauthor=M.+Komatsu&title=p62%2FSqstm1+promotes+malignancy+of+HCV-positive+hepatocellular+carcinoma+through+Nrf2-dependent+metabolic+reprogramming&doi=10.1038%2Fncomms12030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming</span></div><div class="casAuthors">Saito, Tetsuya; Ichimura, Yoshinobu; Taguchi, Keiko; Suzuki, Takafumi; Mizushima, Tsunehiro; Takagi, Kenji; Hirose, Yuki; Nagahashi, Masayuki; Iso, Tetsuro; Fukutomi, Toshiaki; Ohishi, Maki; Endo, Keiko; Uemura, Takefumi; Nishito, Yasumasa; Okuda, Shujiro; Obata, Miki; Kouno, Tsuguka; Imamura, Riyo; Tada, Yukio; Obata, Rika; Yasuda, Daisuke; Takahashi, Kyoko; Fujimura, Tsutomu; Pi, Jingbo; Lee, Myung-Shik; Ueno, Takashi; Ohe, Tomoyuki; Mashino, Tadahiko; Wakai, Toshifumi; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo; Motohashi, Hozumi; Waguri, Satoshi; Soga, Tomoyoshi; Yamamoto, Masayuki; Tanaka, Keiji; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12030</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P62/Sqstm1 is a multifunctional protein involved in cell survival, growth and death, that is degraded by autophagy.  Amplification of the p62/Sqstm1 gene, and aberrant accumulation and phosphorylation of p62/Sqstm1, have been implicated in tumor development.  Herein, we reveal the mol. mechanism of p62/Sqstm1-dependent malignant progression, and suggest that mol. targeting of p62/Sqstm1 represents a potential chemotherapeutic approach against hepatocellular carcinoma (HCC).  Phosphorylation of p62/Sqstm1 at Ser349 directs glucose to the glucuronate pathway, and glutamine towards glutathione synthesis through activation of the transcription factor Nrf2.  These changes provide HCC cells with tolerance to anti-cancer drugs and proliferation potency.  Phosphorylated p62/Sqstm1 accumulates in tumor regions pos. for hepatitis C virus (HCV).  An inhibitor of phosphorylated p62-dependent Nrf2 activation suppresses the proliferation and anticancer agent tolerance of HCC.  Our data indicate that this Nrf2 inhibitor could be used to make cancer cells less resistant to anticancer drugs, esp. in HCV-pos. HCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWPpd-6mfs2rVg90H21EOLACvtfcHk0ljU3flPLxLobw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSisLzF&md5=859f788e0e5ac3e5ed46eeee9da47490</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fncomms12030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12030%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DHirose%26aufirst%3DY.%26aulast%3DNagahashi%26aufirst%3DM.%26aulast%3DIso%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DUemura%26aufirst%3DT.%26aulast%3DNishito%26aufirst%3DY.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DObata%26aufirst%3DM.%26aulast%3DKouno%26aufirst%3DT.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DFujimura%26aufirst%3DT.%26aulast%3DPi%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26aulast%3DWakai%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMotohashi%26aufirst%3DH.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3Dp62%252FSqstm1%2520promotes%2520malignancy%2520of%2520HCV-positive%2520hepatocellular%2520carcinoma%2520through%2520Nrf2-dependent%2520metabolic%2520reprogramming%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12030%26doi%3D10.1038%2Fncomms12030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Keap1-phosphorylated p62 and Keap1–Nrf2 protein–protein interaction inhibitors and their inhibitory activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2016.10.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5956-5959&author=D.+Yasudaauthor=M.+Nakajimaauthor=A.+Yuasaauthor=R.+Obataauthor=K.+Takahashiauthor=T.+Oheauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=T.+Mashino&title=Synthesis+of+Keap1-phosphorylated+p62+and+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitors+and+their+inhibitory+activity&doi=10.1016%2Fj.bmcl.2016.10.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.083%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DA.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520Keap1-phosphorylated%2520p62%2520and%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%2520and%2520their%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5956%26epage%3D5959%26doi%3D10.1016%2Fj.bmcl.2016.10.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashino, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzo[g]indoles as a novel class of non-covalent Keap1–Nrf2 protein–protein interaction inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5006</span>– <span class="NLM_lpage">5009</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.bmcl.2017.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5006-5009&author=D.+Yasudaauthor=A.+Yuasaauthor=R.+Obataauthor=M.+Nakajimaauthor=K.+Takahashiauthor=T.+Oheauthor=Y.+Ichimuraauthor=M.+Komatsuauthor=M.+Yamamotoauthor=R.+Imamuraauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Naganoauthor=T.+Mashino&title=Discovery+of+benzo%5Bg%5Dindoles+as+a+novel+class+of+non-covalent+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitor&doi=10.1016%2Fj.bmcl.2017.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DYuasa%26aufirst%3DA.%26aulast%3DObata%26aufirst%3DR.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhe%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DR.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DMashino%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520benzo%255Bg%255Dindoles%2520as%2520a%2520novel%2520class%2520of%2520non-covalent%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5006%26epage%3D5009%26doi%3D10.1016%2Fj.bmcl.2017.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonchuk, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, J. K.</span></span> <span> </span><span class="NLM_article-title">Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein–protein interaction with high cell potency identified by fragment-based discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3991</span>– <span class="NLM_lpage">4006</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00228</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00228" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3991-4006&author=T.+G.+Daviesauthor=W.+E.+Wixtedauthor=J.+E.+Coyleauthor=C.+Griffiths-Jonesauthor=K.+Hearnauthor=R.+McMenaminauthor=D.+Nortonauthor=S.+J.+Richauthor=C.+Richardsonauthor=G.+Saxtyauthor=H.+M.+Willemsauthor=A.+J.+Woolfordauthor=J.+E.+Cottomauthor=J.+P.+Kouauthor=J.+G.+Yonchukauthor=H.+G.+Feldserauthor=Y.+Sanchezauthor=J.+P.+Foleyauthor=B.+J.+Bologneseauthor=G.+Loganauthor=P.+L.+Podolinauthor=H.+Yanauthor=J.+F.+Callahanauthor=T.+D.+Heightmanauthor=J.+K.+Kerns&title=Monoacidic+inhibitors+of+the+Kelch-like+ECH-associated+protein+1%3A+nuclear+factor+erythroid+2-related+factor+2+%28KEAP1%3ANRF2%29+protein%E2%80%93protein+interaction+with+high+cell+potency+identified+by+fragment-based+discovery&doi=10.1021%2Facs.jmedchem.6b00228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span></div><div class="casAuthors">Davies, Thomas G.; Wixted, William E.; Coyle, Joseph E.; Griffiths-Jones, Charlotte; Hearn, Keisha; McMenamin, Rachel; Norton, David; Rich, Sharna J.; Richardson, Caroline; Saxty, Gordon; Willems, Henriette M. G.; Woolford, Alison J.-A.; Cottom, Joshua E.; Kou, Jen-Pyng; Yonchuk, John G.; Feldser, Heidi G.; Sanchez, Yolanda; Foley, Joseph P.; Bolognese, Brian J.; Logan, Gregory; Podolin, Patricia L.; Yan, Hongxing; Callahan, James F.; Heightman, Tom D.; Kerns, Jeffrey K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3991-4006</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">KEAP1 is the key regulator of the NRF2-mediated cytoprotective response, and increasingly recognized as a target for diseases involving oxidative stress.  Pharmacol. intervention has focused on mols. that decrease NRF2-ubiquitination through covalent modification of KEAP1 cysteine residues, but such electrophilic compds. lack selectivity and may be assocd. with off-target toxicity.  We report here the first use of a fragment-based approach to directly target the KEAP1 Kelch-NRF2 interaction.  X-ray crystallog. screening identified three distinct "hot-spots" for fragment binding within the NRF2 binding pocket of KEAP1, allowing progression of a weak fragment hit to mols. with nanomolar affinity for KEAP1 while maintaining drug-like properties.  This work resulted in a promising lead compd. (I) which exhibits tight and selective binding to KEAP1, and activates the NRF2 antioxidant response in cellular and in vivo models, thereby providing a high quality chem. probe to explore the therapeutic potential of disrupting the KEAP1-NRF2 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-gfBTuYreLVg90H21EOLACvtfcHk0lhXhJ2BLmJWqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Gjtr0%253D&md5=ae42cc9f06d14b340cb3a8f5d6c157a7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00228%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DRichardson%26aufirst%3DC.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DH.%2BM.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26aulast%3DCottom%26aufirst%3DJ.%2BE.%26aulast%3DKou%26aufirst%3DJ.%2BP.%26aulast%3DYonchuk%26aufirst%3DJ.%2BG.%26aulast%3DFeldser%26aufirst%3DH.%2BG.%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLogan%26aufirst%3DG.%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DKerns%26aufirst%3DJ.%2BK.%26atitle%3DMonoacidic%2520inhibitors%2520of%2520the%2520Kelch-like%2520ECH-associated%2520protein%25201%253A%2520nuclear%2520factor%2520erythroid%25202-related%2520factor%25202%2520%2528KEAP1%253ANRF2%2529%2520protein%25E2%2580%2593protein%2520interaction%2520with%2520high%2520cell%2520potency%2520identified%2520by%2520fragment-based%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3991%26epage%3D4006%26doi%3D10.1021%2Facs.jmedchem.6b00228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span>; <span class="NLM_string-name">Kerns, J. J.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Nie, H.</span>; <span class="NLM_string-name">Pero, J. E.</span>; <span class="NLM_string-name">Davies, T. G.</span>; <span class="NLM_string-name">Heightman, T. D.</span>; <span class="NLM_string-name">Woolford, A.</span>; <span class="NLM_string-name">Griffiths-Jones, C. M.</span>; <span class="NLM_string-name">Norton, D.</span>; <span class="NLM_string-name">Willems, H. M. G.</span>; <span class="NLM_string-name">Verdonk, M. L.</span>; <span class="NLM_string-name">Carr, M. G.</span></span> <span> </span><span class="NLM_article-title">Biaryl Pyrazoles as Nrf2 Regulators</span>. <span class="NLM_patent">WO2017060854</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+F.+Callahan&author=J.+J.+Kerns&author=T.+Li&author=H.+Nie&author=J.+E.+Pero&author=T.+G.+Davies&author=T.+D.+Heightman&author=A.+Woolford&author=C.+M.+Griffiths-Jones&author=D.+Norton&author=H.+M.+G.+Willems&author=M.+L.+Verdonk&author=M.+G.+Carr&title=Biaryl+Pyrazoles+as+Nrf2+Regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26atitle%3DBiaryl%2520Pyrazoles%2520as%2520Nrf2%2520Regulators%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span>; <span class="NLM_string-name">Kerns, J. J.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Nie, H.</span>; <span class="NLM_string-name">Pero, J. E.</span>; <span class="NLM_string-name">Davies, T. G.</span>; <span class="NLM_string-name">Heightman, T. D.</span>; <span class="NLM_string-name">Woolford, A. J.</span>; <span class="NLM_string-name">Griffiths-Jones, C. M.</span>; <span class="NLM_string-name">Norton, D.</span>; <span class="NLM_string-name">Verdonk, M. L.</span>; <span class="NLM_string-name">Howard, S.</span></span> <span> </span><span class="NLM_article-title">Arylcyclohexyl Pyrazoles as Nrf2 Regulators</span>. <span class="NLM_patent">WO2017060855</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+F.+Callahan&author=J.+J.+Kerns&author=T.+Li&author=H.+Nie&author=J.+E.+Pero&author=T.+G.+Davies&author=T.+D.+Heightman&author=A.+J.+Woolford&author=C.+M.+Griffiths-Jones&author=D.+Norton&author=M.+L.+Verdonk&author=S.+Howard&title=Arylcyclohexyl+Pyrazoles+as+Nrf2+Regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26atitle%3DArylcyclohexyl%2520Pyrazoles%2520as%2520Nrf2%2520Regulators%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgakopoulos, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiollier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of triazole derivatives that induce Nrf2 dependent gene products and inhibit the Keap1–Nrf2 protein–protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7186</span>– <span class="NLM_lpage">7194</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7186-7194&author=H.+C.+Bertrandauthor=M.+Schaapauthor=L.+Bairdauthor=N.+D.+Georgakopoulosauthor=A.+Fowkesauthor=C.+Thiollierauthor=H.+Kachiauthor=A.+T.+Dinkova-Kostovaauthor=G.+Wells&title=Design%2C+synthesis%2C+and+evaluation+of+triazole+derivatives+that+induce+Nrf2+dependent+gene+products+and+inhibit+the+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction&doi=10.1021%2Facs.jmedchem.5b00602"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00602%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DH.%2BC.%26aulast%3DSchaap%26aufirst%3DM.%26aulast%3DBaird%26aufirst%3DL.%26aulast%3DGeorgakopoulos%26aufirst%3DN.%2BD.%26aulast%3DFowkes%26aufirst%3DA.%26aulast%3DThiollier%26aufirst%3DC.%26aulast%3DKachi%26aufirst%3DH.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DWells%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520triazole%2520derivatives%2520that%2520induce%2520Nrf2%2520dependent%2520gene%2520products%2520and%2520inhibit%2520the%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7186%26epage%3D7194%26doi%3D10.1021%2Facs.jmedchem.5b00602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazantsev, A. G.</span>; <span class="NLM_string-name">Thompson, L.</span>; <span class="NLM_string-name">Abagyan, R.</span>; <span class="NLM_string-name">Casale, M.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Activators of Nrf2 Pathway</span>. <span class="NLM_patent">WO2014197818</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+G.+Kazantsev&author=L.+Thompson&author=R.+Abagyan&author=M.+Casale&title=Small+Molecule+Activators+of+Nrf2+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSmall%2520Molecule%2520Activators%2520of%2520Nrf2%2520Pathway%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saburi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naitow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimozono, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunishima, N.</span></span> <span> </span><span class="NLM_article-title">Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation</span>. <i>FEBS Open Bio</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.fob.2015.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.fob.2015.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=26199865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaitbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=557-570&author=M.+Satohauthor=H.+Saburiauthor=T.+Tanakaauthor=Y.+Matsuuraauthor=H.+Naitowauthor=R.+Shimozonoauthor=N.+Yamamotoauthor=H.+Inoueauthor=N.+Nakamuraauthor=Y.+Yoshizawaauthor=T.+Aokiauthor=R.+Tanimuraauthor=N.+Kunishima&title=Multiple+binding+modes+of+a+small+molecule+to+human+Keap1+revealed+by+X-ray+crystallography+and+molecular+dynamics+simulation&doi=10.1016%2Fj.fob.2015.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation</span></div><div class="casAuthors">Satoh, Mikiya; Saburi, Hajime; Tanaka, Tomoyuki; Matsuura, Yoshinori; Naitow, Hisashi; Shimozono, Rieko; Yamamoto, Naoyoshi; Inoue, Hideki; Nakamura, Noriko; Yoshizawa, Yoshitaka; Aoki, Takumi; Tanimura, Ryuji; Kunishima, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Open Bio</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">557-570</span>CODEN:
                <span class="NLM_cas:coden">FOBEB3</span>;
        ISSN:<span class="NLM_cas:issn">2211-5463</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Keap1 protein acts as a cellular sensor for oxidative stresses and regulates the transcription level of antioxidant genes through the ubiquitination of a corresponding transcription factor, Nrf2.  A small mol. capable of binding to the Nrf2 interaction site of Keap1 could be a useful medicine.  Here, we report two crystal structures, referred to as the soaking and the cocrystn. forms, of the Kelch domain of Keap1 with a small mol., Ligand1.  In these two forms, the Ligand1 mol. occupied the binding site of Keap1 so as to mimic the ETGE motif of Nrf2, although the mode of binding differed in the two forms.  Because the Ligand1 mol. mediated the crystal packing in both the forms, the influence of crystal packing on the ligand binding was examd. using a mol. dynamics (MD) simulation in aq. conditions.  In the MD structures from the soaking form, the ligand remained bound to Keap1 for over 20 ns, whereas the ligand tended to dissoc. in the cocrystn. form.  The MD structures could be classified into a few clusters that were related to but distinct from the crystal structures, indicating that the binding modes obsd. in crystals might be atypical of those in soln.  However, the dominant ligand recognition residues in the crystal structures were commonly used in the MD structures to anchor the ligand.  Therefore, the present structural information together with the MD simulation will be a useful basis for pharmaceutical drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3082uY55kRbVg90H21EOLACvtfcHk0ljBP-CnEQh8lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaitbfF&md5=b716297a8be096ef649f22cad472c58d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.fob.2015.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fob.2015.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DM.%26aulast%3DSaburi%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DY.%26aulast%3DNaitow%26aufirst%3DH.%26aulast%3DShimozono%26aufirst%3DR.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DTanimura%26aufirst%3DR.%26aulast%3DKunishima%26aufirst%3DN.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520a%2520small%2520molecule%2520to%2520human%2520Keap1%2520revealed%2520by%2520X-ray%2520crystallography%2520and%2520molecular%2520dynamics%2520simulation%26jtitle%3DFEBS%2520Open%2520Bio%26date%3D2015%26volume%3D5%26spage%3D557%26epage%3D570%26doi%3D10.1016%2Fj.fob.2015.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimozono, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, H.</span></span> <span> </span><span class="NLM_article-title">Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1124/mol.112.084269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1124%2Fmol.112.084269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=23592516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=62-70&author=R.+Shimozonoauthor=Y.+Asaokaauthor=Y.+Yoshizawaauthor=T.+Aokiauthor=H.+Nodaauthor=M.+Yamadaauthor=M.+Kainoauthor=H.+Mochizuki&title=Nrf2+activators+attenuate+the+progression+of+nonalcoholic+steatohepatitis-related+fibrosis+in+a+dietary+rat+model&doi=10.1124%2Fmol.112.084269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model</span></div><div class="casAuthors">Shimozono, Rieko; Asaoka, Yoshiji; Yoshizawa, Yoshitaka; Aoki, Takumi; Noda, Hidetoshi; Yamada, Masateru; Kaino, Mie; Mochizuki, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-70</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Oxidative stress is considered to be a key mechanism of hepatocellular injury and disease progression in patients with nonalcoholic steatohepatitis (NASH).  The transcription factor Nrf2 (nuclear factor-erythroid-2-related factor 2) plays a central role in stimulating expression of various antioxidant-assocd. genes in the cellular defense against oxidative stress.  As the cytosolic repressor kelch-like ECH-assocd. protein 1 (Keap1) neg. regulates Nrf2, activation of Nrf2 facilitated by its release from Keap1 may represent a promising strategy in the treatment of NASH.  To test this hypothesis, we used two chem. distinct types of Nrf2 activator.  One is the thiol-reactive agent oltipraz (OPZ), a typical Nrf2 activator, and the other is a novel biaryl urea compd., termed NK-252 (1-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)-3-(pyridin-2-ylmethyl)urea).  NK-252 exhibits a greater Nrf2-activating potential than OPZ.  Furthermore, in vitro binding studies revealed that NK-252 interacts with the domain contg. the Nrf2-binding site of Keap1, whereas OPZ does not.  This finding indicates that NK-252 is more potent than OPZ due to its unique mechanism of action.  For in vivo animal model studies, we used rats on a choline-deficient L-amino acid-defined (CDAA) diet, which demonstrate pathol. findings similar to those seen in human NASH.  The administration of OPZ or NK-252 significantly attenuated the progression of histol. abnormalities in rats on a CDAA diet, esp. hepatic fibrosis.  In conclusion, by using Nrf2 activators with independent mechanisms of action, we show that, in a rat model of NASH, the activation of Nrf2 is responsible for the antifibrotic effects of these drugs.  This strategy of Nrf2 activation presents new opportunities for treatment of NASH patients with hepatic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPPmcfr7KwlbVg90H21EOLACvtfcHk0ljBP-CnEQh8lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsbjJ&md5=6e58be4d60b2ed64524e8799275c04a0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.084269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.084269%26sid%3Dliteratum%253Aachs%26aulast%3DShimozono%26aufirst%3DR.%26aulast%3DAsaoka%26aufirst%3DY.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DKaino%26aufirst%3DM.%26aulast%3DMochizuki%26aufirst%3DH.%26atitle%3DNrf2%2520activators%2520attenuate%2520the%2520progression%2520of%2520nonalcoholic%2520steatohepatitis-related%2520fibrosis%2520in%2520a%2520dietary%2520rat%2520model%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D62%26epage%3D70%26doi%3D10.1124%2Fmol.112.084269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-d.</span></span> <span> </span><span class="NLM_article-title">Novel protein–protein interaction inhibitor of Nrf2–Keap1 discovered by structure-based virtual screening</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1039/C3MD00240C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1039%2FC3MD00240C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=93-98&author=H.-P.+Sunauthor=Z.-Y.+Jiangauthor=M.-Y.+Zhangauthor=M.-C.+Luauthor=T.-T.+Yangauthor=Y.+Panauthor=H.-Z.+Huangauthor=X.-J.+Zhangauthor=Q.-d.+You&title=Novel+protein%E2%80%93protein+interaction+inhibitor+of+Nrf2%E2%80%93Keap1+discovered+by+structure-based+virtual+screening&doi=10.1039%2FC3MD00240C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2FC3MD00240C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MD00240C%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.-P.%26aulast%3DJiang%26aufirst%3DZ.-Y.%26aulast%3DZhang%26aufirst%3DM.-Y.%26aulast%3DLu%26aufirst%3DM.-C.%26aulast%3DYang%26aufirst%3DT.-T.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DH.-Z.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DYou%26aufirst%3DQ.-d.%26atitle%3DNovel%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitor%2520of%2520Nrf2%25E2%2580%2593Keap1%2520discovered%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D93%26epage%3D98%26doi%3D10.1039%2FC3MD00240C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanapillai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span> <span> </span><span class="NLM_article-title">Rapid identification of Keap1–Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1126</span>, <span class="refDoi"> DOI: 10.1021/jm4017174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1121-1126&author=C.+Zhuangauthor=S.+Narayanapillaiauthor=W.+Zhangauthor=Y.+Y.+Shamauthor=C.+Xing&title=Rapid+identification+of+Keap1%E2%80%93Nrf2+small-molecule+inhibitors+through+structure-based+virtual+screening+and+hit-based+substructure+search&doi=10.1021%2Fjm4017174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm4017174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017174%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DNarayanapillai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DXing%26aufirst%3DC.%26atitle%3DRapid%2520identification%2520of%2520Keap1%25E2%2580%2593Nrf2%2520small-molecule%2520inhibitors%2520through%2520structure-based%2520virtual%2520screening%2520and%2520hit-based%2520substructure%2520search%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1121%26epage%3D1126%26doi%3D10.1021%2Fjm4017174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-growing guided design of Keap1–Nrf2 protein–protein interaction inhibitors for targeting myocarditis</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2Fj.freeradbiomed.2018.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=29428410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2018&pages=228-237&author=N.+Mengauthor=H.+Tangauthor=H.+Zhangauthor=C.+Jiangauthor=L.+Suauthor=X.+Minauthor=W.+Zhangauthor=H.+Zhangauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Zhuang&title=Fragment-growing+guided+design+of+Keap1%E2%80%93Nrf2+protein%E2%80%93protein+interaction+inhibitors+for+targeting+myocarditis&doi=10.1016%2Fj.freeradbiomed.2018.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis</span></div><div class="casAuthors">Meng, Ning; Tang, Hua; Zhang, Hao; Jiang, Chengshi; Su, Li; Min, Xiao; Zhang, Wannian; Zhang, Hua; Miao, Zhenyuan; Zhang, Wen; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the Keap1-Nrf2 protein-protein interactions are being intensely pursued as a new therapeutic strategy for oxidative stress-related diseases, such as cancer, diabetes, Alzheimer's disease, arteriosclerosis, inflammation and myocarditis.  However, there are not enough studies on antioxidant treatments using small mols. in myocarditis.  The authors herein provided a series of novel hydronaphthoquinones as the Keap1-Nrf2 interaction inhibitors targeting LPS-induced myocarditis both in vitro and in vivo.  These compds. were designed through an in-silico fragment growing approach based on the previous reported compd.  The new compds. were predicted to form addnl. hydrogen bonds with the S363 residue, leading to higher inhibitory activity.  Among these new derivs., compds. I and II emerged as inhibitors with significant biochem. potency, as detd. by fluorescent anisotropy assay and confirmed by surface plasmon resonance (SPR) and differential scanning fluorometry (DSF) assays.  These inhibitors can dose-dependently protect the H9c2 cardiac cells against LPS-induced injury (100% at 2 μM and 4 μM) and effectively prolong survival or save the life of LPS-injured mice.  Mechanistic studies showed that these inhibitors could release Nrf2 in H9c2 cells and LPS-inflammatory mouse models and translocate into the nucleus in a dose-response manner, which significantly increased the downstream genes (HO-1, NQO-1) and the pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), while ROS prodn. dramatically decreased.  Their protective effects and the mechanism of action were further confirmed by siNrf2 transfected expt.  Collectively, the novel hydronaphthoquinones can be used as promising lead compds. for the study of Keap1-Nrf2 protein-protein interactions and further antimyocarditis drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8LWG_bMTJLVg90H21EOLACvtfcHk0lh2NtG5ZgV7Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVSmtrk%253D&md5=71299d349ff1e7ba6aa29967e9380ebe</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DFragment-growing%2520guided%2520design%2520of%2520Keap1%25E2%2580%2593Nrf2%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%2520for%2520targeting%2520myocarditis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2018%26volume%3D117%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.freeradbiomed.2018.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selzer, P.</span></span> <span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3714</span>– <span class="NLM_lpage">3717</span>, <span class="refDoi"> DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lh2NtG5ZgV7Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rishton, G. M.</span></span> <span> </span><span class="NLM_article-title">Nonleadlikeness and leadlikeness in biochemical screening</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/S1359644602025722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1016%2FS1359644602025722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=12565011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fls1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=86-96&author=G.+M.+Rishton&title=Nonleadlikeness+and+leadlikeness+in+biochemical+screening&doi=10.1016%2FS1359644602025722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Nonleadlikeness and leadlikeness in biochemical screening</span></div><div class="casAuthors">Rishton Gilbert M</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-96</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Biochemical assays have largely supplanted functional biological assays as drug screening tools in the early stages of drug discovery.  The de-selection of compounds that are 'nonleadlike' binders (and bonders) and the proactive selection of those compounds that are 'leadlike' in their binding to the target are vital components of the screening effort.  The physiochemical properties of leadlikeness and the surprising differences between those properties and the now classical definitions of druglikeness are becoming apparent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFoWSt5LTTmsrRqEXsZufAfW6udTcc2eaPuOn1qRHAFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fls1SjtQ%253D%253D&md5=5e34cece6f751fa727f949c3526aa95c</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS1359644602025722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359644602025722%26sid%3Dliteratum%253Aachs%26aulast%3DRishton%26aufirst%3DG.%2BM.%26atitle%3DNonleadlikeness%2520and%2520leadlikeness%2520in%2520biochemical%2520screening%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D86%26epage%3D96%26doi%3D10.1016%2FS1359644602025722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Structural Alerts for Toxicity</span>. In  <i>Burger’s Medicinal Chemistry, Drug Discovery, and Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, D. J.</span>, <span class="NLM_string-name">Rotella, D. P.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">334</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1002%2F0471266949.bmc128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=301-334&author=J.+Blaggauthor=D.+J.+Abraham&author=D.+P.+Rotella&title=Burger%E2%80%99s+Medicinal+Chemistry%2C+Drug+Discovery%2C+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2F0471266949.bmc128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471266949.bmc128%26sid%3Dliteratum%253Aachs%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructural%2520Alerts%2520for%2520Toxicity%26btitle%3DBurger%25E2%2580%2599s%2520Medicinal%2520Chemistry%252C%2520Drug%2520Discovery%252C%2520and%2520Development%26aulast%3DAbraham%26aufirst%3DD.%2BJ.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2010%26spage%3D301%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. D.</span>; <span class="NLM_string-name">Davies, T. G.</span>; <span class="NLM_string-name">Woolford, A. J.</span>; <span class="NLM_string-name">Griffiths-Jones, C. M.</span>; <span class="NLM_string-name">Willems, H. M. G.</span>; <span class="NLM_string-name">Norton, D.</span>; <span class="NLM_string-name">Saxty, G.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Kerns, J. K.</span>; <span class="NLM_string-name">Davies, R. S.</span>; <span class="NLM_string-name">Yan, H.</span></span> <span> </span><span class="NLM_article-title">Nrf2 Regulators</span>. <span class="NLM_patent">WO2015092713</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+D.+Boehm&author=T.+G.+Davies&author=A.+J.+Woolford&author=C.+M.+Griffiths-Jones&author=H.+M.+G.+Willems&author=D.+Norton&author=G.+Saxty&author=T.+Li&author=J.+K.+Kerns&author=R.+S.+Davies&author=H.+Yan&title=Nrf2+Regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DJ.%2BD.%26atitle%3DNrf2%2520Regulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. D.</span></span> <span> </span><span class="NLM_article-title">Metabolic activation and drug toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1021/jm00349a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00349a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=753-765&author=S.+D.+Nelson&title=Metabolic+activation+and+drug+toxicity&doi=10.1021%2Fjm00349a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation and drug toxicity</span></div><div class="casAuthors">Nelson, Sidney D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-65</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review with 128 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzUsG75cxLYLVg90H21EOLACvtfcHk0lg-Ei4VI_RcUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D&md5=89c759fff948a83bb8edebef1c8cdbad</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm00349a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00349a001%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DMetabolic%2520activation%2520and%2520drug%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D753%26epage%3D765%26doi%3D10.1021%2Fjm00349a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanmart, S.</span></span> <span> </span><span class="NLM_article-title">Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00361</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00361" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=497-503&author=M.+Pouliotauthor=S.+Jeanmart&title=Pan+assay+interference+compounds+%28PAINS%29+and+other+promiscuous+compounds+in+antifungal+research&doi=10.1021%2Facs.jmedchem.5b00361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research</span></div><div class="casAuthors">Pouliot, Martin; Jeanmart, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">497-503</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Every week, articles disclosing new antifungal leads reported as promising starting points for optimization projects are published.  In many cases, the mechanism that accounts for their antifungal activity has not been fully elucidated.  More significantly, the detrimental impact that could result from certain embedded chem. features has been underestimated or even overlooked.  In the course of the authors' research in the agrochem. area, the authors have concluded that in many cases such leads are actually nonoptimizable because they either contain what are now recognized as pan assay interference compds. (PAINS) or other promiscuous groups.  This article is aimed at highlighting the pitfalls the authors have encountered and hopefully to steer other research groups away from them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqURFxdfKNQIbVg90H21EOLACvtfcHk0lg-Ei4VI_RcUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE&md5=af11fcafd47de435fcc5fdf05080023a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00361%26sid%3Dliteratum%253Aachs%26aulast%3DPouliot%26aufirst%3DM.%26aulast%3DJeanmart%26aufirst%3DS.%26atitle%3DPan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520and%2520other%2520promiscuous%2520compounds%2520in%2520antifungal%2520research%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D497%26epage%3D503%26doi%3D10.1021%2Facs.jmedchem.5b00361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span> <span> </span><span class="NLM_article-title">PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2091</span>– <span class="NLM_lpage">2113</span>, <span class="refDoi"> DOI: 10.1021/jm5019093</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2091-2113&author=J.+L.+Dahlinauthor=J.+W.+Nissinkauthor=J.+M.+Strasserauthor=S.+Francisauthor=L.+Higginsauthor=H.+Zhouauthor=Z.+Zhangauthor=M.+A.+Walters&title=PAINS+in+the+assay%3A+chemical+mechanisms+of+assay+interference+and+promiscuous+enzymatic+inhibition+observed+during+a+sulfhydryl-scavenging+HTS&doi=10.1021%2Fjm5019093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS</span></div><div class="casAuthors">Dahlin, Jayme L.; Nissink, J. Willem M.; Strasser, Jessica M.; Francis, Subhashree; Higgins, LeeAnn; Zhou, Hui; Zhang, Zhiguo; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2091-2113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant resources in early drug discovery are spent unknowingly pursuing artifacts and promiscuous bioactive compds., while understanding the chem. basis for these adverse behaviors often goes unexplored in pursuit of lead compds.  Nearly all the hits from our recent sulfhydryl-scavenging high-throughput screen (HTS) targeting the histone acetyltransferase Rtt109 were such compds.  Herein, we characterize the chem. basis for assay interference and promiscuous enzymic inhibition for several prominent chemotypes identified by this HTS, including some pan-assay interference compds. (PAINS).  Protein mass spectrometry and ALARM NMR confirmed these compds. react covalently with cysteines on multiple proteins.  Unfortunately, compds. contg. these chemotypes have been published as screening actives in reputable journals and even touted as chem. probes or preclin. candidates.  Our detailed characterization and identification of such thiol-reactive chemotypes should accelerate triage of nuisance compds., guide screening library design, and prevent follow-up on undesirable chem. matter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4XTJapoezkrVg90H21EOLACvtfcHk0lhP4vaGuJys-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeisbY%253D&md5=3f77702544cea2ec4c8184b60dd38b8a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm5019093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019093%26sid%3Dliteratum%253Aachs%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%26aulast%3DStrasser%26aufirst%3DJ.%2BM.%26aulast%3DFrancis%26aufirst%3DS.%26aulast%3DHiggins%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DPAINS%2520in%2520the%2520assay%253A%2520chemical%2520mechanisms%2520of%2520assay%2520interference%2520and%2520promiscuous%2520enzymatic%2520inhibition%2520observed%2520during%2520a%2520sulfhydryl-scavenging%2520HTS%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2091%26epage%3D2113%26doi%3D10.1021%2Fjm5019093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">8238</span>– <span class="NLM_lpage">8259</span>, <span class="refDoi"> DOI: 10.1039/C5CS00252D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1039%2FC5CS00252D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=8238-8259&author=C.+Shengauthor=G.+Dongauthor=Z.+Miaoauthor=W.+Zhangauthor=W.+Wang&title=State-of-the-art+strategies+for+targeting+protein%E2%80%93protein+interactions+by+small-molecule+inhibitors&doi=10.1039%2FC5CS00252D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1039%2FC5CS00252D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00252D%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DState-of-the-art%2520strategies%2520for%2520targeting%2520protein%25E2%2580%2593protein%2520interactions%2520by%2520small-molecule%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D8238%26epage%3D8259%26doi%3D10.1039%2FC5CS00252D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0lhP4vaGuJys-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrd1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=15286733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=660-672&author=D.+C.+Reesauthor=M.+Congreveauthor=C.+W.+Murrayauthor=R.+Carr&title=Fragment-based+lead+discovery&doi=10.1038%2Fnrd1467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery</span></div><div class="casAuthors">Rees, David C.; Congreve, Miles; Murray, Christopher W.; Carr, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery is gaining momentum in both large pharmaceutical companies and biotechnol. labs. as a complementary approach to traditional screening.  This is because fragment-based approaches require significantly fewer compds. to be screened and synthesized, and are showing a high success rate in generating chem. series with lead-like properties.  Compared with traditional screening hits, the starting fragments have considerably lower mol. mass, and although the binding interactions of these fragments with a target protein are weak, they are structurally understood through x-ray crystallog. or NMR, and they exhibit high 'ligand efficiency'.  Here, the authors use examples from 25 different protein targets to describe chem. strategies that exploit this structural knowledge to rapidly develop fragments into high-affinity leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbKeUzFFIlhbVg90H21EOLACvtfcHk0lhP4vaGuJys-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D&md5=8d49ac7f698c9b9d573ee3c3485eced8</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnrd1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1467%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DR.%26atitle%3DFragment-based%2520lead%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D660%26epage%3D672%26doi%3D10.1038%2Fnrd1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based approaches in drug discovery and chemical biology</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4990</span>– <span class="NLM_lpage">5003</span>, <span class="refDoi"> DOI: 10.1021/bi3005126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3005126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4990-5003&author=D.+E.+Scottauthor=A.+G.+Coyneauthor=S.+A.+Hudsonauthor=C.+Abell&title=Fragment-based+approaches+in+drug+discovery+and+chemical+biology&doi=10.1021%2Fbi3005126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Scott, Duncan E.; Coyne, Anthony G.; Hudson, Sean A.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4990-5003</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based approaches to finding novel small mols. that bind to proteins are now firmly established in drug discovery and chem. biol.  Initially developed primarily in a few centers in the biotech and pharma industry, this methodol. has now been adopted widely in both the pharmaceutical industry and academia.  After the initial success with kinase targets, the versatility of this approach has now expanded to a broad range of different protein classes.  Herein we describe recent fragment-based approaches to a wide range of target types, including Hsp90, β-secretase, and allosteric sites in human immunodeficiency virus protease and fanesyl pyrophosphate synthase.  The role of fragment-based approaches in an academic research environment is also examd. with an emphasis on neglected diseases such as tuberculosis.  The development of a fragment library, the fragment screening process, and the subsequent fragment hit elaboration will be discussed using examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2ry6mWC83bVg90H21EOLACvtfcHk0lhbWeJYzwrjNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D&md5=39a6f0f741e711fd572e24c95142f55d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fbi3005126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3005126%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DHudson%26aufirst%3DS.%2BA.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-based%2520approaches%2520in%2520drug%2520discovery%2520and%2520chemical%2520biology%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D4990%26epage%3D5003%26doi%3D10.1021%2Fbi3005126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lhbWeJYzwrjNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lassalas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasfargeas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayendran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Structure property relationships of carboxylic acid isosteres</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3183</span>– <span class="NLM_lpage">3203</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3183-3203&author=P.+Lassalasauthor=B.+Gayauthor=C.+Lasfargeasauthor=M.+J.+Jamesauthor=V.+Tranauthor=K.+G.+Vijayendranauthor=K.+R.+Brundenauthor=M.+C.+Kozlowskiauthor=C.+J.+Thomasauthor=A.+B.+Smithauthor=D.+M.+Hurynauthor=C.+Ballatore&title=Structure+property+relationships+of+carboxylic+acid+isosteres&doi=10.1021%2Facs.jmedchem.5b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Property Relationships of Carboxylic Acid Isosteres</span></div><div class="casAuthors">Lassalas, Pierrik; Gay, Bryant; Lasfargeas, Caroline; James, Michael J.; Tran, Van; Vijayendran, Krishna G.; Brunden, Kurt R.; Kozlowski, Marisa C.; Thomas, Craig J.; Smith, Amos B.; Huryn, Donna M.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3183-3203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of a carboxylic acid with a surrogate structure, or (bio)-isostere, is a classical strategy in medicinal chem.  The general underlying principle is that by maintaining the features of the carboxylic acid crit. for biol. activity, but appropriately modifying the physicochem. properties, improved analogs may result.  In this context, a systematic assessment of the physicochem. properties of carboxylic acid isosteres would be desirable to enable more informed decisions of potential replacements to be used for analog design.  Herein we report the structure-property relationships (SPR) of 35 phenylpropionic acid derivs., in which the carboxylic acid moiety is replaced with a series of known isosteres.  The data set generated provides an assessment of the relative impact on the physicochem. properties that these replacements may have compared to the carboxylic acid analog.  As such, this study presents a framework for how to rationally apply isosteric replacements of the carboxylic acid functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIF98i2ITNrLVg90H21EOLACvtfcHk0lhbWeJYzwrjNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D&md5=34490fc72fdb321d8c9751bef1bf79c5</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01963%26sid%3Dliteratum%253Aachs%26aulast%3DLassalas%26aufirst%3DP.%26aulast%3DGay%26aufirst%3DB.%26aulast%3DLasfargeas%26aufirst%3DC.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DTran%26aufirst%3DV.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DKozlowski%26aufirst%3DM.%2BC.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DStructure%2520property%2520relationships%2520of%2520carboxylic%2520acid%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3183%26epage%3D3203%26doi%3D10.1021%2Facs.jmedchem.5b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalpiaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciliberti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vertuani, S.</span></span> <span> </span><span class="NLM_article-title">Progress in drug delivery to the central nervous system by the prodrug approach</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1065</span>, <span class="refDoi"> DOI: 10.3390/molecules13051035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.3390%2Fmolecules13051035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=1035-1065&author=B.+Pavanauthor=A.+Dalpiazauthor=N.+Cilibertiauthor=C.+Biondiauthor=S.+Manfrediniauthor=S.+Vertuani&title=Progress+in+drug+delivery+to+the+central+nervous+system+by+the+prodrug+approach&doi=10.3390%2Fmolecules13051035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13051035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13051035%26sid%3Dliteratum%253Aachs%26aulast%3DPavan%26aufirst%3DB.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DCiliberti%26aufirst%3DN.%26aulast%3DBiondi%26aufirst%3DC.%26aulast%3DManfredini%26aufirst%3DS.%26aulast%3DVertuani%26aufirst%3DS.%26atitle%3DProgress%2520in%2520drug%2520delivery%2520to%2520the%2520central%2520nervous%2520system%2520by%2520the%2520prodrug%2520approach%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D1035%26epage%3D1065%26doi%3D10.3390%2Fmolecules13051035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gynther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, J.</span></span> <span> </span><span class="NLM_article-title">Prodrug approaches for CNS delivery</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1208/s12248-008-9009-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1208%2Fs12248-008-9009-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=18446509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=92-102&author=J.+Rautioauthor=K.+Laineauthor=M.+Gyntherauthor=J.+Savolainen&title=Prodrug+approaches+for+CNS+delivery&doi=10.1208%2Fs12248-008-9009-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrug approaches for CNS delivery</span></div><div class="casAuthors">Rautio, Jarkko; Laine, Krista; Gynther, Mikko; Savolainen, Jouko</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-102</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Central nervous system (CNS) drug delivery remains a major challenge, despite extensive efforts that have been made to develop novel strategies to overcome obstacles.  Prodrugs are bioreversible derivs. of drug mols. that must undergo an enzymic and/or chem. transformation in vivo to release the active parent drug, which subsequently exerts the desired pharmacol. effect.  In both drug discovery and drug development, prodrugs have become an established tool for improving physicochem., biopharmaceutical or pharmacokinetic properties of pharmacol. active agents that overcome barriers to a drug's usefulness.  This review provides insight into various prodrug strategies explored to date for CNS drug delivery, including lipophilic prodrugs, carrier- and receptor-mediated prodrug delivery systems, and gene-directed enzyme prodrug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSfsvhXux64rVg90H21EOLACvtfcHk0liYutpRaBlQ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLrI&md5=bb800b45fb0c0d7f76b47fb6893a3f1a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1208%2Fs12248-008-9009-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-008-9009-8%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DGynther%26aufirst%3DM.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrug%2520approaches%2520for%2520CNS%2520delivery%26jtitle%3DAAPS%2520J.%26date%3D2008%26volume%3D10%26spage%3D92%26epage%3D102%26doi%3D10.1208%2Fs12248-008-9009-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maag, H.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Carboxylic Acids</span>. In  <i>Prodrugs: Challenges and Rewards</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>, <span class="NLM_string-name">Borchardt, R. T.</span>, <span class="NLM_string-name">Hageman, M. J.</span>, <span class="NLM_string-name">Oliyai, R.</span>, <span class="NLM_string-name">Maag, H.</span>, <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_series">Biotechnology: Pharmaceutical Aspects</span>, Vol.  <span class="NLM_volume">V</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">729</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1007%2F978-0-387-49785-3_20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=703-729&author=H.+Maagauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs%3A+Challenges+and+Rewards"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-49785-3_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-49785-3_20%26sid%3Dliteratum%253Aachs%26aulast%3DMaag%26aufirst%3DH.%26atitle%3DProdrugs%2520of%2520Carboxylic%2520Acids%26btitle%3DProdrugs%253A%2520Challenges%2520and%2520Rewards%26aulast%3DStella%26aufirst%3DV.%2BJ.%26volume%3DV%26pub%3DSpringer%26date%3D2007%26spage%3D703%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span> <span> </span><span class="NLM_article-title">Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer’s disease</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.3109/10611860008997913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.3109%2F10611860008997913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=11328663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVOlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=371-381&author=Y.+Deguchiauthor=H.+Hayashiauthor=S.+Fujiiauthor=T.+Naitoauthor=Y.+Yokoyamaauthor=S.+Yamadaauthor=R.+Kimura&title=Improved+brain+delivery+of+a+nonsteroidal+anti-inflammatory+drug+with+a+synthetic+glyceride+ester%3A+a+preliminary+attempt+at+a+CNS+drug+delivery+system+for+the+therapy+of+Alzheimer%E2%80%99s+disease&doi=10.3109%2F10611860008997913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease</span></div><div class="casAuthors">Deguchi, Yoshiharu; Hayashi, Hideki; Fujii, Shinobu; Naito, Takafumi; Yokoyama, Yoshinari; Yamada, Shizuo; Kimura, Ryohei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">371-381</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">1,3-Diacetyl-2-ketoprofen glyceride (DAKG), a prodrug of ketoprofen, was synthesized as a model compd. in our attempt to develop a central nervous system (CNS) drug delivery system to treat Alzheimer's disease.  The primary purpose of the present study is to test whether DAKG improves the delivery of ketoprofen to the brain and to quant. evaluate several factors that influence the brain distribution of this prodrug.  DdY mice were injected with either ketoprofen or DAKG at a dose of 40 μmol/kg and then the plasma and brain pharmacokinetics of these agents were assessed.  The brain uptake clearance of ketoprofen and DAKG across the BBB was measured by in situ mouse brain perfusion.  In addn., the efflux permeability of ketoprofen through the BBB was evaluated using the in vivo mouse brain microdialysis technique.  The in vivo metab. of DAKG in the brain was assessed by a short infusion into the internal carotid artery coupled with the brain metab. index (BMI) method.  Administration of DAKG produced an approx. 3-fold increase in the area under the brain concn. - time curve of ketoprofen, compared with administration of ketoprofen itself.  The brain uptake clearance (CLin) of ketoprofen across the BBB was 0.0308 ± 0.0046 mL/min/g whereas the CLin of DAKG was 1.60 ± 0.16 mL/min/g, suggesting a marked increase in BBB permeability following lipidization of ketoprofen.  The BMI method confirmed that DAKG is taken up by the brain to rapidly release ketoprofen in a dose-dependent manner.  The in vitro metab. studies revealed that isolated bovine brain capillaries as well as whole brain homogenate have the hydrolysis activity to DAKG.  In addn., the brain concn. of ketoprofen after DAKG administration was maintained for a significant period following co-administration of probenecid.  These results suggest that DAKG improves the delivery of ketoprofen to the brain, and this improved delivery is due to avid uptake of DAKG across the BBB followed by rapid hydrolysis to ketoprofen within the brain.  The ketoprofen produced in the brain was probably cleared by the active efflux system operating in the BBB.  Significant inhibition of this efflux system by co-administration of probenecid could result in a sustained concn. of ketoprofen in the brain following DAKG administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSshGDxzDXuLVg90H21EOLACvtfcHk0liYutpRaBlQ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVOlsLc%253D&md5=54fc943c4423f082e2251baff9f20c87</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3109%2F10611860008997913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611860008997913%26sid%3Dliteratum%253Aachs%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DR.%26atitle%3DImproved%2520brain%2520delivery%2520of%2520a%2520nonsteroidal%2520anti-inflammatory%2520drug%2520with%2520a%2520synthetic%2520glyceride%2520ester%253A%2520a%2520preliminary%2520attempt%2520at%2520a%2520CNS%2520drug%2520delivery%2520system%2520for%2520the%2520therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2000%26volume%3D8%26spage%3D371%26epage%3D381%26doi%3D10.3109%2F10611860008997913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. R.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo investigation of dexibuprofen derivatives for CNS delivery</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/aps.2011.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1038%2Faps.2011.144" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=279-288&author=X.+Zhangauthor=X.+Liuauthor=T.+Gongauthor=X.+Sunauthor=Z.+R.+Zhang&title=In+vitro+and+in+vivo+investigation+of+dexibuprofen+derivatives+for+CNS+delivery&doi=10.1038%2Faps.2011.144"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.144%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%2BR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520investigation%2520of%2520dexibuprofen%2520derivatives%2520for%2520CNS%2520delivery%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2012%26volume%3D33%26spage%3D279%26epage%3D288%26doi%3D10.1038%2Faps.2011.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vestergaard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Round, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastrup, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajhede, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristensen, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundström, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambertsen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strømgaard, K.</span></span> <span> </span><span class="NLM_article-title">A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1–2 and protects against ischemic brain damage</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3317</span>– <span class="NLM_lpage">3322</span>, <span class="refDoi"> DOI: 10.1073/pnas.1113761109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=10.1073%2Fpnas.1113761109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=3317-3322&author=A.+Bachauthor=B.+H.+Clausenauthor=M.+M%C3%B8llerauthor=B.+Vestergaardauthor=C.+N.+Chiauthor=A.+Roundauthor=P.+L.+S%C3%B8rensenauthor=K.+B.+Nissenauthor=J.+S.+Kastrupauthor=M.+Gajhedeauthor=P.+Jemthauthor=A.+S.+Kristensenauthor=P.+Lundstr%C3%B6mauthor=K.+L.+Lambertsenauthor=K.+Str%C3%B8mgaard&title=A+high-affinity%2C+dimeric+inhibitor+of+PSD-95+bivalently+interacts+with+PDZ1%E2%80%932+and+protects+against+ischemic+brain+damage&doi=10.1073%2Fpnas.1113761109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1113761109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1113761109%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DA.%26aulast%3DClausen%26aufirst%3DB.%2BH.%26aulast%3DM%25C3%25B8ller%26aufirst%3DM.%26aulast%3DVestergaard%26aufirst%3DB.%26aulast%3DChi%26aufirst%3DC.%2BN.%26aulast%3DRound%26aufirst%3DA.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DP.%2BL.%26aulast%3DNissen%26aufirst%3DK.%2BB.%26aulast%3DKastrup%26aufirst%3DJ.%2BS.%26aulast%3DGajhede%26aufirst%3DM.%26aulast%3DJemth%26aufirst%3DP.%26aulast%3DKristensen%26aufirst%3DA.%2BS.%26aulast%3DLundstr%25C3%25B6m%26aufirst%3DP.%26aulast%3DLambertsen%26aufirst%3DK.%2BL.%26aulast%3DStr%25C3%25B8mgaard%26aufirst%3DK.%26atitle%3DA%2520high-affinity%252C%2520dimeric%2520inhibitor%2520of%2520PSD-95%2520bivalently%2520interacts%2520with%2520PDZ1%25E2%2580%25932%2520and%2520protects%2520against%2520ischemic%2520brain%2520damage%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D3317%26epage%3D3322%26doi%3D10.1073%2Fpnas.1113761109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia Boy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nothelfer, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leotta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics of cell-penetrating peptides</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2224</span>– <span class="NLM_lpage">2231</span>, <span class="refDoi"> DOI: 10.1021/mp100223d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100223d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gkur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=2224-2231&author=D.+Sarkoauthor=B.+Beijerauthor=R.+Garcia+Boyauthor=E.+M.+Nothelferauthor=K.+Leottaauthor=M.+Eisenhutauthor=A.+Altmannauthor=U.+Haberkornauthor=W.+Mier&title=The+pharmacokinetics+of+cell-penetrating+peptides&doi=10.1021%2Fmp100223d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The Pharmacokinetics of Cell-Penetrating Peptides</span></div><div class="casAuthors">Sarko, Dikran; Beijer, Barbro; Boy, Regine Garcia; Nothelfer, Eva-Maria; Leotta, Karin; Eisenhut, Michael; Altmann, Annette; Haberkorn, Uwe; Mier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2224-2231</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are able to penetrate the cell membrane carrying cargoes such as peptides, proteins, oligonucleotides, siRNAs, radioisotopes, liposomes, and nanoparticles.  Consequently, many delivery approaches have been developed to use CPPs as tools for drug delivery.  However, until now a systematic anal. of their in vivo properties including potential tumor binding specificity for drug targeting purposes has not been conducted.  Ten of the most commonly applied CPPs were obtained by solid phase peptide synthesis and labeled with 111In or 68Ga.  Uptake studies were conducted using a panel of six tumor cell lines of different origin.  The stability of the peptides was examd. in human serum.  Biodistribution expts. were conducted in nude mice bearing human prostate carcinoma.  Finally, positron emission tomog. (PET) measurements were performed in male Wistar rats.  The in vitro uptake studies revealed high cellular uptake values, but no specificity toward any of the cell lines.  The biodistribution in PC-3 tumor-bearing nude mice showed a high transient accumulation in well-perfused organs and a rapid clearance from the blood.  All of the CPPs revealed a relatively low accumulation rate in the brain.  The highest uptake values were obsd. in the liver (with a maximal uptake of 51 %ID/g obsd. for oligoarginine (R9)) and the kidneys (with a maximal uptake of 94 %ID/g obsd. for NLS).  The uptake values in the PC-3 tumor were low at all time points, indicating a lack of tumor specific accumulation for all peptides studied.  A micro-PET imaging study with 68Ga-labeled penetratin, Tat and transportan10 (TP10) confirmed the organ distribution data.  These data reveal that CPPs do not show evidence for application in tumor targeting purposes in vivo.  However, CPPs readily penetrate into most organs and show rapid clearance from the circulation.  The high uptake rates obsd. in vitro and the relatively low specificity in vivo imply that CPPs would be better suited for topical application in combination with cargoes which show passive targeting and dominate the pharmacokinetic behavior.  In conclusion, CPPs are suitable as drug carriers for in vivo application provided that their pharmacokinetic properties are also considered in design of CPP drug delivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqalW7MWeOmobVg90H21EOLACvtfcHk0lgCNHkH52QzaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gkur%252FI&md5=a45b2dc677852994c347fb9c46b75bc5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fmp100223d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100223d%26sid%3Dliteratum%253Aachs%26aulast%3DSarko%26aufirst%3DD.%26aulast%3DBeijer%26aufirst%3DB.%26aulast%3DGarcia%2BBoy%26aufirst%3DR.%26aulast%3DNothelfer%26aufirst%3DE.%2BM.%26aulast%3DLeotta%26aufirst%3DK.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DAltmann%26aufirst%3DA.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DMier%26aufirst%3DW.%26atitle%3DThe%2520pharmacokinetics%2520of%2520cell-penetrating%2520peptides%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D2224%26epage%3D2231%26doi%3D10.1021%2Fmp100223d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FLU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FLU','PDB','2FLU'); return false;">PDB: 2FLU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WN7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WN7','PDB','3WN7'); return false;">PDB: 3WN7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNQ','PDB','5FNQ'); return false;">PDB: 5FNQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZJ','PDB','5FZJ'); return false;">PDB: 5FZJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FZN','PDB','5FZN'); return false;">PDB: 5FZN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FNT','PDB','5FNT'); return false;">PDB: 5FNT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VNH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VNH','PDB','3VNH'); return false;">PDB: 3VNH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VNG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VNG','PDB','3VNG'); return false;">PDB: 3VNG</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00358&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00358%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-18%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00358" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                13MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996c161fc23d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
